3133 genotypes with 6079 annotations displayed
of selected term and subterms
|
Searched Term: abnormal lipid level
|
0610040J01Rikem1(IMPC)Ccpcz/0610040J01Rikem1(IMPC)Ccpcz
(C57BL/6NCrl-0610040J01Rikem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
1700008P02Rikem1(IMPC)J/1700008P02Rikem1(IMPC)J
(C57BL/6NJ-1700008P02Rikem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
2010003K11Rikem1Cya/2010003K11Rikem1Cya
(C57BL/6-2010003K11Rikem1Cya/Cya)
|
increased circulating cholesterol level
|
J:326325
|
increased circulating triglyceride level
|
J:326325
|
increased liver cholesterol level
|
J:326325
|
increased liver triglyceride level
|
J:326325
|
3930402G23Rikem1.1Gonz/3930402G23Rikem1.1Gonz
(C57BL/6J-3930402G23Rikem1.1Gonz)
|
increased liver cholesterol level
|
J:340239
|
increased liver free fatty acids level
|
J:340239
|
increased liver triglyceride level
|
J:340239
|
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Rik+
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
A1cftm1c(EUCOMM)Hmgu/A1cftm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6N * DBA)
|
decreased liver triglyceride level
|
J:281365
|
increased circulating cholesterol level
|
J:281365
|
increased circulating triglyceride level
|
J:281365
|
Ay/a Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
|
increased circulating cholesterol level
|
J:177084
|
increased circulating triglyceride level
|
J:177084
|
Ay/a Apoetm1Unc/Apoetm1Unc Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)
|
increased circulating cholesterol level
|
J:177084
|
Aak1tm1b(EUCOMM)Hmgu/Aak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Aak1tm1b(EUCOMM)Hmgu/Orl)
|
decreased circulating cholesterol level
|
J:211773
|
Abca1m4620Dajl/Abca1+
(involves: C3H/HeSnJ * C57BL/6J * SWR)
|
decreased circulating cholesterol level
|
J:149088
|
decreased circulating HDL cholesterol level
|
J:149088
|
Abca1m4620Dajl/Abca1m4620Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR)
|
decreased circulating cholesterol level
|
J:149088
|
decreased circulating HDL cholesterol level
|
J:149088
|
increased circulating triglyceride level
|
J:149088
|
Abca1mpc227H/Abca1mpc227H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
decreased circulating cholesterol level
|
J:234901
|
Abca1tm1.1Jp/Abca1tm1.1Jp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal circulating phospholipid level
|
J:98093
|
decreased circulating cholesterol level
|
J:98093
|
decreased circulating HDL cholesterol level
|
J:98093
|
Abca1tm1Jdm/Abca1+
(DBA/1LacJ-Abca1tm1Jdm)
|
abnormal circulating phospholipid level
|
J:61679
|
decreased circulating cholesterol level
|
J:61679
|
decreased circulating HDL cholesterol level
|
J:61679
|
decreased circulating LDL cholesterol level
|
J:61679
|
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1LacJ-Abca1tm1Jdm)
|
abnormal circulating phospholipid level
|
J:61679
|
decreased circulating cholesterol level
|
J:60210,
J:61679
|
decreased circulating HDL cholesterol level
|
J:60210,
J:61679
|
decreased circulating LDL cholesterol level
|
J:61679
|
Abca1tm1Jdm/Abca1tm1Jdm
(involves: DBA/1LacJ)
|
decreased circulating HDL cholesterol level
|
J:89906
|
decreased circulating phytosterol level
|
J:87209
|
Abca1tm1Jdm/Abca1tm1Jdm
(involves: C57BL/6 * DBA/1LacJ)
|
decreased circulating cholesterol level
|
J:132254
|
decreased circulating HDL cholesterol level
|
J:132254
|
Abca1tm1Jdm/Abca1tm1Jdm Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6 * DBA/1LacJ)
|
decreased circulating cholesterol level
|
J:132254
|
decreased circulating HDL cholesterol level
|
J:132254
|
Abca1tm1Jp/Abca1+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)
|
abnormal circulating phospholipid level
|
J:98093
|
decreased circulating cholesterol level
|
J:98093
|
decreased circulating HDL cholesterol level
|
J:98093
|
Abca1tm1Jp/Abca1+ Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased circulating cholesterol level
|
J:107802
|
decreased circulating HDL cholesterol level
|
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)
|
abnormal circulating phospholipid level
|
J:98093
|
decreased circulating cholesterol level
|
J:98093
|
decreased circulating HDL cholesterol level
|
J:98093
|
decreased circulating LDL cholesterol level
|
J:98093
|
increased circulating triglyceride level
|
J:98093
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased circulating HDL cholesterol level
|
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA * SJL)
|
decreased circulating HDL cholesterol level
|
J:107802
|
Abca1tm1Jp/Abca1tm1Jp Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased circulating cholesterol level
|
J:107802
|
decreased circulating HDL cholesterol level
|
J:107802
|
decreased circulating LDL cholesterol level
|
J:107802
|
Abca1tm1Wpfl/Abca1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:64390
|
decreased circulating HDL cholesterol level
|
J:64390
|
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:68431,
J:64390
|
decreased circulating HDL cholesterol level
|
J:68431,
J:64390
|
Abca1tm1Wpfl/Abca1tm1Wpfl Npc1m1N/Npc1m1N
(involves: 129P2/OlaHsd * BALB/c)
|
decreased brain cholesterol level
|
J:130969
|
increased cholesterol level
|
J:130969
|
increased liver cholesterol level
|
J:130969
|
increased lung cholesterol level
|
J:130969
|
Abca1tm2Jp/Abca1+ Tg(APOA1)427Bres/?
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal circulating cholesterol level
|
J:104719
|
decreased circulating HDL cholesterol level
|
J:104719
|
decreased circulating phospholipid level
|
J:104719
|
Abca1tm2Jp/Abca1tm2Jp Tg(APOA1)427Bres/?
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal circulating cholesterol level
|
J:104719
|
decreased circulating HDL cholesterol level
|
J:104719
|
decreased circulating phospholipid level
|
J:104719
|
Abca2tm1Nina/Abca2tm1Nina
(involves: 129X1/SvJ * C57BL/6)
|
abnormal lipid level
|
J:123521
|
Abca7tm1Frm/Abca7tm1Frm
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:96865
|
decreased circulating HDL cholesterol level
|
J:96865
|
Abca8btm1a(EUCOMM)Wtsi/Abca8btm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating cholesterol level
|
J:269226
|
decreased circulating HDL cholesterol level
|
J:269226
|
decreased circulating LDL cholesterol level
|
J:269226
|
decreased circulating triglyceride level
|
J:269226
|
Abca12el12/Abca12el12
(involves: 129/Sv * C57BL/6)
|
increased cholesterol level
|
J:161652
|
Abcb1atm1Bor/Abcb1atm1Bor Npc1m1N/Npc1m1N
(involves: 129/Ola * BALB/c)
|
increased liver cholesterol level
|
J:76395
|
Abcb4em1(IMPC)H/Abcb4em1(IMPC)H
(C57BL/6NTac-Abcb4em1(IMPC)H/H)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Abcb4tm1Bor/Abcb4tm1Bor
(involves: 129P2/OlaHsd * FVB/N)
|
decreased circulating cholesterol level
|
J:114411
|
decreased feces bile salt level
|
J:175015
|
increased bile salt level
|
J:175015
|
Abcb4tm1Bor/Abcb4tm1Bor
(FVB.129P2-Abcb4tm1Bor/J)
|
abnormal feces lipid level
|
J:100491
|
Abcb4tm1Bor/Abcb4tm1Bor
(C.129P2-Abcb4tm1Bor)
|
decreased vitamin D level
|
J:199949
|
Abcb4tm1Bor/Abcb4tm1Bor Pemttm1J/Pemttm1J
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased bile salt level
|
J:175015
|
increased feces bile salt level
|
J:175015
|
Abcb4tm1Bor/Abcb4tm1Bor Portm1Wolf/Portm1Wolf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N)
|
increased bile salt level
|
J:215915
|
Abcb11tm1b(EUCOMM)Hmgu/Abcb11+
(C57BL/6N-Abcb11tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Abcb11tm1Wng/Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal bile salt level
|
J:67548
|
abnormal phospholipid level
|
J:67548
|
increased bile salt level
|
J:67548
|
increased cholesterol level
|
J:67548
|
Abcc2tm1Dgen/Abcc2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:134950
|
Abcc2tm2b(KOMP)Wtsi/Abcc2tm2b(KOMP)Wtsi
(C57BL/6N-Abcc2tm2b(KOMP)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Abcc3tm1Kruh/Abcc3tm1Kruh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal bile salt level
|
J:114229
|
Abcc4Gt(RRC212)Byg/Abcc4Gt(RRC212)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prostaglandin level
|
J:139829
|
Abcc6tm1Aabb/Abcc6tm1Aabb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:105062
|
Abcd1tm1Kan/Y
(involves: 129 * BALB/cJ * C57BL/6J * Swiss)
|
increased fatty acids level
|
J:257393
|
Abcd1tm1Kan/Y Gt(ROSA)26Sortm2.1(CAG-ELOVL1)Geno/Gt(ROSA)26Sor+ Cnptm1(cre)Kan/Cnp+
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased fatty acids level
|
J:257393
|
Abcd1tm1Kan/Y Gt(ROSA)26Sortm2.1(CAG-ELOVL1)Geno/Gt(ROSA)26Sor+ Tg(CMV-cre)1Cgn/0
(involves: 129 * BALB/cJ * C57BL/6J * Swiss)
|
increased fatty acids level
|
J:257393
|
Abcd1tm1Kds/Y
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
|
increased saturated fatty acids level
|
J:42479
|
Abcd1tm1Kds/Y
(involves: 129S4/SvJae * C57BL/6J)
|
increased fatty acids level
|
J:94583
|
Abcd1tm1Kds/Y Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
increased fatty acids level
|
J:94583,
J:104122
|
Abcd1tm1Kds/Abcd1tm1Kds
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
|
increased saturated fatty acids level
|
J:42479
|
Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased fatty acids level
|
J:94583,
J:104122
|
Abcd3em1(IMPC)J/Abcd3em1(IMPC)J
(C57BL/6NJ-Abcd3em1(IMPC)J/J)
|
decreased circulating triglyceride level
|
J:211773
|
Abcg1tm1Dgen/Abcg1+ Abcg4tm1Dgen/Abcg4tm1Dgen
(involves: 129P2/OlaHsd)
|
abnormal lipid level
|
J:141549
|
Abcg1tm1Dgen/Abcg1tm1Dgen
(B6.129P2-Abcg1tm1Dgen)
|
abnormal phospholipid level
|
J:117028
|
increased liver cholesterol level
|
J:117028
|
increased liver triglyceride level
|
J:117028
|
increased lung cholesterol level
|
J:117028
|
increased triglyceride level
|
J:117028
|
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
lipidosis
|
J:132952
|
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd)
|
abnormal lipid level
|
J:141549
|
Abcg1tm1Dgen/Abcg1tm1Dgen Abcg4tm1Dgen/Abcg4+
(involves: 129P2/OlaHsd)
|
abnormal lipid level
|
J:141549
|
Abcg1tm1Dgen/Abcg1tm1Dgen Abcg4tm1Dgen/Abcg4tm1Dgen
(involves: 129P2/OlaHsd)
|
abnormal lipid level
|
J:141549
|
Abcg2tm1.1(KOMP)Vlcg/Abcg2tm1.1(KOMP)Vlcg
(B6N(Cg)-Abcg2tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Abcg4tm1Dgen/Abcg4tm1Dgen
(Not Specified)
|
abnormal lipid level
|
J:141549
|
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb Abcg8tm1.1Hobb/Abcg8tm1.1Hobb Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: C57BL/6 * DBA * SJL)
|
abnormal phytosterol level
|
J:215443
|
decreased circulating cholesterol level
|
J:215443
|
decreased phytosterol level
|
J:215443
|
increased cholesterol level
|
J:215443
|
increased circulating phytosterol level
|
J:215443
|
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb Abcg8tm1.1Hobb/Abcg8tm1.1Hobb Tg(CAG-cre/Esr1*)5Amc/?
(involves: C57BL/6 * CBA * SJL)
|
abnormal phytosterol level
|
J:215443
|
decreased cholesterol level
|
J:215443
|
decreased circulating cholesterol level
|
J:215443
|
decreased phytosterol level
|
J:215443
|
increased circulating phytosterol level
|
J:215443
|
increased phytosterol level
|
J:215443
|
Abcg5tm1.1Hobb/Abcg5tm1.1Hobb Abcg8tm1.1Hobb/Abcg8tm1.1Hobb Tg(Vil1-cre)997Gum/?
(involves: C57BL/6 * SJL)
|
increased circulating phytosterol level
|
J:215443
|
increased phytosterol level
|
J:215443
|
Abcg5tm1Plo/Abcg5tm1Plo
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal phospholipid level
|
J:87209
|
decreased cholesterol level
|
J:87209
|
decreased circulating cholesterol level
|
J:87209
|
increased circulating phytosterol level
|
J:87209
|
increased circulating triglyceride level
|
J:87209
|
increased circulating VLDL triglyceride level
|
J:87209
|
Abcg5trac/Abcg5trac
(A/J-Abcg5trac)
|
abnormal circulating cholesterol level
|
J:157223
|
abnormal circulating lipid level
|
J:157223
|
Abcg8tm1b(KOMP)Wtsi/Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Abcg8tm1Elk/Abcg8+
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:94759
|
Abcg8tm1Elk/Abcg8tm1Elk
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased cholesterol level
|
J:94759
|
decreased circulating cholesterol level
|
J:94759
|
increased circulating free fatty acids level
|
J:192806
|
increased circulating phytosterol level
|
J:94759
|
increased circulating triglyceride level
|
J:94759
|
Abhd5tm1.1Lqyu/Abhd5tm1.1Lqyu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal lipid level
|
J:199570
|
abnormal phospholipid level
|
J:199570
|
increased liver cholesterol level
|
J:199570
|
increased liver free fatty acids level
|
J:199570
|
increased liver triglyceride level
|
J:199570
|
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lipid level
|
J:160725
|
decreased circulating triglyceride level
|
J:160725
|
decreased fatty acids level
|
J:160725
|
increased liver triglyceride level
|
J:160725
|
increased triglyceride level
|
J:160725
|
Abhd5tm1Murm/Abhd5tm1Murm
(B6.129S-Abhd5tm1Murm)
|
abnormal ceramide level
|
J:240682
|
increased triglyceride level
|
J:240682
|
Abhd5tm1Rze/Abhd5tm1Rze Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased circulating free fatty acids level
|
J:197835
|
decreased circulating triglyceride level
|
J:197835
|
decreased liver triglyceride level
|
J:197835
|
increased cardiac muscle triglyceride level
|
J:197835
|
increased skeletal muscle triglyceride level
|
J:197835
|
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
|
abnormal lipid level
|
J:215257
|
decreased liver triglyceride level
|
J:234876
|
Abhd8tm1b(EUCOMM)Wtsi/Abhd8tm1b(EUCOMM)Wtsi
(C57BL/6N-Abhd8tm1b(EUCOMM)Wtsi/Bay)
|
decreased circulating cholesterol level
|
J:211773
|
Abhd11tm1Esco/Abhd11tm1Esco
(involves: C57BL/6)
|
abnormal feces lipid level
|
J:294591
|
Abhd12tm1Crv/Abhd12tm1Crv
(involves: C57BL/6)
|
abnormal phospholipid level
|
J:193716
|
Abhd14atm2a(EUCOMM)Wtsi/Abhd14atm2a(EUCOMM)Wtsi
(C57BL/6N-Abhd14atm2a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Abhd16atm1a(EUCOMM)Wtsi/Abhd16atm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
abnormal phospholipid level
|
J:232688
|
Acacatm1Jkus/Acacatm1Jkus Tg(Fabp1-cre)1Mmt/0
(involves: 129X1/SvJ * C57BL/6J * SJL)
|
decreased liver triglyceride level
|
J:118861
|
Acacatm2Sjw/Acacatm2Sjw Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S7/SvEvBrd * C57BL/6J * FVB)
|
abnormal lipid level
|
J:110200
|
decreased circulating free fatty acids level
|
J:110200
|
decreased fatty acids level
|
J:110200
|
decreased liver triglyceride level
|
J:110200
|
increased circulating free fatty acids level
|
J:110200
|
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified)
|
decreased circulating free fatty acids level
|
J:68427
|
decreased fatty acids level
|
J:68427
|
decreased liver triglyceride level
|
J:68427
|
increased circulating triglyceride level
|
J:68427
|
Acadltm1Uab/Acadltm1Uab
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
increased circulating free fatty acids level
|
J:51660
|
increased fatty acids level
|
J:72193
|
increased unsaturated fatty acids level
|
J:51660
|
lipidosis
|
J:51660
|
Acadsdel-J/Acadsdel-J
(involves: BALB/cByJ)
|
increased circulating HDL cholesterol level
|
J:164460
|
AcadsHdlq8-C57BL/6J/AcadsHdlq8-C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
|
decreased circulating HDL cholesterol level
|
J:84430
|
AcadsHdlq8-NZB/BlNJ/AcadsHdlq8-NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ)
|
increased circulating HDL cholesterol level
|
J:84430
|
Acbd3tm1b(EUCOMM)Hmgu/Acbd3+
(C57BL/6N-Acbd3tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Acbd5tm1a(EUCOMM)Wtsi/Acbd5tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Acbd5tm1a(EUCOMM)Wtsi/WtsiCnbc)
|
abnormal ether lipid level
|
J:299448
|
abnormal glycerol level
|
J:299448
|
increased fatty acids level
|
J:299448
|
Acbd5tm1b(EUCOMM)Wtsi/Acbd5tm1b(EUCOMM)Wtsi
(C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating triglyceride level
|
J:211773
|
Acdacd/Acdacd
(DW/J-Acdacd Pou1f1+)
|
abnormal corticosterone level
|
J:18027
|
decreased circulating corticosterone level
|
J:18027
|
Acer1tm1a(EUCOMM)Wtsi/Acer1tm1a(EUCOMM)Wtsi
(C57BL/6N-Acer1tm1a(EUCOMM)Wtsi)
|
abnormal ceramide level
|
J:235775
|
abnormal lipid level
|
J:235775
|
abnormal sphingomyelin level
|
J:235775
|
decreased sphingosine level
|
J:235775
|
Acer2em1Mvw/Acer2em1Mvw
(C57BL/6J-Acer2em1Mvw/MvwJ)
|
abnormal sphingolipid level
|
J:256650
|
Acer3tm1Cmao/Acer3tm1Cmao
(B6.129S6-Acer3tm1Cmao/Cmao)
|
abnormal ceramide level
|
J:228886
|
abnormal sphingolipid level
|
J:228886
|
abnormal sphingomyelin level
|
J:228886
|
increased sphingosine level
|
J:228886
|
Acot5tm1a(KOMP)Wtsi/Acot5tm1a(KOMP)Wtsi
(C57BL/6N-Acot5tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Acot7tm1.1Mwol/Acot7tm1.1Mwol Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal circulating lipid level
|
J:203753
|
abnormal phospholipid level
|
J:203753
|
increased circulating free fatty acids level
|
J:203753
|
increased circulating triglyceride level
|
J:203753
|
increased fatty acids level
|
J:203753
|
increased liver triglyceride level
|
J:203753
|
increased triglyceride level
|
J:203753
|
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating cholesterol level
|
J:182660
|
decreased circulating HDL cholesterol level
|
J:182660
|
increased circulating triglyceride level
|
J:182660
|
increased fatty acids level
|
J:182660
|
Acot12em1Holi/Acot12em1Holi
(involves: C57BL/6J * C57BL/6N)
|
abnormal phospholipid level
|
J:335836
|
increased circulating cholesterol level
|
J:335836
|
increased circulating phospholipid level
|
J:335836
|
increased liver cholesterol level
|
J:335836
|
increased liver triglyceride level
|
J:335836
|
Acot13tm1Deco/Acot13tm1Deco
(involves: 129 * C57BL/6)
|
abnormal feces lipid level
|
J:183258
|
abnormal lipid level
|
J:183258
|
decreased circulating free fatty acids level
|
J:183258
|
decreased liver cholesterol level
|
J:183258
|
decreased liver triglyceride level
|
J:183258
|
Acox1tm1Jkr/Acox1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6J)
|
hyperlipidemia
|
J:35794
|
Acsbg1tm1Mld/Acsbg1tm1Mld
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased fatty acids level
|
J:150391
|
increased fatty acids level
|
J:150391
|
Acsl1tm1Rcol/Acsl1tm1Rcol Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glycerol level
|
J:162996
|
hyperlipidemia
|
J:162996
|
increased circulating free fatty acids level
|
J:162996
|
increased circulating triglyceride level
|
J:162996
|
increased fatty acids level
|
J:162996
|
increased triglyceride level
|
J:162996
|
Acsl4tm1Tty/Acsl4+
(involves: C57BL/6NCrj * CBA/JNCrj)
|
increased prostaglandin level
|
J:70023
|
Acsl5tm1.1(KOMP)Vlcg/Acsl5tm1.1(KOMP)Vlcg
(C57BL/6N-Acsl5tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Acss1tm1Jsak/Acss1tm1Jsak
(B6.129-Acss1tm1Jsak/Jsak)
|
abnormal circulating free fatty acids level
|
J:146647
|
Actbtm3.1(Sirt1)Npa/Actb+
(involves: 129/Sv * C57BL/6 * C57BL/6J)
|
decreased circulating cholesterol level
|
J:160212
|
decreased circulating free fatty acids level
|
J:160212
|
decreased circulating HDL cholesterol level
|
J:160212
|
decreased circulating LDL cholesterol level
|
J:160212
|
Actr6tm1a(EUCOMM)Wtsi/Actr6+
(C57BL/6N-Actr6tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating glycerol level
|
J:211773
|
Adamts7tm1a(KOMP)Wtsi/Adamts7tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal triglyceride level
|
J:230573
|
Adamts16em1(IMPC)H/Adamts16em1(IMPC)H
(C57BL/6N-Adamts16em1(IMPC)H/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Adck2tm1(KOMP)Vlcg/Adck2+
(C57BL/6-Adck2tm1(KOMP)Vlcg)
|
decreased circulating free fatty acids level
|
J:280282
|
decreased glycerol level
|
J:280282
|
increased fatty acids level
|
J:280282
|
increased liver free fatty acids level
|
J:280282
|
Adcy2tm1a(KOMP)Wtsi/Adcy2tm1a(KOMP)Wtsi
(C57BL/6N-Adcy2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:211773
|
Adcy3tm2.1Drs/Adcy3tm2.1Drs Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * 129X1/SvJ * C57BL/6)
|
increased circulating corticosterone level
|
J:281839
|
Adcy8tm1Ljm/Adcy8tm1Ljm
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal corticosterone level
|
J:63173
|
Adcy10tm1Lex/Adcy10tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:103485
|
increased triglyceride level
|
J:103485
|
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6))
|
increased circulating cholesterol level
|
J:71968
|
increased circulating corticosterone level
|
J:71968
|
increased circulating free fatty acids level
|
J:71968
|
increased circulating triglyceride level
|
J:71968
|
Adgrf5tm1.1Bstc/Adgrf5tm1.2Bstc Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
abnormal lipid level
|
J:196943
|
increased cholesterol level
|
J:196943
|
Adgrf5tm1.2Bstc/Adgrf5tm1.2Bstc
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal phospholipid level
|
J:196943
|
increased lung cholesterol level
|
J:196943
|
Adgrf5tm1b(KOMP)Wtsi/Adgrf5tm1b(KOMP)Wtsi
(C57BL/6N-Adgrf5tm1b(KOMP)Wtsi/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
Adgrg6tm1Taki/Adgrg6tm1Taki
(involves: C57BL/6)
|
increased cardiac muscle triglyceride level
|
J:202002
|
Adip1LG/J/? Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x LG/J)F1)
|
decreased circulating cholesterol level
|
J:153477
|
decreased circulating free fatty acids level
|
J:153477
|
decreased circulating triglyceride level
|
J:153477
|
Adip1SM/J/? Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x SM/J)F1)
|
decreased circulating cholesterol level
|
J:153477
|
decreased circulating free fatty acids level
|
J:153477
|
decreased circulating triglyceride level
|
J:153477
|
Adipoqtm1Far/Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
increased liver triglyceride level
|
J:111346
|
Adipoqtm1Far/Adipoqtm1Far Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
decreased liver cholesterol level
|
J:111346
|
decreased liver triglyceride level
|
J:111346
|
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal lipid level
|
J:77479
|
increased circulating free fatty acids level
|
J:77479
|
Adipoqtm1Tka/Adipoqtm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating triglyceride level
|
J:77876
|
Adipor1tm1b(EUCOMM)Hmgu/Adipor1tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor1tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Adipor1tm1b(EUCOMM)Hmgu/Adipor1tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor1tm1b(EUCOMM)Hmgu/Orl)
|
increased circulating triglyceride level
|
J:211773
|
Adipor1tm1Dgen/Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc)
|
increased circulating cholesterol level
|
J:122027
|
increased liver triglyceride level
|
J:122027
|
Adipor1tm1Tka/Adipor1tm1Tka Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6)
|
increased liver triglyceride level
|
J:117919
|
Adipor1tm2Tka/Adipor1tm2Tka Tg(Ckmm-cre)5Khn/0
(B6.Cg-Adipor1tm2Tka Tg(Ckmm-cre)5Khn)
|
increased skeletal muscle triglyceride level
|
J:159462
|
Adipor2tm1Dgen/Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen)
|
decreased circulating cholesterol level
|
J:122027
|
decreased circulating HDL cholesterol level
|
J:122027
|
decreased liver triglyceride level
|
J:122027
|
Adipor2tm2Dgen/Adipor2tm2Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:129554
|
decreased circulating HDL cholesterol level
|
J:129554
|
decreased circulating LDL cholesterol level
|
J:129554
|
decreased circulating triglyceride level
|
J:129554
|
decreased circulating VLDL cholesterol level
|
J:129554
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating free fatty acids level
|
J:87718
|
Adss2tm1b(EUCOMM)Wtsi/Adss2+
(C57BL/6N-Adss2tm1b(EUCOMM)Wtsi/Bay)
|
increased circulating HDL cholesterol level
|
J:211773
|
Adtrpem1Sagh/Adtrpem1Sagh
(involves: C57BL/6)
|
increased fatty acids level
|
J:289837
|
Adtrpem1Sagh/Adtrpem1Sagh Aig1em1Sagh/Aig1em1Sagh
(involves: C57BL/6)
|
increased fatty acids level
|
J:289837
|
Aebp1tm1Hsro/Aebp1tm1Hsro
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating cholesterol level
|
J:125333
|
decreased circulating triglyceride level
|
J:125333
|
Agap2tm1Kye/Agap2tm1Kye Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA/2)
|
decreased circulating triglyceride level
|
J:174775
|
decreased liver cholesterol level
|
J:174775
|
decreased liver free fatty acids level
|
J:174775
|
decreased liver triglyceride level
|
J:174775
|
Agltm1b(EUCOMM)Wtsi/Agltm1b(EUCOMM)Wtsi
(C57BL/6N-Agltm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
Agmotm2a(EUCOMM)Wtsi/Agmotm2a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased circulating cholesterol level
|
J:308367
|
Agmotm2a(EUCOMM)Wtsi/Agmotm2a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal ether lipid level
|
J:333103
|
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac)
|
abnormal fatty acids level
|
J:146649
|
abnormal phospholipid level
|
J:146649
|
decreased circulating free fatty acids level
|
J:146649
|
increased circulating cholesterol level
|
J:231617
|
increased circulating triglyceride level
|
J:146649
|
increased liver triglyceride level
|
J:231617,
J:146649
|
Agpat2tm1Garg/Agpat2tm1Garg Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
increased liver triglyceride level
|
J:231617
|
Agpat3tm1a(EUCOMM)Wtsi/Agpat3tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal phospholipid level
|
J:245638
|
Agpat3tm1a(EUCOMM)Wtsi/Agpat3tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal phospholipid level
|
J:246569
|
Agpat4tm1Lex/Agpat4tm1Lex
(B6;129S5-Agpat4tm1Lex/Mmucd)
|
abnormal phospholipid level
|
J:231388
|
Agpsbs2/Agpsbs2
(STOCK Agpsbs2/J)
|
abnormal lipid level
|
J:171265
|
Agrptm1Dgen/Agrptm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating VLDL triglyceride level
|
J:199803
|
decreased liver triglyceride level
|
J:199803
|
Agrptm1Mws/Agrptm1Mws
(B6.129S1-Agrptm1Mws)
|
decreased cholesterol level
|
J:117539
|
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA)
|
decreased circulating aldosterone level
|
J:46506
|
Agtr2tm1a(EUCOMM)Wtsi/Agtr2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Agtr2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal corticosterone level
|
J:102984
|
increased circulating corticosterone level
|
J:102984
|
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd)
|
abnormal skeletal muscle triglyceride level
|
J:105210
|
Agtr2tm1Tin/Agtr2tm1Tin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal corticosterone level
|
J:102984
|
increased circulating corticosterone level
|
J:102984
|
Agtraptm1Tamk/Agtraptm1Tamk
(involves: C57BL/6N)
|
increased circulating free fatty acids level
|
J:263253
|
increased circulating triglyceride level
|
J:263253
|
Ahrrtm1b(KOMP)Wtsi/Ahrr+
(B6N(Cg)-Ahrrtm1b(KOMP)Wtsi/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ahsgtm1Mbl/Ahsgtm1Mbl
(B6.129-Ahsgtm1Mbl)
|
decreased circulating free fatty acids level
|
J:78087
|
decreased circulating triglyceride level
|
J:78087
|
Aidatm1.1Scli/Aidatm1.1Scli
(involves: C57BL/6 * FVB/N)
|
increased circulating triglyceride level
|
J:262001
|
increased triglyceride level
|
J:262001
|
Aifm3em1(IMPC)Rbrc/Aifm3em1(IMPC)Rbrc
(C57BL/6NJcl-Aifm3em1(IMPC)Rbrc/Rbrc)
|
abnormal circulating LDL cholesterol level
|
J:211773
|
Ak4em1(IMPC)Kmpc/Ak4em1(IMPC)Kmpc
(C57BL/6NTac-Ak4em1(IMPC)Kmpc/Kmpc)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Akap9tm1a(KOMP)Wtsi/Akap9+
(B6JTyr;B6N-Akap9tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Akap9tm1a(KOMP)Wtsi/Akap9+
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating cholesterol level
|
J:213427
|
decreased circulating HDL cholesterol level
|
J:213427
|
decreased circulating LDL cholesterol level
|
J:213427
|
Akp3tm1Jlm/Akp3tm1Jlm
(involves: 129S2/SvPas * C57BL/6)
|
abnormal lipid level
|
J:86263
|
increased circulating triglyceride level
|
J:86263
|
Akr1b7tm1.1Anm/Akr1b7tm1.1Anm
(involves: 129)
|
increased circulating glycerol level
|
J:208505
|
increased circulating triglyceride level
|
J:208505
|
increased liver triglyceride level
|
J:208505
|
Akt1tm2.1Mbb/Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
|
decreased liver triglyceride level
|
J:182721
|
Akt2tm1.1Mbb/Akt2+ Lepob/Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb)
|
decreased liver triglyceride level
|
J:155432
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd)
|
decreased liver triglyceride level
|
J:160759
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(B6.129P2-Akt2tm1.1Mbb)
|
decreased liver triglyceride level
|
J:155432
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb Lepob/Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb)
|
decreased circulating cholesterol level
|
J:155432
|
decreased liver triglyceride level
|
J:155432
|
Akt2tm1.2Mbb/Akt2tm1.2Mbb Lepob/Lepob Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL)
|
decreased liver triglyceride level
|
J:155432
|
Akt2tm1.2Mbb/Akt2tm1.2Mbb Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL)
|
decreased liver triglyceride level
|
J:155432
|
Aladem1(IMPC)Tcp/Alad+
(C57BL/6NCrl-Aladem1(IMPC)Tcp/Cmmr)
|
increased circulating triglyceride level
|
J:211773
|
Albtm1(cre/ERT2)Mtz/Alb+ Nr5a2tm1Sjns/Nr5a2tm1Sjns
(involves: 129/Sv * 129S2/SvPas * C57BL/6 * SJL)
|
abnormal bile salt level
|
J:129068
|
abnormal feces lipid level
|
J:129068
|
increased feces bile salt level
|
J:129068
|
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz Slc2a2tm2Thor/Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal bile salt level
|
J:197607
|
decreased liver cholesterol level
|
J:197607
|
decreased liver triglyceride level
|
J:197607
|
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating HDL cholesterol level
|
J:165965
|
decreased circulating LDL cholesterol level
|
J:165965
|
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
(C57BL/6N-Aldh2tm1a(EUCOMM)Wtsi/Ieg)
|
increased circulating free fatty acids level
|
J:165965
|
Aldh3a2tm1a(EUCOMM)Wtsi/Aldh3a2tm1a(EUCOMM)Wtsi Aldh3b2em1Akih/Aldh3b2em1Akih
(involves: C57BL/6J * C57BL/6N)
|
abnormal triglyceride level
|
J:330263
|
decreased ceramide level
|
J:330263
|
Aldh3a2tm1b(EUCOMM)Wtsi/Aldh3a2tm1b(EUCOMM)Wtsi
(involves: C57BL * C57BL/6J * C57BL/6N * DBA)
|
abnormal phospholipid level
|
J:234695
|
Aldoctm1.1(KOMP)Vlcg/Aldoctm1.1(KOMP)Vlcg
(C57BL/6N-Aldoctm1.1(KOMP)Vlcg)
|
decreased circulating cholesterol level
|
J:346664
|
decreased circulating HDL cholesterol level
|
J:346664
|
decreased circulating triglyceride level
|
J:346664
|
increased circulating triglyceride level
|
J:346664
|
Aldoctm1.1(KOMP)Vlcg/Aldoctm1.1(KOMP)Vlcg Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N)
|
decreased circulating cholesterol level
|
J:346664
|
decreased circulating LDL cholesterol level
|
J:346664
|
decreased circulating triglyceride level
|
J:346664
|
decreased liver cholesterol level
|
J:346664
|
decreased liver triglyceride level
|
J:346664
|
Alg8em1(IMPC)J/Alg8+
(C57BL/6NJ-Alg8em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating cholesterol level
|
J:100403
|
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD)
|
abnormal circulating cholesterol level
|
J:118221
|
increased circulating HDL cholesterol level
|
J:118221
|
increased circulating triglyceride level
|
J:118221
|
Alox5tm1Bhk/Alox5tm1Bhk
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
|
abnormal thromboxane level
|
J:68714
|
decreased leukotriene level
|
J:68714
|
increased prostaglandin level
|
J:68714
|
Alox5tm1Fun/Alox5tm1Fun
(B6.129S2-Alox5tm1Fun/J)
|
increased circulating VLDL cholesterol level
|
J:104825
|
Alox5aptm1Bhk/Alox5aptm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv)
|
abnormal thromboxane level
|
J:39229
|
decreased leukotriene level
|
J:39229
|
increased prostaglandin level
|
J:39229
|
Alox5aptm1Jdm/Alox5ap+
(DBA/1LacJ-Alox5aptm1Jdm)
|
decreased leukotriene level
|
J:100736
|
Alox5aptm1Jdm/Alox5aptm1Jdm
(DBA/1LacJ-Alox5aptm1Jdm)
|
abnormal leukotriene level
|
J:100736
|
abnormal prostaglandin level
|
J:100736
|
Alox12btm1.1Krie/Alox12btm1.1Krie
(involves: 129P2/OlaHsd)
|
abnormal lipid level
|
J:196489
|
Aloxe3tm1.2Krie/Aloxe3tm1.2Krie
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
abnormal lipid level
|
J:196489
|
Amacrtm1Jkh/Amacrtm1Jkh
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal circulating cholesterol level
|
J:90370
|
decreased fatty acids level
|
J:90370
|
decreased triglyceride level
|
J:90370
|
increased fatty acids level
|
J:90370
|
Ampd2m4521Dajl/Ampd2m4521Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR)
|
increased circulating cholesterol level
|
J:149088
|
increased circulating LDL cholesterol level
|
J:149088
|
increased circulating triglyceride level
|
J:149088
|
Ampd2tm1b(EUCOMM)Hmgu/Ampd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ampd2tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Anapc15tm1.1(KOMP)Vlcg/Anapc15+
(B6N(Cg)-Anapc15tm1.1(KOMP)Vlcg/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Angptl3hypl/Angptl3hypl
(involves: KK/Snk)
|
decreased circulating cholesterol level
|
J:75358
|
decreased circulating free fatty acids level
|
J:75358
|
decreased circulating HDL cholesterol level
|
J:75358
|
decreased circulating LDL cholesterol level
|
J:75358
|
decreased circulating triglyceride level
|
J:75358
|
decreased circulating VLDL cholesterol level
|
J:75358
|
decreased triglyceride level
|
J:75358
|
Angptl3tm1Akos/Angptl3tm1Akos
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:103363
|
decreased circulating triglyceride level
|
J:103363
|
Angptl3tm1Akos/Angptl3tm1Akos Angptl4tm1Akos/Angptl4tm1Akos
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:103363
|
decreased circulating triglyceride level
|
J:103363
|
Angptl3tm1Kfuj/Angptl3tm1Kfuj
(B6.129S1-Angptl3tm1Kfuj)
|
decreased circulating cholesterol level
|
J:107479
|
decreased circulating free fatty acids level
|
J:107479
|
decreased circulating triglyceride level
|
J:107479
|
decreased circulating VLDL cholesterol level
|
J:107479
|
Angptl3tm1Lex/Angptl3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating triglyceride level
|
J:149912
|
Angptl3tm1Lex/Angptl3tm1Lex Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:149912
|
decreased circulating triglyceride level
|
J:149912
|
Angptl3tm1Lex/Angptl3tm1Lex Ldlrtm1Her/Ldlrtm1Her
(involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:149912
|
decreased circulating triglyceride level
|
J:149912
|
Angptl3tm2b(KOMP)Wtsi/Angptl3tm2b(KOMP)Wtsi
(C57BL/6N-Angptl3tm2b(KOMP)Wtsi/Ccpcz)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Angptl4Gt(OST352973)Lex/Angptl4Gt(OST352973)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:122968
|
decreased circulating VLDL cholesterol level
|
J:122968
|
decreased triglyceride level
|
J:122968
|
Angptl4tm1Akos/Angptl4tm1Akos
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:103363
|
decreased circulating triglyceride level
|
J:103363
|
Angptl4tm1b(EUCOMM)Hmgu/Angptl4tm1b(EUCOMM)Hmgu
(C57BL/6N-Angptl4tm1b(EUCOMM)Hmgu/H)
|
decreased circulating triglyceride level
|
J:211773
|
Angptl4tm1Lex/Angptl4+
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating triglyceride level
|
J:149912
|
Angptl4tm1Lex/Angptl4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:122968
|
decreased circulating triglyceride level
|
J:149912
|
decreased circulating VLDL cholesterol level
|
J:122968
|
decreased triglyceride level
|
J:122968
|
Angptl4tm2Lex/Angptl4tm2Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased triglyceride level
|
J:149912
|
Angptl6tm1Yo/Angptl6tm1Yo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating cholesterol level
|
J:97552
|
increased circulating free fatty acids level
|
J:97552
|
Angptl8tm1(KOMP)Vlcg/Angptl8+
(involves: C57BL/6NTac)
|
decreased circulating triglyceride level
|
J:217262
|
Angptl8tm1(KOMP)Vlcg/Angptl8tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating triglyceride level
|
J:217262
|
decreased circulating VLDL triglyceride level
|
J:217262
|
decreased fatty acids level
|
J:217262
|
Angptl8tm1Lex/Angptl8tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating triglyceride level
|
J:161922,
J:187261
|
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J)
|
increased circulating free fatty acids level
|
J:222913
|
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J)
|
increased circulating free fatty acids level
|
J:222913
|
Ankrd11tm1b(EUCOMM)Wtsi/Ankrd11+
(C57BL/6N-Ankrd11tm1b(EUCOMM)Wtsi/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ankrd26Gt(XK525)Byg/Ankrd26Gt(XK525)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating free fatty acids level
|
J:130984
|
increased circulating triglyceride level
|
J:130984
|
Ano1tm2Jrr/Ano1tm2Jrr Tg(Cdh16-cre)91Igr/0
(involves: 129S6/SvEvTac * ICR)
|
increased circulating aldosterone level
|
J:210158
|
Ano8em1(IMPC)J/Ano8em1(IMPC)J
(C57BL/6NJ-Ano8em1(IMPC)J/J)
|
increased circulating cholesterol level
|
J:211773
|
Anp32btm1Mak/Anp32btm1Mak
(C.129P2(B6)-Anp32btm1Mak)
|
decreased circulating cholesterol level
|
J:227403
|
decreased circulating HDL cholesterol level
|
J:227403
|
anx/anx
(B6C3Fe a/a-anx/J)
|
increased circulating cholesterol level
|
J:7689
|
Ap1m2tm1.1Ohno/Ap1m2tm1.1Ohno
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
increased circulating cholesterol level
|
J:226582
|
Ap2a2em1(IMPC)Wtsi/Ap2a2+
(C57BL/6N-Ap2a2em1(IMPC)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Ap2a2tm1b(EUCOMM)Wtsi/Ap2a2+
(C57BL/6N-Ap2a2tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Ap2a2tm1b(EUCOMM)Wtsi/Ap2a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ap2a2tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Ap4e1em1(IMPC)J/Ap4e1+
(C57BL/6NJ-Ap4e1em1(IMPC)J/J)
|
increased circulating free fatty acids level
|
J:211773
|
Ap4e1em1(IMPC)J/Ap4e1em1(IMPC)J
(C57BL/6NJ-Ap4e1em1(IMPC)J/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Ap4m1tm1b(EUCOMM)Wtsi/Ap4m1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ap4m1tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
ApcMin/Apc+
(involves: AKR/J * C57BL/6J)
|
hyperlipidemia
|
J:10209
|
ApcMin/Apc+
(C57BL/6J-ApcMin)
|
increased circulating free fatty acids level
|
J:86036
|
increased circulating triglyceride level
|
J:86036
|
increased prostaglandin level
|
J:85142
|
ApcMin/Apc+ Hsd11b2tm1.1Mzz/Hsd11b2tm1.1Mzz Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
abnormal corticosterone level
|
J:205456
|
ApcMin/Apc+ Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased prostaglandin level
|
J:64401
|
ApcMin/Apc+ Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased prostaglandin level
|
J:64401
|
Apctm2Rak/Apc+ Trp53tm1Brn/Trp53tm1Brn Tg(Pdx1-cre)6Tuv/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
|
increased circulating cholesterol level
|
J:234310
|
increased circulating triglyceride level
|
J:234310
|
Apctm2Tno/Apc+
(involves: C57BL/6J)
|
hyperlipidemia
|
J:86036
|
increased circulating cholesterol level
|
J:86036
|
increased circulating free fatty acids level
|
J:86036
|
increased circulating triglyceride level
|
J:86036
|
Apmapem1(IMPC)J/Apmapem1(IMPC)J
(C57BL/6NJ-Apmapem1(IMPC)J/Mmjax)
|
increased circulating HDL cholesterol level
|
J:211773
|
Apoa1tm1(APOA1)Prli/Apoa1tm2(APOA1)Prli
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:81908
|
Apoa1tm1Bres/Apoa1+
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:40819
|
Apoa1tm1Bres/Apoa1tm1Bres
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:40819
|
decreased circulating HDL cholesterol level
|
J:40819
|
decreased circulating LDL cholesterol level
|
J:40819
|
decreased circulating VLDL cholesterol level
|
J:40819
|
increased circulating triglyceride level
|
J:40819
|
Apoa1tm1Bres/Apoa1tm1Bres Apoa2tm1Bres/Apoa2tm1Bres
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:40819
|
Apoa1tm1Bres/Apoa1tm1Bres Tg(Mt1-CETP)#Tall/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
decreased circulating HDL cholesterol level
|
J:40819
|
Apoa1tm1Unc/Apoa1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:2109
|
decreased circulating HDL cholesterol level
|
J:2109
|
Apoa1tm1Unc/Apoa1+
(B6.129P2-Apoa1tm1Unc)
|
decreased circulating cholesterol level
|
J:22986
|
Apoa1tm1Unc/Apoa1tm1Unc
(B6.129P2-Apoa1tm1Unc/J)
|
decreased circulating cholesterol level
|
J:114205
|
decreased circulating HDL cholesterol level
|
J:114205
|
decreased circulating phospholipid level
|
J:114205
|
increased circulating cholesterol level
|
J:114205
|
increased circulating triglyceride level
|
J:114205
|
Apoa1tm1Unc/Apoa1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:2109
|
decreased circulating HDL cholesterol level
|
J:2109
|
Apoa1tm1Unc/Apoa1tm1Unc
(B6.129P2-Apoa1tm1Unc)
|
decreased circulating cholesterol level
|
J:22986
|
Apoa1tm1Unc/Apoa1tm1Unc
(involves: 129P2/OlaHsd)
|
decreased circulating cholesterol level
|
J:129136
|
decreased circulating HDL cholesterol level
|
J:129136
|
decreased circulating phospholipid level
|
J:129136
|
Apoa1tm1Unc/Apoa1tm1Unc Ldlrtm1Her/Ldlrtm1Her
(B6.129-Ldlrtm1Her Apoa1tm1Unc)
|
decreased cholesterol level
|
J:85174
|
decreased circulating cholesterol level
|
J:85174
|
decreased circulating HDL cholesterol level
|
J:85174
|
decreased circulating LDL cholesterol level
|
J:85174
|
decreased circulating VLDL cholesterol level
|
J:85174
|
decreased liver cholesterol level
|
J:85174
|
increased circulating triglyceride level
|
J:85174
|
Apoa1tm1Unc/Apoa1tm1Unc Tg(APOA1)1Rub/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:129136
|
increased circulating HDL cholesterol level
|
J:129136
|
increased circulating triglyceride level
|
J:129136
|
Apoa1tm1Unc/Apoa1tm1Unc Tg(APOA2)3Rub/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:129136
|
increased circulating triglyceride level
|
J:129136
|
Apoa1tm2(APOA1)Prli/Apoa1tm2(APOA1)Prli
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:81908
|
decreased circulating HDL cholesterol level
|
J:81908
|
Apoa2b/?
(involves: KK * RR)
|
increased circulating cholesterol level
|
J:99474
|
Apoa2tm1Bres/Apoa2+ Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased circulating cholesterol level
|
J:37250
|
Apoa2tm1Bres/Apoa2tm1Bres
(involves: 129S4/SvJae)
|
decreased circulating cholesterol level
|
J:37250
|
decreased circulating free fatty acids level
|
J:37250
|
decreased circulating HDL cholesterol level
|
J:37250
|
Apoa2tm1Bres/Apoa2tm1Bres Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased circulating cholesterol level
|
J:37250
|
decreased circulating HDL cholesterol level
|
J:37250
|
Apoa4tm1Bres/Apoa4tm1Bres
(either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))
|
decreased circulating cholesterol level
|
J:43015
|
decreased circulating HDL cholesterol level
|
J:43015
|
decreased circulating triglyceride level
|
J:43015
|
decreased circulating VLDL triglyceride level
|
J:43015
|
Apoa5tm1Hgc/Apoa5+
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating VLDL cholesterol level
|
J:72092
|
Apoa5tm1Hgc/Apoa5tm1Hgc
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating triglyceride level
|
J:72092
|
increased circulating VLDL cholesterol level
|
J:72092
|
Apobtm1.1Zc/Apob+
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating LDL cholesterol level
|
J:65191
|
decreased circulating VLDL cholesterol level
|
J:65191
|
Apobtm1.1Zc/Apobtm1.1Zc
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:65191
|
decreased circulating LDL cholesterol level
|
J:65191
|
decreased circulating triglyceride level
|
J:65191
|
decreased circulating VLDL cholesterol level
|
J:65191
|
Apobtm1Mae/Apob+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal triglyceride level
|
J:113171
|
decreased circulating cholesterol level
|
J:113171
|
Apobtm1Mae/Apobtm1Mae
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating HDL cholesterol level
|
J:36426
|
decreased circulating cholesterol level
|
J:36426
|
decreased circulating LDL cholesterol level
|
J:36426
|
decreased circulating VLDL cholesterol level
|
J:36426
|
Apobtm1Sgy/Apobtm1Sgy
(involves: 129/Sv * C57BL/6)
|
decreased circulating LDL cholesterol level
|
J:33830
|
decreased circulating triglyceride level
|
J:33830
|
Apobtm1Sgy/Apobtm1Sgy Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:41510
|
increased circulating triglyceride level
|
J:41510
|
increased circulating VLDL cholesterol level
|
J:41510
|
Apobtm1Unc/Apob+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:16352
|
decreased circulating HDL cholesterol level
|
J:16352
|
decreased circulating triglyceride level
|
J:16352
|
Apobtm1Unc/Apobtm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:16352
|
decreased circulating HDL cholesterol level
|
J:16352
|
decreased circulating triglyceride level
|
J:16352
|
Apobtm1Zc/Apob+
(involves: 129/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:76047
|
decreased circulating HDL cholesterol level
|
J:76047
|
decreased circulating LDL cholesterol level
|
J:76047
|
decreased circulating triglyceride level
|
J:76047
|
decreased circulating VLDL cholesterol level
|
J:76047
|
Apobtm1Zc/Apobtm1.1Zc
(involves: 129/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:76047
|
decreased circulating HDL cholesterol level
|
J:76047
|
decreased circulating LDL cholesterol level
|
J:76047
|
decreased circulating triglyceride level
|
J:76047
|
decreased circulating VLDL cholesterol level
|
J:76047
|
Apobtm1Zc/Apobtm1Zc
(involves: 129/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:76047
|
decreased circulating triglyceride level
|
J:76047
|
Apobtm2Sgy/Apobtm2Sgy
(involves: 129/Sv * C57BL/6)
|
increased circulating LDL cholesterol level
|
J:33830
|
increased circulating triglyceride level
|
J:33830
|
Apobtm2Sgy/Apobtm2Sgy Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:41510
|
increased circulating HDL cholesterol level
|
J:41510
|
increased circulating triglyceride level
|
J:41510
|
increased circulating VLDL cholesterol level
|
J:41510
|
increased circulating VLDL triglyceride level
|
J:41510
|
Apobtm2Sgy/Apobtm2Sgy Apoetm1Unc/Apoetm1Unc Lepob/Lepob
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:133453
|
decreased circulating HDL cholesterol level
|
J:133453
|
increased circulating cholesterol level
|
J:133453
|
increased circulating free fatty acids level
|
J:133453
|
increased circulating triglyceride level
|
J:133453
|
increased circulating VLDL cholesterol level
|
J:133453
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:227165
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:133453
|
decreased circulating HDL cholesterol level
|
J:133453
|
increased circulating cholesterol level
|
J:133453
|
increased circulating free fatty acids level
|
J:133453
|
increased circulating LDL cholesterol level
|
J:133453
|
increased circulating triglyceride level
|
J:133453
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
increased circulating cholesterol level
|
J:227165
|
Apobtm2Sgy/Apobtm4Sgy
(involves: 129/Sv * 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:46549
|
Apobtm3Sgy/Apob+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:23315
|
decreased circulating HDL cholesterol level
|
J:23315
|
Apobtm5Sgy/Apobtm5Sgy
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating LDL cholesterol level
|
J:51549
|
decreased circulating VLDL cholesterol level
|
J:51549
|
Apobec1tm1Chan/Apobec1tm1Chan
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:36051
|
Apobec1tm1Chan/Apobec1tm1Chan Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal circulating cholesterol level
|
J:48202
|
decreased circulating cholesterol level
|
J:48202
|
increased circulating cholesterol level
|
J:48202
|
increased circulating triglyceride level
|
J:48202
|
Apobec1tm1Chan/Apobec1tm1Chan Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal circulating cholesterol level
|
J:48202
|
decreased circulating triglyceride level
|
J:48202
|
increased circulating cholesterol level
|
J:48202
|
increased circulating triglyceride level
|
J:48202
|
Apobec1tm1Chan/Apobec1tm1Chan Tg(CETP)5203Tall/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
abnormal circulating cholesterol level
|
J:48202
|
decreased circulating HDL cholesterol level
|
J:48202
|
decreased circulating triglyceride level
|
J:48202
|
increased circulating cholesterol level
|
J:48202
|
increased circulating triglyceride level
|
J:48202
|
Apobec1tm1Ddsn/Apobec1tm1Ddsn
(B6.129S4-Apobec1tm1Ddsn)
|
abnormal triglyceride level
|
J:108052
|
Apobec1tm1Ddsn/Apobec1tm1Ddsn Fggtm1Fjc/Fggtm1Fjc Ldlrtm1Her/Ldlrtm1Her
(B6.129-Fggtm1Fjc Apobec1tm1Ddsn Ldlrtm1Her)
|
increased circulating LDL cholesterol level
|
J:132734
|
Apobec1tm1Ddsn/Apobec1tm1Ddsn Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:49125
|
increased circulating LDL cholesterol level
|
J:49125
|
increased circulating triglyceride level
|
J:49125
|
Apobec1tm1Ddsn/Apobec1tm1Ddsn Ldlrtm1Her/Ldlrtm1Her
(B6.129-Apobec1tm1Ddsn Ldlrtm1Her)
|
increased circulating LDL cholesterol level
|
J:132734
|
Apobec1tm1Ishi/Apobec1tm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:41982
|
increased cholesterol level
|
J:41982
|
Apobec1tm1Ishi/Apobec1tm1Ishi Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:41982
|
increased circulating triglyceride level
|
J:41982
|
Apobec1tm1Rub/Apobec1tm1Rub
(involves: C57BL/6 * DBA)
|
decreased circulating HDL cholesterol level
|
J:74021
|
increased circulating LDL cholesterol level
|
J:74021
|
Apobec1tm1Rub/Apobec1tm1Rub Apoetm1(APOE*2)Mae/Apoetm1(APOE*2)Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:79196
|
decreased circulating LDL cholesterol level
|
J:79196
|
increased circulating HDL cholesterol level
|
J:79196
|
increased circulating triglyceride level
|
J:79196
|
increased circulating VLDL triglyceride level
|
J:79196
|
Apoc1tm1Lmh/Apoc1tm1Lmh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:22858
|
abnormal lipid level
|
J:117482
|
increased cholesterol level
|
J:117482
|
increased circulating cholesterol level
|
J:22858
|
increased circulating triglyceride level
|
J:22858
|
increased liver triglyceride level
|
J:117482
|
Apoc1tm1Lmh/Apoc1tm1Lmh Tg(CETP)5203Tall/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA/J)
|
abnormal lipid level
|
J:117482
|
abnormal phospholipid level
|
J:117482
|
increased bile salt level
|
J:117482
|
increased cholesterol level
|
J:117482
|
increased liver triglyceride level
|
J:117482
|
Apoc1tm2Lmh/Apoc1tm2Lmh Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:28261
|
Apoc2em1Arem/Apoc2+
(involves: C57BL/6 * FVB/NJ)
|
increased circulating HDL cholesterol level
|
J:227332
|
increased circulating triglyceride level
|
J:227332
|
increased circulating VLDL triglyceride level
|
J:227332
|
Apoc2em1Arem/Apoc2em1Arem
(involves: C57BL/6 * FVB/NJ)
|
abnormal circulating cholesterol level
|
J:227332
|
decreased circulating HDL cholesterol level
|
J:227332
|
increased circulating triglyceride level
|
J:227332
|
increased circulating VLDL triglyceride level
|
J:227332
|
Apoc2em2Arem/Apoc2+
(involves: C57BL/6 * CBA)
|
increased circulating HDL cholesterol level
|
J:227332
|
increased circulating triglyceride level
|
J:227332
|
increased circulating VLDL triglyceride level
|
J:227332
|
Apoc2em2Arem/Apoc2em2Arem
(involves: C57BL/6 * CBA)
|
abnormal circulating cholesterol level
|
J:227332
|
decreased circulating HDL cholesterol level
|
J:227332
|
increased circulating triglyceride level
|
J:227332
|
increased circulating VLDL triglyceride level
|
J:227332
|
Apoc3tm1Unc/Apoc3+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:21750
|
decreased circulating HDL cholesterol level
|
J:21750
|
decreased circulating triglyceride level
|
J:21750
|
Apoc3tm1Unc/Apoc3+
(involves: 129)
|
decreased circulating cholesterol level
|
J:21750
|
decreased circulating LDL cholesterol level
|
J:21750
|
decreased circulating triglyceride level
|
J:21750
|
decreased circulating VLDL cholesterol level
|
J:21750
|
Apoc3tm1Unc/Apoc3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:21750
|
decreased circulating HDL cholesterol level
|
J:21750
|
decreased circulating LDL cholesterol level
|
J:21750
|
decreased circulating triglyceride level
|
J:21750
|
decreased circulating VLDL cholesterol level
|
J:21750
|
Apoc3tm1Unc/Apoc3tm1Unc
(involves: 129)
|
decreased circulating cholesterol level
|
J:21750
|
decreased circulating LDL cholesterol level
|
J:21750
|
decreased circulating triglyceride level
|
J:21750
|
decreased circulating VLDL cholesterol level
|
J:21750
|
Apoc3tm1Unc/Apoc3tm1Unc
(B6.129-Apoc3tm1Unc/J)
|
decreased circulating triglyceride level
|
J:105136
|
lipidosis
|
J:105136
|
Apoc4tm1.1(KOMP)Mbp/Apoc4tm1.1(KOMP)Mbp
(C57BL/6N-Apoc4tm1.1(KOMP)Mbp/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Apoeshl/Apoeshl
(KOR-Apoeshl)
|
increased circulating cholesterol level
|
J:75488
|
Apoeshl/Apoeshl
(C3.KOR-Apoeshl)
|
increased circulating cholesterol level
|
J:75488
|
Apoeshl/Apoeshl
(C.KOR-Apoeshl)
|
increased circulating cholesterol level
|
J:75488
|
Apoeshl/Apoeshl
(B6.KOR-Apoeshl)
|
increased circulating cholesterol level
|
J:75488
|
Apoeshl/Apoeshl
(involves: C3H/He * KOR)
|
increased circulating cholesterol level
|
J:54051
|
Apoeshl/Apoeshl
(involves: BALB/c * KOR)
|
increased circulating cholesterol level
|
J:54051
|
Apoeshl/Apoeshl
(involves: C57BL/6 * KOR)
|
increased circulating cholesterol level
|
J:54051
|
Apoeshl/Apoetm1Unc
(involves: 129P2/OlaHsd * KOR)
|
increased circulating cholesterol level
|
J:54051
|
ApoeTg(rtTA)1Gaga/ApoeTg(rtTA)1Gaga
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating cholesterol level
|
J:136987
|
ApoeTg(rtTA)1Gaga/ApoeTg(rtTA)1Gaga Igs7tm1(tetO-Apoe)Gaga/0
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating cholesterol level
|
J:136987
|
Apoetm1(APOE*2)Mae/Apoetm1(APOE*2)Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lipid level
|
J:67282,
J:48565
|
hyperlipidemia
|
J:48565
|
increased circulating cholesterol level
|
J:67282,
J:48565
|
increased circulating triglyceride level
|
J:67282,
J:48565
|
Apoetm1(APOE_i4)Sfu/Apoetm1(APOE_i4)Sfu
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal phospholipid level
|
J:60590
|
decreased brain cholesterol level
|
J:60590
|
increased circulating cholesterol level
|
J:60590
|
increased circulating LDL cholesterol level
|
J:60590
|
increased circulating VLDL cholesterol level
|
J:60590
|
Apoetm1(APOE_i4)Sfu/Apoetm1(APOE_i4)Sfu
(involves: 129P2/OlaHsd)
|
abnormal circulating cholesterol level
|
J:104859
|
Apoetm1.1Mae/Apoetm1.1Mae Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev)
|
decreased cardiac muscle triglyceride level
|
J:219838
|
decreased cholesterol level
|
J:219838
|
decreased circulating cholesterol level
|
J:219838
|
decreased circulating triglyceride level
|
J:219838
|
decreased liver cholesterol level
|
J:219838
|
decreased liver triglyceride level
|
J:219838
|
decreased skeletal muscle triglyceride level
|
J:219838
|
decreased triglyceride level
|
J:219838
|
increased cholesterol level
|
J:219838
|
Apoetm1Bres/Apoe+
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6J))
|
increased circulating cholesterol level
|
J:2809
|
Apoetm1Bres/Apoetm1Bres
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6J))
|
abnormal circulating LDL cholesterol level
|
J:2809
|
increased circulating cholesterol level
|
J:2809,
J:42426
|
increased circulating VLDL cholesterol level
|
J:2809
|
increased triglyceride level
|
J:2809
|
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6 * NIH Black Swiss)
|
decreased circulating HDL cholesterol level
|
J:42927
|
increased circulating cholesterol level
|
J:42927
|
increased circulating triglyceride level
|
J:42927
|
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:29950
|
Apoetm1Bres/Apoetm1Bres
(B6.129P2-Apoetm1Bres)
|
abnormal circulating cholesterol level
|
J:68574
|
Apoetm1Bres/Apoetm1Bres Esr1tm1Ksk/Esr1tm1Ksk
(B6.129P2-Apoetm1Bres Esr1tm1Ksk)
|
abnormal circulating cholesterol level
|
J:68574
|
Apoetm1Bres/Apoetm1Bres Fn1tm1Bwg/Fn1tm1Bwg
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating VLDL cholesterol level
|
J:90917
|
Apoetm1Bres/Apoetm1Bres Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:40921
|
increased circulating phospholipid level
|
J:40921
|
Apoetm1Bres/Apoetm1Bres Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * C57BL/6 * NIH Black Swiss)
|
decreased circulating HDL cholesterol level
|
J:42927
|
Apoetm1Khw/Apoetm1Khw
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating cholesterol level
|
J:75681
|
increased circulating LDL cholesterol level
|
J:75681
|
increased circulating triglyceride level
|
J:75681
|
increased circulating VLDL cholesterol level
|
J:75681
|
Apoetm1Khw/Apoetm1Khw Tg(Mx1-cre)29-4Her/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:75681
|
increased circulating LDL cholesterol level
|
J:75681
|
increased circulating triglyceride level
|
J:75681
|
increased circulating VLDL cholesterol level
|
J:75681
|
Apoetm1Khw/Apoetm1Khw Tg(Mx1-cre)29-4Her/0
(B6.Cg-Apoetm1Khw Tg(Mx1-cre)29-4Her)
|
abnormal circulating lipid level
|
J:196923
|
hyperlipidemia
|
J:196923
|
increased circulating cholesterol level
|
J:196923
|
increased circulating VLDL cholesterol level
|
J:196923
|
Apoetm1Lmh/Apoe+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:22347
|
increased circulating HDL cholesterol level
|
J:22347
|
increased circulating VLDL cholesterol level
|
J:22347
|
Apoetm1Lmh/Apoetm1Lmh
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:22347
|
increased circulating HDL cholesterol level
|
J:22347
|
increased circulating VLDL cholesterol level
|
J:22347
|
Apoetm1Lmh/Apoetm1Lmh Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:117317
|
increased circulating HDL cholesterol level
|
J:117317
|
increased circulating LDL cholesterol level
|
J:117317
|
increased circulating triglyceride level
|
J:117317
|
Apoetm1Lmh/Apoetm1Lmh Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:90547
|
decreased circulating LDL cholesterol level
|
J:90547
|
decreased circulating triglyceride level
|
J:90547
|
decreased circulating VLDL cholesterol level
|
J:90547
|
increased circulating cholesterol level
|
J:117317
|
increased circulating HDL cholesterol level
|
J:117317
|
increased circulating LDL cholesterol level
|
J:117317
|
increased circulating triglyceride level
|
J:117317
|
Apoetm1Rraf/Apoetm1Rraf Tg(Mx1-cre)29-4Her/0
(B6.Cg-Apoetm1Rraf Tg(Mx1-cre)29-4Her)
|
abnormal circulating cholesterol level
|
J:196923
|
decreased circulating VLDL cholesterol level
|
J:196923
|
hyperlipidemia
|
J:196923
|
increased circulating cholesterol level
|
J:196923
|
Apoetm1Unc/Apoe+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating triglyceride level
|
J:16573
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
abnormal circulating cholesterol level
|
J:73202
|
decreased circulating HDL cholesterol level
|
J:91058
|
decreased circulating triglyceride level
|
J:93987
|
hyperlipidemia
|
J:101576
|
increased circulating cholesterol level
|
J:104609,
J:97385,
J:125978,
J:91058,
J:101576,
J:73202,
J:133606
|
increased circulating HDL cholesterol level
|
J:226403
|
increased circulating LDL cholesterol level
|
J:91058,
J:101576,
J:93987
|
increased circulating triglyceride level
|
J:91058,
J:101576,
J:73202
|
increased circulating VLDL cholesterol level
|
J:91058,
J:101576,
J:93987
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:16573
|
hyperlipidemia
|
J:80689
|
increased circulating cholesterol level
|
J:40136,
J:41510,
J:16573,
J:80689
|
increased circulating LDL cholesterol level
|
J:16573
|
increased circulating triglyceride level
|
J:16573,
J:80689
|
increased circulating VLDL cholesterol level
|
J:41510,
J:16573
|
increased prostaglandin level
|
J:125376
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd)
|
abnormal circulating cholesterol level
|
J:48202
|
increased circulating cholesterol level
|
J:48202
|
increased circulating corticosterone level
|
J:101973
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc)
|
abnormal lipid level
|
J:125366
|
increased circulating cholesterol level
|
J:61287
|
Apoetm1Unc/Apoetm1Unc
(B6.Cg-Apoetm1Unc Faslpr)
|
increased circulating cholesterol level
|
J:133606
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
decreased circulating HDL cholesterol level
|
J:75567
|
increased circulating cholesterol level
|
J:75567
|
increased circulating phospholipid level
|
J:75567
|
Apoetm1Unc/Apoetm1Unc Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * C57BL/6N)
|
decreased circulating cholesterol level
|
J:338121
|
increased circulating triglyceride level
|
J:338121
|
Apoetm1Unc/Apoetm1Unc Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * SJL)
|
increased circulating cholesterol level
|
J:101788
|
increased circulating LDL cholesterol level
|
J:101788
|
increased circulating triglyceride level
|
J:101788
|
increased circulating VLDL cholesterol level
|
J:101788
|
Apoetm1Unc/Apoetm1Unc Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal lipid level
|
J:61672
|
decreased circulating triglyceride level
|
J:61672
|
increased cholesterol level
|
J:61672
|
Apoetm1Unc/Apoetm1Unc Crptm1Hjf/Crptm1Hjf
(B6.Cg-Crptm1Hjf Apoetm1Unc)
|
decreased circulating HDL cholesterol level
|
J:170409
|
decreased circulating triglyceride level
|
J:170409
|
increased circulating HDL cholesterol level
|
J:170409
|
Apoetm1Unc/Apoetm1Unc Csf1op/Csf1op
(involves: 129P2/OlaHsd * C3HeB/Fe * C57BL/6)
|
increased circulating cholesterol level
|
J:40136
|
Apoetm1Unc/Apoetm1Unc Cyp4f13Gt(OST14770)Lex/Cyp4f13Gt(OST14770)Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)
|
decreased cholesterol level
|
J:289999
|
Apoetm1Unc/Apoetm1Unc Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:184647
|
increased circulating cholesterol level
|
J:184647
|
increased circulating LDL cholesterol level
|
J:184647
|
increased circulating triglyceride level
|
J:184647
|
increased circulating VLDL cholesterol level
|
J:184647
|
Apoetm1Unc/Apoetm1Unc Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Apoetm1Unc)
|
decreased circulating cholesterol level
|
J:102223
|
decreased circulating triglyceride level
|
J:102223
|
Apoetm1Unc/Apoetm1Unc Faslpr/Faslpr
(MRL.Cg-Apoetm1Unc Faslpr)
|
increased circulating cholesterol level
|
J:133606
|
Apoetm1Unc/Apoetm1Unc Faslpr/Faslpr
(B6.Cg-Apoetm1Unc Faslpr)
|
decreased circulating cholesterol level
|
J:121671
|
Apoetm1Unc/Apoetm1Unc Faslgld/Faslgld
(B6.Cg-Faslgld Apoetm1Unc)
|
decreased circulating HDL cholesterol level
|
J:91058
|
increased circulating cholesterol level
|
J:200141,
J:91058
|
increased circulating LDL cholesterol level
|
J:91058
|
increased circulating triglyceride level
|
J:91058
|
increased circulating VLDL cholesterol level
|
J:91058
|
Apoetm1Unc/Apoetm1Unc Hdl5C57BL/6J/Hdl5C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Hdlq19C57BL/6J/Hdlq19C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Hdlq86C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:129301
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
increased triglyceride level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Hdlq86C3H/HeJ/Hdlq86C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:129301
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
increased triglyceride level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Hdlq91C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Hsd11b1tm1Lex/Hsd11b1tm1Lex
(B6.129-Hsd11b1tm1Lex Apoetm1Unc)
|
decreased cholesterol level
|
J:199430
|
hyperlipidemia
|
J:199430
|
Apoetm1Unc/Apoetm1Unc Il1rntm1Dih/Il1rntm1Dih
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
decreased circulating cholesterol level
|
J:132570
|
Apoetm1Unc/Apoetm1Unc Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:105858
|
decreased circulating VLDL cholesterol level
|
J:105858
|
increased circulating LDL cholesterol level
|
J:105858
|
Apoetm1Unc/Apoetm1Unc Klf15tm1Jain/Klf15tm1Jain
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
increased circulating cholesterol level
|
J:203920
|
increased circulating triglyceride level
|
J:203920
|
Apoetm1Unc/Apoetm1Unc Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased circulating cholesterol level
|
J:59491
|
Apoetm1Unc/Apoetm1Unc Lgals3tm1Poi/Lgals3tm1Poi
(involves: 129/Sv * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:130923
|
Apoetm1Unc/Apoetm1Unc Lipgtm1Tq/Lipgtm1Tq
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
increased circulating cholesterol level
|
J:93987
|
increased circulating HDL cholesterol level
|
J:93987
|
increased circulating LDL cholesterol level
|
J:93987
|
increased circulating phospholipid level
|
J:93987
|
increased circulating triglyceride level
|
J:93987
|
increased circulating VLDL cholesterol level
|
J:93987
|
Apoetm1Unc/Apoetm1Unc Lpltm1Sem/Lpltm1Sem
(involves: 129P2/OlaHsd)
|
abnormal circulating cholesterol level
|
J:151434
|
abnormal circulating lipid level
|
J:151434
|
hyperlipidemia
|
J:151434
|
increased circulating cholesterol level
|
J:151434
|
increased circulating triglyceride level
|
J:151434
|
Apoetm1Unc/Apoetm1Unc Msr1tm1Csk/Msr1tm1Csk
(either: (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J * ICR) or (involves: 129P2/OlaHsd * 129X1/SvJ * 129/Sv * ICR))
|
increased circulating cholesterol level
|
J:39079
|
Apoetm1Unc/Apoetm1Unc Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating triglyceride level
|
J:143903
|
Apoetm1Unc/Apoetm1Unc Nhdlq11C3H/HeJ/Nhdlq11C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
increased triglyceride level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Nhdlq11C3H/HeJ/Nhdlq11C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
increased triglyceride level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Nhdlq12C3H/HeJ/Nhdlq12C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Nhdlq12C57BL/6J/Nhdlq12C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased cholesterol level
|
J:64566
|
Apoetm1Unc/Apoetm1Unc Npc1m1N/Npc1m1N
(involves: 129P2/OlaHsd * BALB/c)
|
increased circulating VLDL cholesterol level
|
J:104996
|
Apoetm1Unc/Apoetm1Unc Pik3cgtm1Dwu/Pik3cgtm1Dwu
(B6.Cg-Apoetm1Unc Pik3cgtm1Dwu)
|
decreased circulating cholesterol level
|
J:121582
|
Apoetm1Unc/Apoetm1Unc Pla2g15tm1Ytan/Pla2g15tm1Ytan
(involves: 129S/SvEv * B6.129P2-Apoetm1Unc/J)
|
increased circulating cholesterol level
|
J:97471
|
Apoetm1Unc/Apoetm1Unc Pnhdlc1C57BL/6J/Pnhdlc1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Pnhdlc6C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:129301
|
increased circulating VLDL cholesterol level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Ptgdrtm1Dgen/Ptgdrtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cholesterol level
|
J:192168
|
increased circulating cholesterol level
|
J:192168
|
increased circulating triglyceride level
|
J:192168
|
Apoetm1Unc/Apoetm1Unc Rag2tm1Fwa/Rag2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased circulating cholesterol level
|
J:59156
|
decreased circulating HDL cholesterol level
|
J:59156
|
Apoetm1Unc/Apoetm1Unc Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased circulating cholesterol level
|
J:59156
|
decreased circulating HDL cholesterol level
|
J:59156
|
Apoetm1Unc/Apoetm1Unc Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129-Serpine1tm1Mlg Apoetm1Unc)
|
increased circulating cholesterol level
|
J:61287
|
Apoetm1Unc/Apoetm1Unc Smarcd1tm1.1Jddl/Smarcd1tm1.1Jddl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:228944
|
Apoetm1Unc/Apoetm1Unc Soat1tm1Far/Soat1tm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
abnormal cholesterol level
|
J:61147
|
decreased circulating cholesterol level
|
J:61147
|
decreased circulating VLDL cholesterol level
|
J:61147
|
Apoetm1Unc/Apoetm1Unc Soat2tm1Far/Soat2tm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
decreased circulating cholesterol level
|
J:81836
|
increased circulating HDL cholesterol level
|
J:81836
|
increased circulating triglyceride level
|
J:81836
|
Apoetm1Unc/Apoetm1Unc Spp1tm1Rit/Spp1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:103051
|
increased circulating triglyceride level
|
J:103051
|
Apoetm1Unc/Apoetm1Unc Spp1tm1Rit/Spp1tm1Rit
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:103051
|
increased circulating triglyceride level
|
J:103051
|
Apoetm1Unc/Apoetm1Unc Tg(APOC1)1Bres/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
hyperlipidemia
|
J:80689
|
increased circulating cholesterol level
|
J:80689
|
increased circulating LDL cholesterol level
|
J:80689
|
increased circulating triglyceride level
|
J:80689
|
increased circulating VLDL cholesterol level
|
J:80689
|
increased circulating VLDL triglyceride level
|
J:80689
|
Apoetm1Unc/Apoetm1Unc Tg(CMV-Serpine1)1Dgi/0
(B6.Cg-Apoetm1Unc Tg(CMV-Serpine1)1Dgi)
|
increased circulating cholesterol level
|
J:61287
|
Apoetm1Unc/Apoetm1Unc Tg(Cyp21a1-Apoe)614Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal circulating cholesterol level
|
J:130658
|
Apoetm1Unc/Apoetm1Unc Tg(Cyp21a1-Apoe)619Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal lipid level
|
J:130658
|
increased circulating cholesterol level
|
J:130658
|
Apoetm1Unc/Apoetm1Unc Tg(NOS3)2Crom/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased circulating cholesterol level
|
J:80701
|
Apoetm1Unc/Apoetm1Unc Tg(NOS3)3Crom/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased circulating cholesterol level
|
J:80701
|
Apoetm1Unc/Apoetm1Unc Thbs4tm1Olsa/Thbs4tm1Olsa
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased cholesterol level
|
J:345752
|
Apoetm1Unc/Apoetm1Unc Trigq3C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased triglyceride level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Trigq3C3H/HeJ/Trigq3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased triglyceride level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Trigq4C3H/HeJ/Trigq4C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased triglyceride level
|
J:129301
|
Apoetm1Unc/Apoetm1Unc Trigq4C3H/HeJ/Trigq4C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased triglyceride level
|
J:129301
|
Apoetm2(APOE*3)Mae/Apoetm2(APOE*3)Mae
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal lipid level
|
J:41705
|
abnormal triglyceride level
|
J:41705
|
decreased circulating LDL cholesterol level
|
J:41705
|
decreased circulating VLDL cholesterol level
|
J:74417
|
decreased circulating VLDL triglyceride level
|
J:74417
|
increased circulating cholesterol level
|
J:41705
|
increased circulating HDL cholesterol level
|
J:74417
|
increased circulating triglyceride level
|
J:74417
|
Apoetm2(APOE*3)Mae/Apoetm2(APOE*3)Mae Ldlrtm1(LDLR)Mae/Ldlr+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating lipid level
|
J:146721
|
Apoetm2(APOE_i2)Sfu/Apoetm2(APOE_i2)Sfu
(involves: 129P2/OlaHsd)
|
decreased circulating cholesterol level
|
J:104859
|
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating lipid level
|
J:151284
|
abnormal lipid level
|
J:74417
|
decreased circulating HDL cholesterol level
|
J:74417
|
decreased circulating triglyceride level
|
J:74417
|
increased circulating VLDL cholesterol level
|
J:74417
|
increased circulating VLDL triglyceride level
|
J:74417
|
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae Ldlrtm1(LDLR)Mae/Ldlr+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating lipid level
|
J:146721
|
increased circulating cholesterol level
|
J:146721
|
increased circulating triglyceride level
|
J:146721
|
Apoetm3(APOE_i3)Sfu/Apoetm3(APOE_i3)Sfu
(involves: 129P2/OlaHsd)
|
decreased circulating cholesterol level
|
J:104859
|
Apoetm4Mae/Apoetm4Mae
(129S6/SvEvTac-Apoetm4Mae)
|
abnormal circulating lipid level
|
J:172417
|
increased circulating cholesterol level
|
J:172417
|
increased circulating HDL cholesterol level
|
J:172417
|
increased circulating triglyceride level
|
J:172417
|
increased circulating VLDL cholesterol level
|
J:172417
|
Apoftm1(KOMP)Vlcg/Apof+
(involves: C57BL/6J * C57BL/6NTac)
|
decreased circulating triglyceride level
|
J:185314
|
increased circulating HDL cholesterol level
|
J:185314
|
Apoftm1(KOMP)Vlcg/Apoftm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
decreased circulating triglyceride level
|
J:185314
|
increased liver cholesterol level
|
J:185314
|
Apol6em1Hsul/Apol6em1Hsul
(Not Specified)
|
decreased circulating cholesterol level
|
J:344362
|
decreased circulating HDL cholesterol level
|
J:344362
|
decreased circulating triglyceride level
|
J:344362
|
increased circulating free fatty acids level
|
J:344362
|
Apomtm1Cchr/Apomtm1Cchr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:130647
|
decreased circulating triglyceride level
|
J:130647
|
Apomtm1Stf/Apomtm1Stf
(Not Specified)
|
decreased circulating HDL cholesterol level
|
J:138581
|
Apptm1Ck/Apptm1Ck Psen1tm1Mpm/Psen1tm1Mpm
(involves: 129 * 129S1/Sv * 129X1/SvJ)
|
increased circulating corticosterone level
|
J:191170
|
Apptm1Dbo/Apptm1Dbo Npc1m1N/Npc1m1N
(C.Cg-Apptm1Dbo Npc1m1N)
|
increased brain cholesterol level
|
J:172769
|
Aqp1tm1b(EUCOMM)Wtsi/Aqp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Aqp1tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Aqp3tm1Ask/Aqp3tm1Ask
(involves: C57BL/6J)
|
decreased circulating triglyceride level
|
J:61675
|
Aqp3tm2b(EUCOMM)Wtsi/Aqp3tm2b(EUCOMM)Wtsi
(C57BL/6N-Aqp3tm2b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased glycerol level
|
J:125011
|
Aqp7tm1Nlsn/Aqp7tm1Nlsn
(involves: 129S1/Sv * C57BL/6)
|
decreased urine glycerol level
|
J:147631
|
Aqp7tm1Tfun/Aqp7tm1Tfun
(B6N.129X1-Aqp7tm1Tfun)
|
decreased circulating glycerol level
|
J:95278
|
increased glycerol level
|
J:95278
|
Aqp8tm1Ask/Aqp8tm1Ask
(involves: 129/Sv * C57BL/6 * CD-1)
|
increased circulating cholesterol level
|
J:104681
|
increased circulating triglyceride level
|
J:104681
|
Aqp9tm1Nlsn/Aqp9tm1Nlsn
(involves: 129S1/Sv * C57BL/6)
|
increased circulating glycerol level
|
J:123742
|
increased circulating triglyceride level
|
J:123742
|
Aqp9tm1Nlsn/Aqp9tm1Nlsn Leprdb/Leprdb
(involves: 129S1/Sv * C57BL/6 * C57BLKS/J)
|
increased circulating glycerol level
|
J:123742
|
Aqp11tm1.1Nlsn/Aqp11tm1.1Nlsn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA)
|
decreased circulating free fatty acids level
|
J:194939
|
decreased circulating glycerol level
|
J:194939
|
decreased circulating triglyceride level
|
J:194939
|
increased circulating HDL cholesterol level
|
J:194939
|
Aqp12tm1Rai/Aqp12tm1Rai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased cholesterol level
|
J:155920
|
Artm1Chc/Y Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
increased circulating triglyceride level
|
J:98775
|
increased liver triglyceride level
|
J:98775
|
increased skeletal muscle triglyceride level
|
J:98775
|
Artm1Verh/Y Tg(Fabp4-cre)1Rev/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating triglyceride level
|
J:196857
|
Arhgap22tm1a(KOMP)Wtsi/Arhgap22tm1a(KOMP)Wtsi
(C57BL/6N-Arhgap22tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:211773
|
Arhgdiatm1Ytk/Arhgdiatm1Ytk
(involves: 129S/SvEv * C57BL/6 * DBA)
|
increased circulating cholesterol level
|
J:57995
|
Arhgef4tm1a(KOMP)Wtsi/Arhgef4tm1a(KOMP)Wtsi
(C57BL/6N-Arhgef4tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating triglyceride level
|
J:165965
|
Arhgef38tm1a(KOMP)Wtsi/Arhgef38tm1a(KOMP)Wtsi
(C57BL/6N-Arhgef38tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
Arid3atm1b(KOMP)Wtsi/Arid3a+
(B6N(Cg)-Arid3atm1b(KOMP)Wtsi/J)
|
increased circulating triglyceride level
|
J:211773
|
Armc3em1(IMPC)J/Armc3+
(C57BL/6NJ-Armc3em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Armc5tm1Stra/Armc5+
(involves: 129 * C57BL/6N * Swiss)
|
decreased circulating corticosterone level
|
J:244906
|
increased circulating corticosterone level
|
J:244906
|
Armc10em1(IMPC)J/Armc10em1(IMPC)J
(C57BL/6NJ-Armc10em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Arr3em1(IMPC)J/Arr3em1(IMPC)J
(C57BL/6NJ-Arr3em1(IMPC)J/J)
|
decreased circulating triglyceride level
|
J:211773
|
Arrb2tm1.1(KOMP)Vlcg/Arrb2+
(B6N(Cg)-Arrb2tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Arrb2tm1.1(KOMP)Vlcg/Arrb2tm1.1(KOMP)Vlcg
(B6N(Cg)-Arrb2tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating triglyceride level
|
J:179646
|
Art5em1(IMPC)J/Art5em1(IMPC)J
(C57BL/6NJ-Art5em1(IMPC)J/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Arv1tm1.2Geno/Arv1+
(involves: C57BL/6 * C57BL/6J)
|
increased circulating cholesterol level
|
J:263695
|
increased circulating HDL cholesterol level
|
J:263695
|
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J)
|
decreased circulating cholesterol level
|
J:263695
|
decreased circulating HDL cholesterol level
|
J:263695
|
decreased circulating triglyceride level
|
J:263695
|
decreased liver cholesterol level
|
J:263695
|
decreased liver free fatty acids level
|
J:263695
|
decreased liver triglyceride level
|
J:263695
|
decreased unsaturated fatty acids level
|
J:263695
|
increased bile salt level
|
J:263695
|
increased saturated fatty acids level
|
J:263695
|
increased unsaturated fatty acids level
|
J:263695
|
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
|
abnormal circulating lipid level
|
J:241193
|
decreased circulating cholesterol level
|
J:241193
|
decreased circulating HDL cholesterol level
|
J:241193
|
Asah1tm1.1Jhkh/Asah1+ Smpd1tm1Esc/Smpd1+
(involves: 129S1/Sv)
|
abnormal ceramide level
|
J:199833
|
Asah1tm1.1Jhkh/Asah1tm1.1Jhkh
(Not Specified)
|
abnormal ceramide level
|
J:199833
|
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6)
|
abnormal sphingomyelin level
|
J:285931
|
increased ceramide level
|
J:285931
|
increased sphingosine level
|
J:285931
|
Asah1tm1Medin/Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1)
|
abnormal ceramide level
|
J:232306
|
Asah2tm1Rlp/Asah2tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal lipid level
|
J:110485
|
Asic1em1(IMPC)Mbp/Asic1em1(IMPC)Mbp
(C57BL/6N-Asic1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating triglyceride level
|
J:211773
|
Aspanur7/Aspanur7
(involves: C57BL/6J)
|
abnormal sphingolipid level
|
J:226682
|
Aspmtm1a(KOMP)Wtsi/Aspmtm1a(KOMP)Wtsi
(C57BL/6N-Aspmtm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Aspntm1b(EUCOMM)Hmgu/Aspntm1b(EUCOMM)Hmgu
(C57BL/6N-Aspntm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Aspscr1tm1.1Jsbo/Aspscr1tm1.1Jsbo Tg(Ckmm-cre)5Khn/0
(B6.Cg-Aspscr1tm1.1Jsbo Tg(Ckmm-cre)5Khn)
|
increased skeletal muscle triglyceride level
|
J:308358
|
Asxl1tm1a(EUCOMM)Wtsi/Asxl1+
(C57BL/6N-Asxl1tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating free fatty acids level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Asxl2tm1b(EUCOMM)Hmgu/Asxl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Asxl2tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
Atad2btm1b(EUCOMM)Hmgu/Atad2btm1b(EUCOMM)Hmgu
(C57BL/6N-Atad2btm1b(EUCOMM)Hmgu/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Atad3atm1a(KOMP)Wtsi/Atad3a+
(C57BL/6N-Atad3atm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Atg2bem1(IMPC)J/Atg2bem1(IMPC)J
(C57BL/6NJ-Atg2bem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Atg4btm1b(EUCOMM)Hmgu/Atg4btm1b(EUCOMM)Hmgu
(C57BL/6N-Atg4btm1b(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ath9FVB/NCr/Ath9C57BL/6J
(involves: C57BL/6J * FVB/NCr)
|
increased circulating HDL cholesterol level
|
J:76127
|
Ath9FVB/NCr/Ath9FVB/NCr
(involves: C57BL/6J * FVB/NCr)
|
increased circulating HDL cholesterol level
|
J:76127
|
Atn1tm1b(EUCOMM)Wtsi/Atn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Atn1tm1b(EUCOMM)Wtsi/Cnrm)
|
increased circulating triglyceride level
|
J:211773
|
Atp1a1tm1Ling/Atp1a1+
(involves: 129P2/OlaHsd * Black Swiss)
|
increased circulating corticosterone level
|
J:117414
|
Atp6ap2tm1.1Ics/Y Tg(NPHS2-cre)295Lbh/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
increased circulating cholesterol level
|
J:232697
|
Atp6v0d1em1Nju/Atp6v0d1em1Nju Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ)
|
decreased circulating triglyceride level
|
J:346448
|
increased circulating cholesterol level
|
J:346448
|
increased circulating free fatty acids level
|
J:346448
|
increased liver cholesterol level
|
J:346448
|
increased liver free fatty acids level
|
J:346448
|
increased liver triglyceride level
|
J:346448
|
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp)
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Atp8b1tm1Nbf/Atp8b1tm1Nbf
(involves: 129S1/SvImJ * 129S4/SvJae)
|
abnormal bile salt level
|
J:89817
|
Atp8b1tm1Nbf/Atp8b1tm1Nbf Portm1Wolf/Portm1Wolf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
|
increased bile salt level
|
J:215915
|
Atp11cem1(IMPC)J/Y
(C57BL/6NJ-Atp11cem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Atp11cem1(IMPC)J/Atp11cem1(IMPC)J
(C57BL/6NJ-Atp11cem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Atp13a3em1(IMPC)J/Atp13a3em1(IMPC)J
(C57BL/6NJ-Atp13a3em1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lipid level
|
J:135320
|
increased circulating cholesterol level
|
J:135320
|
Atxn7l2em1(IMPC)Mbp/Atxn7l2em1(IMPC)Mbp
(C57BL/6NCrl-Atxn7l2em1(IMPC)Mbp/Mmucd)
|
increased circulating HDL cholesterol level
|
J:211773
|
Avpr1atm1Gzt/Avpr1atm1Gzt
(involves: 129 * C57BL/6J)
|
abnormal circulating corticosterone level
|
J:110099
|
Avpr1btm1Gzt/Avpr1btm1Gzt
(involves: 129 * C57BL/6J)
|
decreased circulating corticosterone level
|
J:87707
|
B4galnt1tm1Rlp/B4galnt1tm1Rlp St3gal5tm1Rlp/St3gal5tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal ganglioside level
|
J:96830
|
Baatem1(IMPC)Mbp/Baatem1(IMPC)Mbp
(C57BL/6NCrl-Baatem1(IMPC)Mbp/Mmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl)
|
decreased circulating cholesterol level
|
J:144416
|
decreased circulating triglyceride level
|
J:144416
|
Banpem1(IMPC)J/Banp+
(C57BL/6NJ-Banpem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Baz1btm2a(KOMP)Wtsi/Baz1b+
(Not Specified)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating HDL cholesterol level
|
J:165965
|
Bbs2tm1.1Huss/Bbs2tm1.1Huss
(involves: 129S6/SvEv * C57BL/6)
|
increased ceramide level
|
J:296033
|
increased circulating triglyceride level
|
J:296033
|
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd)
|
abnormal circulating lipid level
|
J:134093
|
increased circulating cholesterol level
|
J:134093
|
increased circulating HDL cholesterol level
|
J:134093
|
increased circulating LDL cholesterol level
|
J:134093
|
increased circulating VLDL cholesterol level
|
J:134093
|
Bbs5tm1b(EUCOMM)Wtsi/Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H)
|
decreased circulating triglyceride level
|
J:211773
|
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating free fatty acids level
|
J:189019
|
Bcat2tm1.2Clyn/Bcat2tm1.2Clyn
(involves: BALB/cJ * C57BL/6J * C57BL/6N)
|
decreased circulating free fatty acids level
|
J:129967
|
Bckdhatm1a(EUCOMM)Hmgu/Bckdhatm1a(EUCOMM)Hmgu Tg(Ucp1-cre)1Evdr/0
(involves: C57BL/6N * FVB)
|
increased liver triglyceride level
|
J:278806
|
Bcl2tm1.1Sjk/Bcl2tm1.1Sjk Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL)
|
abnormal triglyceride level
|
J:181308
|
Bcl6tm1Gdba/Bcl6tm1Gdba Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ)
|
abnormal lipid level
|
J:271078
|
decreased ceramide level
|
J:271078
|
decreased circulating free fatty acids level
|
J:271078
|
decreased circulating triglyceride level
|
J:271078
|
decreased liver triglyceride level
|
J:271078
|
Bco1tm1Dnp/Bco1tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating cholesterol level
|
J:128383
|
increased circulating free fatty acids level
|
J:128383
|
Bco2tm1Dnp/Bco2+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased liver triglyceride level
|
J:170742
|
Bco2tm1Dnp/Bco2tm1Dnp
(involves: 129S6/SvEvTac * C57BL/6)
|
increased liver triglyceride level
|
J:170742
|
Bcorl1em1(IMPC)Tcp/Y
(C57BL/6NCrl-Bcorl1em1(IMPC)Tcp/Cmmr)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Bdnftm3Jae/Bdnftm3Jae Tg(Camk2a-cre)93Kln/0
(involves: 129S4/SvJae * CBA/J)
|
increased cholesterol level
|
J:71969
|
Bdt3DBA/2J/Bdt3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased circulating VLDL cholesterol level
|
J:104825
|
Becn1tm1b(KOMP)Wtsi/Becn1+
(C57BL/6N-Becn1tm1b(KOMP)Wtsi/Ieg)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
increased circulating triglyceride level
|
J:126780
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
increased circulating triglyceride level
|
J:126780
|
Bhlhe40tm1b(KOMP)Wtsi/Bhlhe40tm1b(KOMP)Wtsi
(C57BL/6N-Bhlhe40tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glycerol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Bhmttm1.2Zei/Bhmttm1.2Zei
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating lipid level
|
J:177569
|
abnormal lipid level
|
J:177569
|
abnormal phospholipid level
|
J:177569
|
decreased circulating cholesterol level
|
J:177569
|
decreased circulating HDL cholesterol level
|
J:177569
|
decreased circulating phospholipid level
|
J:177569
|
increased triglyceride level
|
J:177569
|
Bloc1s1tm1a(EUCOMM)Hmgu/Bloc1s1+
(C57BL/6N-Bloc1s1tm1a(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:165965
|
Bloc1s2tm1.1(KOMP)Mbp/Bloc1s2+
(B6N(Cg)-Bloc1s2tm1.1(KOMP)Mbp/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Bltp3bem1(IMPC)J/Bltp3bem1(IMPC)J
(C57BL/6NJ-Bltp3bem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Blvratm1c(EUCOMM)Hmgu/Blvratm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6J * C57BL/6N)
|
increased fatty acids level
|
J:237631
|
increased liver triglyceride level
|
J:237631
|
Bmal1tm1.2Shbi/Bmal1tm1.2Shbi
(involves: C57BL/6J)
|
abnormal lipid level
|
J:177865
|
decreased circulating HDL cholesterol level
|
J:177865
|
decreased circulating VLDL triglyceride level
|
J:177865
|
increased circulating cholesterol level
|
J:177865
|
increased circulating free fatty acids level
|
J:177865
|
increased circulating HDL cholesterol level
|
J:177865
|
increased circulating LDL cholesterol level
|
J:177865
|
increased circulating triglyceride level
|
J:177865
|
increased circulating VLDL cholesterol level
|
J:177865
|
increased liver triglyceride level
|
J:177865
|
increased skeletal muscle triglyceride level
|
J:177865
|
Bnip3em1(IMPC)Mbp/Bnip3em1(IMPC)Mbp
(C57BL/6N-Bnip3em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
Boctm1b(KOMP)Wtsi/Boctm1b(KOMP)Wtsi
(C57BL/6N-Boctm1b(KOMP)Wtsi/H)
|
increased circulating triglyceride level
|
J:211773
|
Bodwt1C3H/HeJ/Bodwt1C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:106521
|
increased circulating HDL cholesterol level
|
J:106521
|
increased circulating triglyceride level
|
J:106521
|
Bodwt1C3H/HeJ/Bodwt1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:106521
|
increased circulating HDL cholesterol level
|
J:106521
|
increased circulating triglyceride level
|
J:106521
|
Bpnt1tm1Yrk/Bpnt1tm1Yrk
(involves: 129S/SvEv * C57BL/6)
|
decreased cholesterol level
|
J:194247
|
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg)
|
abnormal circulating lipid level
|
J:159964
|
increased circulating cholesterol level
|
J:159964
|
increased circulating triglyceride level
|
J:159964
|
Brd7tm2a(EUCOMM)Wtsi/Brd7+
(Not Specified)
|
decreased circulating LDL cholesterol level
|
J:175295
|
Brd9em1(IMPC)Tcp/Brd9+
(C57BL/6N-Brd9em1(IMPC)Tcp/Cmmr)
|
increased circulating HDL cholesterol level
|
J:211773
|
Brwd1em1(IMPC)Tcp/Brwd1em1(IMPC)Tcp
(C57BL/6N-Brwd1em1(IMPC)Tcp/Cmmr)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Bsbob3SPRET/EiJ/? Bsbob4SPRET/EiJ/?
(involves: B6.129P2-Lipctm1Unc/J * SPRET/EiJ)
|
increased circulating cholesterol level
|
J:90614
|
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu Tg(Ddx4-cre)1Dcas/0
(involves: 129 * 129S4/SvJaeSor * FVB/N)
|
abnormal phospholipid level
|
J:211072
|
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu Tg(Fabp4-cre)1Rev/0
(involves: 129 * 129S4/SvJaeSor)
|
increased circulating cholesterol level
|
J:211072
|
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased circulating free fatty acids level
|
J:183701
|
decreased circulating glycerol level
|
J:183701
|
decreased circulating triglyceride level
|
J:183701
|
increased circulating free fatty acids level
|
J:183701
|
increased circulating glycerol level
|
J:183701
|
increased circulating triglyceride level
|
J:183701
|
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal phospholipid level
|
J:211072
|
increased circulating cholesterol level
|
J:211072,
J:173404
|
increased circulating triglyceride level
|
J:173404
|
increased liver triglyceride level
|
J:173404
|
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Bscl2tm1c(EUCOMM)Hmgu/Bscl2tm1c(EUCOMM)Hmgu Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ)
|
abnormal triglyceride level
|
J:260853
|
increased liver triglyceride level
|
J:260853
|
Bscl2tm1Geno/Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno)
|
decreased circulating free fatty acids level
|
J:200947
|
decreased circulating triglyceride level
|
J:200947
|
increased circulating HDL cholesterol level
|
J:200947
|
increased liver triglyceride level
|
J:200947
|
Bsndtm1Suc/Bsndtm1Suc
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating aldosterone level
|
J:175265
|
Btbd9tm1b(EUCOMM)Wtsi/Btbd9tm1b(EUCOMM)Wtsi
(C57BL/6N-Btbd9tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Btbd16tm2b(EUCOMM)Hmgu/Btbd16tm2b(EUCOMM)Hmgu
(C57BL/6N-Btbd16tm2b(EUCOMM)Hmgu/Bay)
|
decreased circulating triglyceride level
|
J:211773
|
Bzw2tm1b(KOMP)Mbp/Bzw2tm1b(KOMP)Mbp
(B6N(Cg)-Bzw2tm1b(KOMP)Mbp/J)
|
decreased circulating cholesterol level
|
J:211773
|
C1ql4tm1Lex/C1ql4tm1Lex
(B6.129S5-C1ql4tm1Lex)
|
increased circulating cholesterol level
|
J:344722
|
C1qtnf1em1(IMPC)Mbp/C1qtnf1em1(IMPC)Mbp
(C57BL/6N-C1qtnf1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex)
|
decreased circulating free fatty acids level
|
J:241403
|
decreased circulating triglyceride level
|
J:241403
|
decreased liver cholesterol level
|
J:241403
|
decreased liver triglyceride level
|
J:241403
|
increased liver triglyceride level
|
J:241403
|
C1qtnf2tm1Lex/C1qtnf2tm1Lex
(B6.129S5-C1qtnf2tm1Lex)
|
abnormal phospholipid level
|
J:282612
|
decreased cholesterol level
|
J:282612
|
decreased circulating cholesterol level
|
J:282612
|
decreased circulating HDL cholesterol level
|
J:282612
|
decreased circulating LDL cholesterol level
|
J:282612
|
decreased liver cholesterol level
|
J:282612
|
decreased liver triglyceride level
|
J:282612
|
increased circulating free fatty acids level
|
J:282612
|
increased circulating glycerol level
|
J:282612
|
increased circulating triglyceride level
|
J:282612
|
increased circulating VLDL cholesterol level
|
J:282612
|
increased circulating VLDL triglyceride level
|
J:282612
|
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased liver triglyceride level
|
J:237401
|
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg)
|
increased liver triglyceride level
|
J:212299
|
C2cd4bem1(IMPC)Wtsi/C2cd4bem1(IMPC)Wtsi
(C57BL/6N-C2cd4bem1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm)
|
decreased circulating free fatty acids level
|
J:284780
|
increased liver triglyceride level
|
J:284780
|
C3tm1Crr/C3tm1Crr
(B6;129S4-C3tm1Crr/J)
|
decreased circulating free fatty acids level
|
J:214214
|
C3tm1Hrc/C3tm1Hrc
(involves: 129/Sv * C57BL/6)
|
decreased circulating triglyceride level
|
J:60633
|
increased circulating free fatty acids level
|
J:60633,
J:58966
|
increased triglyceride level
|
J:58966
|
C3tm1Hrc/C3tm1Hrc
(involves: 129)
|
increased circulating free fatty acids level
|
J:87945
|
increased triglyceride level
|
J:87945
|
C3tm1Hrc/C3tm1Hrc Lepob/Lepob
(involves: 129 * C57BL/6)
|
increased circulating free fatty acids level
|
J:80546
|
increased triglyceride level
|
J:80546
|
C3ar1tm1Cge/C3ar1tm1Cge
(B6.129S4(C)-C3ar1tm1Cge)
|
decreased circulating free fatty acids level
|
J:214214
|
decreased circulating phospholipid level
|
J:214214
|
C3ar1tm1Cge/C3ar1tm1Cge C5ar1tm1Cge/C5ar1tm1Cge
(B6.Cg-C3ar1tm1Cge C5ar1tm1Cge)
|
decreased circulating free fatty acids level
|
J:214214
|
decreased circulating phospholipid level
|
J:214214
|
C4bptm1b(KOMP)Wtsi/C4bptm1b(KOMP)Wtsi
(C57BL/6N-C4bptm1b(KOMP)Wtsi/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
C5ar1tm1Cge/C5ar1tm1Cge
(B6.129S4(Cg)-C5ar1tm1Cge)
|
decreased circulating free fatty acids level
|
J:214214
|
Cacfd1tm1Lex/Cacfd1tm1Lex
(B6;129S5-Cacfd1tm1Lex/Mmucd)
|
increased circulating cholesterol level
|
J:171883
|
increased circulating triglyceride level
|
J:171883
|
Cacna1btm1Ksw/Cacna1btm1Ksw
(involves: C57BL/6 * CBA)
|
abnormal lipid level
|
J:105212
|
decreased circulating triglyceride level
|
J:105212
|
Cacna2d3tm1b(KOMP)Wtsi/Cacna2d3+
(B6N(Cg)-Cacna2d3tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Cacng3tm1Dgen/Cacng3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:101679
|
increased circulating HDL cholesterol level
|
J:101679
|
Camsap3tm1a(EUCOMM)Wtsi/Camsap3+
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
Cap2tm1a(EUCOMM)Wtsi/Cap2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cap2tm1a(EUCOMM)Wtsi/Ieg)
|
decreased circulating triglyceride level
|
J:165965
|
Car7tm1b(KOMP)Wtsi/Car7+
(B6N(Cg)-Car7tm1b(KOMP)Wtsi/J)
|
increased circulating free fatty acids level
|
J:211773
|
Casp8tm1Clie/Casp8tm1Clie Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Tg(Alb1-cre)7Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased bile salt level
|
J:218665
|
Catb/Catb
(Not Specified)
|
decreased circulating cholesterol level
|
J:5205,
J:5351
|
decreased circulating triglyceride level
|
J:5205,
J:5351
|
Cav1em2(IMPC)Ics/Cav1em2(IMPC)Ics
(C57BL/6N-Cav1em2(IMPC)Ics/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cav1tm1Kur/Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6)
|
abnormal lipid level
|
J:112452
|
decreased liver triglyceride level
|
J:112452
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal circulating free fatty acids level
|
J:75192
|
increased circulating triglyceride level
|
J:75192
|
increased circulating VLDL triglyceride level
|
J:75192
|
Cav1tm1Mls/Cav1tm1Mls
(B6.Cg-Cav1tm1Mls)
|
abnormal triglyceride level
|
J:105133
|
decreased fatty acids level
|
J:105133
|
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls)
|
abnormal free fatty acids level
|
J:182288
|
increased circulating glycerol level
|
J:182288
|
increased triglyceride level
|
J:182288
|
Cav1tm1Pesch/Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(FVB.Cg-Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn)
|
decreased circulating glycerol level
|
J:182288
|
Cavin1tm1Pfp/Cavin1tm1Pfp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal circulating lipid level
|
J:143425
|
hyperlipidemia
|
J:143425
|
increased circulating free fatty acids level
|
J:143425
|
increased circulating triglyceride level
|
J:143425
|
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating free fatty acids level
|
J:94416
|
decreased liver triglyceride level
|
J:94416
|
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating free fatty acids level
|
J:121012
|
decreased circulating triglyceride level
|
J:121012
|
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi)
|
decreased circulating cholesterol level
|
J:236022
|
decreased circulating glycerol level
|
J:236022
|
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Cc2d1btm1a(KOMP)Wtsi/Cc2d1b+
(Not Specified)
|
decreased circulating free fatty acids level
|
J:165965
|
Cc2d1btm1a(KOMP)Wtsi/Cc2d1btm1a(KOMP)Wtsi
(Not Specified)
|
decreased circulating free fatty acids level
|
J:165965
|
Ccar2tm1Dac/Ccar2tm1Dac
(involves: 129 * C57BL/6J)
|
increased unsaturated fatty acids level
|
J:228688
|
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J)
|
decreased liver triglyceride level
|
J:220560
|
Ccdc18tm1a(EUCOMM)Wtsi/Ccdc18tm1a(EUCOMM)Wtsi
(C57BL/6N-Ccdc18tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Ccdc77tm1a(EUCOMM)Wtsi/Ccdc77tm1a(EUCOMM)Wtsi
(C57BL/6N-Ccdc77tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm)
|
increased circulating free fatty acids level
|
J:189183
|
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp)
|
decreased circulating cholesterol level
|
J:332421
|
decreased circulating LDL cholesterol level
|
J:332421
|
decreased circulating triglyceride level
|
J:332421
|
decreased liver triglyceride level
|
J:332421
|
Ccdc92tm1b(KOMP)Mbp/Ccdc92tm1b(KOMP)Mbp
(C57BL/6N-Ccdc92tm1b(KOMP)Mbp/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
Ccdc120tm1.1(KOMP)Vlcg/Y
(B6N(Cg)-Ccdc120tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J)
|
decreased circulating free fatty acids level
|
J:110277
|
Ccl2tm1Rol/Ccl2tm1Rol Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
increased circulating triglyceride level
|
J:75837
|
increased circulating VLDL cholesterol level
|
J:75837
|
Ccl9tm1(KOMP)Vlcg/Ccl9tm1(KOMP)Vlcg
(C57BL/6N-Ccl9tm1(KOMP)Vlcg/Ucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ccnqtm1.1(KOMP)Vlcg/Ccnq+
(C57BL/6N-Ccnqtm1.1(KOMP)Vlcg/Ucd)
|
increased circulating triglyceride level
|
J:211773
|
Ccnytm1.1Smoc/Ccnytm1.1Smoc
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:224589
|
decreased circulating free fatty acids level
|
J:224589
|
decreased circulating triglyceride level
|
J:224589
|
decreased liver triglyceride level
|
J:224589
|
Cd1d1tm1Luc/Cd1d1tm1Luc Ldlrtm1Her/Ldlrtm1Her
(B6.129S-Cd1d1tm1Luc Ldlrtm1Her)
|
decreased circulating VLDL cholesterol level
|
J:110061
|
Cd4tm1Mak/Cd4tm1Mak
(B6.129S2-Cd4tm1Mak/J)
|
abnormal bile salt level
|
J:133047
|
Cd22tm1b(EUCOMM)Wtsi/Cd22tm1b(EUCOMM)Wtsi
(C57BL/6N-Cd22tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
Cd36em1(IMPC)Mbp/Cd36em1(IMPC)Mbp
(C57BL/6N-Cd36em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating triglyceride level
|
J:211773
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6)
|
abnormal triglyceride level
|
J:123605
|
decreased cardiac muscle triglyceride level
|
J:83611
|
increased circulating cholesterol level
|
J:56081
|
increased circulating HDL cholesterol level
|
J:56081
|
increased circulating triglyceride level
|
J:56081
|
increased circulating VLDL triglyceride level
|
J:56081
|
increased fatty acids level
|
J:56081
|
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe)
|
abnormal circulating lipid level
|
J:87372
|
abnormal fatty acids level
|
J:87372
|
abnormal lipid level
|
J:87372
|
decreased fatty acids level
|
J:87372
|
decreased liver free fatty acids level
|
J:135594
|
decreased liver triglyceride level
|
J:135594
|
increased circulating free fatty acids level
|
J:87372
|
increased circulating triglyceride level
|
J:87372
|
increased fatty acids level
|
J:87372
|
increased liver triglyceride level
|
J:87372
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv)
|
abnormal triglyceride level
|
J:220343
|
decreased circulating triglyceride level
|
J:220343
|
Cd36tm2.1Mfe/Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(B6.Cg-Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk)
|
decreased cardiac muscle triglyceride level
|
J:225392
|
decreased fatty acids level
|
J:225392
|
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lipid level
|
J:108938
|
decreased cholesterol level
|
J:108938
|
Cdc20bem1(IMPC)Wtsi/Cdc20bem1(IMPC)Wtsi
(C57BL/6N-Cdc20bem1(IMPC)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Cdc42tm1b(EUCOMM)Hmgu/Cdc42+
(C57BL/6N-Cdc42tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cdca7lem1(IMPC)Mbp/Cdca7lem1(IMPC)Mbp
(C57BL/6NCrl-Cdca7lem1(IMPC)Mbp/Mmucd)
|
increased circulating cholesterol level
|
J:211773
|
Cdca8tm1a(KOMP)Wtsi/Cdca8+
(C57BL/6N-Cdca8tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:175295
|
increased circulating LDL cholesterol level
|
J:175295
|
Cdh9tm1b(KOMP)Wtsi/Cdh9tm1b(KOMP)Wtsi
(C57BL/6N-Cdh9tm1b(KOMP)Wtsi/Ics)
|
increased circulating cholesterol level
|
J:211773
|
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu Tg(Foxa3-cre)1Khk/0
(involves: 129S4/SvJaeSor * C57BL/6N * DBA)
|
decreased circulating cholesterol level
|
J:272566
|
decreased circulating triglyceride level
|
J:272566
|
Cdk12em1(IMPC)Tcp/Cdk12+
(C57BL/6NCrl-Cdk12em1(IMPC)Tcp/Tcp)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Cdk15tm1b(KOMP)Wtsi/Cdk15tm1b(KOMP)Wtsi
(B6N(Cg)-Cdk15tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj)
|
decreased liver triglyceride level
|
J:195460
|
decreased skeletal muscle triglyceride level
|
J:195460
|
increased liver triglyceride level
|
J:195460
|
increased skeletal muscle triglyceride level
|
J:195460
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas)
|
increased circulating cholesterol level
|
J:118516
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * 129S2/SvPas)
|
increased circulating cholesterol level
|
J:118516
|
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv)
|
increased circulating cholesterol level
|
J:118516
|
Cdkn1btm1Kin/Cdkn1b+ Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J)
|
hyperlipidemia
|
J:96047
|
Cdkn1btm1Kin/Cdkn1btm1Kin Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J)
|
hyperlipidemia
|
J:96047
|
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating triglyceride level
|
J:181979
|
increased skeletal muscle triglyceride level
|
J:181979
|
Ceacam16tm1.1(KOMP)Wtsi/Ceacam16tm1.1(KOMP)Wtsi
(B6N(Cg)-Ceacam16tm1.1(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Ceacam23em1(IMPC)Wtsi/Ceacam23em1(IMPC)Wtsi
(C57BL/6N-Ceacam23em1(IMPC)Wtsi/WtsiOulu)
|
increased circulating HDL cholesterol level
|
J:211773
|
Cebpam4443Dajl/Cebpam4443Dajl
(involves: C3H/HeSnJ * C57BL/6J * SWR)
|
increased circulating cholesterol level
|
J:149088
|
increased circulating HDL cholesterol level
|
J:149088
|
increased circulating LDL cholesterol level
|
J:149088
|
increased circulating triglyceride level
|
J:149088
|
Cebpatm1Gonz/Cebpatm1Gonz Lepob/Lepob Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased circulating cholesterol level
|
J:93579
|
decreased circulating HDL cholesterol level
|
J:93579
|
decreased circulating LDL cholesterol level
|
J:93579
|
decreased liver cholesterol level
|
J:93579
|
decreased liver triglyceride level
|
J:93579
|
increased circulating free fatty acids level
|
J:93579
|
increased circulating VLDL cholesterol level
|
J:93579
|
Cebpatm1Gonz/Cebpatm1Gonz Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * FVB/N)
|
increased circulating free fatty acids level
|
J:93579
|
Cebpatm1Timc/Cebpatm1Timc
(Not Specified)
|
increased circulating triglyceride level
|
J:163725
|
Cebpatm5Nerl/Cebpatm5Nerl
(involves: 129P2/OlaHsd * C57BL/6)
|
increased liver triglyceride level
|
J:120098
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
abnormal circulating free fatty acids level
|
J:52286
|
decreased circulating free fatty acids level
|
J:62132,
J:52286
|
decreased circulating triglyceride level
|
J:52286
|
increased circulating corticosterone level
|
J:52286
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6)
|
decreased triglyceride level
|
J:117502
|
increased circulating triglyceride level
|
J:117502
|
Celtm1Dyh/Celtm1Dyh Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:124658
|
Celf4tm1a(EUCOMM)Wtsi/Celf4+
(C57BL/6N-Celf4tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Cenphtm1b(EUCOMM)Hmgu/Cenph+
(C57BL/6N-Cenphtm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Cenpotm1b(KOMP)Mbp/Cenpo+
(B6N(Cg)-Cenpotm1b(KOMP)Mbp/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Cep19tm2.1Jmgi/Cep19tm2.1Jmgi
(involves: C57BL/6NTac)
|
increased circulating triglyceride level
|
J:206667
|
Cerktm1Fbor/Cerktm1Fbor
(involves: BALB/c)
|
abnormal ceramide level
|
J:137892
|
Cers1fln/Cers1fln
(NOD.Cg-Cers1fln/Sz)
|
abnormal lipid level
|
J:172719
|
Cers1tm1.1Kwi/Cers1tm1.1Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lipid level
|
J:193419
|
Cers3tm1.1Rsnd/Cers3tm1.1Rsnd
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lipid level
|
J:179754
|
Cers4tm1.1Kwi/Cers4tm1.1Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal ceramide level
|
J:213606
|
abnormal sphingomyelin level
|
J:213606
|
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N)
|
abnormal ceramide level
|
J:215519
|
Cers6tm1Arte/Cers6tm1Arte Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6N * FVB/N)
|
abnormal ceramide level
|
J:215519
|
Ces1dtm1Reli/Ces1dtm1Reli
(involves: 129S6/SvEvTac)
|
abnormal circulating lipid level
|
J:158743
|
decreased circulating cholesterol level
|
J:158743
|
decreased circulating free fatty acids level
|
J:158743
|
decreased circulating glycerol level
|
J:158743
|
decreased circulating triglyceride level
|
J:158743
|
decreased circulating VLDL cholesterol level
|
J:158743
|
decreased circulating VLDL triglyceride level
|
J:158743
|
decreased liver triglyceride level
|
J:158743
|
Ces1gtm1Reli/Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6)
|
decreased saturated fatty acids level
|
J:262803
|
hyperlipidemia
|
J:262803
|
increased circulating cholesterol level
|
J:262803
|
increased circulating free fatty acids level
|
J:262803
|
increased circulating phospholipid level
|
J:262803
|
increased circulating triglyceride level
|
J:262803
|
increased circulating VLDL cholesterol level
|
J:262803
|
increased circulating VLDL triglyceride level
|
J:262803
|
increased liver cholesterol level
|
J:262803
|
increased liver triglyceride level
|
J:262803
|
increased unsaturated fatty acids level
|
J:262803
|
Ces2atm1(KOMP)Vlcg/Ces2atm1(KOMP)Vlcg
(C57BL6/N-Ces2atm1(KOMP)Vlcg)
|
decreased circulating triglyceride level
|
J:335459
|
increased ceramide level
|
J:335459
|
increased cholesterol level
|
J:335459
|
increased liver cholesterol level
|
J:335459
|
increased liver triglyceride level
|
J:335459
|
Cfap119tm1b(EUCOMM)Hmgu/Cfap119tm1b(EUCOMM)Hmgu
(C57BL/6N-Cfap119tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cftrtm1Unc/Cftrtm1Unc
(B6.129P2-Cftrtm1Unc/J)
|
abnormal phospholipid level
|
J:58571
|
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
|
lipidosis
|
J:146743
|
Chd7Whi/Chd7+
(C3HeB/FeJ-Chd7Whi)
|
abnormal circulating lipid level
|
J:330596
|
decreased circulating cholesterol level
|
J:330596
|
decreased circulating free fatty acids level
|
J:330596
|
decreased circulating glycerol level
|
J:330596
|
decreased circulating triglyceride level
|
J:330596
|
Chgatm1Skmt/Chgatm1Skmt
(involves: 129S1/Sv * C57BL/6J)
|
abnormal corticosterone level
|
J:99805
|
ChkaGt(XH252)Byg/Chka+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased liver triglyceride level
|
J:130726
|
Chkbrmd/Chkbrmd
(involves: BALB/cByJ * C57BL/6J)
|
abnormal lipid level
|
J:108320
|
Chldq1MRL/MpJ/Chldq1MRL/MpJ
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq1MRL/MpJ/Chldq1SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq2MRL/MpJ/Chldq2MRL/MpJ
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq2MRL/MpJ/Chldq2SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq3MRL/MpJ/Chldq3MRL/MpJ
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033,
J:123776
|
increased circulating HDL cholesterol level
|
J:106033,
J:123776
|
Chldq3MRL/MpJ/Chldq3SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq4MRL/MpJ/Chldq4MRL/MpJ
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq4MRL/MpJ/Chldq4SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating cholesterol level
|
J:106033
|
increased circulating HDL cholesterol level
|
J:106033
|
Chldq7NZB/BlNJ/Chldq7NZB/BlNJ
(involves: NZB/BlNJ * RF/J)
|
increased circulating HDL cholesterol level
|
J:123776
|
Chldq7NZB/BlNJ/Chldq7RF/J
(involves: NZB/BlNJ * RF/J)
|
increased circulating HDL cholesterol level
|
J:123776
|
Chldq9NZB/BlNJ/Chldq9RF/J
(involves: NZB/BlNJ * RF/J)
|
decreased circulating HDL cholesterol level
|
J:123776
|
Chldq9RF/J/Chldq9RF/J
(involves: NZB/BlNJ * RF/J)
|
decreased circulating HDL cholesterol level
|
J:123776
|
Chldq12NZB/BlNJ/Chldq12NZB/BlNJ
(involves: NZB/BlNJ * RF/J)
|
increased circulating cholesterol level
|
J:123776
|
increased circulating HDL cholesterol level
|
J:123776
|
Chldq12NZB/BlNJ/Chldq12RF/J
(involves: NZB/BlNJ * RF/J)
|
increased circulating cholesterol level
|
J:123776
|
increased circulating HDL cholesterol level
|
J:123776
|
Chlq1DBA/2J/?
(involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)
|
abnormal circulating corticosterone level
|
J:104331
|
Chn1tm1.1(KOMP)Vlcg/Chn1tm1.1(KOMP)Vlcg
(B6N(Cg)-Chn1tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Chohd2/Chohd2+
(C3HeB/FeJ-Chohd2/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
Chohd3/Chohd3+
(C3HeB/FeJ-Chohd3/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
Chohd4/Chohd4+
(C3HeB/FeJ-Chohd4/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
Chohd5/Chohd5+
(C3HeB/FeJ-Chohd5/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
increased circulating LDL cholesterol level
|
J:94145
|
Chohd6/Chohd6+
(C3HeB/FeJ-Chohd6/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
increased circulating LDL cholesterol level
|
J:94145
|
chohr1/chohr1
(C3HeB/FeJ-chohr1/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
chohr2/chohr2
(C3HeB/FeJ-chohr2/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
increased circulating LDL cholesterol level
|
J:94145
|
chohr3/chohr3
(C3HeB/FeJ-chohr3/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
increased circulating LDL cholesterol level
|
J:94145
|
Chol6CAST/Ei/Chol6CAST/Ei
(involves: CAST/Ei * DBA/2J)
|
abnormal circulating cholesterol level
|
J:83460
|
increased circulating cholesterol level
|
J:83460
|
Chol7129S1/SvImJ/Chol7129S1/SvImJ
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol7129S1/SvImJ/Chol7CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol8129S1/SvImJ/Chol8CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol8CAST/Ei/Chol8CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol9129S1/SvImJ/Chol9CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol9CAST/Ei/Chol9CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating cholesterol level
|
J:88732
|
Chol10129S1/SvImJ/Chol10129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating cholesterol level
|
J:89282
|
Chol10129S1/SvImJ/Chol10RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating cholesterol level
|
J:89282
|
Chol11129S1/SvImJ/Chol11129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating cholesterol level
|
J:89282
|
Chol11129S1/SvImJ/Chol11RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating cholesterol level
|
J:89282
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating triglyceride level
|
J:67919
|
Chrna7tm1b(EUCOMM)Hmgu/Chrna7tm1b(EUCOMM)Hmgu
(C57BL/6N-Chrna7tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Chuktm1Mpa/Chuktm1Mpa Tg(KRT14-cre)1Cgn/?
(involves: C57BL/6)
|
decreased circulating free fatty acids level
|
J:122320
|
increased cholesterol level
|
J:122320
|
CiartGt(IST11761C7)Tigm/CiartGt(IST11761C7)Tigm
(C57BL/6-CiartGt(IST11761C7)Tigm)
|
increased circulating corticosterone level
|
J:209571
|
Cib2tm1b(EUCOMM)Wtsi/Cib2tm1b(EUCOMM)Wtsi
(C57BL/6N-Cib2tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Cibar1tm1b(KOMP)Wtsi/Cibar1tm1b(KOMP)Wtsi
(C57BL/6N-Cibar1tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:211773
|
Cideatm1Pli/Cideatm1Pli
(involves: 129X1/SvJ)
|
decreased circulating triglyceride level
|
J:85229
|
decreased fatty acids level
|
J:85229
|
Cidebtm1Pli/Cidebtm1Pli
(Not Specified)
|
decreased circulating free fatty acids level
|
J:126556
|
decreased circulating triglyceride level
|
J:126556
|
Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel/?
(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel)
|
abnormal circulating lipid level
|
J:226899
|
increased circulating free fatty acids level
|
J:226899
|
increased circulating triglyceride level
|
J:226899
|
Cidectm1b(EUCOMM)Wtsi/Cidectm1b(EUCOMM)Wtsi
(C57BL/6N-Cidectm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
Cidectm1Pli/Cidectm1Pli
(Not Specified)
|
decreased circulating free fatty acids level
|
J:140122
|
decreased circulating triglyceride level
|
J:140122
|
Cidectm1Pli/Cidectm1Pli Lepob/Lepob
(involves: C57BL/10J)
|
decreased circulating free fatty acids level
|
J:140122
|
decreased circulating triglyceride level
|
J:140122
|
Cisd1em1(IMPC)Hmgu/Cisd1em1(IMPC)Hmgu
(C57BL/6N-Cisd1em1(IMPC)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Cisd2tm1a(EUCOMM)Wtsi/Cisd2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cisd2tm1a(EUCOMM)Wtsi/H)
|
decreased circulating triglyceride level
|
J:165965
|
Clcn1em1(IMPC)Mbp/Clcn1em1(IMPC)Mbp
(C57BL/6NCrl-Clcn1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Clcn2em1Uis/Clcn2+
(C57BL/6N-Clcn2em1Uis)
|
increased circulating aldosterone level
|
J:282228
|
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
Cldn4tm1.1Jhou/Cldn4tm1.1Jhou Tg(Aqp2-cre)1Dek/0
(B6.Cg-Cldn4tm1.1Jhou Tg(Aqp2-cre)1Dek)
|
increased circulating aldosterone level
|
J:216399
|
Cldn7tm1Yche/Cldn7tm1Yche
(involves: C57BL/6)
|
increased circulating aldosterone level
|
J:155363
|
Cldn8tm1.1Jhou/Cldn8tm1.1Jhou Tg(Aqp2-cre)1Dek/0
(B6.Cg-Cldn8tm1.1Jhou Tg(Aqp2-cre)1Dek)
|
increased circulating aldosterone level
|
J:220813
|
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg)
|
abnormal circulating non-HDL cholesterol level
|
J:279934
|
decreased circulating free fatty acids level
|
J:279934
|
decreased circulating triglyceride level
|
J:279934
|
Cldn16tm1.1Dmu/Cldn16tm1.1Dmu
(involves: 129 * BALB/cJ * C57BL/6)
|
abnormal vitamin D level
|
J:159706
|
Cldn19tm1.1(KOMP)Vlcg/Cldn19tm1.1(KOMP)Vlcg
(B6N(Cg)-Cldn19tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Cldn23em1(IMPC)J/Cldn23em1(IMPC)J
(C57BL/6NJ-Cldn23em1(IMPC)J/Mmjax)
|
decreased circulating triglyceride level
|
J:211773
|
Clk2tm1.1Ppgr/Clk2tm1.1Ppgr Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6NTac * FVB/N)
|
decreased liver triglyceride level
|
J:229283
|
Clockem1(IMPC)Ccpcz/Clockem1(IMPC)Ccpcz
(C57BL/6NCrl-Clockem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Clockm1Jt/Clockm1Jt
(C57BL/6-Clockm1Jt)
|
decreased circulating corticosterone level
|
J:98343
|
increased circulating cholesterol level
|
J:98343
|
increased circulating triglyceride level
|
J:98343
|
Clockm1Jt/Clockm1Jt Lepob/Lepob
(involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR)
|
increased circulating cholesterol level
|
J:135847
|
increased circulating free fatty acids level
|
J:135847
|
increased circulating triglyceride level
|
J:135847
|
Clpptm1a(EUCOMM)Wtsi/Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
Clpstm1Lowe/Clpstm1Lowe
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating triglyceride level
|
J:75167
|
increased circulating cholesterol level
|
J:75167
|
steatorrhea
|
J:75167
|
Clpstm2.1Lowe/Clpstm2.1Lowe
(B6.129X1-Clpstm2.1Lowe)
|
decreased circulating HDL cholesterol level
|
J:159587
|
increased circulating cholesterol level
|
J:159587
|
Cmklr2tm1.1Dgen/Cmklr2tm1.1Dgen
(involves: C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:273922
|
Cmpk2tm1b(KOMP)Wtsi/Cmpk2tm1b(KOMP)Wtsi
(C57BL/6N-Cmpk2tm1b(KOMP)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
Cnot3em1(IMPC)Rbrc/Cnot3+
(C57BL/6NJcl-Cnot3em1(IMPC)Rbrc/Rbrc)
|
decreased circulating triglyceride level
|
J:211773
|
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya)
|
decreased circulating triglyceride level
|
J:180033
|
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya)
|
abnormal circulating lipid level
|
J:274297
|
Cnpy2tm1.2Zhli/Cnpy2tm1.2Zhli
(B6.Cg-Cnpy2tm1.2Zhli)
|
decreased circulating triglyceride level
|
J:277868
|
Cnr1tm1Zim/Cnr1tm1Zim
(involves: 129 * C57BL/6J)
|
increased circulating corticosterone level
|
J:144423
|
Cog2tm1a(KOMP)Wtsi/Cog2+
(B6JTyr;B6N-Cog2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:175295
|
Col1a1tm1(tetO-Deptor)Dmsa/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
increased triglyceride level
|
J:187378
|
Col1a1tm1(tetO-URI1)Ndj/Col1a1+ Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
|
increased bile salt level
|
J:217463
|
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+ Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI)
|
decreased liver triglyceride level
|
J:210545
|
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+ Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI)
|
decreased circulating cholesterol level
|
J:213764
|
decreased liver triglyceride level
|
J:210545
|
increased bile salt level
|
J:213764
|
increased circulating cholesterol level
|
J:210545
|
increased circulating triglyceride level
|
J:210545
|
Col1a1tm4(tetO-Jun/Fosl2)Wag/Col1a1+ Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI)
|
decreased liver triglyceride level
|
J:210545
|
Col4a5tm1b(EUCOMM)Wtsi/Y
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Col4a5tm1b(EUCOMM)Wtsi/Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Col6a3em1(IMPC)Kmpc/Col6a3em1(IMPC)Kmpc
(C57BL/6NTac-Col6a3em1(IMPC)Kmpc/Kmpc)
|
increased circulating LDL cholesterol level
|
J:211773
|
Col9a2tm1b(EUCOMM)Wtsi/Col9a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col9a2tm1b(EUCOMM)Wtsi/H)
|
increased circulating triglyceride level
|
J:211773
|
Col9a3em1(IMPC)Tcp/Col9a3em1(IMPC)Tcp
(C57BL/6N-Col9a3em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Col11a2tm1b(KOMP)Wtsi/Col11a2+
(C57BL/6N-Col11a2tm1b(KOMP)Wtsi/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Col18a1tm1.1(KOMP)Vlcg/Col18a1tm1.1(KOMP)Vlcg
(B6N(Cg)-Col18a1tm1.1(KOMP)Vlcg/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Col18a1tm1Hms/Col18a1tm1Hms
(B6.129S4-Col18a1tm1Hms)
|
increased circulating triglyceride level
|
J:167008
|
increased circulating VLDL triglyceride level
|
J:167008
|
Colec10em2(IMPC)Tcp/Colec10em2(IMPC)Tcp
(C57BL/6NCrl-Colec10em2(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Copg1tm1a(EUCOMM)Wtsi/Copg1+
(C57BL/6N-Copg1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
Coq8atm1.1Ics/Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
hyperlipidemia
|
J:249129
|
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J)
|
increased circulating cholesterol level
|
J:19043,
J:18161
|
increased circulating HDL cholesterol level
|
J:19043,
J:18161
|
increased circulating LDL cholesterol level
|
J:19043
|
increased circulating triglyceride level
|
J:19043
|
increased circulating VLDL cholesterol level
|
J:19043
|
Cpefat/Cpefat Find2C57BLKS/J/Find2C57BLKS/J
(involves: C57BLKS/J * HRS/J)
|
increased circulating cholesterol level
|
J:100832
|
Cpgi5563tm1.1(NCC)Wcs/Cpgi5563tm1.1(NCC)Wcs
(C57BL/6N-Cpgi5563tm1.1(NCC)Wcs/Wtsi)
|
decreased circulating cholesterol level
|
J:277622
|
decreased circulating triglyceride level
|
J:277622
|
Cps1em1(IMPC)H/Cps1+
(C57BL/6NTac-Cps1em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cpt1atm1Pwo/Cpt1a+
(either: 129S6/SvEvTac-Cpt1atm1Pwo or (involves: 129S6/SvEvTac * C57BL/6NTac))
|
increased circulating free fatty acids level
|
J:101934
|
Cpt1ctm1Dhwu/Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J)
|
increased liver triglyceride level
|
J:148205
|
Cpt1ctm1Fghe/Cpt1ctm1Fghe
(B6.129S-Cpt1ctm1Fghe)
|
abnormal lipid level
|
J:186508
|
Cpt1ctm1Mdln/Cpt1ctm1Mdln
(involves: C57BL/6)
|
hyperlipidemia
|
J:109455
|
increased circulating triglyceride level
|
J:109455
|
Cq1C57BL/6J/Cq1C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:54322
|
Cq1KK/Cq1C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:54322
|
Cq1KK/Cq1KK
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:54322
|
Cq2KK/Cq2C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:54322
|
Cq2KK/Cq2KK
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:54322
|
Cq2KK/Cq2KK Cq3C57BL/6J/Cq3C57BL/6J
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:108417
|
Cq3C57BL/6J/?
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:108417
|
Cq4C57BL/6J/Cq4KK-A(y)
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:87328
|
Cq4KK-A(y)/Cq4KK-A(y)
(involves: C57BL/6J * KK-Ay)
|
increased circulating cholesterol level
|
J:87328
|
Cq5KK-A(y)/Cq5KK-A(y)
(involves: KK-Ay * RR)
|
increased circulating cholesterol level
|
J:87328
|
Cq6C57BL/6J/Cq6RR
(involves: C57BL/6J * RR)
|
increased circulating cholesterol level
|
J:94251
|
Cq6RR/Cq6RR
(involves: C57BL/6J * RR)
|
increased circulating cholesterol level
|
J:94251
|
Cracdltm1b(KOMP)Wtsi/Cracdltm1b(KOMP)Wtsi
(C57BL/6N-Cracdltm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Crattm1.1Pbrc/Crattm1.1Pbrc Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
decreased circulating free fatty acids level
|
J:184778
|
decreased circulating triglyceride level
|
J:184778
|
Crbntm1Csp/Crbntm1Csp
(B6N.Cg-Crbntm1Csp)
|
decreased circulating free fatty acids level
|
J:208570
|
decreased liver triglyceride level
|
J:208570
|
Creb3Gt1Mbac/Creb3+
(B6NTac.Cg-Creb3Gt1Mbac)
|
abnormal lipid level
|
J:345514
|
abnormal phospholipid level
|
J:345514
|
decreased liver triglyceride level
|
J:345514
|
decreased skeletal muscle triglyceride level
|
J:345514
|
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA)
|
decreased circulating free fatty acids level
|
J:75361
|
decreased triglyceride level
|
J:75361
|
CrebrfGt(YHD319)Byg/CrebrfGt(YHD319)Byg
(B6.129P2-CrebrfGt(YHD319)Byg)
|
decreased circulating corticosterone level
|
J:192857
|
Creg1em1Yal/Creg1em1Yal Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased liver cholesterol level
|
J:263073
|
increased liver free fatty acids level
|
J:263073
|
Creld2tm1.1Emass/Creld2tm1.1Emass
(B6.129P2(SJL)-Creld2tm1.1Emass)
|
increased ceramide level
|
J:316411
|
Crhm1H/Crh+
(involves: C3H/HeH * C57BL/6J)
|
abnormal corticosterone level
|
J:208708
|
increased circulating cholesterol level
|
J:208708
|
increased circulating corticosterone level
|
J:208708
|
increased circulating triglyceride level
|
J:208708
|
increased urine corticosterone level
|
J:208708
|
Crhtm1Maj/Crh+ Tg(MECP2)1Hzo/0
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal corticosterone level
|
J:181213
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal circulating corticosterone level
|
J:23082
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal circulating corticosterone level
|
J:90690,
J:72196,
J:102987,
J:105629,
J:54256
|
decreased circulating corticosterone level
|
J:105629
|
Crhtm2.1Maj/Crhtm2.1Maj Tg(Sim1-cre)1Lowl/?
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased circulating corticosterone level
|
J:238330
|
Crhtm2.2Maj/Crhtm2.2Maj
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased circulating corticosterone level
|
J:238330
|
Crhr1tm1Jde/Crhr1tm1Jde
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal corticosterone level
|
J:176339
|
Crhr1tm2.3Jde/Crhr1tm2.3Jde
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac)
|
decreased circulating corticosterone level
|
J:187372
|
Crhr1tm2Jde/Crhr1tm2Jde
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating corticosterone level
|
J:187372
|
Crhr1tm2Wrst/Crhr1tm2Wrst Tg(Camk2a-cre)159Kln/0
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating corticosterone level
|
J:85745
|
Crhr2tm1Klee/Crhr2tm1Klee
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:83683
|
decreased circulating free fatty acids level
|
J:83683
|
decreased circulating triglyceride level
|
J:83683
|
Crispld2tm1.1(KOMP)Vlcg/Crispld2+
(C57BL/6N-Crispld2tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating triglyceride level
|
J:211773
|
Crptm1Hjf/Crptm1Hjf Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Crptm1Hjf Ldlrtm1Her)
|
decreased circulating LDL cholesterol level
|
J:170409
|
decreased circulating VLDL cholesterol level
|
J:170409
|
increased circulating cholesterol level
|
J:170409
|
increased circulating triglyceride level
|
J:170409
|
Crtc1Gt(XK522)Byg/Crtc1Gt(XK522)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating triglyceride level
|
J:142448
|
Crtc2tm1.1Khk/Crtc2tm1.1Khk
(involves: C57BL/6 * C57BL/6J * FVB/N)
|
decreased circulating corticosterone level
|
J:151618
|
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating free fatty acids level
|
J:167211
|
Crygstm1b(KOMP)Wtsi/Crygstm1b(KOMP)Wtsi
(B6N(Cg)-Crygstm1b(KOMP)Wtsi/2J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg)
|
abnormal lipid level
|
J:102499
|
increased circulating free fatty acids level
|
J:102499
|
increased circulating triglyceride level
|
J:102499
|
Csf2raem1Szut/Csf2raem1Szut
(C57BL/6-Csf2raem1Szut)
|
increased cholesterol level
|
J:322934
|
Csmd3em1(IMPC)Mbp/Csmd3em1(IMPC)Mbp
(C57BL/6NCrl-Csmd3em1(IMPC)Mbp/Mmucd)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Csnk1g3tm1a(EUCOMM)Wtsi/Csnk1g3tm1a(EUCOMM)Wtsi
(C57BL/6N-Csnk1g3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Csnk2a2em1(IMPC)Mbp/Csnk2a2em1(IMPC)Mbp
(C57BL/6N-Csnk2a2em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ)
|
increased circulating cholesterol level
|
J:184220
|
increased circulating HDL cholesterol level
|
J:184220
|
increased circulating LDL cholesterol level
|
J:184220
|
Cstbtm1b(EUCOMM)Wtsi/Cstbtm1b(EUCOMM)Wtsi
(C57BL/6N-Cstbtm1b(EUCOMM)Wtsi/Orl)
|
increased circulating triglyceride level
|
J:211773
|
Ct45atm1e(KOMP)Wtsi/Y
(C57BL/6N-Ct45atm1e(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Ct45atm1e(KOMP)Wtsi/Ct45atm1e(KOMP)Wtsi
(C57BL/6N-Ct45atm1e(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ctf1tm1Msd/Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd)
|
decreased circulating free fatty acids level
|
J:176727
|
increased circulating cholesterol level
|
J:176727
|
Cthtm1Iish/Cthtm1Iish
(B6.129-Cthtm1Iish/Iish)
|
increased circulating triglyceride level
|
J:166184
|
Ctsatm2b(EUCOMM)Hmgu/Ctsatm2b(EUCOMM)Hmgu
(C57BL/6N-Ctsatm2b(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Ctsstm1Hap/Ctsstm1Hap Ldlrtm1Her/Ldlrtm1Her
(B6.129S-Ctsstm1Hap Ldlrtm1Her)
|
decreased circulating cholesterol level
|
J:82520
|
decreased circulating LDL cholesterol level
|
J:82520
|
Cul3tm1.1Arte/Cul3+
(involves: C57BL/6J * C57BL/6N)
|
increased circulating aldosterone level
|
J:229424
|
Cx3cl1tm1Sgs/Cx3cl1tm1Sgs Ldlrtm1Her/Ldlr+
(involves: B6.129S4-Cx3cl1tm1Sgs * B6.129S7-Ldlrtm1Her/J)
|
decreased circulating cholesterol level
|
J:95279
|
decreased circulating LDL cholesterol level
|
J:95279
|
Cx3cl1tm1Sgs/Cx3cl1tm1Sgs Ldlrtm1Her/Ldlrtm1Her
(involves: B6.129S4-Cx3cl1tm1Sgs * B6.129S7-Ldlrtm1Her/J)
|
decreased circulating cholesterol level
|
J:95279
|
decreased circulating LDL cholesterol level
|
J:95279
|
Cxcl9tm1b(EUCOMM)Wtsi/Cxcl9tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl9tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA)
|
decreased circulating cholesterol level
|
J:126841
|
decreased liver triglyceride level
|
J:126841
|
Cyb5d1tm1.1(KOMP)Vlcg/Cyb5d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cyb5d1tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN)
|
hyperlipidemia
|
J:91486
|
Cyb561tm1a(EUCOMM)Wtsi/Cyb561tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Cyb561tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
Cyb561tm1b(EUCOMM)Wtsi/Cyb561tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyb561tm1b(EUCOMM)Wtsi/H)
|
increased circulating triglyceride level
|
J:211773
|
Cybbtm1.1Abk/Cybbtm1.1Abk Lyz2tm1(cre)Ifo/?
(B6.Cg-Lyz2tm1(cre)Ifo Cybbtm1.1Abk)
|
decreased cholesterol level
|
J:245699
|
decreased circulating LDL cholesterol level
|
J:245699
|
decreased triglyceride level
|
J:245699
|
increased circulating HDL cholesterol level
|
J:245699
|
Cybrd1tm1b(EUCOMM)Hmgu/Cybrd1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cybrd1tm1b(EUCOMM)Hmgu/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Cygbtm1b(EUCOMM)Wtsi/Cygbtm1b(EUCOMM)Wtsi
(C57BL/6N-Cygbtm1b(EUCOMM)Wtsi/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
Cyp2a12em1Utr/Cyp2a12em1Utr Cyp2c70em1Utr/Cyp2c70em1Utr
(C57BL/6J-Cyp2a12em1Utr Cyp2c70em1Utr)
|
decreased bile salt level
|
J:302190
|
decreased circulating cholesterol level
|
J:302190
|
decreased feces bile salt level
|
J:302190
|
Cyp2c23Gt(OST85045)Lex/Cyp2c23Gt(OST85045)Lex
(129-Cyp2c23Gt(OST85045)Lex)
|
decreased circulating aldosterone level
|
J:204734
|
Cyp2c23tm1b(EUCOMM)Hmgu/Cyp2c23tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp2c23tm1b(EUCOMM)Hmgu/J)
|
increased circulating cholesterol level
|
J:211773
|
Cyp2c70em1Sjka/Cyp2c70em1Sjka
(C57BL/6-Cyp2c70em1Sjka)
|
increased bile salt level
|
J:330641
|
Cyp2c70em1Utr/Cyp2c70em1Utr
(C57BL/6J-Cyp2c70em1Utr)
|
decreased bile salt level
|
J:302190
|
decreased feces bile salt level
|
J:302190
|
increased circulating cholesterol level
|
J:302190
|
increased liver cholesterol level
|
J:302190
|
Cyp2ctm1104Arte/Cyp2ctm1104Arte
(B6NTac(Cg)-Cyp2ctm1104Arte/Arte)
|
decreased circulating cholesterol level
|
J:241121
|
decreased circulating HDL cholesterol level
|
J:241121
|
Cyp2r1tm1(KOMP)Vlcg/Cyp2r1+
(involves: C57BL/6NTac)
|
abnormal vitamin D level
|
J:223194
|
Cyp2r1tm1(KOMP)Vlcg/Cyp2r1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal vitamin D level
|
J:223194
|
Cyp4b1tm1b(KOMP)Wtsi/Cyp4b1tm1b(KOMP)Wtsi
(C57BL/6N-Cyp4b1tm1b(KOMP)Wtsi/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Cyp4f18tm1.1Pchr/Cyp4f18tm1.1Pchr
(B6.Cg-Cyp4f18tm1.1Pchr)
|
decreased leukotriene level
|
J:212489
|
Cyp4f39em1Akih/Cyp4f39em1Akih
(C57BL/6J-Cyp4f39em1Akih)
|
decreased ceramide level
|
J:286705
|
Cyp4v3tm1(KOMP)Vlcg/Cyp4v3tm1(KOMP)Vlcg
(B6(Cg)-Cyp4v3tm1(KOMP)Vlcg)
|
abnormal fatty acids level
|
J:230232
|
Cyp7a1tm1b(EUCOMM)Wtsi/Cyp7a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp7a1tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cyp7a1tm1Rus/Cyp7a1tm1Rus
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal bile salt level
|
J:34870
|
steatorrhea
|
J:34342
|
Cyp8b1tm1Rus/Cyp8b1tm1Rus
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal bile salt level
|
J:100206
|
decreased circulating cholesterol level
|
J:100246
|
steatorrhea
|
J:100206
|
Cyp11a1tm1.1Bcc/Cyp11a1tm1.1Bcc
(B6.129(FVB)-Cyp11a1tm1.1Bcc)
|
abnormal corticosterone level
|
J:191801
|
Cyp11a1tm1Bcc/Cyp11a1tm1Bcc
(involves: 129 * C57BL/6)
|
abnormal lipid level
|
J:78062
|
decreased circulating aldosterone level
|
J:78062
|
decreased circulating corticosterone level
|
J:78062
|
Cyp11a1tm2Bcc/Cyp11a1tm2Bcc
(Not Specified)
|
decreased circulating corticosterone level
|
J:133007
|
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating corticosterone level
|
J:147610
|
decreased urine corticosterone level
|
J:147610
|
Cyp11b2tm1Hsk/Cyp11b2tm1Hsk
(involves: 129S6/SvEvTac)
|
decreased circulating aldosterone level
|
J:99269
|
increased circulating corticosterone level
|
J:99269
|
Cyp17a1tm1b(EUCOMM)Wtsi/Cyp17a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp17a1tm1b(EUCOMM)Wtsi/Nju)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac)
|
increased circulating cholesterol level
|
J:65805
|
increased circulating HDL cholesterol level
|
J:65805
|
increased circulating triglyceride level
|
J:65805
|
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating cholesterol level
|
J:82070
|
increased circulating triglyceride level
|
J:82070
|
Cyp24a1tm1Star/Cyp24a1tm1Star
(involves: 129S4/SvJae)
|
abnormal vitamin D level
|
J:63457
|
Cyp27a1tm1.1(KOMP)Vlcg/Cyp27a1tm1.1(KOMP)Vlcg
(C57BL/6N-Cyp27a1tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(involves: 129/Sv * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:48127
|
abnormal feces lipid level
|
J:115373
|
decreased bile salt level
|
J:115373
|
decreased feces bile salt level
|
J:115373
|
decreased lung cholesterol level
|
J:115373
|
increased cholesterol level
|
J:115373,
J:48127
|
increased circulating cholesterol level
|
J:115373
|
increased circulating triglyceride level
|
J:115373
|
increased circulating VLDL cholesterol level
|
J:115373
|
increased circulating VLDL triglyceride level
|
J:115373
|
increased fatty acids level
|
J:115373
|
increased liver triglyceride level
|
J:115373
|
increased sterol level
|
J:115373
|
increased vitamin D level
|
J:48127
|
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(B6.129-Cyp27a1tm1Elt/J)
|
abnormal vitamin D level
|
J:223194
|
Cyp27a1tm1Elt/Cyp27a1tm1Elt Cyp2r1tm1(KOMP)Vlcg/Cyp2r1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
abnormal vitamin D level
|
J:223194
|
Cysltr2tm1Ykn/Cysltr2tm1Ykn
(C57BL/6-Cysltr2tm1Ykn)
|
abnormal prostaglandin level
|
J:94488
|
Cyth3tm2a(KOMP)Wtsi/Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi)
|
abnormal feces lipid level
|
J:272118
|
decreased circulating triglyceride level
|
J:272118
|
decreased liver triglyceride level
|
J:272118
|
D6Wsu163etm1b(EUCOMM)Wtsi/D6Wsu163etm1b(EUCOMM)Wtsi
(C57BL/6N-D6Wsu163etm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
D630045J12Riktm1b(KOMP)Wtsi/D630045J12Riktm1b(KOMP)Wtsi
(C57BL/6N-D630045J12Riktm1b(KOMP)Wtsi/Tcp)
|
decreased circulating triglyceride level
|
J:211773
|
Dab2tm2.1Xxx/Dab2tm2.2Xxx Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:205046
|
increased circulating LDL cholesterol level
|
J:205046
|
Daglatm1Pado/Daglatm1Pado
(C57BL/6-Daglatm1Pado)
|
abnormal lipid level
|
J:157850
|
DaglbGt(OST195261)Lex/DaglbGt(OST195261)Lex
(B6.129S5-DaglbGt(OST195261)Lex)
|
abnormal lipid level
|
J:157850
|
Daptm1a(KOMP)Mbp/Daptm1a(KOMP)Mbp
(C57BL/6N-Daptm1a(KOMP)Mbp/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Dars2tm1a(KOMP)Wtsi/Dars2+
(C57BL/6N-Dars2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Dbhtm1Rpa/Dbhtm1Rpa
(either: (involves: 129S7/SvEvBrd * 129/SvCpj) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
increased circulating corticosterone level
|
J:97566
|
Dbhtm1Rpa/Dbhtm1Rpa
(involves: 129S7/SvEvBrd * 129/SvCPJ * C57BL/6J)
|
increased circulating corticosterone level
|
J:85772
|
Dbitm1Smdp/Dbitm1Smdp
(B6JBomTac.129-Dbitm1Smdp)
|
increased circulating cholesterol level
|
J:168744
|
increased liver cholesterol level
|
J:168744
|
increased liver triglyceride level
|
J:168744
|
Dbitm1Smdp/Dbitm1Smdp
(involves: 129S1/Sv * 129X1/SvJ)
|
increased liver cholesterol level
|
J:204137
|
increased liver triglyceride level
|
J:204137
|
Dbitm2.1Smdp/Dbitm2.2Smdp Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
increased liver cholesterol level
|
J:204137
|
Dbn1tm1a(KOMP)Wtsi/Dbn1tm1a(KOMP)Wtsi
(C57BL/6N-Dbn1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Bay)
|
decreased circulating cholesterol level
|
J:211773
|
Dbnltm1b(KOMP)Wtsi/Dbnltm1b(KOMP)Wtsi
(C57BL/6N-Dbnltm1b(KOMP)Wtsi/Orl)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Dbptm1Schb/Dbptm1Schb Hlftm1Schb/Hlftm1Schb Teftm1Schb/Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased circulating aldosterone level
|
J:164398
|
Dctn4em1(IMPC)Wtsi/Dctn4+
(C57BL/6N-Dctn4em1(IMPC)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Dcun1d3em1(IMPC)Wtsi/Dcun1d3em1(IMPC)Wtsi
(C57BL/6N-Dcun1d3em1(IMPC)Wtsi/WtsiIeg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ddctm1.1Rhrs/Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn/0
(involves: 129 * C57BL/6 * SJL)
|
decreased circulating aldosterone level
|
J:175630
|
Ddctm1.1Rhrs/Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn/0
(129.Cg-Ddctm1.1Rhrs Tg(Ggt1-cre)M3Egn)
|
decreased circulating aldosterone level
|
J:175630
|
Ddhd2tm1Crv/Ddhd2tm1Crv
(involves: C57BL/6)
|
abnormal lipid level
|
J:216446
|
increased triglyceride level
|
J:216446
|
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J)
|
increased cholesterol level
|
J:214136
|
Ddx51tm1a(KOMP)Wtsi/Ddx51+
(C57BL/6N-Ddx51tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Decr1tm1Jkh/Decr1tm1Jkh
(B6.129X1-Decr1tm1Jkh)
|
increased fatty acids level
|
J:151622
|
Defb14tm1b(KOMP)Wtsi/Defb14tm1b(KOMP)Wtsi
(C57BL/6N-Defb14tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:211773
|
Degs1Gt(OST368559)Lex/Degs1+
(involves: 129S5/SvEvBrd)
|
abnormal ceramide level
|
J:203554
|
Degs1Gt(OST368559)Lex/Degs1Gt(OST368559)Lex
(involves: 129S5/SvEvBrd)
|
abnormal ceramide level
|
J:203554
|
Degs2tm1Akih/Degs2tm1Akih
(Not Specified)
|
decreased ceramide level
|
J:335270
|
Del(6Ephb6-Trpv6)1Mhed/Del(6Ephb6-Trpv6)1Mhed
(involves: 129S/SvEv)
|
abnormal vitamin D level
|
J:133151
|
Del(6Slco1b2-Slco1a5)1Nki/+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased bile salt level
|
J:163765
|
increased circulating HDL cholesterol level
|
J:163765
|
increased circulating triglyceride level
|
J:163765
|
Del(7Ffar2-Ffar3)1Soff/Del(7Ffar2-Ffar3)1Soff
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating free fatty acids level
|
J:227939
|
Del(7Saa1-Saa2)1Itl/Del(7Saa1-Saa2)1Itl
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
increased circulating cholesterol level
|
J:165605
|
increased circulating phospholipid level
|
J:165605
|
Del(9Apoa1-Apoa4)1Hmez/Del(9Apoa1-Apoa4)1Hmez
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:109005
|
decreased circulating HDL cholesterol level
|
J:109005
|
decreased circulating triglyceride level
|
J:109005
|
Del(11Irf1-D11Mit23)1Rub/+
(129/Sv-Del(11Irf1-D11Mit23)1Rub)
|
increased circulating VLDL triglyceride level
|
J:60187
|
Del(11Irf1-D11Mit23)1Rub/Del(11Irf1-D11Mit23)1Rub
(129/Sv-Del(11Irf1-D11Mit23)1Rub)
|
increased cardiac muscle triglyceride level
|
J:60187
|
increased cholesterol level
|
J:60187
|
increased circulating free fatty acids level
|
J:60187
|
increased circulating triglyceride level
|
J:60187
|
increased circulating VLDL triglyceride level
|
J:60187
|
increased liver cholesterol level
|
J:60187
|
increased liver triglyceride level
|
J:60187
|
Del(17Abcg5-Abcg8)1Hobb/Del(17Abcg5-Abcg8)1Hobb
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating cholesterol level
|
J:80679
|
decreased liver cholesterol level
|
J:80679
|
increased circulating cholesterol level
|
J:80679
|
increased circulating phytosterol level
|
J:80679
|
increased liver cholesterol level
|
J:80679
|
Dennd5bem1(IMPC)Tcp/Dennd5bem1(IMPC)Tcp
(C57BL/6N-Dennd5bem1(IMPC)Tcp/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Dennd5bem1Smgo/Dennd5bem1Smgo
(involves: C57BL/6 * CBA)
|
abnormal circulating lipid level
|
J:276600
|
decreased circulating HDL cholesterol level
|
J:276600
|
decreased liver cholesterol level
|
J:276600
|
decreased liver free fatty acids level
|
J:276600
|
increased circulating VLDL triglyceride level
|
J:276600
|
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
decreased liver cholesterol level
|
J:111346
|
decreased liver triglyceride level
|
J:111346
|
Dgat1tm1Ryyo/Dgat1tm1Ryyo
(involves: C57BL/6)
|
decreased circulating triglyceride level
|
J:155626
|
Dgat2tm1Far/Dgat2tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal lipid level
|
J:88742
|
abnormal phospholipid level
|
J:88742
|
decreased circulating free fatty acids level
|
J:88742
|
decreased circulating triglyceride level
|
J:88742
|
decreased fatty acids level
|
J:88742
|
decreased liver triglyceride level
|
J:88742
|
decreased triglyceride level
|
J:88742
|
decreased unsaturated fatty acids level
|
J:88742
|
DgkbTn(sb-lacZ,GFP)IR3.PV122Jtak/DgkbTn(sb-lacZ,GFP)IR3.PV122Jtak
(involves: C3H * C57BL/6 * DBA/2 * ICR)
|
abnormal lipid level
|
J:163104
|
Dgkiem1(IMPC)Wtsi/Dgkiem1(IMPC)Wtsi
(C57BL/6N-Dgkiem1(IMPC)Wtsi/Wtsi)
|
increased circulating glycerol level
|
J:295189,
J:211773
|
Dgkkem1(IMPC)Ics/Y
(C57BL/6N-Dgkkem1(IMPC)Ics/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N)
|
increased circulating cholesterol level
|
J:294620
|
Dhcr7tm1.1Sbpa/Dhcr7tm1.1Sbpa Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Dhcr7tm1.1Sbpa Speer6-ps1Tg(Alb-cre)21Mgn)
|
abnormal sterol level
|
J:303316
|
decreased liver cholesterol level
|
J:303316
|
increased bile salt level
|
J:303316
|
Dhcr7tm1Fdp/Dhcr7tm1Fdp
(involves: 129S4/SvJae)
|
decreased cholesterol level
|
J:68084
|
Dhcr7tm1Fdp/Dhcr7tm2Fdp
(involves: 129S4/SvJae)
|
abnormal cholesterol level
|
J:106758
|
decreased cholesterol level
|
J:106758
|
Dhcr7tm1Gst/Dhcr7tm1Gst
(involves: 129P2/OlaHsd)
|
abnormal lipid level
|
J:71611
|
decreased brain cholesterol level
|
J:71611
|
decreased liver cholesterol level
|
J:71611
|
Dhcr7tm1Gst/Dhcr7tm1Gst
(B6.129P2-Dhcr7tm1Gst)
|
decreased lung cholesterol level
|
J:93296
|
decreased sterol level
|
J:93296
|
increased circulating corticosterone level
|
J:93296
|
Dhcr7tm1Gst/Dhcr7tm1Gst Tg(APOE-DHCR7)2Hoyu/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6J * FVB/N)
|
decreased brain cholesterol level
|
J:141730
|
decreased circulating cholesterol level
|
J:141730
|
decreased liver cholesterol level
|
J:141730
|
decreased lung cholesterol level
|
J:141730
|
Dhcr7tm2Fdp/Dhcr7tm2Fdp
(involves: 129S4/SvJae)
|
abnormal cholesterol level
|
J:106758
|
decreased cholesterol level
|
J:106758
|
Dhcr24tm1a(EUCOMM)Wtsi/Dhcr24+
(B6JTyr;B6N-Dhcr24tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating triglyceride level
|
J:175295
|
Dhcr24tm1c(EUCOMM)Wtsi/Dhcr24tm1c(EUCOMM)Wtsi Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * C57BL/6N)
|
abnormal sterol level
|
J:304449
|
decreased circulating cholesterol level
|
J:304449
|
Dhcr24tm1c(EUCOMM)Wtsi/Dhcr24tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Dhcr24tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn)
|
abnormal sterol level
|
J:304449
|
decreased liver cholesterol level
|
J:304449
|
Dhcr24tm1Lex/Dhcr24tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:87402
|
decreased circulating cholesterol level
|
J:87402
|
Dhrs7bem1(IMPC)Mbp/Dhrs7b+
(C57BL/6NCrl-Dhrs7bem1(IMPC)Mbp/MbpMmucd)
|
increased circulating HDL cholesterol level
|
J:211773
|
Dhtkd1tm1Mmgu/Dhtkd1tm1Mmgu
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:288186
|
decreased circulating glycerol level
|
J:288186
|
decreased circulating triglyceride level
|
J:288186
|
increased circulating phospholipid level
|
J:288186
|
Dhx30tm1.1(KOMP)Vlcg/Dhx30+
(C57BL/6N-Dhx30tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Dhx40tm1(NCOM)Cmhd/Dhx40tm1(NCOM)Cmhd
(C57BL/6N-Dhx40tm1(NCOM)Cmhd/Tcp)
|
decreased circulating cholesterol level
|
J:165965
|
Diaph3tm1b(KOMP)Mbp/Diaph3+
(C57BL/6N-Diaph3tm1b(KOMP)Mbp/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Dido1tm3Cmar/Dido1tm3.1Cmar Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6)
|
increased circulating cholesterol level
|
J:328215
|
Dio1tm1Vag/Dio1tm1Vag
(involves: 129 * C57BL/6)
|
decreased circulating cholesterol level
|
J:104508
|
Dip2btm1a(EUCOMM)Wtsi/Dip2b+
(B6JTyr;B6N-Dip2btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating free fatty acids level
|
J:175295
|
Dkk3tm1Cni/Dkk3tm1Cni
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating aldosterone level
|
J:188335
|
Dkk3tm1Cni/Dkk3tm1Cni Kcnk3tm1Sgb/Kcnk3tm1Sgb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating aldosterone level
|
J:188335
|
Dlg4tm2.1Grnt/Dlg4tm2.1Grnt
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating corticosterone level
|
J:175436
|
Dlk1tm1Hsul/Dlk1tm1Hsul
(either: (involves: 129 * BALB/c) or (involves: 129 * C57BL/6J))
|
hyperlipidemia
|
J:77909
|
increased circulating cholesterol level
|
J:77909
|
Dll1m1Mhda/Dll1+
(C3HeB/FeJ-Dll1m1Mhda)
|
decreased circulating cholesterol level
|
J:150183
|
decreased circulating triglyceride level
|
J:150183
|
Dll1tm1Gos/Dll1+
(C3Fe.129-Dll1tm1Gos)
|
decreased circulating cholesterol level
|
J:150183
|
decreased circulating triglyceride level
|
J:150183
|
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2+
(C57BL/6N-Atm1Brd Dmxl2tm1a(EUCOMM)Wtsi/WtsiH)
|
decreased circulating cholesterol level
|
J:211773
|
Dnajc2em1(IMPC)J/Dnajc2+
(C57BL/6NJ-Dnajc2em1(IMPC)J/Mmjax)
|
increased circulating triglyceride level
|
J:211773
|
Dnajc7tm1.2Neg/Dnajc7tm1.2Neg
(involves: 129S/SvEv * C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:225381
|
Dnajc9tm1.1(KOMP)Vlcg/Dnajc9+
(C57BL/6N-Dnajc9tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg)
|
decreased circulating free fatty acids level
|
J:204025
|
decreased circulating triglyceride level
|
J:204025
|
decreased liver cholesterol level
|
J:204025
|
Dnase2btm1a(EUCOMM)Hmgu/Dnase2btm1a(EUCOMM)Hmgu
(C57BL/6N-Dnase2btm1a(EUCOMM)Hmgu/H)
|
increased circulating HDL cholesterol level
|
J:165965
|
Dnmt3atm1b(KOMP)Wtsi/Dnmt3a+
(C57BL/6N-Dnmt3atm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Dntttm2b(KOMP)Wtsi/Dntttm2b(KOMP)Wtsi
(C57BL/6N-Dntttm2b(KOMP)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Dop1btm1a(EUCOMM)Wtsi/Dop1btm1a(EUCOMM)Wtsi
(C57BL/6N-Dop1btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating glycerol level
|
J:211773
|
Dpp9tm1a(EUCOMM)Hmgu/Dpp9+
(C57BL/6N-Dpp9tm1a(EUCOMM)Hmgu/Cnrm)
|
decreased circulating triglyceride level
|
J:165965
|
Dpy19l3tm1a(EUCOMM)Wtsi/Dpy19l3tm1a(EUCOMM)Wtsi
(C57BL/6N-Dpy19l3tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating free fatty acids level
|
J:165965
|
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating corticosterone level
|
J:110599
|
Dsg1cem1(IMPC)Mbp/Dsg1cem1(IMPC)Mbp
(C57BL/6N-Dsg1cem1(IMPC)Mbp/Ucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Dtx1em1(IMPC)H/Dtx1em1(IMPC)H
(C57BL/6N-Dtx1em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
Duox2em1(IMPC)Mbp/Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Duoxa2tm1b(KOMP)Wtsi/Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating cholesterol level
|
J:129718
|
decreased circulating free fatty acids level
|
J:129718
|
decreased circulating triglyceride level
|
J:129718
|
Dusp1tm1Lex/Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased prostaglandin level
|
J:126383
|
Dusp3tm1b(KOMP)Wtsi/Dusp3tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Dusp3tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating glycerol level
|
J:211773
|
Dusp7tm1(KOMP)Wtsi/Dusp7tm1(KOMP)Wtsi
(C57BL/6N-Dusp7tm1(KOMP)Wtsi/Nju)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Dusp16em1(IMPC)Tcp/Dusp16em1(IMPC)Tcp
(C57BL/6NCrl-Dusp16em1(IMPC)Tcp/Tcp)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Dusp26em1Jhxia/Dusp26em1Jhxia Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased liver cholesterol level
|
J:279111
|
increased liver free fatty acids level
|
J:279111
|
increased liver triglyceride level
|
J:279111
|
Dusp26tm1a(KOMP)Wtsi/Dusp26tm1a(KOMP)Wtsi
(C57BL/6N-Dusp26tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
Dymem1(IMPC)Tcp/Dymem1(IMPC)Tcp
(C57BL/6N-Dymem1(IMPC)Tcp/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Dync1i2tm1a(EUCOMM)Wtsi/Dync1i2+
(C57BL/6N-Dync1i2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
E2f1tm1Meg/E2f1tm1Meg E2f3tm2.1Gle/E2f3tm2.1Gle
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
decreased circulating triglyceride level
|
J:138289
|
E130308A19Rikem1(IMPC)J/E130308A19Rikem1(IMPC)J
(C57BL/6NJ-E130308A19Rikem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Echdc1em1(IMPC)J/Echdc1em1(IMPC)J
(C57BL/6NJ-Echdc1em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:346664
|
increased circulating LDL cholesterol level
|
J:346664
|
increased circulating triglyceride level
|
J:346664
|
increased circulating VLDL cholesterol level
|
J:346664
|
increased circulating VLDL triglyceride level
|
J:346664
|
Echs1em1Jynz/Echs1+
(C57BL/6-Echs1em1Jynz)
|
abnormal free fatty acids level
|
J:283707
|
abnormal lipid level
|
J:283707
|
Eci1tm1Wst/Eci1tm1Wst
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lipid level
|
J:76763
|
increased triglyceride level
|
J:76763
|
increased unsaturated fatty acids level
|
J:76763
|
Ecrg4tm1b(EUCOMM)Hmgu/Ecrg4tm1b(EUCOMM)Hmgu
(C57BL/6N-Ecrg4tm1b(EUCOMM)Hmgu/Orl)
|
increased circulating cholesterol level
|
J:211773
|
Ecscrtm1a(KOMP)Wtsi/Ecscrtm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
increased circulating free fatty acids level
|
J:236657
|
increased circulating glycerol level
|
J:236657
|
increased circulating triglyceride level
|
J:236657
|
Edaraddcr/Edaraddcr
(B6C3Fe a/a-Edaraddcr/J)
|
abnormal lipid level
|
J:5870
|
Edem1em1(IMPC)Kmpc/Edem1em1(IMPC)Kmpc
(C57BL/6NTac-Edem1em1(IMPC)Kmpc/Kmpc)
|
increased circulating HDL cholesterol level
|
J:211773
|
Eftud2tm1b(KOMP)Wtsi/Eftud2+
(C57BL/6N-Eftud2tm1b(KOMP)Wtsi/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
|
increased liver triglyceride level
|
J:105638
|
Ehd2tm1.1Cbm/Ehd2tm1.1Cbm
(B6N.129(Cg)-Ehd2tm1.1Cbm)
|
decreased circulating free fatty acids level
|
J:285350
|
Ehhadhtm1Jkr/Ehhadhtm1Jkr Hsd17b4tm1Baes/Hsd17b4tm1Baes
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal bile salt level
|
J:99925
|
abnormal lipid level
|
J:89945,
J:104835
|
decreased fatty acids level
|
J:89945
|
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara Tg(Adipoq-cre)1Evdr/0
(involves: 129P2/OlaHsd * FVB/NJ)
|
increased circulating free fatty acids level
|
J:207678
|
increased liver triglyceride level
|
J:207678
|
Ehmt1tm1b(EUCOMM)Hmgu/Ehmt1+
(C57BL/6N-Ehmt1tm1b(EUCOMM)Hmgu/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Eif2ak3tm1Dron/Eif2ak3tm1Dron
(involves: 129S6/SvEvTac * Swiss Webster)
|
steatorrhea
|
J:70005
|
Eif4e3tm1a(KOMP)Wtsi/Eif4e3tm1a(KOMP)Wtsi
(B6JTyr;B6N-Eif4e3tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Elk3em1(IMPC)Ics/Elk3+
(C57BL/6N-Elk3em1(IMPC)Ics/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Elk4tm1a(EUCOMM)Wtsi/Elk4tm1a(EUCOMM)Wtsi
(C57BL/6N-Elk4tm1a(EUCOMM)Wtsi/H)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating HDL cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Elk4tm1a(EUCOMM)Wtsi/Elk4tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating glycerol level
|
J:165965
|
Elmod1tm1a(EUCOMM)Hmgu/Elmod1tm1a(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1a(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating HDL cholesterol level
|
J:165965
|
Elmod2tm1b(EUCOMM)Hmgu/Elmod2+
(C57BL/6N-Elmod2tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Elovl1tm1.1Akih/Elovl1tm1.1Akih
(involves: 129P2/OlaHsd * C57BL * C57BL/6J * DBA)
|
abnormal ceramide level
|
J:204477
|
abnormal phospholipid level
|
J:204477
|
abnormal sphingomyelin level
|
J:204477
|
Elovl2em1Haml/Elovl2em1Haml
(C57BL/6N-Elovl2em1Haml)
|
decreased unsaturated fatty acids level
|
J:284063
|
increased unsaturated fatty acids level
|
J:284063
|
Elovl2tm1Jaco/Elovl2tm1Jaco
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased fatty acids level
|
J:168856
|
Elovl4tm1Rayy/Elovl4+
(involves: 129 * C57BL/6J)
|
abnormal fatty acids level
|
J:114752
|
Elovl4tm3Kzh/Elovl4tm3Kzh Tg(Rho-cre)#Yzl/?
(Not Specified)
|
decreased unsaturated fatty acids level
|
J:194246
|
Elovl4tm3Kzh/Elovl4tm3Kzh Tg(Rho-icre)1Ck/?
(involves: C57BL/6 * SJL)
|
decreased unsaturated fatty acids level
|
J:194246
|
Elovl5em1(IMPC)Tcp/Elovl5em1(IMPC)Tcp
(C57BL/6NCrl-Elovl5em1(IMPC)Tcp/Tcp)
|
increased circulating HDL cholesterol level
|
J:211773
|
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(B6;129S5-Elovl6Gt(OST222498)Lex/Orl)
|
decreased circulating cholesterol level
|
J:82809
|
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal fatty acids level
|
J:130031
|
Elovl6tm1b(EUCOMM)Hmgu/Elovl6tm1b(EUCOMM)Hmgu
(C57BL/6N-Elovl6tm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Emcnem1(IMPC)Wtsi/Emcnem1(IMPC)Wtsi
(C57BL/6N-Emcnem1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Emid1tm1a(EUCOMM)Wtsi/Emid1tm1a(EUCOMM)Wtsi
(C57BL/6N-Emid1tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating free fatty acids level
|
J:165965
|
EnamAbte2/Enam+
(C3HeB/FeJ-EnamAbte2)
|
decreased circulating cholesterol level
|
J:220423
|
decreased circulating triglyceride level
|
J:220423
|
Enamabte/Enam+
(C3HeB/FeJ-Enamabte)
|
decreased circulating cholesterol level
|
J:220423
|
Enc1tm1a(EUCOMM)Wtsi/Enc1tm1a(EUCOMM)Wtsi
(C57BL/6N-Enc1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Enhotm1.1Butl/Enho+
(B6.Cg-Enhotm1.1Butl)
|
increased liver triglyceride level
|
J:225402
|
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl)
|
increased circulating triglyceride level
|
J:225402
|
increased liver triglyceride level
|
J:225402
|
Entpd1tm1a(EUCOMM)Wtsi/Entpd1tm1a(EUCOMM)Wtsi
(C57BL/6N-Entpd1tm1a(EUCOMM)Wtsi/Ieg)
|
decreased circulating glycerol level
|
J:165965
|
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased cholesterol level
|
J:163795
|
decreased triglyceride level
|
J:163795
|
Entr1em1(IMPC)Mbp/Entr1em1(IMPC)Mbp
(C57BL/6N-Entr1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Epb41l5tm1a(EUCOMM)Hmgu/Epb41l5+
(C57BL/6N-Epb41l5tm1a(EUCOMM)Hmgu/H)
|
decreased circulating glycerol level
|
J:165965
|
Ephx2tm1Gonz/Ephx2tm1Gonz
(B6.129X1-Ephx2tm1Gonz)
|
abnormal lipid level
|
J:208344
|
epi/?
(involves: CBA/J)
|
abnormal feces lipid level
|
J:5421
|
steatorrhea
|
J:5421
|
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating cholesterol level
|
J:173769
|
increased circulating free fatty acids level
|
J:173769
|
increased circulating triglyceride level
|
J:173769
|
increased liver cholesterol level
|
J:173769
|
increased liver triglyceride level
|
J:173769
|
Eps8l2tm1b(EUCOMM)Wtsi/Eps8l2tm1b(EUCOMM)Wtsi
(C57BL/6N-Eps8l2tm1b(EUCOMM)Wtsi/H)
|
decreased circulating cholesterol level
|
J:211773
|
Eps15tm1a(KOMP)Wtsi/Eps15tm1a(KOMP)Wtsi
(B6JTyr;B6N-Eps15tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:175295
|
increased circulating LDL cholesterol level
|
J:175295
|
Epxtm1b(EUCOMM)Wtsi/Epxtm1b(EUCOMM)Wtsi
(C57BL/6N-Epxtm1b(EUCOMM)Wtsi/Orl)
|
increased circulating triglyceride level
|
J:211773
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
increased liver triglyceride level
|
J:117488
|
Ercc8em1(IMPC)H/Ercc8em1(IMPC)H
(C57BL/6N-Ercc8em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ermnem1(IMPC)H/Ermnem1(IMPC)H
(C57BL/6N-Ermnem1(IMPC)H/H)
|
increased circulating triglyceride level
|
J:211773
|
Ern1tm1Rjk/Ern1tm2.1Rjk Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal lipid level
|
J:171230
|
decreased circulating cholesterol level
|
J:171230
|
increased liver triglyceride level
|
J:171230
|
Esco1tm1(KOMP)Wtsi/Esco1tm1(KOMP)Wtsi
(C57BL/6N-Esco1tm1(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating cholesterol level
|
J:66077
|
increased circulating HDL cholesterol level
|
J:66077
|
Esr1tm1Ksk/Esr1tm1Ksk Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating cholesterol level
|
J:66077
|
increased circulating HDL cholesterol level
|
J:66077
|
Esrratm1Vgi/Esrratm1Vgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased triglyceride level
|
J:119525
|
Etnppltm1.2Mrl/Etnppltm1.2Mrl
(C57BL/6-Etnppltm1.2Mrl/Tac)
|
abnormal phospholipid level
|
J:309545
|
Etv6em1(IMPC)Rbrc/Etv6+
(C57BL/6NJcl-Etv6em1(IMPC)Rbrc/Rbrc)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ezh2tm1a(EUCOMM)Wtsi/Ezh2+
(C57BL/6N-Ezh2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:175295
|
Fa2hem1(IMPC)Mbp/Fa2hem1(IMPC)Mbp
(C57BL/6NCrl-Fa2hem1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Fa2htm1.1Hama/Fa2htm1.1Hama
(involves: 129 * C57BL/6)
|
abnormal galactolipid level
|
J:171655
|
abnormal lipid level
|
J:171655
|
decreased cholesterol level
|
J:171655
|
Fa2htm1Hama/Fa2htm1Hama Cnptm1(cre)Kan/Cnp+
(involves: 129 * C57BL/6)
|
abnormal galactolipid level
|
J:171655
|
abnormal lipid level
|
J:171655
|
Faahtm1.1Flee/Faah+
(B6.Cg-Faahtm1.1Flee)
|
increased anandamide level
|
J:221783
|
Faahtm1.1Flee/Faahtm1.1Flee
(B6.Cg-Faahtm1.1Flee)
|
increased anandamide level
|
J:221783
|
Fabp1tm1Ddsn/Fabp1tm1Ddsn
(involves: 129X1/SvJ * C57BL/6)
|
abnormal lipid level
|
J:87278
|
decreased liver triglyceride level
|
J:87278
|
Fabp2tm1Mto/Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto)
|
abnormal circulating lipid level
|
J:64975
|
decreased circulating cholesterol level
|
J:64975
|
increased circulating glycerol level
|
J:64975
|
Fabp3Gt(XE705)Byg/Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal free fatty acids level
|
J:167535
|
abnormal triglyceride level
|
J:167535
|
decreased fatty acids level
|
J:167535
|
decreased triglyceride level
|
J:167535
|
increased circulating free fatty acids level
|
J:167535
|
increased circulating triglyceride level
|
J:167535
|
increased fatty acids level
|
J:167535
|
increased triglyceride level
|
J:167535
|
Fabp3tm1Bin/Fabp3tm1Bin
(involves: 129P2/OlaHsd * BALB/c)
|
increased circulating free fatty acids level
|
J:54614
|
Fabp4tm1Brsp/Fabp4tm1Brsp
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased circulating triglyceride level
|
J:37027
|
increased fatty acids level
|
J:37027
|
Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
decreased triglyceride level
|
J:217245
|
increased circulating free fatty acids level
|
J:217245
|
Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob)
|
decreased circulating cholesterol level
|
J:111878
|
decreased circulating triglyceride level
|
J:111878
|
decreased liver triglyceride level
|
J:111878
|
increased fatty acids level
|
J:111878
|
Fabp6tm1Lbal/Fabp6tm1Lbal
(B6.129-Fabp6tm1Lbal)
|
decreased circulating cholesterol level
|
J:195544
|
decreased circulating triglyceride level
|
J:195544
|
decreased liver cholesterol level
|
J:195544
|
increased bile salt level
|
J:195544
|
Fabp7tm1Owad/Fabp7tm1Owad
(B6.Cg-Fabp7tm1Owad)
|
decreased fatty acids level
|
J:111540
|
Fads1Gt(IST11525H2)Tigm/Fads1+
(C57BL/6-Fads1Gt(IST11525H2)Tigm)
|
decreased prostaglandin level
|
J:186265
|
increased prostaglandin level
|
J:186265
|
Fads1Gt(IST11525H2)Tigm/Fads1Gt(IST11525H2)Tigm
(C57BL/6-Fads1Gt(IST11525H2)Tigm)
|
abnormal circulating lipid level
|
J:186265
|
abnormal lipid level
|
J:186265
|
decreased prostaglandin level
|
J:186265
|
increased prostaglandin level
|
J:186265
|
Fads1tm1.1(KOMP)Vlcg/Fads1tm1.1(KOMP)Vlcg
(C57BL/6N-Fads1tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Fads2tm1Mtna/Fads2tm1Mtna
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased liver triglyceride level
|
J:153293
|
Fads2tm1Wst/Fads2tm1Wst
(involves: 129P2/OlaHsd)
|
decreased prostaglandin level
|
J:140341
|
decreased thromboxane level
|
J:140341
|
decreased unsaturated fatty acids level
|
J:140341
|
Fads3tm1a(KOMP)Wtsi/Fads3tm1a(KOMP)Wtsi
(C57BL/6-Fads3tm1a(KOMP)Wtsi)
|
decreased fatty acids level
|
J:256005
|
decreased liver free fatty acids level
|
J:256005
|
increased fatty acids level
|
J:256005
|
increased liver free fatty acids level
|
J:256005
|
Faf2tm1Tfji/Faf2tm1Tfji Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * CBA * DBA)
|
decreased circulating free fatty acids level
|
J:235325
|
decreased circulating phospholipid level
|
J:235325
|
decreased circulating triglyceride level
|
J:235325
|
decreased circulating VLDL triglyceride level
|
J:235325
|
increased circulating phospholipid level
|
J:235325
|
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi)
|
increased circulating free fatty acids level
|
J:258290
|
Fam20ctm1.1Cqi/Fam20ctm1.1Cqi Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal vitamin D level
|
J:185208
|
Fam81bem1(IMPC)J/Fam81bem1(IMPC)J
(C57BL/6NJ-Fam81bem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Fam83gtm1a(EUCOMM)Wtsi/Fam83gtm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Fam117btm1a(EUCOMM)Wtsi/Fam117btm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating HDL cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Fam161atm1b(KOMP)Wtsi/Fam161atm1b(KOMP)Wtsi
(C57BL/6N-Fam161atm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Fam186btm1b(KOMP)Mbp/Fam186btm1b(KOMP)Mbp
(C57BL/6N-Fam186btm1b(KOMP)Mbp/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Fam210atm1b(EUCOMM)Wtsi/Fam210a+
(C57BL/6N-Fam210atm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Fam234btm1a(EUCOMM)Wtsi/Fam234btm1a(EUCOMM)Wtsi
(C57BL/6N-Fam234btm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating LDL cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Far1em1(IMPC)Wtsi/Far1em1(IMPC)Wtsi
(C57BL/6N-Far1em1(IMPC)Wtsi)
|
abnormal ether lipid level
|
J:339470
|
Far2tm2b(KOMP)Wtsi/Far2tm2b(KOMP)Wtsi
(C57BL/6N-Far2tm2b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Far2tm2b(KOMP)Wtsi/Far2tm2b(KOMP)Wtsi
(B6N(Cg)-Far2tm2b(KOMP)Wtsi/2J)
|
abnormal lipid level
|
J:267002
|
Farp2tm1a(KOMP)Wtsi/Farp2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Farp2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating triglyceride level
|
J:175295
|
Fasntm1Sem/Fasntm1Sem Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:127793
|
decreased liver cholesterol level
|
J:127793
|
decreased saturated fatty acids level
|
J:127793
|
increased circulating free fatty acids level
|
J:127793
|
increased triglyceride level
|
J:127793
|
Fasntm1Sem/Fasntm1Sem Tg(Ins2-cre)25Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
abnormal fatty acids level
|
J:127482
|
decreased circulating free fatty acids level
|
J:127482
|
increased circulating triglyceride level
|
J:127482
|
Fbf1tm1a(EUCOMM)Wtsi/Fbf1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbf1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
Fbxo9tm1b(EUCOMM)Hmgu/Fbxo9tm1b(EUCOMM)Hmgu
(C57BL/6N-Fbxo9tm1b(EUCOMM)Hmgu/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Fbxo10tm1b(KOMP)Wtsi/Fbxo10tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo10tm1b(KOMP)Wtsi/Nju)
|
decreased circulating triglyceride level
|
J:211773
|
Fbxo41tm1.1(KOMP)Vlcg/Fbxo41tm1.1(KOMP)Vlcg
(C57BL/6N-Fbxo41tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
Fcer1gtm1Rav/Fcer1gtm1Rav Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal lipid level
|
J:87617
|
Ffal1C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased circulating free fatty acids level
|
J:84091
|
Ffaq2NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating free fatty acids level
|
J:138463
|
Ffaq3NZB/BlNJ/Ffaq3NZB/BlNJ Ffaq4NZB/BlNJ/Ffaq4NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ)
|
increased circulating free fatty acids level
|
J:138463
|
Ffar1tm1Dgen/Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal triglyceride level
|
J:141957
|
decreased circulating triglyceride level
|
J:141957
|
increased liver triglyceride level
|
J:141957
|
Ffar1tm1Heed/Ffar1tm1Heed
(Not Specified)
|
abnormal circulating triglyceride level
|
J:129843
|
Ffar2tm1Lex/Ffar2tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J)
|
abnormal circulating free fatty acids level
|
J:138134
|
Ffar2tm2Soff/Ffar2tm2Soff Ffar3tm2.1Soff/Ffar3tm2.1Soff Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
decreased circulating free fatty acids level
|
J:227939
|
Ffar3tm1Reh/Ffar3tm1Reh
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased liver triglyceride level
|
J:143567
|
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6)
|
abnormal lipid level
|
J:182599
|
increased circulating cholesterol level
|
J:182599
|
increased circulating HDL cholesterol level
|
J:182599
|
increased circulating LDL cholesterol level
|
J:182599
|
increased liver triglyceride level
|
J:182599
|
Fgd4tm1a(EUCOMM)Wtsi/Fgd4tm1a(EUCOMM)Wtsi
(C57BL/6N-Fgd4tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Fgd5em1(IMPC)Mbp/Fgd5+
(C57BL/6NCrl-Fgd5em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
Fgf10tm1b(EUCOMM)Wtsi/Fgf10+
(C57BL/6N-Fgf10tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Fgf20em1(IMPC)Ccpcz/Fgf20em1(IMPC)Ccpcz
(C57BL/6NCrl-Fgf20em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf)
|
abnormal lipid level
|
J:157309
|
decreased fatty acids level
|
J:157309
|
increased circulating cholesterol level
|
J:157309
|
increased circulating triglyceride level
|
J:157309
|
increased liver triglyceride level
|
J:157309
|
Fgf21tm1Nit/Fgf21tm1Nit
(C57BL/6-Fgf21tm1Nit)
|
abnormal circulating free fatty acids level
|
J:157334
|
decreased circulating free fatty acids level
|
J:157334
|
increased circulating free fatty acids level
|
J:157334
|
Fgf23tm1.1Kew/Fgf23tm1.1Kew
(B6.129-Fgf23tm1.1Kew)
|
abnormal vitamin D level
|
J:180061
|
Fgf23tm1Sliu/Fgf23+ PhexHyp/Y
(involves: 129S/SvEv * C57BL/6)
|
abnormal vitamin D level
|
J:110579
|
Fgf23tm1Sliu/Fgf23tm1Sliu
(involves: 129S/SvEv * C57BL/6)
|
abnormal vitamin D level
|
J:110579
|
Fgf23tm1Sliu/Fgf23tm1Sliu PhexHyp/Y
(involves: 129S/SvEv * C57BL/6)
|
abnormal vitamin D level
|
J:110579
|
Fgf23tm1Tyam/Fgf23tm1Tyam
(involves: C57BL/6 * CBA)
|
abnormal vitamin D level
|
J:88172
|
decreased circulating triglyceride level
|
J:88172
|
increased circulating cholesterol level
|
J:88172
|
Fgl1tm1Cuko/Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
decreased circulating cholesterol level
|
J:199844
|
decreased circulating free fatty acids level
|
J:199844
|
decreased circulating HDL cholesterol level
|
J:199844
|
increased liver triglyceride level
|
J:199844
|
Fhip2bem1Wwan/Fhip2bem1Wwan
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:302658
|
decreased circulating LDL cholesterol level
|
J:302658
|
increased liver cholesterol level
|
J:302658
|
increased liver triglyceride level
|
J:302658
|
Fhl1tm1a(EUCOMM)Wtsi/Fhl1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fhl1tm1a(EUCOMM)Wtsi/H)
|
decreased circulating cholesterol level
|
J:165965
|
Firrmtm1a(EUCOMM)Hmgu/Firrm+
(C57BL/6N-Firrmtm1a(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:165965
|
increased circulating HDL cholesterol level
|
J:165965
|
Fitm2tm1.1Dls/Fitm2tm1.1Dls Tg(Fabp4-cre)1Rev/?
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal fatty acids level
|
J:212437
|
Fkbp5tm1Dvds/Fkbp5tm1Dvds
(involves: 129X1/SvJ * C57BL/6 * Swiss Webster)
|
decreased circulating corticosterone level
|
J:177683
|
Fl1saA/J/?
(involves: A/JSlc * SM/JNshm)
|
abnormal lipid level
|
J:124974
|
increased liver triglyceride level
|
J:124974
|
Fl1saSM/JNshm/Fl1saSM/JNshm
(A/J-Chr 12SM/J/Nshm)
|
decreased liver triglyceride level
|
J:124974
|
Fl2saA/JNshm/Fl2saA/JNshm
(involves: A/JSlc * SM/JNshm)
|
abnormal lipid level
|
J:124974
|
Flgtm1Amag/Flgtm1Amag
(involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac)
|
abnormal lipid level
|
J:198332
|
increased cholesterol level
|
J:198332
|
Flvcr2tm1a(EUCOMM)Hmgu/Flvcr2+
(C57BL/6N-Flvcr2tm1a(EUCOMM)Hmgu/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
fm/fm
(involves: CBA/H)
|
abnormal cholesterol level
|
J:5112
|
abnormal sphingomyelin level
|
J:5112
|
sphingomyelinosis
|
J:5112
|
Fmo5tm1Eshe/Fmo5tm1Eshe
(B6.129P2-Fmo5tm1Eshe)
|
decreased circulating cholesterol level
|
J:223365
|
decreased circulating HDL cholesterol level
|
J:223365
|
decreased circulating LDL cholesterol level
|
J:223365
|
decreased triglyceride level
|
J:223365
|
Fndc5em21Gpt/Fndc5em21Gpt
(C57BL/6JGpt-Fndc5em21Cd/Gpt)
|
abnormal circulating lipid level
|
J:247171
|
Fndc7tm1.1(KOMP)Vlcg/Fndc7tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc7tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Foxa1tm1Stf/Foxa1+
(Not Specified)
|
decreased circulating HDL cholesterol level
|
J:138581
|
Foxa1tm1Stf/Foxa1tm1Stf
(Not Specified)
|
decreased circulating triglyceride level
|
J:57493
|
increased circulating cortisol level
|
J:57493
|
Foxa2tm1.1Stf/Foxa2tm1.1Stf Tg(Nes-cre)1Kln/0
(B6.Cg-Foxa2tm1.1Stf Tg(Nes-cre)1Kln)
|
decreased circulating free fatty acids level
|
J:155391
|
Foxa2tm1Dnl/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating free fatty acids level
|
J:95662
|
increased circulating triglyceride level
|
J:95662
|
increased liver triglyceride level
|
J:95662
|
Foxa3tm1Khk/Foxa3tm1Khk
(B6.129P2-Foxa3tm1Khk)
|
decreased circulating cholesterol level
|
J:216477
|
Foxo1tm1Rdp/Foxo1tm1Rdp Irs1tm1Mfw/Irs1tm1Mfw Irs2tm2Mfw/Irs2tm2Mfw Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB)
|
abnormal triglyceride level
|
J:137845
|
decreased circulating cholesterol level
|
J:137845
|
decreased circulating free fatty acids level
|
J:137845
|
decreased circulating HDL cholesterol level
|
J:137845
|
decreased circulating triglyceride level
|
J:137845
|
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(Not Specified)
|
decreased circulating cholesterol level
|
J:179687
|
decreased circulating free fatty acids level
|
J:179687
|
decreased circulating triglyceride level
|
J:179687
|
decreased circulating VLDL triglyceride level
|
J:179687
|
decreased liver triglyceride level
|
J:179687
|
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(B6.Cg-Foxo1tm2.1Dac)
|
decreased liver cholesterol level
|
J:179687
|
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg)
|
decreased circulating cholesterol level
|
J:236585
|
decreased liver triglyceride level
|
J:236585
|
Fpr3tm1b(EUCOMM)Hmgu/Fpr3tm1b(EUCOMM)Hmgu
(C57BL/6N-Fpr3tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:211773
|
Frrs1tm1a(EUCOMM)Wtsi/Frrs1+
(C57BL/6N-Frrs1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Fstl1tm1b(EUCOMM)Hmgu/Fstl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fstl1tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
FtoI367F/FtoI367F
(involves: C3H/HeH * C57BL/6J)
|
increased circulating cholesterol level
|
J:152163
|
increased circulating HDL cholesterol level
|
J:152163
|
increased circulating triglyceride level
|
J:152163
|
Ftotm1a(EUCOMM)Wtsi/Ftotm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Ftotm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
Fuca1tm1Tlub/Fuca1tm1Tlub
(involves: 129S2/SvPas * C57BL/6)
|
increased brain cholesterol level
|
J:235359
|
Fyco1tm1.1Arte/Fyco1tm1.1Arte Tg(Prm-cre)58Og/0
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6J * C57BL/6NTac)
|
abnormal phospholipid level
|
J:336796
|
Fyco1tm1.2Arte/Fyco1tm1.2Arte
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac * FVB/N)
|
abnormal phospholipid level
|
J:336796
|
G0s2tm1(KOMP)Vlcg/G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased liver triglyceride level
|
J:209000
|
increased circulating free fatty acids level
|
J:209000
|
increased circulating glycerol level
|
J:225236
|
G0s2tm1Jgte/G0s2tm1Jgte
(involves: 129S7/SvEvBrd)
|
decreased liver triglyceride level
|
J:219653
|
G6pc1em1Jyc/G6pc1em1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating cholesterol level
|
J:320697
|
increased circulating triglyceride level
|
J:320697
|
increased liver triglyceride level
|
J:320697
|
G6pc1tm1.1Ics/G6pc1tm1.1Ics Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129S2/SvPas * C57BL/6J)
|
increased circulating cholesterol level
|
J:195257
|
increased circulating triglyceride level
|
J:195257
|
increased liver triglyceride level
|
J:195257
|
G6pc1tm1Jyc/G6pc1tm1Jyc
(involves: 129S4/SvJae)
|
increased circulating cholesterol level
|
J:33212
|
increased circulating triglyceride level
|
J:33212
|
G6pc1tm2.2Jyc/G6pc1tm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N)
|
increased circulating cholesterol level
|
J:155990
|
increased circulating triglyceride level
|
J:155990
|
G6pc2tm1Lex/G6pc2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating triglyceride level
|
J:141593
|
G6pc3tm1Rmob/G6pc3tm1Rmob
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:117664
|
Gab1tm1Gsf/Gab1tm1Gsf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating free fatty acids level
|
J:98318
|
decreased circulating triglyceride level
|
J:98318
|
Galtm1Wyn/Galtm1Wyn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glucocorticoid level
|
J:84420
|
Galctwi/Galctwi
(B6.CE-Galctwi/J)
|
abnormal lipid level
|
J:165361
|
abnormal sphingomyelin level
|
J:165361
|
Galctwi/Galctwi
(involves: CE/J)
|
abnormal lipid level
|
J:78223
|
Galctwi/Galctwi Glb1tm1Adz/Glb1+
(involves: 129P2/OlaHsd * C57BL/6J * CE/J)
|
abnormal lipid level
|
J:63197
|
Galctwi/Galctwi Glb1tm1Adz/Glb1tm1Adz
(involves: 129P2/OlaHsd * C57BL/6J * CE/J)
|
abnormal lipid level
|
J:63197
|
Galnt2tm1.2Mrl/Galnt2tm1.2Mrl
(involves: C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:251899
|
increased triglyceride level
|
J:251899
|
Galnt3tcal/Galnt3tcal
(involves: C3H * C57BL/6J)
|
increased vitamin D level
|
J:187064
|
Galnt3tm1Mjec/Galnt3tm1Mjec
(involves: 129S/SvEv * C57BL/6J)
|
abnormal vitamin D level
|
J:151805
|
Galnt11tm1Kgth/Galnt11tm1Kgth
(B6NHsd.Cg-Galnt11tm1Kgth)
|
increased circulating LDL cholesterol level
|
J:287843
|
Galr3tm1Lex/Galr3tm1Lex
(B6;129S5-Galr3tm1Lex/Orl)
|
increased cholesterol level
|
J:82809
|
increased triglyceride level
|
J:82809
|
Gars1em1(IMPC)Tcp/Gars1+
(C57BL/6NCrl-Gars1em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb)
|
decreased circulating cholesterol level
|
J:191142
|
decreased circulating triglyceride level
|
J:191142
|
decreased liver triglyceride level
|
J:191142
|
Gatmtm1b(KOMP)Wtsi/Gatmtm1b(KOMP)Wtsi
(C57BL/6N-Gatmtm1b(KOMP)Wtsi/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
Gba1tm1.1Pmis/Gba1tm1.1Pmis Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased circulating HDL cholesterol level
|
J:167081
|
Gba1tm1.1Pmis/Gba1tm1.2Pmis Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased circulating HDL cholesterol level
|
J:167081
|
Gba1tm1Rlp/Gba1tm1Rlp
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating cholesterol level
|
J:76409
|
Gba2tm1Rus/Gba2tm1Rus
(involves: 129S6/SvEv * C57BL/6J)
|
abnormal lipid level
|
J:114991
|
Gctm1.1(KOMP)Vlcg/Gctm1.1(KOMP)Vlcg
(C57BL/6N-Gctm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Gctm1Nec/Gctm1Nec
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vitamin D level
|
J:52225
|
Gcgrtm1.1(KOMP)Vlcg/Gcgrtm1.1(KOMP)Vlcg
(C57BL/6N-Gcgrtm1.1(KOMP)Vlcg/Ucd)
|
increased circulating cholesterol level
|
J:211773
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased triglyceride level
|
J:81772
|
increased circulating LDL cholesterol level
|
J:81772
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL)
|
increased bile salt level
|
J:208604
|
Gcgrtm1Mjch/Gcgrtm1Mjch Leprtm1Jke/Leprtm1Jke
(involves: 129 * 129X1/SvJ * C57BL/6J * SJL)
|
increased liver triglyceride level
|
J:216393
|
Gcgrtm2.1Mjch/Gcgrtm2.1Mjch Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL)
|
increased bile salt level
|
J:208604
|
Gcktm1.2Mgn/Gcktm1.2Mgn
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating free fatty acids level
|
J:51826
|
Gcktm1Ts/Gcktm1Ts
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J))
|
abnormal circulating cholesterol level
|
J:29255
|
increased circulating triglyceride level
|
J:29255
|
Gdatm1a(KOMP)Wtsi/Gdatm1a(KOMP)Wtsi
(C57BL/6N-Gdatm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Gde1tm1b(EUCOMM)Hmgu/Gde1+
(C57BL/6N-Gde1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
Gdf15tm1Sjl/Gdf15tm1Sjl Leprdb/Leprdb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BLKS/J)
|
increased cholesterol level
|
J:202996
|
increased circulating HDL cholesterol level
|
J:202996
|
Gemin4em1(IMPC)Ics/Gemin4+
(C57BL/6N-Gemin4em1(IMPC)Ics/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Gena327/Gena327+
(involves: BALB/c * C3H/HeH)
|
increased circulating triglyceride level
|
J:82809,
J:79719
|
Gena360/Gena360+
(involves: BALB/c * C3H/HeH)
|
decreased circulating cholesterol level
|
J:82809,
J:79719
|
decreased circulating HDL cholesterol level
|
J:82809,
J:79719
|
Gena381/Gena381+
(involves: BALB/c * C3H/HeH)
|
decreased cholesterol level
|
J:169366
|
Gena391/Gena391+
(involves: BALB/c * C3H/He)
|
increased circulating HDL cholesterol level
|
J:82809
|
increased circulating triglyceride level
|
J:82809
|
Gfertm1.1Crg/Gfertm1.1Crg Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA)
|
decreased liver cholesterol level
|
J:227242
|
increased liver cholesterol level
|
J:227242
|
increased liver triglyceride level
|
J:227242
|
Gfm1tm1a(EUCOMM)Wtsi/Gfm1+
(C57BL/6N-Gfm1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:175295
|
Gfpt1tm1b(EUCOMM)Wtsi/Gfpt1+
(C57BL/6N-Gfpt1tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Gfraltm1Lex/Gfraltm1Lex
(B6.129S5-Gfraltm1Lex)
|
abnormal circulating triglyceride level
|
J:254140
|
abnormal free fatty acids level
|
J:254140
|
Ggps1tm1b(EUCOMM)Wtsi/Ggps1+
(C57BL/6N-Ggps1tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ghrtm1.1Masp/Ghrtm1.1Masp Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJaeSor * C57BL/6 * DBA)
|
decreased circulating triglyceride level
|
J:152627
|
decreased liver triglyceride level
|
J:152627
|
increased circulating free fatty acids level
|
J:152627
|
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal circulating lipid level
|
J:105686
|
decreased circulating cholesterol level
|
J:105686
|
decreased circulating HDL cholesterol level
|
J:105686
|
decreased circulating LDL cholesterol level
|
J:105686
|
decreased circulating triglyceride level
|
J:105686
|
decreased circulating VLDL cholesterol level
|
J:105686
|
increased circulating corticosterone level
|
J:105686
|
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
increased circulating corticosterone level
|
J:103286
|
Ghrhrtm1.1(KOMP)Vlcg/Ghrhrtm1.1(KOMP)Vlcg
(C57BL/6N-Ghrhrtm1.1(KOMP)Vlcg/J)
|
increased circulating triglyceride level
|
J:211773
|
Gimap6tm1b(KOMP)Wtsi/Gimap6tm1b(KOMP)Wtsi
(C57BL/6N-Gimap6tm1b(KOMP)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Gja8Aey69/Gja8Aey69 H3c14Aey69/H3c14Aey69
(C3HeB/FeJ)
|
hypolipidemia
|
J:277247
|
Gk5m1Btlr/Gk5m1Btlr
(C57BL/6J-Gk5m1Btlr)
|
abnormal ceramide level
|
J:243852
|
abnormal lipid level
|
J:243852
|
increased cholesterol level
|
J:243852
|
increased triglyceride level
|
J:243852
|
Gktm1Wjc/Y
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating glycerol level
|
J:43449
|
increased fatty acids level
|
J:43449
|
increased urine glycerol level
|
J:43449
|
Gktm1Wjc/Gk+
(involves: 129S7/SvEvBrd)
|
decreased fatty acids level
|
J:148831
|
Glg1tm1a(KOMP)Wtsi/Glg1+
(C57BL/6N-Glg1tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating glycerol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Glra4tm1b(KOMP)Wtsi/Y
(C57BL/6N-Glra4tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Gm94tm1b(KOMP)Wtsi/Gm94+
(C57BL/6N-Gm94tm1b(KOMP)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
Gm5127em1(IMPC)J/Y
(C57BL/6NJ-Gm5127em1(IMPC)J/Mmjax)
|
increased circulating triglyceride level
|
J:211773
|
Gm5134tm1a(EUCOMM)Hmgu/Gm5134tm1a(EUCOMM)Hmgu
(C57BL/6N-Gm5134tm1a(EUCOMM)Hmgu/H)
|
decreased circulating triglyceride level
|
J:165965
|
Gm20646em1(IMPC)Wtsi/Gm20646em1(IMPC)Wtsi
(C57BL/6N-Gm20646em1(IMPC)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Gm26330em1Liuq/Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq)
|
increased circulating triglyceride level
|
J:341056
|
Gna11tm1a(EUCOMM)Wtsi/Gna11tm1a(EUCOMM)Wtsi
(C57BL/6N-Gna11tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating triglyceride level
|
J:165965
|
Gna11tm1Soff/Gna11tm1Soff
(involves: 129S7/SvEvBrd)
|
increased circulating triglyceride level
|
J:172091
|
increased liver triglyceride level
|
J:172091
|
Gnai1tm1Drs/Gnai1tm1Drs Gnai3tm1Lbi/Gnai3tm1Lbi
(involves: 129S/SvEv)
|
abnormal thromboxane level
|
J:104683
|
Gnao1tm1b(EUCOMM)Hmgu/Gnao1+
(C57BL/6N-Gnao1tm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Gnastm1Lsw/Gnas+
(involves: 129S4/SvJae * CD-1)
|
decreased circulating cholesterol level
|
J:60971
|
decreased circulating triglyceride level
|
J:60971
|
Gnastm3Lsw/Gnastm3Lsw Ren1tm2(cre)Gom/Ren1+
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating aldosterone level
|
J:118076
|
Gnastm4Lsw/Gnas+
(involves: 129S6/SvEvTac * Black Swiss * CD-1)
|
increased circulating triglyceride level
|
J:99237
|
Gnastm5.1Lsw/Gnastm5.1Lsw Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * Black Swiss * FVB/N)
|
increased circulating triglyceride level
|
J:102504
|
Gnastm5.1Lsw/Gnastm5.1Lsw Tg(Fabp4-cre)1Abel/0
(involves: FVB)
|
decreased circulating free fatty acids level
|
J:159612
|
decreased circulating triglyceride level
|
J:159612
|
decreased liver triglyceride level
|
J:159612
|
decreased skeletal muscle triglyceride level
|
J:159612
|
increased circulating corticosterone level
|
J:159612
|
Gnastm5.1Lsw/Gnastm5.1Lsw Tg(Slc5a2-cre)1Tauc/0
(involves: C57BL/6 * DBA/2)
|
decreased vitamin D level
|
J:233851
|
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6)
|
increased circulating cholesterol level
|
J:147857
|
Golph3em1(IMPC)Tcp/Golph3em1(IMPC)Tcp
(C57BL/6NCrl-Golph3em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Gpamtm1.1Dali/Gpamtm1.1Dali
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating cholesterol level
|
J:134068
|
decreased circulating triglyceride level
|
J:134068
|
decreased liver triglyceride level
|
J:134068
|
Gpamtm1Rcol/Gpamtm1Rcol
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal fatty acids level
|
J:84541
|
decreased circulating cholesterol level
|
J:84541
|
decreased circulating HDL cholesterol level
|
J:84541
|
decreased circulating triglyceride level
|
J:84541
|
decreased circulating VLDL triglyceride level
|
J:84541
|
decreased liver triglyceride level
|
J:84541
|
Gpat3tm1Reg/Gpat3tm1Reg
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:213618
|
increased circulating cholesterol level
|
J:213618
|
increased liver cholesterol level
|
J:213618
|
Gpbar1tm1Ktan/Gpbar1tm1Ktan
(involves: 129X1/SvJ * C57BL/6N)
|
increased circulating cholesterol level
|
J:114971
|
Gpcpd1tm1c(EUCOMM)Hmgu/Gpcpd1tm1c(EUCOMM)Hmgu Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * FVB)
|
increased glycerophosphocholine level
|
J:345630
|
Gpd2tm1Tka/Gpd2tm1Tka
(B6.Cg-Gpd2tm1Tka)
|
increased circulating cholesterol level
|
J:124766
|
Gpd2tm1Tka/Gpd2tm1Tka Slc25a13tm1Lct/Slc25a13tm1Lct
(B6.Cg-Gpd2tm1Tka Slc25a13tm1Lct)
|
increased circulating free fatty acids level
|
J:124766
|
increased circulating glycerol level
|
J:124766
|
increased liver triglyceride level
|
J:124766
|
Gpihbp1tm1Sgy/Gpihbp1tm1Sgy
(Not Specified)
|
decreased circulating HDL cholesterol level
|
J:129764
|
increased circulating cholesterol level
|
J:129764
|
increased circulating triglyceride level
|
J:129764
|
increased circulating VLDL cholesterol level
|
J:129764
|
Gpld1tm1.1(KOMP)Vlcg/Gpld1tm1.1(KOMP)Vlcg
(C57BL/6N-Gpld1tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
Gpm6btm1KanPlp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased cholesterol level
|
J:193310
|
Gpr12tm1Dgen/Gpr12tm1Dgen
(B6.129P2-Gpr12tm1Dgen)
|
increased circulating cholesterol level
|
J:111942
|
increased circulating HDL cholesterol level
|
J:111942
|
increased circulating LDL cholesterol level
|
J:111942
|
increased liver triglyceride level
|
J:111942
|
Gpr26tm1Yugs/Gpr26tm1Yugs
(involves: C57BL/6)
|
increased circulating cholesterol level
|
J:189617
|
increased circulating triglyceride level
|
J:189617
|
Gpr35em2Niess/Gpr35em2Niess Cx3cr1tm2.1(cre/ERT2)Litt/Cx3cr1+
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal corticosterone level
|
J:300275
|
Gpr39tm1Lex/Gpr39tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:124913
|
Gpr61tm1Dgen/Gpr61tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating triglyceride level
|
J:302257
|
increased liver triglyceride level
|
J:302257
|
Gpr82tm1Shbg/Y
(C3Fe.Cg-Gpr82tm1Shbg)
|
decreased circulating VLDL cholesterol level
|
J:301613
|
decreased triglyceride level
|
J:301613
|
Gpr82tm1Shbg/Gpr82tm1Shbg
(C3Fe.Cg-Gpr82tm1Shbg)
|
decreased circulating VLDL cholesterol level
|
J:301613
|
decreased triglyceride level
|
J:301613
|
Gpr142tm1Lex/Gpr142tm1Lex
(B6.129S-Gpr142tm1Lex)
|
abnormal circulating non-HDL cholesterol level
|
J:249154
|
Gpr146em1(IMPC)H/Gpr146em1(IMPC)H
(C57BL/6NTac-Gpr146em1(IMPC)H/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Gprc6atm1Ldq/Gprc6atm1Ldq
(involves: 129X1/SvJ * C57BL/6)
|
increased liver triglyceride level
|
J:144372
|
Gpx1tm1Mgr/Gpx1tm1Mgr
(involves: 129 * C57BL/6J)
|
abnormal lipid level
|
J:62395
|
Gramd1bem1Pton/Gramd1bem1Pton
(involves: C57BL/6N)
|
decreased circulating corticosterone level
|
J:266462
|
Gramd1ctm1a(KOMP)Wtsi/Gramd1ctm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Gramd1ctm1a(KOMP)Wtsi/JMmucd)
|
decreased bile salt level
|
J:347902
|
decreased circulating corticosterone level
|
J:347902
|
increased circulating cortisol level
|
J:347902
|
increased liver cholesterol level
|
J:347902
|
increased liver triglyceride level
|
J:347902
|
Gramd1ctm1b(KOMP)Wtsi/Gramd1ctm1b(KOMP)Wtsi
(C57BL/6N-Gramd1ctm1b(KOMP)Wtsi/J)
|
increased circulating triglyceride level
|
J:211773
|
Grhl3tm1a(EUCOMM)Wtsi/Grhl3+
(C57BL/6N-Grhl3tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating triglyceride level
|
J:165965
|
Grhl3tm1Bogi/Grhl3tm1Bogi
(involves: C57BL/6J)
|
abnormal lipid level
|
J:114626
|
Grid2Lc/Grid2+
(involves: C57BL/6 * CBA)
|
increased circulating corticosterone level
|
J:44206
|
Grin2dtm1a(EUCOMM)Wtsi/Grin2dtm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Grin3btm1b(KOMP)Wtsi/Grin3btm1b(KOMP)Wtsi
(C57BL/6N-Grin3btm1b(KOMP)Wtsi/H)
|
decreased circulating triglyceride level
|
J:211773
|
Grm3tm1b(KOMP)Wtsi/Grm3tm1b(KOMP)Wtsi
(C57BL/6N-Grm3tm1b(KOMP)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
gro22/gro22
(Not Specified)
|
decreased circulating cholesterol level
|
J:85113
|
Grxcr1em1(IMPC)J/Grxcr1em1(IMPC)J
(C57BL/6NJ-Grxcr1em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Gsk3atm1a(EUCOMM)Wtsi/Gsk3atm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Gsk3atm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:175295
|
Gsk3atm1Dral/Gsk3atm1Dral Gsk3btm1Dral/Gsk3btm1Dral
(involves: 129P2/OlaHsd)
|
increased circulating corticosterone level
|
J:200517
|
Gstk1tm1Pgb/Gstk1tm1Pgb
(BALB/c-Gstk1tm1Pgb)
|
decreased circulating triglyceride level
|
J:177201
|
Gt(ROSA)26Sortm1(CAG-Foxo1*)Jcbr/Gt(ROSA)26Sor+ Pdpk1tm1Jcbr/Pdpk1tm1Jcbr Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating corticosterone level
|
J:134336
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+ Hprt1tm6(CAG-fat-1)Geno/Hprt1tm6(CAG-fat-1)Geno
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal fatty acids level
|
J:213660
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sortm1(cre/ERT2)Tyj Nus1tm1.1Qrm/Nus1tm1.1Qrm
(involves: 129 * C57BL/6 * SJL)
|
increased liver free fatty acids level
|
J:243753
|
increased liver triglyceride level
|
J:243753
|
Gt(ROSA)26Sortm1(DTA)Vlcg/Gt(ROSA)26Sortm1(DTA)Vlcg Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N)
|
abnormal lipid level
|
J:201507
|
Gt(ROSA)26Sortm1(Gphb5)Lmac/Gt(ROSA)26Sor+
(Not Specified)
|
decreased circulating cholesterol level
|
J:96633
|
decreased triglyceride level
|
J:96633
|
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+ Tg(Gh1-cre)bKnmn/0
(involves: C57BL/6 * FVB/N)
|
decreased liver triglyceride level
|
J:169459
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(tetO-Xbp1_is)#Pesch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB)
|
increased circulating free fatty acids level
|
J:194290
|
increased liver triglyceride level
|
J:194290
|
Gt(ROSA)26Sortm1.1(Alb-PCSK9)Mby/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6N)
|
increased circulating cholesterol level
|
J:280156
|
increased circulating LDL cholesterol level
|
J:280156
|
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
abnormal circulating lipid level
|
J:166829
|
decreased circulating LDL cholesterol level
|
J:166829
|
increased circulating free fatty acids level
|
J:166829
|
increased circulating HDL cholesterol level
|
J:166829
|
increased circulating triglyceride level
|
J:166829
|
Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc/Gt(ROSA)26Sortm1.1(CAG-Fto)Rdc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
abnormal circulating lipid level
|
J:166829
|
decreased circulating LDL cholesterol level
|
J:166829
|
increased circulating free fatty acids level
|
J:166829
|
increased circulating HDL cholesterol level
|
J:166829
|
increased circulating triglyceride level
|
J:166829
|
Gt(ROSA)26Sortm8(RNAi:Crhr1)Rkuhn/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating corticosterone level
|
J:151155
|
Gtf2ird1Tg(Alb1-Myc)166.8Sst/Gtf2ird1Tg(Alb1-Myc)166.8Sst
(involves: C57BL/6J * CBA/J)
|
increased circulating corticosterone level
|
J:190478
|
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating corticosterone level
|
J:182346
|
Gucy2ctm1Gar/Gucy2ctm1Gar
(B6.129S6-Gucy2ctm1Gar)
|
increased liver triglyceride level
|
J:178241
|
Guloem1(IMPC)Ccpcz/Guloem1(IMPC)Ccpcz
(C57BL/6NCrl-Guloem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Gulotm1Mae/Gulotm1Mae
(involves: 129 * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:59931
|
increased circulating cholesterol level
|
J:59931
|
Gusbmps/Gusbmps
(involves: C57BL/6By)
|
decreased circulating cholesterol level
|
J:13923
|
Gys2tm1.1Arte/Gys2+
(Not Specified)
|
increased liver triglyceride level
|
J:208923
|
Gys2tm1.1Arte/Gys2tm1.1Arte
(Not Specified)
|
increased liver triglyceride level
|
J:208923
|
Gys2tm1.1Pro/Gys2tm1.1Pro Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)
|
abnormal triglyceride level
|
J:162043
|
increased liver triglyceride level
|
J:162043
|
Gys2tm1a(KOMP)Wtsi/Gys2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Gys2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:175295
|
H1f10tm1.1(KOMP)Vlcg/H1f10+
(C57BL/6N-H1f10tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
H3f3btm1.1(KOMP)Mbp/H3f3btm1.1(KOMP)Mbp
(C57BL/6N-H3f3btm1.1(KOMP)Mbp/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
H6pdtm1c(EUCOMM)Wtsi/H6pdtm1c(EUCOMM)Wtsi Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ)
|
abnormal corticosterone level
|
J:292236
|
decreased circulating free fatty acids level
|
J:292236
|
H6pdtm1Pmst/H6pdtm1Pmst
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating corticosterone level
|
J:189132,
J:108281
|
Hacd2tm1b(EUCOMM)Hmgu/Hacd2tm1b(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal phospholipid level
|
J:333944
|
HadhGt(RRM279)Byg/HadhGt(RRM279)Byg
(B6.129P2-HadhGt(RRM279)Byg)
|
increased circulating free fatty acids level
|
J:179084
|
increased circulating triglyceride level
|
J:179084
|
Hadhtm1Csta/Hadhtm1Csta
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss)
|
abnormal fatty acids level
|
J:166803
|
increased fatty acids level
|
J:166803
|
Hadhatm1Jib/Hadha+
(involves: 129X1/SvJ * NIH Black Swiss)
|
increased circulating free fatty acids level
|
J:101304
|
Hbs1ltm1a(KOMP)Wtsi/Hbs1ltm1a(KOMP)Wtsi
(C57BL/6N-Hbs1ltm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Hdac3tm1.1Eno/Hdac3tm1.1Eno Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6)
|
abnormal lipid level
|
J:144604
|
increased cardiac muscle triglyceride level
|
J:144604
|
Hdac3tm1Swh/Hdac3tm1.1Swh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased cholesterol level
|
J:134288
|
increased circulating cholesterol level
|
J:134288
|
increased circulating LDL cholesterol level
|
J:134288
|
increased circulating triglyceride level
|
J:134288
|
increased liver triglyceride level
|
J:134288
|
Hdl1C57BL/6J/?
(involves: C57BL/6J * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:66421
|
Hdl2CAST/EiJ/?
(involves: C57BL/6J * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:66421
|
Hdl3C57BL/6J/?
(involves: C57BL/6J * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:66421
|
Hdl4CAST/EiJ/?
(involves: C57BL/6J * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:66421
|
Hdl5C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:84091
|
increased circulating LDL cholesterol level
|
J:84091
|
Hdl6DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:84091
|
Hdl7DBA/2J/Hdl7DBA/2J
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdl34C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:38473
|
Hdl35C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:38473
|
Hdl36C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:38473
|
Hdl40C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:38473
|
Hdlcl1C57BL/6J/Hdlcl1C57BL/6J
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:94548
|
Hdlcl2C57BL/6J/Hdlcl2PERA/EiJ
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:94548
|
Hdlq2NZB/BlNJ/Hdlq2NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707,
J:89309
|
Hdlq2NZB/BlNJ/Hdlq2SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707,
J:89309
|
Hdlq3NZB/BlNJ/?
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707
|
Hdlq4NZB/BlNJ/Hdlq4SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707
|
Hdlq5C57BL/6J/Hdlq5C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
|
decreased circulating HDL cholesterol level
|
J:84430
|
Hdlq5NZB/BlNJ/Hdlq5NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ)
|
increased circulating HDL cholesterol level
|
J:84430
|
Hdlq6C57BL/6J/Hdlq6C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
|
decreased circulating HDL cholesterol level
|
J:84430
|
Hdlq6NZB/BlNJ/Hdlq6NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ)
|
increased circulating HDL cholesterol level
|
J:84430
|
Hdlq7C57BL/6J/Hdlq7C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
|
decreased circulating HDL cholesterol level
|
J:84430
|
Hdlq7C57BL/6J/Hdlq7C57BL/6J Hdlq9C57BL/6J/Hdlq9C57BL/6J
(involves: C57BL/6J * NZB/BlNJ)
|
decreased circulating HDL cholesterol level
|
J:84430
|
Hdlq7NZB/BlNJ/Hdlq7NZB/BlNJ
(involves: C57BL/6J * NZB/BlNJ)
|
increased circulating HDL cholesterol level
|
J:84430
|
Hdlq10CAST/Ei/Hdlq10CAST/Ei
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq10CAST/Ei/Hdlq10CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:88732
|
Hdlq10CAST/Ei/Hdlq10DBA/2J
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq11DBA/2J/Hdlq11CAST/Ei
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq11DBA/2J/Hdlq11DBA/2J
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq12DBA/2J/Hdlq12CAST/EiJ
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq12DBA/2J/Hdlq12DBA/2J
(involves: CAST/Ei * DBA/2J)
|
increased circulating HDL cholesterol level
|
J:83460
|
Hdlq13129S1/SvImJ/Hdlq13129S1/SvImJ
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:88732
|
Hdlq13129S1/SvImJ/Hdlq13CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:88732
|
Hdlq14129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq14C57BL/6J/Hdlq14C57BL/6J Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:88486
|
Hdlq15129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089,
J:88486
|
Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ Hdlq58C57BL/6J/Hdlq58C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ Hdlq60129S1/SvImJ/Hdlq60C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq15129S1/SvImJ/Hdlq15129S1/SvImJ Hdlq60C57BL/6J/Hdlq60C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq15C57BL/6J/Hdlq15C57BL/6J Hdlq19129S1/SvImJ/Hdlq19129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:88486
|
Hdlq16129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq17129S1/SvImJ/Hdlq17129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq17129S1/SvImJ/Hdlq17129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq17129S1/SvImJ/Hdlq17C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq18129S1/SvImJ/Hdlq18129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq18129S1/SvImJ/Hdlq18129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq18129S1/SvImJ/Hdlq18C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:88486
|
Hdlq18C57BL/6J/Hdlq18C57BL/6J Hdlq59C57BL/6J/Hdlq59C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:144089
|
Hdlq20NZB/BlNJ/Hdlq20NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq20NZB/BlNJ/Hdlq20SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq21NZB/BlNJ/Hdlq21NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq21NZB/BlNJ/Hdlq21SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq22NZB/BlNJ/Hdlq22NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq22NZB/BlNJ/Hdlq22SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq23NZB/BlNJ/Hdlq23NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq23NZB/BlNJ/Hdlq23SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq24NZB/BlNJ/Hdlq24NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq24NZB/BlNJ/Hdlq24SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq25NZB/BlNJ/Hdlq25NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq25NZB/BlNJ/Hdlq25SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq26NZB/BlNJ/Hdlq26NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq27NZB/BlNJ/Hdlq27NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq28NZB/BlNJ/Hdlq28NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq28NZB/BlNJ/Hdlq28SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq29NZB/BlNJ/Hdlq29NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq29NZB/BlNJ/Hdlq29SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq30NZB/BlNJ/Hdlq30NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq30NZB/BlNJ/Hdlq30SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq31NZB/BlNJ/Hdlq31NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq31NZB/BlNJ/Hdlq31SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq32NZB/BlNJ/Hdlq32NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:89309
|
Hdlq33PERA/EiJ/?
(involves: DBA/2J * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq34PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq35PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq37PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq37PERA/EiJ/?
(involves: DBA/2J * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq40A/J/Hdlq40C57BL/6J Hdlq41A/J/?
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq42A/J/Hdlq42A/J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq42A/J/Hdlq42C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq42C57BL/6J/Hdlq42C57BL/6J Hdlq44A/J/Hdlq44A/J
(involves: A/J * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:114073
|
Hdlq43C57BL/6J/Hdlq43C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq44A/J/Hdlq44C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq44C57BL/6J/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq44C57BL/6J/Hdlq44C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq45A/J/Hdlq45C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq45C57BL/6J/Hdlq45C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq46C57BL/6J/Hdlq46C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq47C57BL/6J/Hdlq47C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq48C57BL/6J/Hdlq48C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq49A/J/Hdlq49C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq49C57BL/6J/Hdlq49C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq50A/J/Hdlq50C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq50C57BL/6J/Hdlq50C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq51A/J/Hdlq51C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq51C57BL/6J/Hdlq51C57BL/6J
(involves: A/J * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:114073
|
Hdlq52129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq53129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq54129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq55129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq56C57BL/6J/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq57129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq67129S1/SvImJ/?
(involves: 129S1/SvImJ * CAST/Ei)
|
increased circulating HDL cholesterol level
|
J:88732
|
Hdlq83PERA/EiJ/?
(involves: DBA/2J * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq83PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ)
|
increased circulating HDL cholesterol level
|
J:112668
|
Hdlq89RIIIS/J/?
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq90RIIIS/J/?
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq92C57BL/6J/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Hdlq99129S1/SvImJ/Hdlq99129S1/SvImJ
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq99129S1/SvImJ/Hdlq99RIIIS/J
(involves: 129S1/SvImJ * RIIIS/J)
|
increased circulating HDL cholesterol level
|
J:89282
|
Hdlq102129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Heatr3tm1a(EUCOMM)Hmgu/Heatr3+
(C57BL/6N-Heatr3tm1a(EUCOMM)Hmgu/Ics)
|
increased circulating glycerol level
|
J:165965
|
Hellstm1a(EUCOMM)Wtsi/Hellstm1a(EUCOMM)Wtsi
(C57BL/6N-Hellstm1a(EUCOMM)Wtsi/Ieg)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating LDL cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Helz2tm1Tesa/Helz2tm1Tesa
(B6.Cg-Helz2tm1Tesa)
|
abnormal lipid level
|
J:218127
|
decreased liver triglyceride level
|
J:218127
|
Hfetm2Sly/Hfetm2Sly
(involves: 129X1/SvJ * C57BL/6J)
|
decreased brain cholesterol level
|
J:213886
|
Hif1atm1Stom/Hif1atm1Stom Tg(Vil1-cre)20Syr/0
(B6.Cg-Hif1atm1Stom Tg(Vil1-cre)20Syr)
|
increased bile salt level
|
J:325395
|
Hif1antm1.2Rsjo/Hif1antm1.2Rsjo
(B6.129-Hif1antm1.2Rsjo)
|
decreased circulating cholesterol level
|
J:160941
|
decreased circulating HDL cholesterol level
|
J:160941
|
decreased circulating LDL cholesterol level
|
J:160941
|
decreased circulating triglyceride level
|
J:160941
|
decreased circulating VLDL triglyceride level
|
J:160941
|
decreased liver triglyceride level
|
J:160941
|
increased circulating cholesterol level
|
J:160941
|
Hilpdatm1Xen/Hilpdatm1Xen
(C57BL/6-Hilpdatm1Xen)
|
increased circulating HDL cholesterol level
|
J:301866
|
Hint2tm1.1Geno/Hint2tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J)
|
decreased circulating triglyceride level
|
J:237329
|
increased circulating cholesterol level
|
J:237329
|
increased circulating corticosterone level
|
J:237329
|
increased liver triglyceride level
|
J:237329
|
hipr/hipr
(involves: C57BL/6J)
|
increased circulating corticosterone level
|
J:196485
|
Hkdc1tm1a(KOMP)Wtsi/Hkdc1+
(involves: C57BL/6N)
|
decreased liver triglyceride level
|
J:240354
|
Hlb206/?
(C57BL/6J-Hlb206)
|
decreased circulating HDL cholesterol level
|
J:82961
|
Hlb211/?
(involves: 129 * C57BL/6)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb212/?
(involves: 129 * C57BL/6)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb216/?
(C57BL/6J-Hlb216)
|
decreased circulating HDL cholesterol level
|
J:82961
|
Hlb237/?
(C57BL/6J-Hlb237)
|
decreased circulating cholesterol level
|
J:82961
|
decreased circulating HDL cholesterol level
|
J:82961
|
Hlb239/?
(involves: 129 * C57BL/6)
|
increased circulating cholesterol level
|
J:82961
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb240/?
(involves: 129 * C57BL/6)
|
increased circulating HDL cholesterol level
|
J:82961
|
hlb241/?
(C57BL/6J-hlb241/J)
|
decreased circulating HDL cholesterol level
|
J:82961
|
increased circulating cholesterol level
|
J:82961
|
hlb242/?
(C57BL/6J-hlb242/J)
|
increased circulating cholesterol level
|
J:82961
|
hlb243/hlb243
(C57BL/6J-hlb243/J)
|
increased circulating cholesterol level
|
J:82961
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb245/?
(C57BL/6J-Hlb245/J)
|
increased circulating cholesterol level
|
J:82961
|
Hlb250/?
(involves: 129 * C57BL/6)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb252/?
(involves: 129 * C57BL/6)
|
decreased circulating cholesterol level
|
J:82961
|
decreased circulating HDL cholesterol level
|
J:82961
|
Hlb280/?
(C57BL/6J-Hlb280/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb295/?
(C57BL/6J-Hlb295)
|
decreased circulating HDL cholesterol level
|
J:82961
|
Hlb299/?
(C57BL/6J-Hlb299/J)
|
increased circulating cholesterol level
|
J:82961
|
Hlb300/?
(C57BL/6J-Hlb300)
|
increased circulating cholesterol level
|
J:82961
|
hlb388/hlb388
(C57BL/6J-hlb388/J)
|
increased circulating HDL cholesterol level
|
J:77944
|
Hlb395/?
(C57BL/6J-Hlb395)
|
increased circulating triglyceride level
|
J:82961
|
Hlb396/?
(C57BL/6J-Hlb396)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb397/?
(C57BL/6J-Hlb397/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb446/?
(C57BL/6J-Hlb446/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb476/?
(C57BL/6J-Hlb476/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb477/Hlb477
(C57BL/6J-Hlb477/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
hlb497/hlb497
(C57BL/6J-hlb497/J)
|
increased circulating triglyceride level
|
J:82961
|
hlb505/?
(C57BL/6J-hlb505/J)
|
increased circulating triglyceride level
|
J:77944
|
Hlb529/?
(C57BL/6J-Hlb529/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
hlb560/?
(C57BL/6J-hlb560/J)
|
increased circulating triglyceride level
|
J:77944
|
Hlb561/?
(C57BL/6J-Hlb561/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb586/?
(C57BL/6J-Hlb586/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb589/?
(C57BL/6J-Hlb589/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb592/?
(C57BL/6J-Hlb592/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hlb594/?
(C57BL/6J-Hlb594/J)
|
increased circulating HDL cholesterol level
|
J:82961
|
Hmgcrem1Bcgen/Hmgcrem1Bcgen
(Not Specified)
|
increased circulating triglyceride level
|
J:299971
|
Hmgcrem1Bcgen/Hmgcrem1Bcgen Usp20em1Gpt/Usp20em1Gpt Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6JGpt * DBA)
|
increased circulating triglyceride level
|
J:299971
|
Hmgcrtm2Ishi/Hmgcrtm2Ishi Tg(Alb1-cre)1Dlr/0
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:201488
|
decreased circulating LDL cholesterol level
|
J:201488
|
decreased circulating triglyceride level
|
J:201488
|
decreased liver cholesterol level
|
J:201488
|
increased circulating cholesterol level
|
J:201488
|
increased circulating free fatty acids level
|
J:201488
|
increased circulating LDL cholesterol level
|
J:201488
|
increased circulating phospholipid level
|
J:201488
|
increased fatty acids level
|
J:201488
|
increased liver triglyceride level
|
J:201488
|
increased unsaturated fatty acids level
|
J:201488
|
Hmgcs2em1(IMPC)Tcp/Hmgcs2em1(IMPC)Tcp
(C57BL/6NCrl-Hmgcs2em1(IMPC)Tcp)
|
increased liver triglyceride level
|
J:326918
|
Hmgn1tm1Mbus/Hmgn1tm1Mbus
(involves: 129X1/SvJ)
|
decreased circulating corticosterone level
|
J:199604
|
Hmgn3tm1.2Mbus/Hmgn3tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating corticosterone level
|
J:199604
|
Hmox1tm1.1Hes/Hmox1tm1.1Hes Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
decreased circulating free fatty acids level
|
J:214639
|
Hnf1atm1.1Ylee/Hnf1atm1.1Ylee
(involves: 129X1/SvJ * C57BL/6J)
|
increased cholesterol level
|
J:47008
|
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas)
|
increased circulating cholesterol level
|
J:31627
|
Hnf1atm2Mya/Hnf1atm2Mya
(involves: 129S2/SvPas)
|
increased circulating cholesterol level
|
J:31627
|
Hnf1btm1Mya/Hnf1btm3Mya Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:75935
|
increased circulating triglyceride level
|
J:75935
|
Hnf4atm1.1Gonz/Hnf4atm1.1Gonz Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * FVB/N)
|
decreased circulating cholesterol level
|
J:67396
|
decreased circulating HDL cholesterol level
|
J:67396
|
decreased circulating triglyceride level
|
J:67396
|
Hnf4atm1b(EUCOMM)Hmgu/Hnf4a+
(C57BL/6N-Hnf4atm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Hnf4atm2.1Mwei/Hnf4atm2.1Mwei
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
decreased circulating cholesterol level
|
J:106993
|
decreased circulating free fatty acids level
|
J:106993
|
decreased circulating triglyceride level
|
J:106993
|
Hpgdtm1Bhk/Hpgdtm1Bhk
(involves: 129P2/OlaHsd)
|
increased prostaglandin level
|
J:74466
|
Hpgdtm1Bhk/Hpgdtm1Bhk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal prostaglandin level
|
J:105183
|
Hpgdtm1Ljm/Hpgdtm1Ljm
(involves: 129S6/SvEvTac * C57BL/6)
|
increased prostaglandin level
|
J:130001
|
HpnHlb320/?
(C57BL/6J-HpnHlb320/J)
|
decreased circulating HDL cholesterol level
|
J:82961
|
increased circulating cholesterol level
|
J:82961
|
HpnHlb320/Hpn+
(involves: C57BL/6J * C57L/J)
|
decreased circulating cholesterol level
|
J:187708
|
decreased circulating HDL cholesterol level
|
J:187708
|
decreased circulating triglyceride level
|
J:187708
|
HpnHlb320/HpnHlb320
(C57BL/6J-HpnHlb320/J)
|
decreased circulating cholesterol level
|
J:187708
|
decreased circulating HDL cholesterol level
|
J:187708
|
decreased circulating triglyceride level
|
J:187708
|
HpnHlb320/HpnHlb320
(involves: C57BL/6J * C57L/J)
|
decreased circulating cholesterol level
|
J:187708
|
decreased circulating HDL cholesterol level
|
J:187708
|
decreased circulating triglyceride level
|
J:187708
|
Hprt1tm1.1(CAG-Smpd1)Jhkh/Hprt1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal ceramide level
|
J:199833
|
Hprt1tm6(CAG-fat-1)Geno/Y Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal fatty acids level
|
J:213660
|
Hrem1(IMPC)H/Hrem1(IMPC)H
(C57BL/6NTac-Hrem1(IMPC)H/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Hrhr/Hrhr Ptgs1tm1Unc/Ptgs1+
(involves: 129P2/OlaHsd * C57BL/6 * SKH1)
|
decreased prostaglandin level
|
J:121635
|
Hrhr/Hrhr Ptgs2tm1Unc/Ptgs2+
(involves: 129P2/OlaHsd * C57BL/6 * SKH1)
|
decreased prostaglandin level
|
J:121635
|
Hrhr/Hrhr Tg(KRT14-Ptgs2)1Sumf/0
(involves: C57BL/6 * DBA/2 * FVB/N * SKH1)
|
increased prostaglandin level
|
J:121635
|
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn)
|
increased circulating free fatty acids level
|
J:107191
|
increased liver triglyceride level
|
J:107191
|
increased skeletal muscle triglyceride level
|
J:107191
|
Hs2st1tm1.1Je/Hs2st1tm1.1Je Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Hs2st1tm1.1Je Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased circulating triglyceride level
|
J:158299
|
Hsd3b7tm1Rus/Hsd3b7tm1Rus
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating triglyceride level
|
J:122973
|
increased fatty acids level
|
J:122973
|
increased liver triglyceride level
|
J:122973
|
Hsd11b1tm1.1Ggla/Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd)
|
decreased circulating corticosterone level
|
J:189059
|
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1+
(involves: C57BL/6Jcl * C57BL/6N)
|
abnormal corticosterone level
|
J:214146
|
increased circulating corticosterone level
|
J:214146
|
Hsd11b1tm1a(KOMP)Wtsi/Hsd11b1tm1a(KOMP)Wtsi
(involves: C57BL/6Jcl * C57BL/6N)
|
abnormal corticosterone level
|
J:214146
|
increased circulating corticosterone level
|
J:214146
|
Hsd11b1tm1Ggla/Hsd11b1tm1Ggla Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
decreased circulating corticosterone level
|
J:189059
|
increased circulating HDL cholesterol level
|
J:189059
|
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(involves: 129P2/OlaHsd * MF1)
|
abnormal circulating cholesterol level
|
J:72402
|
abnormal corticosterone level
|
J:67184,
J:45085
|
decreased circulating triglyceride level
|
J:72402
|
increased circulating cholesterol level
|
J:72402
|
increased circulating HDL cholesterol level
|
J:72402
|
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(B6.129P2(Cg)-Hsd11b1tm1Yko)
|
decreased circulating LDL cholesterol level
|
J:89080
|
increased circulating HDL cholesterol level
|
J:89080
|
Hsd11b2tm1Yko/Hsd11b2tm1Yko
(involves: 129P2/OlaHsd * MF1)
|
decreased circulating aldosterone level
|
J:53391
|
Hsd17b4tm1Baes/Hsd17b4tm1Baes
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal bile salt level
|
J:99925
|
abnormal lipid level
|
J:62314
|
increased fatty acids level
|
J:201698
|
Hsd17b4tm2Baes/Hsd17b4tm2Baes Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased fatty acids level
|
J:201698
|
Hsd17b4tm2Baes/Hsd17b4tm2Baes Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
increased fatty acids level
|
J:201698
|
Hsd17b13tm1Lex/Hsd17b13tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6N)
|
increased liver triglyceride level
|
J:273927
|
Hsf2bptm1a(EUCOMM)Hmgu/Hsf2bptm1a(EUCOMM)Hmgu
(C57BL/6N-Hsf2bptm1a(EUCOMM)Hmgu/Cnrm)
|
increased circulating HDL cholesterol level
|
J:165965
|
Hspa5tm1.1(KOMP)Vlcg/Hspa5+
(C57BL/6N-Hspa5tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Hspb3tm1.1(KOMP)Vlcg/Hspb3tm1.1(KOMP)Vlcg
(C57BL/6N-Hspb3tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
htd/htd
(C3H/HeJ-htd/J)
|
increased circulating corticosterone level
|
J:68094
|
Htr2ctm1Arte/Y
(involves: C57BL/6)
|
increased circulating corticosterone level
|
J:228775
|
Htr2ctm1Knk/Y
(B6.Cg-Htr2ctm1Knk)
|
decreased circulating cholesterol level
|
J:142503
|
decreased circulating triglyceride level
|
J:142503
|
HypchNZO/HlBom/?
(involves: NZO/HlBom * SJL/NBom)
|
increased circulating cholesterol level
|
J:83735
|
Hyplip2MRL/MpJ/Hyplip2MRL/MpJ
(involves: BALB/cJ * MRL/MpJ)
|
decreased circulating HDL cholesterol level
|
J:92871
|
increased circulating cholesterol level
|
J:92871
|
increased triglyceride level
|
J:92871
|
Iars1em2Nsas/Iars1em2Nsas
(C57BL/6-Iars1em2Nsas)
|
increased liver triglyceride level
|
J:340986
|
Icam1tm1Jcgr/Icam1tm1Jcgr Ldlrtm1Her/Ldlrtm1Her Vcam1tm1Dmil/Vcam1tm1Dmil
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:69597
|
Idetm1a(EUCOMM)Wtsi/Idetm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Idetm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
Ifitm1tm1.1Ieg/Ifitm1tm1.1Ieg
(B6.129P2-Ifitm1tm1.1Ieg)
|
decreased circulating corticosterone level
|
J:192287
|
Ift25tm1a(EUCOMM)Wtsi/Ift25+
(B6JTyr;B6N-Ift25tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:175295
|
increased circulating glycerol level
|
J:175295
|
Ift43tm1b(EUCOMM)Hmgu/Ift43+
(C57BL/6N-Ift43tm1b(EUCOMM)Hmgu/Bay)
|
increased circulating cholesterol level
|
J:211773
|
Ift88Tg737Rpw/Ift88Tg737Rpw
(FVB/N-Ift88Tg737Rpw)
|
increased bile salt level
|
J:73583
|
Ift88Tg737Rpw/Ift88Tg737Rpw
(C3.FVB-Ift88Tg737Rpw)
|
increased bile salt level
|
J:73583
|
Igf2bp2tm1Mini/Igf2bp2tm1Mini
(B6.129P2-Igf2bp2tm1Mini)
|
abnormal liver triglyceride level
|
J:271356
|
decreased circulating cholesterol level
|
J:271356
|
decreased circulating free fatty acids level
|
J:271356
|
decreased circulating triglyceride level
|
J:271356
|
Igfalstm1b(KOMP)Wtsi/Igfalstm1b(KOMP)Wtsi
(C57BL/6N-Igfalstm1b(KOMP)Wtsi/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
Igfbp3tm1Lex/Igfbp3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased circulating triglyceride level
|
J:168345
|
Iigp1cem1Btlr/Iigp1cem1Btlr
(C57BL/6J-Iigp1cem1Btlr)
|
decreased liver free fatty acids level
|
J:333470
|
increased circulating triglyceride level
|
J:333470
|
increased liver triglyceride level
|
J:333470
|
Iigp1cM1Btlr/Iigp1c+
(C57BL/6J-Iigp1cM1Btlr)
|
increased liver triglyceride level
|
J:333470
|
Iigp1cM1Btlr/Iigp1cM1Btlr
(C57BL/6J-Iigp1cM1Btlr)
|
increased liver triglyceride level
|
J:333470
|
Iigp1cM2Btlr/Iigp1c+
(C57BL/6J-Iigp1cM2Btlr)
|
increased liver triglyceride level
|
J:333470
|
Iigp1cM2Btlr/Iigp1cM2Btlr
(C57BL/6J-Iigp1cM2Btlr)
|
increased liver triglyceride level
|
J:333470
|
Ikzf2em2(IMPC)H/Ikzf2em2(IMPC)H
(C57BL/6NTac-Ikzf2em2(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
Il1atm1Yiw/Il1atm1Yiw Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating corticosterone level
|
J:47429
|
Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating corticosterone level
|
J:47429
|
Il1rntm1Dih/Il1rntm1Dih
(B6.129S-Il1rntm1Dih)
|
decreased circulating cholesterol level
|
J:76336
|
Il1rntm1Dih/Il1rntm1Dih
(involves: 129S/SvEv * C57BL/6J)
|
decreased circulating cholesterol level
|
J:76336
|
Il2ratm1b(EUCOMM)Wtsi/Il2ratm1b(EUCOMM)Wtsi
(C57BL/6N-Il2ratm1b(EUCOMM)Wtsi/Orl)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Il4/Il13tm1.1Lky/Il4/Il13tm1.1Lky Il4/Il13tm1.1Lky/Il4/Il13tm1.1Lky
(involves: 129P2/OlaHsd * BALB/c)
|
decreased fatty acids level
|
J:178294
|
Il4ratm2Fbb/Il4ratm2Fbb Lyz2tm1(cre)Ifo/?
(involves: 129P2/OlaHsd * BALB/c)
|
decreased fatty acids level
|
J:178294
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lipid level
|
J:129479
|
decreased circulating cholesterol level
|
J:129479
|
increased circulating cholesterol level
|
J:129479
|
increased fatty acids level
|
J:129479
|
increased leukotriene level
|
J:62283
|
increased liver triglyceride level
|
J:129479
|
Il12atm1b(EUCOMM)Hmgu/Il12atm1b(EUCOMM)Hmgu
(C57BL/6N-Il12atm1b(EUCOMM)Hmgu/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Il13tm1.1(KOMP)Vlcg/Il13tm1.1(KOMP)Vlcg
(C57BL/6N-Il13tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating HDL cholesterol level
|
J:211773
|
Il17rcem1(IMPC)Mbp/Il17rcem1(IMPC)Mbp
(C57BL/6NCrl-Il17rcem1(IMPC)Mbp/MbpMmucd)
|
decreased circulating triglyceride level
|
J:211773
|
Il21rtm1Lex/Il21rtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating triglyceride level
|
J:103485
|
Il25tm1Lex/Il25tm1Lex
(B6;129S5-Il25tm1Lex/Orl)
|
increased circulating triglyceride level
|
J:82809
|
Ilktm1Star/Ilktm1Star Tg(NPHS2-cre)295Lbh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:129244
|
IlkapGt(OST55141)Lex/IlkapGt(OST55141)Lex
(B6;129S5-IlkapGt(OST55141)Lex/Ieg)
|
increased cholesterol level
|
J:82809
|
Ilruntm1a(KOMP)Wtsi/Ilruntm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal circulating non-HDL cholesterol level
|
J:302091
|
decreased circulating cholesterol level
|
J:302091
|
decreased circulating HDL cholesterol level
|
J:302091
|
decreased circulating LDL cholesterol level
|
J:302091
|
decreased circulating phospholipid level
|
J:302091
|
decreased circulating triglyceride level
|
J:302091
|
decreased circulating VLDL triglyceride level
|
J:302091
|
decreased liver cholesterol level
|
J:302091
|
decreased liver triglyceride level
|
J:302091
|
Impactem1(IMPC)Ccpcz/Impactem1(IMPC)Ccpcz
(C57BL/6NCrl-Impactem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
Ing5em1(IMPC)J/Ing5em1(IMPC)J
(C57BL/6NJ-Ing5em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Inpp5ktm1Brd/Inpp5k+
(B6.Cg-Inpp5ktm1Brd)
|
decreased cholesterol level
|
J:139745
|
decreased circulating free fatty acids level
|
J:139745
|
decreased circulating triglyceride level
|
J:139745
|
Inppl1tm1Glas/Inppl1tm1Glas
(involves: C57BL/6J)
|
decreased circulating cholesterol level
|
J:96048
|
decreased circulating free fatty acids level
|
J:96048
|
decreased circulating triglyceride level
|
J:96048
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas)
|
increased circulating triglyceride level
|
J:40377
|
Ins2Akita/?
(involves: C57BL/6NSlc)
|
decreased circulating triglyceride level
|
J:130021
|
decreased liver triglyceride level
|
J:130021
|
decreased skeletal muscle triglyceride level
|
J:130021
|
Ins2Akita/Ins2Akita Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Ins2Akita Ldlrtm1Her)
|
increased circulating cholesterol level
|
J:174983
|
increased circulating HDL cholesterol level
|
J:174983
|
increased circulating LDL cholesterol level
|
J:174983
|
increased circulating triglyceride level
|
J:174983
|
increased circulating VLDL cholesterol level
|
J:174983
|
Insig1tm1.1Aztc/Insig1tm1.1Aztc
(Not Specified)
|
decreased circulating triglyceride level
|
J:208931
|
Insig1tm1Mbjg/Insig1tm1Mbjg Insig2tm1Mbjg/Insig2tm1Mbjg Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * SJL)
|
decreased circulating triglyceride level
|
J:101203
|
increased circulating cholesterol level
|
J:101203
|
increased fatty acids level
|
J:101203
|
increased liver cholesterol level
|
J:101203
|
increased liver triglyceride level
|
J:101203
|
Insrtm1Jja/Insrtm1Jja
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
increased circulating free fatty acids level
|
J:32538
|
increased circulating triglyceride level
|
J:32538
|
Insrtm1Jja/Insrtm1Jja Tg(PAH-INSR)1Rjv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * DBA/2)
|
increased triglyceride level
|
J:80773
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB)
|
decreased circulating free fatty acids level
|
J:63878
|
decreased circulating triglyceride level
|
J:63878
|
increased bile salt level
|
J:92861
|
Insrtm1Khn/Insrtm1Khn Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * C57BL/6J * FVB)
|
increased fatty acids level
|
J:51266
|
increased triglyceride level
|
J:51266
|
Insrtm1Khn/Insrtm1Khn Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
increased circulating triglyceride level
|
J:64790
|
Insrtm1Khn/Insrtm1Khn Tg(Slc2a4-cre)546Dac/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB)
|
increased circulating free fatty acids level
|
J:169404
|
Ints12tm1b(EUCOMM)Wtsi/Ints12+
(C57BL/6N-Ints12tm1b(EUCOMM)Wtsi/H)
|
increased circulating triglyceride level
|
J:211773
|
Ipo7em1(IMPC)Mbp/Ipo7+
(C57BL/6N-Ipo7em1(IMPC)Mbp/Ucd)
|
increased circulating triglyceride level
|
J:211773
|
Irf8tm1b(KOMP)Wtsi/Irf8tm1b(KOMP)Wtsi
(C57BL/6N-Irf8tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Irgm1em1(IMPC)Wtsi/Irgm1em1(IMPC)Wtsi
(C57BL/6N-Irgm1em1(IMPC)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Irs1tm1Jos/Irs1tm1Jos Irs3tm1Lhd/Irs3tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
decreased circulating free fatty acids level
|
J:80976
|
decreased circulating triglyceride level
|
J:80976
|
decreased triglyceride level
|
J:80976
|
Irs1tm1Mfw/Irs1tm1Mfw Irs2tm2Mfw/Irs2tm2Mfw Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal triglyceride level
|
J:137845
|
decreased circulating cholesterol level
|
J:137845
|
decreased circulating free fatty acids level
|
J:137845
|
decreased circulating HDL cholesterol level
|
J:137845
|
decreased circulating triglyceride level
|
J:137845
|
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA)
|
abnormal lipid level
|
J:47029
|
decreased circulating HDL cholesterol level
|
J:47029
|
increased circulating free fatty acids level
|
J:99746
|
increased circulating triglyceride level
|
J:47029,
J:99746
|
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:99746
|
increased circulating free fatty acids level
|
J:99746
|
increased circulating HDL cholesterol level
|
J:99746
|
increased circulating triglyceride level
|
J:99746
|
Irs2tm2Tka/Irs2tm2Tka Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating cholesterol level
|
J:93416
|
increased circulating triglyceride level
|
J:93416
|
Ism1em1(IMPC)Ccpcz/Ism1em1(IMPC)Ccpcz
(C57BL/6NCrl-Ism1em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
Itga8tm1b(KOMP)Wtsi/Itga8+
(C57BL/6N-Itga8tm1b(KOMP)Wtsi/J)
|
increased circulating free fatty acids level
|
J:211773
|
Itgb1tm1Efu/Itgb1tm1Efu Tg(Vil1-cre)997Gum/0
(involves: 129X1/SvJ * C57BL/6J * SJL)
|
abnormal circulating lipid level
|
J:119155
|
steatorrhea
|
J:119155
|
Itgb3tm1Hyn/Itgb3tm1Hyn Ldlrtm1Her/Ldlrtm1Her
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:83615
|
Itgbl1em1(IMPC)Kmpc/Itgbl1em1(IMPC)Kmpc
(C57BL/6NTac-Itgbl1em1(IMPC)Kmpc/Kmpc)
|
increased circulating triglyceride level
|
J:211773
|
Itpr2tm1Kmik/Itpr2tm1Kmik Itpr3tm1Kmik/Itpr3tm1Kmik
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal feces lipid level
|
J:101380
|
steatorrhea
|
J:101380
|
Itprid2tm1Sawa/Itprid2tm1Sawa
(B6.Cg-Itprid2tm1Sawa)
|
decreased liver triglyceride level
|
J:144968
|
decreased skeletal muscle triglyceride level
|
J:144968
|
Jag1tm1Frad/Jag1tm1Frad Tg(Tagln-cre)1Her/0
(B6.Cg-Jag1tm1Frad Tg(Tagln-cre)1Her)
|
increased circulating cholesterol level
|
J:166890
|
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda)
|
decreased circulating cholesterol level
|
J:199153
|
decreased triglyceride level
|
J:199153
|
Jakmip3em1(IMPC)J/Jakmip3em1(IMPC)J
(C57BL/6NJ-Jakmip3em1(IMPC)J/Mmjax)
|
decreased circulating triglyceride level
|
J:211773
|
Jundtm1Mya/Jundtm1Mya
(involves: 129S2/SvPas * C57BL/6J)
|
decreased liver triglyceride level
|
J:210545
|
increased circulating cholesterol level
|
J:210545
|
Kash5em1(IMPC)J/Kash5em1(IMPC)J
(C57BL/6NJ-Kash5em1(IMPC)J/Mmjax)
|
increased circulating HDL cholesterol level
|
J:211773
|
Kat2bem1(IMPC)Wtsi/Kat2bem1(IMPC)Wtsi
(C57BL/6N-Kat2bem1(IMPC)Wtsi/WtsiIeg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Kat8em1(IMPC)Mbp/Kat8+
(C57BL/6N-Kat8em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
Kat8tm1.2Avo/Kat8tm1.2Avo Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
increased fatty acids level
|
J:291094
|
Kbtbd2m1Btlr/Kbtbd2m1Btlr
(C57BL/6J-Kbtbd2m1Btlr)
|
increased liver triglyceride level
|
J:236520
|
Kcna6tm1Lex/Kcna6tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating triglyceride level
|
J:103485
|
Kcne1tm1Sfh/Kcne1tm1Sfh
(involves: 129S1/Sv)
|
increased circulating aldosterone level
|
J:77288
|
Kcne3tm1Gwab/Kcne3tm1Gwab
(involves: C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:210381
|
increased circulating aldosterone level
|
J:210381
|
increased circulating cholesterol level
|
J:210381
|
increased circulating LDL cholesterol level
|
J:210381
|
Kcnh3tm1.1(KOMP)Vlcg/Kcnh3+
(C57BL/6N-Kcnh3tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Kcnk3tm1.1Daba/Kcnk3tm1.1Daba Kcnk9tm1.1Daba/Kcnk9tm1.1Daba
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased circulating aldosterone level
|
J:131927
|
Kcnk3tm1Sgb/Kcnk3tm1Sgb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating aldosterone level
|
J:188335
|
Kctd1em1(IMPC)J/Kctd1em1(IMPC)J
(C57BL/6NJ-Kctd1em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Kctd19em1(IMPC)J/Kctd19em1(IMPC)J
(C57BL/6NJ-Kctd19em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Kdm3atm1.1Jsak/Kdm3atm1.1Jsak
(involves: C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:158258
|
increased circulating triglyceride level
|
J:158258
|
Kdm3atm1.1Yzha/Kdm3atm1.1Yzha
(B6.129P2-Kdm3atm1.1Yzha)
|
hyperlipidemia
|
J:147295
|
increased circulating cholesterol level
|
J:147295
|
increased circulating free fatty acids level
|
J:147295
|
increased circulating triglyceride level
|
J:147295
|
Kics2tm1b(KOMP)Wtsi/Kics2tm1b(KOMP)Wtsi
(C57BL/6N-Kics2tm1b(KOMP)Wtsi/Nju)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Kif2ctm1.1(KOMP)Vlcg/Kif2c+
(C57BL/6N-Kif2ctm1.1(KOMP)Vlcg/Rbrc)
|
increased circulating triglyceride level
|
J:211773
|
Kif13bGt(AF0005)Wtsi/Kif13bGt(AF0005)Wtsi
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating cholesterol level
|
J:282570
|
increased circulating HDL cholesterol level
|
J:282570
|
increased circulating LDL cholesterol level
|
J:282570
|
Kif13btm1.1Noh/Kif13btm1.1Noh
(B6.Cg-Kif13btm1.1Noh)
|
increased circulating cholesterol level
|
J:208261
|
increased circulating HDL cholesterol level
|
J:208261
|
increased circulating LDL cholesterol level
|
J:208261
|
Kif13btm1b(EUCOMM)Wtsi/Kif13btm1b(EUCOMM)Wtsi
(C57BL/6N-Kif13btm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Kif18btm1a(EUCOMM)Wtsi/Kif18b+
(C57BL/6N-Kif18btm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Kif26btm2b(KOMP)Wtsi/Kif26b+
(C57BL/6N-Kif26btm2b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Kiss1rtm1.1Lex/Kiss1rtm1.1Lex
(involves: 129S4/SvJae)
|
decreased circulating cholesterol level
|
J:181650
|
decreased circulating triglyceride level
|
J:181650
|
KitMhdasco5/KitMhdasco5
(C3HeB/FeJ-KitMhdasco5)
|
decreased circulating cholesterol level
|
J:125831
|
decreased circulating HDL cholesterol level
|
J:125831
|
decreased circulating LDL cholesterol level
|
J:125831
|
Klecalc1/Klecalc1
(involves: C3H/HeH * C57BL/6J)
|
increased vitamin D level
|
J:229255
|
Kltm1Yin/Kltm1Yin
(Not Specified)
|
abnormal vitamin D level
|
J:86859
|
Klbtm1.1Akha/Klbtm1.1Akha
(C57BL/6-Klbtm1.1Akha)
|
abnormal circulating cholesterol level
|
J:195570
|
decreased circulating cholesterol level
|
J:195570
|
Klbtm1.2Sakl/Klb+ Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6)
|
decreased circulating cholesterol level
|
J:189018
|
decreased circulating free fatty acids level
|
J:189018
|
decreased circulating triglyceride level
|
J:189018
|
decreased liver cholesterol level
|
J:189018
|
decreased liver triglyceride level
|
J:189018
|
Klbtm1.2Sakl/Klbtm1.2Sakl
(involves: 129 * 129S4/SvJaeSor * C57BL/6)
|
decreased circulating triglyceride level
|
J:189018
|
Klbtm1.2Sakl/Klbtm1.2Sakl Tg(Apoe-Fgf21)1Sakl/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6)
|
decreased circulating free fatty acids level
|
J:189018
|
Klc2tm1e(EUCOMM)Wtsi/Klc2tm1e(EUCOMM)Wtsi
(C57BL/6N-Klc2tm1e(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Klf14tm1.1Yec/Klf14tm1.1Yec Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
decreased circulating HDL cholesterol level
|
J:226403
|
Klf15hlb444/?
(C57BL/6J-Klf15hlb444/J)
|
increased circulating triglyceride level
|
J:77944
|
Klf15tm1Jain/Klf15tm1Jain
(B6.129X1-Klf15tm1Jain)
|
increased glycerol level
|
J:129763
|
Klhl3tm1.1Slin/Klhl3+
(Not Specified)
|
increased circulating aldosterone level
|
J:284284
|
Klhl3tm1.1Slin/Klhl3tm1.1Slin
(Not Specified)
|
increased circulating aldosterone level
|
J:284284
|
Klhl5tm1b(EUCOMM)Hmgu/Klhl5tm1b(EUCOMM)Hmgu
(C57BL/6N-Klhl5tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased circulating triglyceride level
|
J:211773
|
Kmt2bGena263/Kmt2b+
(involves: BALB/c * C3H/HeH)
|
increased circulating cholesterol level
|
J:203736
|
increased circulating triglyceride level
|
J:203736
|
increased liver free fatty acids level
|
J:203736
|
increased liver triglyceride level
|
J:203736
|
Kmt2ctm1.1Jwle/Kmt2c+ Kmt2dGt(RRT024)Byg/Kmt2d+
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
increased bile salt level
|
J:301497
|
Kmt2dGt(RRT024)Byg/Kmt2d+
(involves: 129P2/OlaHsd)
|
increased bile salt level
|
J:301497
|
Kpna1tm1.2Yyo/Kpna1tm1.2Yyo
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
decreased circulating cholesterol level
|
J:188099
|
Krt7tm1b(KOMP)Wtsi/Krt7tm1b(KOMP)Wtsi
(C57BL/6N-Krt7tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Krt34em1(IMPC)Ccpcz/Krt34em1(IMPC)Ccpcz
(C57BL/6NCrl-Krt34em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
Krtap17-1tm1.1(KOMP)Vlcg/Krtap17-1tm1.1(KOMP)Vlcg
(C57BL/6N-Krtap17-1tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Lacc1tm1a(KOMP)Wtsi/Lacc1tm1a(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
decreased fatty acids level
|
J:244365
|
Lactbtm1.1(KOMP)Mbp/Lactbtm1.1(KOMP)Mbp
(C57BL/6N-Lactbtm1.1(KOMP)Mbp/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Lama2dy/Lama2dy
(129P1/ReJ-Lama2dy/J)
|
abnormal galactolipid level
|
J:7911
|
abnormal lipid level
|
J:7911
|
increased cholesterol level
|
J:7911
|
Lama5tm2Jhm/Lama5tm1Jhm Tg(NPHS2-cre)295Lbh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
increased circulating cholesterol level
|
J:185850
|
Lamb2npht/Lamb2npht
(involves: C57BL/6)
|
increased circulating cholesterol level
|
J:208069
|
increased circulating triglyceride level
|
J:208069
|
Lamp2tm1Amcu/Y Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
increased liver triglyceride level
|
J:215605
|
Larp1em1(IMPC)Mbp/Larp1+
(C57BL/6N-Larp1em1(IMPC)Mbp/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Larp6em1(IMPC)Tcp/Larp6em1(IMPC)Tcp
(C57BL/6NCrl-Larp6em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Lca5lem1(IMPC)Ics/Lca5lem1(IMPC)Ics
(C57BL/6N-Lca5lem1(IMPC)Ics/Ics)
|
increased circulating cholesterol level
|
J:211773
|
Lcattm1Hgc/Lcat+
(involves: C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:41208
|
Lcattm1Hgc/Lcattm1Hgc
(involves: C57BL/6 * DBA)
|
abnormal lipid level
|
J:41208
|
decreased cholesterol level
|
J:41208
|
decreased circulating cholesterol level
|
J:41208
|
decreased circulating HDL cholesterol level
|
J:41208
|
increased cholesterol level
|
J:41208
|
Lcattm1Hgc/Lcattm1Hgc
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
decreased circulating HDL cholesterol level
|
J:75567
|
Lcattm1Hgc/Lcattm1Hgc Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA)
|
decreased circulating HDL cholesterol level
|
J:89015,
J:75567
|
decreased circulating LDL cholesterol level
|
J:89015
|
increased circulating cholesterol level
|
J:75567
|
increased circulating triglyceride level
|
J:89015,
J:75567
|
increased circulating VLDL cholesterol level
|
J:89015,
J:75567
|
Lcattm1Hgc/Lcattm1Hgc Tg(SREBP1a)7343Reh/?
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating HDL cholesterol level
|
J:93775
|
decreased circulating LDL cholesterol level
|
J:93775
|
decreased circulating triglyceride level
|
J:93775
|
increased circulating cholesterol level
|
J:93775
|
increased circulating phospholipid level
|
J:93775
|
increased circulating VLDL cholesterol level
|
J:93775
|
Lcattm1Nsa/Lcat+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal lipid level
|
J:39237
|
decreased circulating cholesterol level
|
J:39237
|
decreased circulating HDL cholesterol level
|
J:39237
|
increased circulating triglyceride level
|
J:39237
|
Lcattm1Nsa/Lcattm1Nsa
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal lipid level
|
J:39237
|
decreased circulating cholesterol level
|
J:39237
|
decreased circulating HDL cholesterol level
|
J:39237
|
increased circulating triglyceride level
|
J:39237
|
Lcattm1Nsa/Lcattm1Nsa
(B6.Cg-Lcattm1Nsa)
|
abnormal circulating phospholipid level
|
J:69299
|
abnormal lipid level
|
J:69299
|
decreased circulating cholesterol level
|
J:69299
|
decreased circulating HDL cholesterol level
|
J:69299
|
decreased circulating VLDL cholesterol level
|
J:69299
|
increased circulating triglyceride level
|
J:69299
|
Lch/Lch+
(involves: BALB/c * C3H/HeH)
|
decreased circulating cholesterol level
|
J:72447,
J:79719
|
decreased circulating HDL cholesterol level
|
J:72447,
J:79719
|
Lch2/Lch2+
(involves: BALB/c * C3H/HeH)
|
decreased circulating cholesterol level
|
J:79719,
J:79307
|
decreased circulating HDL cholesterol level
|
J:79719,
J:79307
|
Lcn2tm1Aade/Lcn2tm1Aade
(B6.129P2-Lcn2tm1Aade)
|
increased circulating cholesterol level
|
J:169355
|
increased circulating LDL cholesterol level
|
J:169355
|
increased liver triglyceride level
|
J:169355
|
Ldhatm1a(EUCOMM)Wtsi/Ldha+
(B6JTyr;B6N-Ldhatm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:175295
|
LdlrHlb301/Ldlr+
(C57BL/6J-LdlrHlb301/J)
|
increased circulating cholesterol level
|
J:82961
|
increased circulating HDL cholesterol level
|
J:82961
|
LdlrHlb301/LdlrHlb301
(C57BL/6J-LdlrHlb301/J)
|
increased circulating cholesterol level
|
J:82961
|
increased circulating HDL cholesterol level
|
J:82961
|
LdlrRgsc366/Ldlr+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased circulating cholesterol level
|
J:133634
|
Ldlrtm1(LDLR)Mae/Ldlr+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal circulating lipid level
|
J:67282
|
decreased circulating cholesterol level
|
J:67282
|
decreased circulating HDL cholesterol level
|
J:67282
|
Ldlrtm1b(EUCOMM)Wtsi/Ldlrtm1b(EUCOMM)Wtsi
(C57BL/6N-Ldlrtm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ldlrtm1Her/Ldlr+
(B6.129S7-Ldlrtm1Her)
|
increased circulating cholesterol level
|
J:72027
|
increased circulating triglyceride level
|
J:72027
|
Ldlrtm1Her/Ldlr+ Lepob/Lepob
(B6.Cg-Lepob Ldlrtm1Her)
|
increased circulating cholesterol level
|
J:72027
|
increased circulating HDL cholesterol level
|
J:72027
|
increased liver cholesterol level
|
J:72027
|
increased liver triglyceride level
|
J:72027
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating corticosterone level
|
J:108412
|
increased circulating cholesterol level
|
J:175559
|
increased circulating free fatty acids level
|
J:175559
|
increased circulating LDL cholesterol level
|
J:102291
|
increased circulating triglyceride level
|
J:175559
|
increased liver cholesterol level
|
J:175559
|
increased liver triglyceride level
|
J:175559
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd)
|
abnormal circulating cholesterol level
|
J:48202
|
abnormal circulating LDL cholesterol level
|
J:84694
|
increased circulating cholesterol level
|
J:84694,
J:228420,
J:48202
|
increased circulating LDL cholesterol level
|
J:114949,
J:169834,
J:84694
|
increased circulating triglyceride level
|
J:48202
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:96110
|
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her)
|
abnormal circulating cholesterol level
|
J:100916,
J:130278
|
abnormal triglyceride level
|
J:130278
|
decreased circulating HDL cholesterol level
|
J:130794
|
increased circulating cholesterol level
|
J:61287,
J:135078,
J:137264,
J:72027
|
increased circulating HDL cholesterol level
|
J:72027
|
increased circulating LDL cholesterol level
|
J:130794,
J:72027
|
increased circulating triglyceride level
|
J:130278,
J:137264,
J:72027
|
increased circulating VLDL cholesterol level
|
J:130278,
J:130794
|
increased circulating VLDL triglyceride level
|
J:130278
|
increased liver cholesterol level
|
J:72027
|
increased liver triglyceride level
|
J:130278
|
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her/J)
|
decreased circulating triglyceride level
|
J:85174
|
increased cholesterol level
|
J:85174
|
increased circulating cholesterol level
|
J:104609,
J:85174
|
increased circulating HDL cholesterol level
|
J:85174
|
increased circulating LDL cholesterol level
|
J:85174,
J:149005
|
increased circulating triglyceride level
|
J:149005
|
increased circulating VLDL cholesterol level
|
J:85174,
J:149005
|
increased liver cholesterol level
|
J:85174
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:114480
|
increased circulating LDL cholesterol level
|
J:114480
|
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:29950
|
Ldlrtm1Her/Ldlrtm1Her Lepob/Lepob
(B6.Cg-Lepob Ldlrtm1Her)
|
abnormal circulating cholesterol level
|
J:72027
|
hyperlipidemia
|
J:72027
|
increased circulating cholesterol level
|
J:72027
|
increased circulating HDL cholesterol level
|
J:72027
|
increased circulating triglyceride level
|
J:72027
|
increased liver cholesterol level
|
J:72027
|
increased liver triglyceride level
|
J:72027
|
Ldlrtm1Her/Ldlrtm1Her Lipctm1Unc/Lipctm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal lipid level
|
J:108412
|
decreased circulating corticosterone level
|
J:108412
|
increased circulating cholesterol level
|
J:108412
|
increased circulating HDL cholesterol level
|
J:108412
|
increased circulating LDL cholesterol level
|
J:108412
|
Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her
(involves: 129S7/SvEvBrd)
|
abnormal cholesterol level
|
J:67929
|
increased circulating cholesterol level
|
J:67929
|
increased circulating LDL cholesterol level
|
J:67929
|
increased circulating triglyceride level
|
J:67929
|
increased circulating VLDL cholesterol level
|
J:67929
|
Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:117317
|
increased circulating triglyceride level
|
J:117317
|
Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
increased circulating cholesterol level
|
J:67929
|
increased circulating LDL cholesterol level
|
J:67929
|
increased circulating triglyceride level
|
J:67929
|
increased circulating VLDL cholesterol level
|
J:67929
|
Ldlrtm1Her/Ldlrtm1Her Lrpap1tm1Her/Lrpap1tm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal lipid level
|
J:43736
|
increased circulating cholesterol level
|
J:43736
|
increased circulating triglyceride level
|
J:43736
|
Ldlrtm1Her/Ldlrtm1Her Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:142788
|
Ldlrtm1Her/Ldlrtm1Her Mobq5CAST/EiJ/Mobq5CAST/EiJ
(B6.CAST-Mobq5CAST/EiJ)
|
abnormal circulating VLDL cholesterol level
|
J:116503
|
decreased circulating cholesterol level
|
J:116503
|
decreased circulating HDL cholesterol level
|
J:116503
|
decreased circulating LDL cholesterol level
|
J:116503
|
Ldlrtm1Her/Ldlrtm1Her Mobq6CAST/EiJ/Mobq6CAST/EiJ
(B6.CAST-Mobq6CAST/EiJ)
|
decreased circulating cholesterol level
|
J:116503
|
decreased circulating HDL cholesterol level
|
J:116503
|
decreased circulating LDL cholesterol level
|
J:116503
|
decreased circulating VLDL cholesterol level
|
J:116503
|
Ldlrtm1Her/Ldlrtm1Her Npc1m1N/Npc1m1N
(involves: 129S7/SvEvBrd * BALB/c)
|
decreased brain cholesterol level
|
J:130969
|
increased cholesterol level
|
J:130969
|
increased circulating LDL cholesterol level
|
J:104996,
J:130969
|
increased liver cholesterol level
|
J:130969
|
increased lung cholesterol level
|
J:130969
|
Ldlrtm1Her/Ldlrtm1Her Nr0b2tm1.1Mjev/Nr0b2tm1.1Mjev
(involves: 129S/SvEvBrd * 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
decreased circulating LDL cholesterol level
|
J:149005
|
increased circulating HDL cholesterol level
|
J:149005
|
Ldlrtm1Her/Ldlrtm1Her Nr1h3tm1.1Djm/Nr1h3tm1.1Djm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:184536
|
decreased circulating triglyceride level
|
J:184536
|
increased liver cholesterol level
|
J:184536
|
Ldlrtm1Her/Ldlrtm1Her Nr5a2tm1Sjns/Nr5a2tm1Sjns Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * DBA)
|
abnormal feces lipid level
|
J:215556
|
abnormal sterol level
|
J:215556
|
Ldlrtm1Her/Ldlrtm1Her Nr5a2tm3.1Sjns/Nr5a2tm3.1Sjns
(involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N)
|
decreased cholesterol level
|
J:215556
|
decreased circulating LDL cholesterol level
|
J:215556
|
decreased circulating triglyceride level
|
J:215556
|
increased liver cholesterol level
|
J:215556
|
Ldlrtm1Her/Ldlrtm1Her Olr1tm1Meht/Olr1tm1Meht
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6)
|
decreased circulating HDL cholesterol level
|
J:130794
|
increased circulating LDL cholesterol level
|
J:130794
|
increased circulating VLDL cholesterol level
|
J:130794
|
Ldlrtm1Her/Ldlrtm1Her Pcsk9tm1.2Prat/Pcsk9tm1.2Prat
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)
|
increased circulating LDL cholesterol level
|
J:169834
|
Ldlrtm1Her/Ldlrtm1Her Scd1ab-2J/Scd1ab-2J
(B6.Cg-Ldlrtm1Her Scd1ab-2J)
|
abnormal circulating cholesterol level
|
J:130278
|
abnormal lipid level
|
J:130278
|
abnormal triglyceride level
|
J:130278
|
decreased circulating triglyceride level
|
J:130278
|
decreased circulating VLDL cholesterol level
|
J:130278
|
decreased circulating VLDL triglyceride level
|
J:130278
|
decreased liver triglyceride level
|
J:130278
|
Ldlrtm1Her/Ldlrtm1Her Scd1ab-J/Scd1ab-J
(B6.Cg-Ldlrtm1Her Scd1ab-J)
|
abnormal lipid level
|
J:130278
|
decreased circulating cholesterol level
|
J:130278
|
decreased circulating triglyceride level
|
J:130278
|
decreased circulating VLDL cholesterol level
|
J:130278
|
decreased circulating VLDL triglyceride level
|
J:130278
|
decreased liver triglyceride level
|
J:130278
|
Ldlrtm1Her/Ldlrtm1Her Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129S-Serpine1tm1Mlg Ldlrtm1Her)
|
increased circulating cholesterol level
|
J:61287
|
Ldlrtm1Her/Ldlrtm1Her Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:61147
|
Ldlrtm1Her/Ldlrtm1Her Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:96110
|
Ldlrtm1Her/Ldlrtm1Her Tg(APOC1)1Lmh/?
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:65146
|
increased circulating triglyceride level
|
J:65146
|
increased circulating VLDL cholesterol level
|
J:65146
|
increased circulating VLDL triglyceride level
|
J:65146
|
Ldlrtm1Her/Ldlrtm1Her Tg(APOC3)3707Bres/?
(involves: 129S7/SvEvBrd * C57BL/6J * CBA/J)
|
increased circulating LDL cholesterol level
|
J:37861
|
increased circulating VLDL cholesterol level
|
J:37861
|
Ldlrtm1Her/Ldlrtm1Her Tg(APOC3)3707Bres/? Tg(Mt1-CETP)#Tall/?
(involves: 129S7/SvEvBrd * C57BL/6J * CBA/J)
|
decreased circulating HDL cholesterol level
|
J:37861
|
increased circulating LDL cholesterol level
|
J:37861
|
increased circulating triglyceride level
|
J:37861
|
increased circulating VLDL cholesterol level
|
J:37861
|
Ldlrtm1Her/Ldlrtm1Her Tg(APOM)NCchr/0
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * CBA)
|
decreased circulating triglyceride level
|
J:130647
|
Ldlrtm1Her/Ldlrtm1Her Tg(APPSWE)2576Kha/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:114480
|
increased circulating LDL cholesterol level
|
J:114480
|
Ldlrtm1Her/Ldlrtm1Her Tg(CMV-Serpine1)1Dgi/0
(B6.Cg-Ldlrtm1Her Tg(CMV-Serpine1)1Dgi)
|
increased circulating cholesterol level
|
J:61287
|
Ldlrtm1Her/Ldlrtm1Her Tg(H2-K-AKR1B1)1Tj/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
abnormal circulating cholesterol level
|
J:100916
|
Ldlrtm1Her/Ldlrtm1Her Tg(Il1rn)1Dih/Tg(Il1rn)1Dih
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:76336
|
increased circulating triglyceride level
|
J:76336
|
Ldlrtm1Her/Ldlrtm1Her Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir Ldlrtm1Her)
|
decreased circulating cholesterol level
|
J:102502
|
Ldlrap1Gt(OST149604)Lex/Ldlrap1Gt(OST149604)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:102291
|
increased circulating LDL cholesterol level
|
J:102291
|
Ldlrap1tm1Her/Ldlrap1tm1Her
(involves: 129S6/SvEvTac)
|
abnormal circulating LDL cholesterol level
|
J:84694
|
increased circulating cholesterol level
|
J:84694
|
increased circulating LDL cholesterol level
|
J:84694
|
increased circulating triglyceride level
|
J:84694
|
Lepm1Yst/Lepm1Yst
(C57BL/6J-Lepm1Yst)
|
increased circulating cholesterol level
|
J:167736
|
increased circulating triglyceride level
|
J:167736
|
Lepob/Lepob
(involves: C57BL/6J)
|
abnormal corticosterone level
|
J:13151
|
increased circulating corticosterone level
|
J:60001
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
abnormal circulating cholesterol level
|
J:18161
|
increased circulating cholesterol level
|
J:18161
|
increased circulating HDL cholesterol level
|
J:18161
|
increased circulating LDL cholesterol level
|
J:18161
|
increased circulating triglyceride level
|
J:18161,
J:104171
|
increased circulating VLDL cholesterol level
|
J:18161
|
Lepob/Lepob
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating cholesterol level
|
J:107169
|
increased circulating corticosterone level
|
J:107169,
J:76479
|
increased circulating triglyceride level
|
J:107169
|
Lepob/Lepob
(involves: 129 * C57BL/6)
|
abnormal lipid level
|
J:121534
|
Lepob/Lepob
(BKS.Cg-Lepob/J)
|
abnormal circulating cholesterol level
|
J:18161
|
increased circulating cholesterol level
|
J:18161
|
increased circulating HDL cholesterol level
|
J:18161
|
increased circulating LDL cholesterol level
|
J:18161
|
increased circulating triglyceride level
|
J:18161
|
increased circulating VLDL cholesterol level
|
J:18161
|
Lepob/Lepob
(B6.Cg-Lepob/JBomTac)
|
increased circulating triglyceride level
|
J:149091
|
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs)
|
decreased liver triglyceride level
|
J:199803
|
increased liver triglyceride level
|
J:199803
|
Lepob/Lepob
(involves: C57BL/6)
|
increased circulating cholesterol level
|
J:72027
|
increased circulating HDL cholesterol level
|
J:72027
|
increased circulating triglyceride level
|
J:72027
|
increased liver cholesterol level
|
J:72027
|
increased liver triglyceride level
|
J:72027
|
Lepob/Lepob
(BTBR.Cg-Lepob/WiscJ)
|
increased cholesterol level
|
J:185261
|
increased circulating triglyceride level
|
J:106121,
J:185261
|
Lepob/Lepob
(B6.Cg-Lepob/JRj)
|
increased cholesterol level
|
J:277927
|
increased circulating free fatty acids level
|
J:277927
|
Lepob/Lepob Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae)
|
increased circulating cholesterol level
|
J:231617
|
increased circulating triglyceride level
|
J:231617
|
increased liver triglyceride level
|
J:231617
|
Lepob/Lepob Nfe2l2tm1.1Jgpi/Nfe2l2tm1.1Jgpi Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6)
|
increased circulating triglyceride level
|
J:208590
|
Lepob/Lepob Nfe2l2tm1Mym/Nfe2l2tm1Mym
(B6.Cg-Nfe2l2tm1Mym Lepob)
|
decreased liver triglyceride level
|
J:208590
|
increased circulating triglyceride level
|
J:208590
|
Lepob/Lepob Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating corticosterone level
|
J:107169
|
increased circulating cholesterol level
|
J:107169
|
increased circulating triglyceride level
|
J:107169
|
Lepob/Lepob Npy2rtm1Pern/Npy2rtm1Pern
(involves: 129 * BALB/c * C57BL/10J)
|
decreased circulating free fatty acids level
|
J:102651
|
decreased circulating LDL cholesterol level
|
J:102651
|
increased circulating cholesterol level
|
J:102651
|
increased circulating HDL cholesterol level
|
J:102651
|
increased triglyceride level
|
J:102651
|
Lepob/Lepob Npy4rtm1.1Hhz/Npy4rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating corticosterone level
|
J:76479
|
Lepob/Lepob Nr1i3tm1Dgen/Nr1i3tm1Dgen
(B6.Cg-Nr1i3tm1Dgen Lepob)
|
decreased circulating triglyceride level
|
J:149091
|
Lepob/Lepob Plin4tm1Vlcg/Plin4tm1Vlcg
(involves: C57BL/6J)
|
decreased cardiac muscle triglyceride level
|
J:195987
|
Lepob/Lepob Pmchtm1Emf/Pmchtm1Emf
(involves: 129S4/SvJae * C57BL/6)
|
abnormal circulating corticosterone level
|
J:85176
|
Lepob/Lepob Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating triglyceride level
|
J:116568
|
Lepob/Lepob Ppargtm2Avp/Ppargtm2Avp
(involves: 129 * C57BL/6)
|
decreased liver triglyceride level
|
J:121534
|
decreased triglyceride level
|
J:121534
|
increased circulating free fatty acids level
|
J:121534
|
increased circulating triglyceride level
|
J:121534
|
Lepob/Lepob Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased liver triglyceride level
|
J:189021
|
Lepob/Lepob Tg(Eno2-Pomc)1Mobb/?
(involves: C3H * C57BL/6)
|
abnormal fatty acids level
|
J:86303
|
Leprdb-lb/Leprdb-lb
(C57BL/6NCrl-Leprdb-lb/Crl)
|
abnormal lipid level
|
J:171755
|
Leprdb-Nokl/Leprdb-Nokl
(C57BL/6N-Leprdb-Nokl)
|
increased circulating cholesterol level
|
J:313303
|
increased circulating HDL cholesterol level
|
J:313303
|
increased circulating LDL cholesterol level
|
J:313303
|
increased circulating triglyceride level
|
J:313303
|
increased liver triglyceride level
|
J:313303
|
Leprdb-Pas/Leprdb-Pas
(involves: DW/Pas)
|
increased circulating cholesterol level
|
J:174584
|
Leprdb/Lepr+ Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: C3H * C57BL/6 * C57BLKS/J)
|
abnormal circulating cholesterol level
|
J:186924
|
Leprdb/Leprdb-Nokl
(B6NTac.Cg-Leprdb Leprdb-Nokl)
|
increased circulating cholesterol level
|
J:313303
|
increased circulating HDL cholesterol level
|
J:313303
|
increased circulating LDL cholesterol level
|
J:313303
|
increased circulating triglyceride level
|
J:313303
|
increased liver triglyceride level
|
J:313303
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
hyperlipidemia
|
J:96047
|
increased circulating cholesterol level
|
J:232827
|
increased circulating corticosterone level
|
J:89242
|
increased circulating free fatty acids level
|
J:106871,
J:232827
|
increased circulating triglyceride level
|
J:232827
|
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J)
|
abnormal circulating cholesterol level
|
J:18161
|
abnormal circulating lipid level
|
J:18161
|
increased circulating cholesterol level
|
J:18161
|
increased circulating HDL cholesterol level
|
J:18161
|
increased circulating LDL cholesterol level
|
J:18161
|
increased circulating triglyceride level
|
J:18161,
J:82334
|
increased circulating VLDL cholesterol level
|
J:18161
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/J)
|
abnormal circulating cholesterol level
|
J:18161
|
abnormal circulating lipid level
|
J:18161
|
decreased circulating triglyceride level
|
J:91813
|
decreased prostaglandin level
|
J:185546
|
increased circulating cholesterol level
|
J:18161
|
increased circulating HDL cholesterol level
|
J:18161
|
increased circulating LDL cholesterol level
|
J:18161
|
increased circulating triglyceride level
|
J:18161
|
increased circulating VLDL cholesterol level
|
J:18161
|
Leprdb/Leprdb
(B6.BKS(D)-Leprdb/JOrlRj)
|
increased cholesterol level
|
J:277927
|
Leprdb/Leprdb
(B6NTac.BKS(D)-Leprdb)
|
increased circulating cholesterol level
|
J:313303
|
increased circulating HDL cholesterol level
|
J:313303
|
increased circulating LDL cholesterol level
|
J:313303
|
increased circulating triglyceride level
|
J:313303
|
increased liver triglyceride level
|
J:313303
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb)
|
increased circulating cholesterol level
|
J:346348
|
increased circulating triglyceride level
|
J:346348
|
Leprdb/Leprdb Tg(SHBG)4-aGlha/0
(involves: C57BL/6 * C57BLKS/J * CBA)
|
increased circulating cholesterol level
|
J:232827
|
increased circulating free fatty acids level
|
J:232827
|
increased circulating triglyceride level
|
J:232827
|
increased liver triglyceride level
|
J:232827
|
Leprtm1.1Chua/Leprtm1.1Chua Tg(Agrp-cre)1Gsb/0
(involves: 129 * FVB/N)
|
decreased liver triglyceride level
|
J:199803
|
Leprtm1.1Chua/Leprtm1.2Chua Nos1tm1(cre)Mgmj/Nos1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating corticosterone level
|
J:183754
|
Leprtm1.2Chua/Leprtm1.2Chua Nos1tm1(cre)Mgmj/Nos1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating corticosterone level
|
J:183754
|
Leprtm1b(EUCOMM)Wtsi/Leprtm1b(EUCOMM)Wtsi
(C57BL/6N-Leprtm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ * C57BL/6J)
|
increased circulating cholesterol level
|
J:184572
|
increased circulating triglyceride level
|
J:184572
|
increased liver triglyceride level
|
J:184572
|
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ)
|
increased liver triglyceride level
|
J:216393
|
Leprtm1Jke/Leprtm1Jke Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased circulating cholesterol level
|
J:184572
|
decreased circulating triglyceride level
|
J:184572
|
decreased liver triglyceride level
|
J:184572
|
increased circulating cholesterol level
|
J:184572
|
increased circulating triglyceride level
|
J:184572
|
increased liver triglyceride level
|
J:184572
|
Leprtm1Mgmj/Leprtm1Mgmj
(B6.129-Leprtm1Mgmj)
|
increased circulating triglyceride level
|
J:82334
|
Leprottm1.2Damj/Leprottm1.2Damj
(involves: 129S2/SvPas * C57BL/6N * FVB/N)
|
decreased cholesterol level
|
J:349250
|
Lexis1tm1.1Pton/Lexis1tm1.1Pton
(B6.Cg-Lexis1tm1.1Pton)
|
increased liver cholesterol level
|
J:233670
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * CD-1)
|
increased liver triglyceride level
|
J:116073
|
Lgals7tm1a(EUCOMM)Wtsi/Lgals7tm1a(EUCOMM)Wtsi
(C57BL/6N-Lgals7tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
Lgals12tm1Ftl/Lgals12tm1Ftl
(B6.129-Lgals12tm1Ftl)
|
abnormal free fatty acids level
|
J:180097
|
decreased triglyceride level
|
J:180097
|
increased glycerol level
|
J:180097
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * C57BL/6 * MF1)
|
decreased circulating triglyceride level
|
J:87585
|
Lima1tm1.1Blsg/Lima1+
(involves: C57BL/6 * FVB/N)
|
decreased circulating cholesterol level
|
J:263730
|
Lima1tm1Blsg/Lima1tm1Blsg Tg(Vil1-cre/ERT2)23Syr/0
(involves: C57BL/6 * DBA/2)
|
decreased circulating cholesterol level
|
J:263730
|
decreased circulating HDL cholesterol level
|
J:263730
|
decreased circulating LDL cholesterol level
|
J:263730
|
decreased circulating VLDL cholesterol level
|
J:263730
|
decreased liver cholesterol level
|
J:263730
|
Lipatm1c(EUCOMM)Hmgu/Lipatm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1Tg(Alb-cre)21Mgn
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
decreased liver triglyceride level
|
J:270182
|
decreased unsaturated fatty acids level
|
J:270182
|
increased circulating cholesterol level
|
J:270182
|
increased circulating LDL cholesterol level
|
J:270182
|
increased liver cholesterol level
|
J:270182
|
increased unsaturated fatty acids level
|
J:270182
|
Lipatm1Hodu/Lipatm1Hodu
(involves: 129P2/OlaHsd * CF-1)
|
abnormal lipid level
|
J:68812
|
decreased circulating HDL cholesterol level
|
J:68812
|
increased circulating free fatty acids level
|
J:68812
|
increased circulating LDL cholesterol level
|
J:68812
|
increased liver cholesterol level
|
J:49674
|
increased liver triglyceride level
|
J:49674
|
Lipctm1Unc/Lipctm1Unc
(involves: 129)
|
abnormal circulating cholesterol level
|
J:22938
|
abnormal circulating phospholipid level
|
J:22938
|
increased circulating cholesterol level
|
J:22938
|
increased circulating HDL cholesterol level
|
J:22938
|
Lipctm1Unc/Lipctm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:22938
|
abnormal circulating phospholipid level
|
J:22938
|
increased circulating cholesterol level
|
J:22938
|
increased circulating HDL cholesterol level
|
J:22938
|
Lipctm1Unc/Lipctm1Unc
(B6.129P2-Lipctm1Unc)
|
decreased circulating corticosterone level
|
J:108412
|
increased circulating cholesterol level
|
J:120962
|
increased circulating triglyceride level
|
J:120962
|
Lipetm1Gam/Lipetm1Gam
(involves: 129S4/SvJae * BALB/c)
|
abnormal circulating cholesterol level
|
J:82299
|
abnormal circulating free fatty acids level
|
J:82299
|
decreased liver triglyceride level
|
J:82299
|
Lipetm1Ishi/Lipetm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased circulating free fatty acids level
|
J:59889
|
decreased circulating glycerol level
|
J:59889
|
increased triglyceride level
|
J:59889
|
Lipetm1Ishi/Lipetm1Ishi
(B6.129S7-Lipetm1Ishi)
|
increased circulating cholesterol level
|
J:152385
|
increased circulating free fatty acids level
|
J:152385
|
increased circulating triglyceride level
|
J:152385
|
Lipetm1Ishi/Lipetm1Ishi Nceh1tm1Ishi/Nceh1tm1Ishi
(B6.129S7-Nceh1tm1Ishi Lipetm1Ishi)
|
increased circulating cholesterol level
|
J:152385
|
increased circulating free fatty acids level
|
J:152385
|
increased circulating triglyceride level
|
J:152385
|
Lipetm1Land/Lipetm1Land
(involves: 129 * C57BL/6J)
|
abnormal feces lipid level
|
J:133126
|
Lipetm1Rze/Lipetm1Rze
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal fatty acids level
|
J:74644
|
abnormal lipid level
|
J:74644
|
abnormal triglyceride level
|
J:74644
|
decreased cardiac muscle triglyceride level
|
J:74644
|
decreased liver triglyceride level
|
J:74644
|
increased triglyceride level
|
J:74644
|
Lipetm1Rze/Lipetm1Rze
(involves: 129P2/OlaHsd)
|
decreased circulating free fatty acids level
|
J:84822
|
decreased circulating triglyceride level
|
J:84822
|
decreased liver triglyceride level
|
J:84822
|
Lipgtm1Chan/Lipg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating cholesterol level
|
J:82390
|
increased circulating HDL cholesterol level
|
J:82390
|
Lipgtm1Chan/Lipgtm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating cholesterol level
|
J:82390
|
increased circulating HDL cholesterol level
|
J:82390
|
increased circulating phospholipid level
|
J:82390
|
Lipgtm1Tq/Lipg+
(B6.129S6-Lipgtm1Tq)
|
increased circulating HDL cholesterol level
|
J:81821
|
increased circulating phospholipid level
|
J:81821
|
increased circulating triglyceride level
|
J:81821
|
Lipgtm1Tq/Lipgtm1Tq
(B6.129S6-Lipgtm1Tq)
|
increased circulating cholesterol level
|
J:81821
|
increased circulating HDL cholesterol level
|
J:81821
|
increased circulating phospholipid level
|
J:81821
|
Lipgtm1Tq/Lipgtm1Tq
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased circulating cholesterol level
|
J:93987
|
increased circulating HDL cholesterol level
|
J:93987
|
increased circulating phospholipid level
|
J:93987
|
increased circulating triglyceride level
|
J:93987
|
Lipgtm1Tq/Lipgtm1Tq
(involves: 129S6/SvEvTac)
|
abnormal circulating HDL cholesterol level
|
J:129942
|
Lipilpd1/Lipilpd1
(involves: CD-1)
|
increased circulating triglyceride level
|
J:46789
|
increased liver triglyceride level
|
J:46789
|
Lipq1BALB/cJ/Lipq1C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ)
|
increased circulating cholesterol level
|
J:88731
|
increased circulating HDL cholesterol level
|
J:88731
|
Lipq1C57BL/6By/Lipq1C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ)
|
increased circulating cholesterol level
|
J:88731
|
increased circulating HDL cholesterol level
|
J:88731
|
Lipq2BALB/cJ/Lipq2BALB/cJ
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ)
|
increased circulating cholesterol level
|
J:88731
|
increased circulating HDL cholesterol level
|
J:88731
|
Lipq3BALB/cJ/Lipq3C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ)
|
increased circulating cholesterol level
|
J:88731
|
increased circulating HDL cholesterol level
|
J:88731
|
Lipq3C57BL/6By/Lipq3C57BL/6By
(involves: BALB/cJ * B6.C-H25c/(HW65)ByJ)
|
increased circulating cholesterol level
|
J:88731
|
increased circulating HDL cholesterol level
|
J:88731
|
Llgl2tm1b(KOMP)Wtsi/Llgl2+
(C57BL/6N-Llgl2tm1b(KOMP)Wtsi/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Lmf1cld/Lmf1cld
(STOCK T/tw73)
|
increased circulating cholesterol level
|
J:7083
|
increased circulating triglyceride level
|
J:7083
|
Lmf1Gt(OST195742)Lex/Lmf1Gt(OST195742)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
hyperlipidemia
|
J:223457
|
increased circulating cholesterol level
|
J:223457
|
increased circulating triglyceride level
|
J:223457
|
Lmnaem1Fenz/Lmna+
(C57BL/6-Lmnaem1Fenz)
|
increased circulating cholesterol level
|
J:338760
|
increased circulating LDL cholesterol level
|
J:338760
|
increased liver triglyceride level
|
J:338760
|
Lmnatm1Gbon/Lmnatm1Gbon
(involves: 129S2/SvPas * C57BL/6)
|
increased triglyceride level
|
J:95528
|
Lmnatm1Stw/Lmnatm1Stw
(involves: 129S1/Sv * C57BL/6J)
|
decreased circulating triglyceride level
|
J:75101
|
Lmod3em1(IMPC)Mbp/Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Lncenc1em1Smoc/Lncenc1em1Smoc
(C57BL/6J-Lncenc1em1Smoc)
|
decreased circulating cholesterol level
|
J:306153
|
decreased circulating HDL cholesterol level
|
J:306153
|
decreased circulating LDL cholesterol level
|
J:306153
|
decreased circulating triglyceride level
|
J:306153
|
decreased liver cholesterol level
|
J:306153
|
decreased liver triglyceride level
|
J:306153
|
Lncenc1em2Smoc/Lncenc1em2Smoc
(C57BL/6J-Lncenc1em2Smoc)
|
decreased circulating triglyceride level
|
J:306153
|
Lnpeptm1Ske/Lnpeptm1Ske
(B6.129S-Lnpeptm1Ske)
|
decreased circulating cholesterol level
|
J:220356
|
Lonp1tm1b(EUCOMM)Hmgu/Lonp1+
(C57BL/6N-Lonp1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating HDL cholesterol level
|
J:211773
|
Lonrf3tm1a(KOMP)Wtsi/Y
(C57BL/6N-Lonrf3tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Lpar3tm1Jch/Lpar3tm1Jch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased prostaglandin level
|
J:98434
|
Lpcat1rd11-2J/Lpcat1rd11-2J
(B6.Cg-Lpcat1rd11-2J/BocJ)
|
abnormal phospholipid level
|
J:163743
|
Lpcat1rd11/Lpcat1rd11
(B6.Cg-Lpcat1rd11/BocJ)
|
abnormal phospholipid level
|
J:163743
|
Lpcat2em1(IMPC)J/Lpcat2em1(IMPC)J
(C57BL/6NJ-Lpcat2em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased circulating triglyceride level
|
J:220827
|
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal lipid level
|
J:220827
|
abnormal phospholipid level
|
J:220827
|
decreased circulating triglyceride level
|
J:220827
|
decreased circulating VLDL phospholipid level
|
J:220827
|
decreased circulating VLDL triglyceride level
|
J:220827
|
increased liver cholesterol level
|
J:220827
|
increased liver triglyceride level
|
J:220827
|
Lpcat3tm1c(EUCOMM)Wtsi/Lpcat3tm1c(EUCOMM)Wtsi Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal lipid level
|
J:220827
|
decreased circulating triglyceride level
|
J:220827
|
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld/J)
|
increased fatty acids level
|
J:121022
|
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld)
|
abnormal lipid level
|
J:82882
|
abnormal phospholipid level
|
J:82882
|
abnormal triglyceride level
|
J:82882
|
decreased circulating LDL cholesterol level
|
J:63448
|
decreased circulating VLDL cholesterol level
|
J:63448
|
decreased fatty acids level
|
J:63448
|
decreased triglyceride level
|
J:82882
|
increased cholesterol level
|
J:82882
|
increased circulating HDL cholesterol level
|
J:63448
|
increased circulating triglyceride level
|
J:82882
|
increased circulating VLDL triglyceride level
|
J:147417
|
increased fatty acids level
|
J:82882
|
increased liver triglyceride level
|
J:147417,
J:82882
|
increased triglyceride level
|
J:82882
|
Lpin1fld/Lpin1fld
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J)
|
decreased liver triglyceride level
|
J:220917
|
decreased triglyceride level
|
J:220917
|
Lpin1fld/Lpin1fld Lpin3tm1Reue/Lpin3tm1Reue
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J)
|
decreased liver triglyceride level
|
J:220917
|
decreased triglyceride level
|
J:220917
|
Lpin2tm1Reue/Lpin2tm1Reue
(involves: C57BL/6J)
|
decreased circulating free fatty acids level
|
J:189894
|
decreased circulating triglyceride level
|
J:189894
|
increased liver triglyceride level
|
J:189894
|
Lpin3tm1Reue/Lpin3tm1Reue
(involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J)
|
decreased triglyceride level
|
J:220917
|
Lpltm1Bres/Lpl+
(involves: 129S4/SvJae * C57BL/6J)
|
increased circulating cholesterol level
|
J:30062
|
increased circulating triglyceride level
|
J:30062
|
increased circulating VLDL cholesterol level
|
J:30062
|
increased circulating VLDL triglyceride level
|
J:30062
|
Lpltm1Bres/Lpl+
(involves: 129S4/SvJae)
|
increased cholesterol level
|
J:134171
|
increased triglyceride level
|
J:134171
|
Lpltm1Bres/Lpl+ Tg(Myh6-LPL*)357Ijg/0
(involves: 129S4/SvJae)
|
abnormal lipid level
|
J:134550
|
increased fatty acids level
|
J:134550
|
Lpltm1Bres/Lpltm1Bres
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:30062
|
decreased circulating LDL cholesterol level
|
J:30062
|
increased circulating cholesterol level
|
J:30062
|
increased circulating triglyceride level
|
J:30062
|
increased circulating VLDL cholesterol level
|
J:30062
|
Lpltm1Ijg/Lpltm1Ijg Tg(Myh6-cre)2182Mds/?
(involves: C57BL/6)
|
abnormal lipid level
|
J:90737
|
decreased cardiac muscle triglyceride level
|
J:90737
|
decreased fatty acids level
|
J:90737
|
increased circulating triglyceride level
|
J:90737
|
increased circulating VLDL triglyceride level
|
J:90737
|
Lpltm1Ijg/Lpltm1Ijg Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
increased circulating triglyceride level
|
J:110484
|
Lpltm1Sem/Lpl+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased circulating cholesterol level
|
J:25652
|
increased circulating HDL cholesterol level
|
J:25652
|
increased circulating phospholipid level
|
J:25652
|
increased circulating triglyceride level
|
J:25652
|
increased circulating VLDL triglyceride level
|
J:25652
|
Lpltm1Sem/Lpltm1Sem
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:25652
|
hyperlipidemia
|
J:25652
|
increased circulating cholesterol level
|
J:25652
|
increased circulating phospholipid level
|
J:25652
|
increased circulating triglyceride level
|
J:25652
|
Lprq1MRL/MpJ/Lprq1MRL/MpJ
(involves: BALB/cJ * MRL/MpJ)
|
decreased circulating cholesterol level
|
J:53728
|
decreased circulating VLDL cholesterol level
|
J:53728
|
Lprq2MRL/MpJ/Lprq2MRL/MpJ
(involves: BALB/cJ * MRL/MpJ)
|
decreased circulating HDL cholesterol level
|
J:53728
|
Lprq3NZB/BlNJ/?
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:29072
|
Lprq4NZB/BlNJ/?
(involves: NZB/BlNJ * SM/J)
|
abnormal circulating cholesterol level
|
J:29072
|
increased circulating HDL cholesterol level
|
J:29072
|
Lrbaem1(IMPC)Wtsi/Lrbaem1(IMPC)Wtsi
(C57BL/6N-Lrbaem1(IMPC)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Lrig3tm1.1Hhed/Lrig3tm1.1Hhed
(B6.129(Cg)-Lrig3tm1.1Hhed)
|
decreased circulating glycerol level
|
J:242435
|
decreased circulating HDL cholesterol level
|
J:242435
|
Lrp1tm2Her/Lrp1tm2Her Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S7/SvEvBrd * BALB/c * C57BL)
|
abnormal lipid level
|
J:167724
|
decreased brain cholesterol level
|
J:167724
|
decreased triglyceride level
|
J:167724
|
Lrp1tm2Her/Lrp1tm2Her Tg(Fabp4-cre)1Rev/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal circulating lipid level
|
J:127398
|
decreased circulating free fatty acids level
|
J:127398
|
decreased liver triglyceride level
|
J:127398
|
Lrp2tm1Tew/Lrp2tm1Tew Tg(APOE-cre)VITew/0
(Not Specified)
|
abnormal vitamin D level
|
J:81496
|
Lrp5tm1Jsak/Lrp5+
(involves: C57BL/6 * CBA)
|
increased cholesterol level
|
J:81174
|
Lrp5tm1Jsak/Lrp5tm1Jsak
(involves: C57BL/6 * CBA)
|
increased cholesterol level
|
J:81174
|
increased circulating VLDL cholesterol level
|
J:81174
|
Lrp6Gt(LST067)Byg/Lrp6+
(B6.Cg-Lrp6Gt(LST067)Byg)
|
decreased liver triglyceride level
|
J:182772
|
Lrp6tm1Arma/Lrp6+
(C57BL/6-Lrp6tm1Arma)
|
increased cholesterol level
|
J:210538
|
increased circulating LDL cholesterol level
|
J:210538
|
increased circulating triglyceride level
|
J:210538
|
Lrp6tm1Arma/Lrp6tm1Arma
(C57BL/6-Lrp6tm1Arma)
|
abnormal fatty acids level
|
J:210538
|
hyperlipidemia
|
J:210538
|
increased cholesterol level
|
J:210538
|
increased circulating LDL cholesterol level
|
J:210538
|
increased circulating triglyceride level
|
J:210538
|
increased circulating VLDL triglyceride level
|
J:210538
|
increased liver cholesterol level
|
J:210538,
J:225450
|
increased liver triglyceride level
|
J:210538
|
Lrrk1tm1b(KOMP)Wtsi/Lrrk1tm1b(KOMP)Wtsi
(C57BL/6N-Lrrk1tm1b(KOMP)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Lrrk2tm1.1Hlme/Lrrk2tm1.1Hlme
(involves: C57BL/6 * C57BL/6J)
|
abnormal lipid level
|
J:223350
|
Lst1tm1.1(KOMP)Vlcg/Lst1tm1.1(KOMP)Vlcg
(C57BL/6N-Lst1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating triglyceride level
|
J:211773
|
Ltbp1tm1a(EUCOMM)Wtsi/Ltbp1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Ltbp1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Ltkem1(IMPC)H/Ltkem1(IMPC)H
(C57BL/6NTac-Ltkem1(IMPC)H/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Lyntm1b(EUCOMM)Hmgu/Lyntm1b(EUCOMM)Hmgu
(C57BL/6N-Lyntm1b(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Lypd3tm1.1(KOMP)Vlcg/Lypd3+
(C57BL/6N-Lypd3tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating triglyceride level
|
J:211773
|
Lyplal1em1Espel/Lyplal1em1Espel
(C57BL/6J-Lyplal1em1Espel)
|
decreased liver triglyceride level
|
J:340413
|
increased circulating triglyceride level
|
J:340413
|
Mad2l1bptm1.1Itl/Mad2l1bptm1.1Itl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * C57BL/6NTac)
|
decreased liver triglyceride level
|
J:234643
|
increased circulating triglyceride level
|
J:234643
|
Maf1tm1.1Lnh/Maf1tm1.1Lnh
(involves: C57BL/6)
|
decreased circulating phospholipid level
|
J:222253
|
Malrd1C57BL/6ByJ/Malrd1C57BL/6ByJ
(involves: A/J * C57BL/6J)
|
decreased circulating LDL cholesterol level
|
J:61563
|
decreased circulating VLDL cholesterol level
|
J:61563
|
Map3k1tm1a(KOMP)Wtsi/Map3k1+
(C57BL/6N-Map3k1tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Map3k10tm1b(EUCOMM)Hmgu/Map3k10tm1b(EUCOMM)Hmgu
(C57BL/6N-Map3k10tm1b(EUCOMM)Hmgu/Cnrm)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mapk8tm1Jcbr/Mapk8tm1Jcbr Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased liver triglyceride level
|
J:158650
|
Mapk8ip1tm3.1Rjd/Mapk8ip1tm3.1Rjd
(B6.129S6-Mapk8ip1tm3.1Rjd)
|
decreased liver triglyceride level
|
J:163808
|
Marchf5tm1.1Ygi/Marchf5tm1.1Ygi Tg(Emx1-cre)#Ito/0
(involves: C57BL/6)
|
abnormal phospholipid level
|
J:284572
|
Marchf9tm1a(EUCOMM)Wtsi/Marchf9tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating HDL cholesterol level
|
J:165965
|
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:120128
|
decreased circulating triglyceride level
|
J:120128
|
Mark4Gt(XG191)Byg/Mark4Gt(XG191)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:192469
|
decreased circulating triglyceride level
|
J:192469
|
Mboat4tm2Vlcg/Mboat4tm2Vlcg
(Not Specified)
|
increased bile salt level
|
J:180107
|
Mboat7tm1Arai/Mboat7tm1Arai
(B6.129P2-Mboat7tm1Arai)
|
decreased fatty acids level
|
J:200247
|
increased fatty acids level
|
J:200247
|
Mbpshi/Mbpshi
(SWV-Mbpshi)
|
decreased brain cholesterol level
|
J:9907
|
decreased cholesterol level
|
J:9907
|
MbsydC57BL/6J/MbsydPERA/EiJ
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ)
|
increased circulating triglyceride level
|
J:94548
|
Mbtps1tm1Jdh/Mbtps1tm1Jdh Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:72930
|
decreased circulating triglyceride level
|
J:72930
|
decreased liver triglyceride level
|
J:72930
|
Mbtps1wrt/Mbtps1wrt
(C57BL/6J-Mbtps1wrt)
|
decreased circulating cholesterol level
|
J:94077,
J:123123
|
decreased circulating HDL cholesterol level
|
J:123123
|
increased circulating LDL cholesterol level
|
J:123123
|
Mc2rtm1Dchi/Mc2rtm1Dchi
(B6.129P2-Mc2rtm1Dchi)
|
decreased circulating aldosterone level
|
J:127445
|
decreased circulating corticosterone level
|
J:127445
|
Mc3rtm1Butl/Mc3rtm1Butl
(B6.Cg-Mc3rtm1Butl)
|
decreased circulating triglyceride level
|
J:178147
|
Mc3rtm1Butl/Mc3rtm1Butl Tg(Nr5a1-cre)2Lowl/0
(involves: C57BL/6J * FVB/NJ)
|
decreased circulating triglyceride level
|
J:178147
|
Mc4rtm1Lowl/Mc4rtm1Lowl
(involves: 129S4/SvJae * C57BL/6J)
|
increased circulating free fatty acids level
|
J:177386
|
increased liver triglyceride level
|
J:177386
|
Mc4rtm1Matsu/Mc4rtm1Matsu
(C57BL/6J-Mc4rtm1Matsu)
|
increased circulating cholesterol level
|
J:285412
|
increased liver triglyceride level
|
J:285412
|
Mchr1tm1Sqn/Mchr1tm1Sqn
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating corticosterone level
|
J:81787
|
Mcutm1b(EUCOMM)Hmgu/Mcu+
(C57BL/6N-Mcutm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mdktm1.1(KOMP)Mbp/Mdktm1.1(KOMP)Mbp
(C57BL/6N-Mdktm1.1(KOMP)Mbp/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
increased brain cholesterol level
|
J:198551
|
increased circulating cholesterol level
|
J:198551
|
increased circulating LDL cholesterol level
|
J:198551
|
increased circulating triglyceride level
|
J:198551
|
increased liver triglyceride level
|
J:198551
|
Mecp2tm1.1Jae/Y
(B6.Cg-Mecp2tm1.1Jae)
|
increased brain cholesterol level
|
J:198551
|
increased liver triglyceride level
|
J:198551
|
Med13tm1Eno/Med13tm1Eno Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:186193
|
increased circulating triglyceride level
|
J:186193
|
increased liver triglyceride level
|
J:186193
|
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ)
|
increased liver triglyceride level
|
J:298822
|
Med23em1(IMPC)Wtsi/Med23+
(C57BL/6N-Med23em1(IMPC)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:211773
|
Megf6em1(IMPC)Kmpc/Megf6em1(IMPC)Kmpc
(C57BL/6NTac-Megf6em1(IMPC)Kmpc/Kmpc)
|
increased circulating cholesterol level
|
J:211773
|
Memo1tm1.1Neh/Memo1tm1.1Neh Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased vitamin D level
|
J:206626
|
Men1tm1Rvt/Men1+
(involves: 129 * C57BL/6)
|
increased circulating corticosterone level
|
J:191261
|
Mettl16tm1b(KOMP)Mbp/Mettl16+
(C57BL/6N-Mettl16tm1b(KOMP)Mbp/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mettl22tm1.1(KOMP)Vlcg/Mettl22tm1.1(KOMP)Vlcg
(C57BL/6N-Mettl22tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mexistm1.1Pton/Mexistm1.1Pton
(involves: C57BL/6)
|
increased cholesterol level
|
J:264834
|
Mfsd1em1(IMPC)Tcp/Mfsd1em1(IMPC)Tcp
(C57BL/6N-Mfsd1em1(IMPC)Tcp/Tcp)
|
decreased circulating triglyceride level
|
J:211773
|
Mfsd2atm1Dls/Mfsd2atm1Dls
(B6.Cg-Mfsd2atm1Dls)
|
decreased circulating triglyceride level
|
J:194781
|
decreased triglyceride level
|
J:194781
|
decreased unsaturated fatty acids level
|
J:234197
|
increased unsaturated fatty acids level
|
J:234197
|
Mfsd2btm1a(KOMP)Wtsi/Mfsd2btm1a(KOMP)Wtsi
(C57BL/6-Mfsd2btm1a(KOMP)Wtsi)
|
abnormal ceramide level
|
J:250123
|
decreased sphingosine level
|
J:250123
|
increased sphingosine level
|
J:250123
|
Mgat4atm1.1Jxm/Mgat4atm1.1Jxm
(B6.Cg-Mgat4atm1.1Jxm)
|
increased circulating free fatty acids level
|
J:117542
|
increased circulating triglyceride level
|
J:117542
|
Mgat4btm1.1Jxm/Mgat4btm1.1Jxm
(B6.129-Mgat4btm1.1Jxm)
|
decreased circulating VLDL cholesterol level
|
J:212313
|
MgllGt(OST113734)Lex/MgllGt(OST113734)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased fatty acids level
|
J:165274
|
Mglltm1.1Rzim/Mglltm1.1Rzim
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating glycerol level
|
J:172679
|
decreased circulating triglyceride level
|
J:172679
|
decreased liver triglyceride level
|
J:172679
|
Mgst1em1(IMPC)J/Mgst1em1(IMPC)J
(C57BL/6NJ-Mgst1em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mia2cpto/Mia2cpto
(C57BL/6-Mia2cpto)
|
decreased circulating cholesterol level
|
J:176259
|
decreased circulating HDL cholesterol level
|
J:176259
|
decreased circulating triglyceride level
|
J:176259
|
decreased circulating VLDL triglyceride level
|
J:176259
|
Mia2tm1Zhxu/Mia2tm1Zhxu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:268333
|
decreased circulating triglyceride level
|
J:268333
|
increased liver cholesterol level
|
J:268333
|
increased liver triglyceride level
|
J:268333
|
Micos13tm1.1(KOMP)Vlcg/Micos13+
(C57BL/6N-Micos13tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Mier1tm1a(EUCOMM)Wtsi/Mier1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Mier1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating free fatty acids level
|
J:165965
|
Miga2tm1a(KOMP)Wtsi/Miga2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Miga2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Mindy1tm1a(EUCOMM)Wtsi/Mindy1tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating free fatty acids level
|
J:165965
|
decreased circulating glycerol level
|
J:165965
|
Mir22tm1Boet/Mir22tm1Boet
(B6.129S2-Mir22tm1Boet)
|
decreased circulating free fatty acids level
|
J:266382
|
Mir32em1Gpt/Mir32em1Gpt Albem1(icre)Gpt/Alb+
(C57BL/6JGpt-Mir32em1Gpt Albem1(icre)Gpt)
|
decreased circulating cholesterol level
|
J:344660
|
decreased circulating LDL cholesterol level
|
J:344660
|
decreased liver cholesterol level
|
J:344660
|
decreased liver triglyceride level
|
J:344660
|
Mir33tm1.1Koho/Mir33tm1.1Koho
(involves: C57BL/6)
|
increased circulating cholesterol level
|
J:165420
|
increased circulating HDL cholesterol level
|
J:165420
|
Mir122tm1.1Apts/Mir122tm1.1Apts
(involves: 129 * C57BL/6)
|
decreased circulating cholesterol level
|
J:190066
|
decreased circulating HDL cholesterol level
|
J:190066
|
decreased circulating triglyceride level
|
J:190066
|
decreased circulating VLDL cholesterol level
|
J:190066
|
increased liver cholesterol level
|
J:190066
|
increased liver triglyceride level
|
J:190066
|
Mir122tm1.1Kgh/Mir122tm1.1Kgh
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating cholesterol level
|
J:190067
|
decreased circulating HDL cholesterol level
|
J:190067
|
increased bile salt level
|
J:190067
|
increased liver triglyceride level
|
J:190067
|
Mir122tm1.2Kgh/Mir122tm1.2Kgh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:190067
|
decreased circulating HDL cholesterol level
|
J:190067
|
decreased circulating LDL cholesterol level
|
J:190067
|
increased bile salt level
|
J:190067
|
increased liver triglyceride level
|
J:190067
|
Mir378atm1.1Eno/Mir378atm1.1Eno
(involves: 129S/SvEv * C57BL/6)
|
increased circulating triglyceride level
|
J:190154
|
Mirc13tm1.1Mtm/Mirc13tm1.1Mtm
(Not Specified)
|
abnormal phospholipid level
|
J:256444
|
abnormal sphingomyelin level
|
J:256444
|
decreased liver triglyceride level
|
J:256444
|
decreased saturated fatty acids level
|
J:256444
|
increased bile salt level
|
J:256444
|
increased ceramide level
|
J:256444
|
Mirc54tm1.1Syu/Mirc54tm1.1Syu
(Not Specified)
|
decreased circulating cholesterol level
|
J:310890
|
decreased circulating triglyceride level
|
J:310890
|
decreased liver triglyceride level
|
J:310890
|
Mlxipltm1Kuy/Mlxipltm1Kuy
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:89865
|
decreased circulating free fatty acids level
|
J:89865
|
decreased fatty acids level
|
J:89865
|
Mlxipltm1Kuy/Mlxipltm1Kuy
(B6.129S6-Mlxipltm1Kuy/J)
|
decreased circulating cholesterol level
|
J:273754
|
decreased circulating triglyceride level
|
J:273754
|
decreased liver triglyceride level
|
J:273754
|
Mmp8tm1.1(KOMP)Vlcg/Mmp8tm1.1(KOMP)Vlcg
(C57BL/6N-Mmp8tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Mmp9tm1Arnd/Mmp9tm1Arnd
(B6.129P2-Mmp9tm1Arnd)
|
increased prostaglandin level
|
J:110450
|
Mmuttm1.1Mrb/Mmuttm1.1Mrb
(involves: C57BL/6)
|
abnormal fatty acids level
|
J:237040
|
Mmuttm1Pai/Mmuttm1.1Mrb
(involves: 129S1/Sv * C57BL/6)
|
abnormal fatty acids level
|
J:237040
|
abnormal sphingolipid level
|
J:237040
|
Mobq1129P3/J/Mobq1129P3/J
(involves: 129P3/J * C57BL/10SnJ)
|
decreased circulating cholesterol level
|
J:24238
|
Mobq1BALB/cJ/Mobq1BALB/cJ
(involves: BALB/cJ * C57BL/10SnJ)
|
decreased circulating cholesterol level
|
J:24238
|
Mobq1C57BL/6J/Mobq1SPRET/EiJ
(involves: C57BL/6J * SPRET/Ei)
|
increased circulating cholesterol level
|
J:88297
|
Mobq5CAST/EiJ/Mobq5CAST/EiJ
(B6.CAST-Mobq5CAST/EiJ)
|
decreased circulating cholesterol level
|
J:116503
|
decreased circulating free fatty acids level
|
J:116503
|
decreased circulating triglyceride level
|
J:116503
|
Mocosem2(IMPC)Ics/Mocos+
(C57BL/6N-Mocosem2(IMPC)Ics/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Mogat2tm1.1Ryyo/Mogat2tm1.1Ryyo
(B6.Cg-Mogat2tm1.1Ryyo)
|
decreased circulating triglyceride level
|
J:155626
|
Mogat2tm1Far/Mogat2tm1Far
(B6.129S4-Mogat2tm1Far)
|
decreased circulating cholesterol level
|
J:149373
|
decreased circulating LDL cholesterol level
|
J:149373
|
decreased circulating triglyceride level
|
J:149373
|
decreased circulating VLDL cholesterol level
|
J:149373
|
Morc2aem1(IMPC)Wtsi/Morc2a+
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Mpc1tm1c(EUCOMM)Wtsi/Mpc1tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA)
|
decreased circulating cholesterol level
|
J:236662
|
decreased circulating triglyceride level
|
J:236662
|
increased triglyceride level
|
J:236662
|
Mpc2em2Finc/Mpc2em2Finc
(involves: C57BL/6)
|
decreased circulating triglyceride level
|
J:211781
|
mpc96H/mpc96H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:234901
|
decreased circulating LDL cholesterol level
|
J:234901
|
Mpv17/Mpv17
(CFW-Mpv17/J)
|
increased circulating cholesterol level
|
J:10661
|
Mpzl3tm1Tacz/Mpzl3tm1Tacz
(B6.129P2-Mpzl3tm1Tacz)
|
decreased circulating cholesterol level
|
J:199257
|
decreased circulating corticosterone level
|
J:199257
|
decreased circulating free fatty acids level
|
J:199257
|
decreased circulating phospholipid level
|
J:199257
|
decreased circulating triglyceride level
|
J:199257
|
decreased liver triglyceride level
|
J:199257
|
Mraptm1.2Geno/Mraptm1.2Geno
(involves: C57BL/6)
|
decreased circulating corticosterone level
|
J:278935
|
Mrps12em1.2Afi/Mrps12em1.2Afi
(B6N(Cg)-Mrps12em1.2Afi)
|
increased cholesterol level
|
J:284101
|
Ms4a4dem1(IMPC)J/Ms4a4dem1(IMPC)J
(C57BL/6NJ-Ms4a4dem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Msi2em1(IMPC)Mbp/Msi2em1(IMPC)Mbp
(C57BL/6N-Msi2em1(IMPC)Mbp/MbpMmucd)
|
increased circulating triglyceride level
|
J:211773
|
Mstnlean/Mstnlean
(C57BL/6J-Mstnlean)
|
decreased circulating cholesterol level
|
J:146513
|
decreased circulating triglyceride level
|
J:146513
|
Mstntm1Sjl/Mstntm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lipid level
|
J:75178
|
Msto1em1(IMPC)Tcp/Msto1+
(C57BL/6N-Msto1em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Msx1tm1b(KOMP)Wtsi/Msx1+
(C57BL/6N-Msx1tm1b(KOMP)Wtsi/J)
|
increased circulating free fatty acids level
|
J:211773
|
mt-Tl1m1Jiha
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
increased circulating triglyceride level
|
J:344247
|
Mta1tm1a(EUCOMM)Wtsi/Mta1+
(129S/SvEvBrd-Mta1tm1a(EUCOMM)Wtsi/WtsiH)
|
increased circulating triglyceride level
|
J:175295
|
Mta1tm1a(EUCOMM)Wtsi/Mta1tm1a(EUCOMM)Wtsi
(129S/SvEvBrd-Mta1tm1a(EUCOMM)Wtsi/WtsiH)
|
decreased circulating LDL cholesterol level
|
J:175295
|
Mta3tm3a(KOMP)Wtsi/Mta3tm3a(KOMP)Wtsi
(Not Specified)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating LDL cholesterol level
|
J:165965
|
Mtarc1tm1.1Vlcg/Mtarc1tm1.1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal phospholipid level
|
J:346201
|
decreased liver triglyceride level
|
J:346201
|
Mtfmtem1Heb/Mtfmt+
(C57BL/6-Mtfmtem1Heb)
|
decreased circulating triglyceride level
|
J:334467
|
decreased liver triglyceride level
|
J:334467
|
decreased triglyceride level
|
J:334467
|
Mtortm1a(EUCOMM)Wtsi/Mtor+
(C57BL/6N-Mtortm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased circulating LDL cholesterol level
|
J:175295
|
Mttptm1Chan/Mttptm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:53390
|
abnormal triglyceride level
|
J:53390
|
decreased circulating HDL cholesterol level
|
J:53390
|
decreased circulating LDL cholesterol level
|
J:53390
|
decreased circulating VLDL cholesterol level
|
J:53390
|
decreased circulating VLDL triglyceride level
|
J:53390
|
Mttptm1Sgy/Mttp+
(involves: 129S4/SvJae)
|
abnormal circulating cholesterol level
|
J:48934
|
abnormal circulating lipid level
|
J:48934
|
abnormal lipid level
|
J:48934
|
decreased circulating cholesterol level
|
J:48934
|
decreased circulating LDL cholesterol level
|
J:48934
|
decreased circulating VLDL cholesterol level
|
J:48934
|
increased liver cholesterol level
|
J:48934
|
increased liver triglyceride level
|
J:48934
|
Mttptm2Sgy/Mttptm2Sgy Tg(Mx1-cre)1Cgn/Tg(Mx1-cre)1Cgn
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased circulating cholesterol level
|
J:83459
|
decreased circulating HDL cholesterol level
|
J:83459
|
decreased circulating LDL cholesterol level
|
J:83459
|
decreased circulating triglyceride level
|
J:83459
|
decreased circulating VLDL cholesterol level
|
J:83459
|
increased liver cholesterol level
|
J:83459
|
increased liver triglyceride level
|
J:83459
|
Muc2wnn/Muc2wnn
(C57BL/6-Muc2wnn)
|
increased circulating triglyceride level
|
J:194148
|
Myf5tm3(cre)Sor/Myf5+ Stat5btm1Mam/Stat5btm1Mam
(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
|
increased circulating triglyceride level
|
J:119237
|
Myg1tm1Mphi/Myg1tm1Mphi
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal corticosterone level
|
J:154911
|
Myh7btm1a(KOMP)Wtsi/Myh7btm1a(KOMP)Wtsi
(C57BL/6N-Myh7btm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Myo18bem2(IMPC)Ics/Myo18b+
(C57BL/6N-Myo18bem2(IMPC)Ics/Ics)
|
increased circulating triglyceride level
|
J:211773
|
Mysm1tm1a(KOMP)Wtsi/Mysm1+
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Mysm1tm1a(KOMP)Wtsi/Mysm1tm1a(KOMP)Wtsi
(Not Specified)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Myzapem1(IMPC)J/Myzapem1(IMPC)J
(C57BL/6NJ-Myzapem1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Naa40tm1Qwzh/Naa40tm1Qwzh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh)
|
decreased circulating LDL cholesterol level
|
J:183119
|
decreased circulating VLDL triglyceride level
|
J:183119
|
decreased liver free fatty acids level
|
J:183119
|
decreased liver triglyceride level
|
J:183119
|
Nab1em1(IMPC)H/Nab1em1(IMPC)H
(C57BL/6NTac-Nab1em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Nab2tm1b(EUCOMM)Hmgu/Nab2tm1b(EUCOMM)Hmgu
(C57BL/6N-Nab2tm1b(EUCOMM)Hmgu/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Nadk2tm1a(EUCOMM)Wtsi/Nadk2tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
increased circulating free fatty acids level
|
J:255700
|
increased circulating triglyceride level
|
J:255700
|
increased liver triglyceride level
|
J:255700
|
Naxetm1.1Lfan/Naxetm1.1Lfan Tg(APOA1)1Rub/0
(involves: C57BL/6 * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:261549
|
Ncaldtm1.1(KOMP)Vlcg/Ncaldtm1.1(KOMP)Vlcg
(C57BL/6N-Ncaldtm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Ncapd3em1(IMPC)J/Ncapd3+
(C57BL/6NJ-Ncapd3em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ncf1em1(IMPC)Mbp/Ncf1em1(IMPC)Mbp
(C57BL/6N-Ncf1em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo
(involves: 129S/SvEv * C57BL/6J)
|
increased liver triglyceride level
|
J:161276
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating cholesterol level
|
J:144060
|
decreased circulating free fatty acids level
|
J:144060
|
decreased circulating HDL cholesterol level
|
J:144060
|
decreased circulating triglyceride level
|
J:144060
|
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6)
|
increased liver triglyceride level
|
J:207622
|
Ncoa6tm1Jkr/Ncoa6tm1Jkr Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal lipid level
|
J:269856
|
Ncoa6tm2Jxu/Ncoa6tm2Jxu
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal circulating triglyceride level
|
J:129067
|
increased circulating cholesterol level
|
J:129067
|
Ncor1tm1.1Ics/Ncor1tm1.1Ics Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:178827
|
decreased circulating HDL cholesterol level
|
J:178827
|
decreased circulating LDL cholesterol level
|
J:178827
|
Ncor1tm1Anh/Ncor1tm1Anh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * DBA)
|
decreased circulating LDL cholesterol level
|
J:142045
|
Ncor1tm1Laz/Ncor1tm1Laz
(C57BL/6-Ncor1tm1Laz)
|
increased circulating free fatty acids level
|
J:142342
|
Ndst3tm1.1Grob/Ndst3tm1.1Grob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased circulating cholesterol level
|
J:138557
|
decreased circulating HDL cholesterol level
|
J:138557
|
Ndufa1tm1.1Nay/Y
(involves: 129S1/SvImJ * 129S4/SvJaeSor * 129S6/SvEvTac)
|
abnormal corticosterone level
|
J:257477
|
abnormal sphingolipid level
|
J:257477
|
decreased circulating corticosterone level
|
J:257477
|
decreased liver cholesterol level
|
J:257477
|
increased fatty acids level
|
J:257477
|
Ndufs1tm1b(EUCOMM)Hmgu/Ndufs1+
(C57BL/6N-Ndufs1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Ndufs6Gt(AR0138)Wtsi/Ndufs6Gt(AR0138)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased fatty acids level
|
J:183619
|
Nedd4ltm1.2Blyg/Nedd4ltm1.2Blyg
(involves: 129X1/SvJ * C57BL/6J)
|
increased circulating aldosterone level
|
J:148641
|
Negr1m1H/Negr1m1H
(C3.Cg-Negr1m1H)
|
decreased liver triglyceride level
|
J:189719
|
Neil1tm1Rsld/Neil1tm1Rsld
(involves: 129S1/Sv * C57BL/6)
|
increased circulating triglyceride level
|
J:106077
|
Nelfcdem1(IMPC)J/Nelfcd+
(C57BL/6NJ-Nelfcdem1(IMPC)J/Mmjax)
|
increased circulating HDL cholesterol level
|
J:211773
|
Nemftm1b(EUCOMM)Hmgu/Nemf+
(B6N(Cg)-Nemftm1b(EUCOMM)Hmgu/J)
|
decreased circulating cholesterol level
|
J:211773
|
Nepntm1b(KOMP)Wtsi/Nepntm1b(KOMP)Wtsi
(C57BL/6N-Nepntm1b(KOMP)Wtsi/Ucd)
|
decreased circulating triglyceride level
|
J:211773
|
Nestm1b(KOMP)Wtsi/Nestm1b(KOMP)Wtsi
(C57BL/6N-Nestm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
Neu2em1Kyp/Neu2em1Kyp
(C57BL/6J-Neu2em1Kyp)
|
increased circulating cholesterol level
|
J:321653
|
increased circulating free fatty acids level
|
J:321653
|
increased circulating triglyceride level
|
J:321653
|
increased liver free fatty acids level
|
J:321653
|
increased muscle free fatty acids level
|
J:321653
|
Neu4tm1Avps/Neu4tm1Avps
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal lipid level
|
J:135246
|
increased cholesterol level
|
J:135246
|
increased lung cholesterol level
|
J:135246
|
increased unsaturated fatty acids level
|
J:135246
|
Neurog3tm1Fgu/Neurog3tm3.1Ggr Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)
|
decreased circulating cholesterol level
|
J:161480
|
decreased circulating HDL cholesterol level
|
J:161480
|
decreased circulating triglyceride level
|
J:161480
|
steatorrhea
|
J:161480
|
Neurog3tm3.1Ggr/Neurog3tm3.1Ggr Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)
|
decreased circulating cholesterol level
|
J:161480
|
decreased circulating HDL cholesterol level
|
J:161480
|
decreased circulating triglyceride level
|
J:161480
|
steatorrhea
|
J:161480
|
Nexmifem1(IMPC)Tcp/Y
(C57BL/6N-Nexmifem1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Nfasctm1a(EUCOMM)Hmgu/Nfasc+
(C57BL/6N-Nfasctm1a(EUCOMM)Hmgu/Ics)
|
increased circulating triglyceride level
|
J:165965
|
Nfkb1tm1a(KOMP)Wtsi/Nfkb1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Nfkb1tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:175295
|
Nfkbidtm1a(EUCOMM)Wtsi/Nfkbid+
(C57BL/6N-Nfkbidtm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating free fatty acids level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Ngdntm1b(EUCOMM)Wtsi/Ngdn+
(C57BL/6N-Ngdntm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Nhdlq1129S1/SvImJ/Nhdlq1CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
abnormal circulating cholesterol level
|
J:88732
|
Nhdlq1CAST/Ei/Nhdlq1CAST/Ei
(involves: 129S1/SvImJ * CAST/Ei)
|
abnormal circulating cholesterol level
|
J:88732
|
Nhdlq2129S1/SvImJ/?
(involves: 129S1/SvImJ * CAST/Ei)
|
abnormal circulating cholesterol level
|
J:88732
|
Nhdlq4129S1/SvImJ/Nhdlq4129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:93243
|
Nhdlq4129S1/SvImJ/Nhdlq4129S1/SvImJ Nhdlq5C57BL/6J/Nhdlq5C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:93243
|
Nhdlq4129S1/SvImJ/Nhdlq4129S1/SvImJ Nhdlq7C57BL/6J/Nhdlq7C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:93243
|
Nhdlq9DBA/2J/?
(involves: DBA/2J * PERA/EiJ)
|
abnormal circulating cholesterol level
|
J:112668
|
Nhdlq10PERA/EiJ/?
(involves: I/LnJ * PERA/EiJ)
|
abnormal circulating cholesterol level
|
J:112668
|
Ninj2em1Cqxu/Ninj2em1Cqxu
(C57BL/6-Ninj2em1Cqxu)
|
increased skeletal muscle triglyceride level
|
J:332575
|
Nipa1tm1a(KOMP)Wtsi/Nipa1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Nipa1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:175295
|
Nipal4tm1Akih/Nipal4tm1Akih
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased ceramide level
|
J:261184
|
decreased sphingosine level
|
J:261184
|
increased ceramide level
|
J:261184
|
increased sphingosine level
|
J:261184
|
Nischtm1b(EUCOMM)Hmgu/Nischtm1b(EUCOMM)Hmgu
(C57BL/6N-Nischtm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Nkx2-3tm1Rph/Nkx2-3tm1Rph
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating triglyceride level
|
J:64018
|
steatorrhea
|
J:64018
|
Nlgn2tm1.1Gchn/Nlgn2tm1.1Gchn
(involves: 129S/SvEv * C57BL/6J)
|
increased circulating corticosterone level
|
J:272181
|
Nlrp3tm1Bhk/Nlrp3tm1Bhk
(B6.129S6-Nlrp3tm1Bhk/J)
|
increased liver triglyceride level
|
J:256504
|
Nmutm1Mko/Nmutm1Mko
(involves: 129 * C57BL/6)
|
decreased circulating corticosterone level
|
J:93213
|
increased circulating cholesterol level
|
J:93213
|
increased circulating free fatty acids level
|
J:93213
|
increased triglyceride level
|
J:93213
|
NntC57BL/6J/NntC57BL/6J
(C57BL/6J)
|
decreased circulating corticosterone level
|
J:185986
|
Nntem1(IMPC)H/Nntem1(IMPC)H
(C57BL/6N-Nntem1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
Nodaltm1b(EUCOMM)Wtsi/Nodal+
(C57BL/6N-Nodaltm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh)
|
increased circulating triglyceride level
|
J:155090
|
Nos1tm1Plh/Nos1tm1Plh Nos2tm1Mrl/Nos2tm1Mrl Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
increased prostaglandin level
|
J:100308
|
Nos1tm1Plh/Nos1tm1Plh Nos2tm1Mrl/Nos2tm1Mrl Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
increased circulating LDL cholesterol level
|
J:155090
|
increased circulating triglyceride level
|
J:155090
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:97522
|
increased circulating triglyceride level
|
J:155090
|
Nos3tm1.2Taka/Nos3tm1.2Taka
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)
|
increased circulating triglyceride level
|
J:187860
|
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh)
|
increased circulating triglyceride level
|
J:155090
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased prostaglandin level
|
J:108540
|
Nos3tm1Plh/Nos3tm1Plh Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased prostaglandin level
|
J:108540
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd)
|
hyperlipidemia
|
J:103153
|
increased circulating cholesterol level
|
J:103153
|
increased circulating free fatty acids level
|
J:103153
|
increased circulating triglyceride level
|
J:103153
|
Nos3tm2.1Plh/Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6)
|
increased circulating free fatty acids level
|
J:198075
|
increased circulating LDL cholesterol level
|
J:198075
|
Npc1m1N/Npc1m1N
(involves: BALB/c)
|
abnormal phospholipid level
|
J:204311
|
decreased brain cholesterol level
|
J:104996,
J:130969
|
increased brain cholesterol level
|
J:104996
|
increased cholesterol level
|
J:104996,
J:130969
|
increased circulating cholesterol level
|
J:18511
|
increased lipid level
|
J:204311
|
increased liver cholesterol level
|
J:130969
|
increased lung cholesterol level
|
J:204311,
J:130969
|
lipidosis
|
J:204311,
J:18511
|
Npc1m1N/Npc1m1N
(involves: 129S1/Sv * BALB/c * C57BL/6)
|
increased liver cholesterol level
|
J:89617
|
Npc1m1N/Npc1m1N
(BALB/cNctr-Npc1m1N/J)
|
decreased liver cholesterol level
|
J:179744
|
increased ganglioside level
|
J:179744
|
increased liver cholesterol level
|
J:179744
|
Npc1m1N/Npc1m1N
(involves: BALB/c * C57BL/6 * CBA)
|
increased ganglioside level
|
J:144240
|
Npc1m1N/Npc1m1N
(B6.C-Npc1m1N)
|
abnormal lipid level
|
J:221855
|
abnormal sphingomyelin level
|
J:221855
|
increased brain cholesterol level
|
J:157113
|
increased ceramide level
|
J:221855
|
increased liver cholesterol level
|
J:221855
|
Npc1m1N/Npc1m1N
(BALB/c-Npc1m1N)
|
abnormal ceramide level
|
J:221855
|
abnormal lipid level
|
J:221855
|
abnormal sphingomyelin level
|
J:221855
|
increased brain cholesterol level
|
J:172769,
J:221855
|
increased ganglioside level
|
J:221855
|
increased liver cholesterol level
|
J:221855
|
Npc1m1N/Npc1m1N
(involves: BALB/c * C3H/HeJ * C57BL/6J)
|
increased brain cholesterol level
|
J:188345
|
Npc1m1N/Npc1m1N Npc2tm1Plob/Npc2tm1Plob
(involves: 129S1/Sv * BALB/c * C57BL/6)
|
increased liver cholesterol level
|
J:89617
|
Npc1m1N/Npc1m1N Tg(CAG-RAB9A)500Repa/0
(involves: BALB/c * C57BL/6 * CBA)
|
decreased ganglioside level
|
J:144240
|
Npc1m1N/Npc1m1N Tg(PRNP-APPSweInd)8Dwst/0
(involves: BALB/c * C3H/HeJ * C57BL/6J)
|
increased brain cholesterol level
|
J:188345
|
Npc1m1N/Npc1tm1.1Apl Tg(CAG-cre/Esr1*)5Amc/0
(B6J.Cg-Npc1m1N/Npc1tm1.1Apl Tg(CAG-cre/Esr1*)5Amc)
|
increased brain cholesterol level
|
J:176888
|
Npc1m1N/Npc1tm1.1Apl Tg(Syn1-cre)671Jxm/0
(B6J.Cg-Npc1m1N/Npc1tm1.1Apl Tg(Syn1-cre)671Jxm)
|
increased brain cholesterol level
|
J:176888
|
Npc1m1N/Npc1tm1.2Apl
(B6.Cg-Npc1m1N/Npc1tm1.2Apl)
|
increased cholesterol level
|
J:157113
|
Npc1nmf164/Npc1nmf164
(C57BL/6J-Npc1nmf164/J)
|
abnormal lipid level
|
J:179744
|
decreased liver cholesterol level
|
J:179744
|
increased brain cholesterol level
|
J:179744
|
increased liver cholesterol level
|
J:179744
|
sphingomyelinosis
|
J:179744
|
Npc1spm/Npc1spm
(C57BLKS/J-Npc1spm/J)
|
abnormal cholesterol level
|
J:7245
|
increased liver cholesterol level
|
J:102782,
J:7245
|
sphingomyelinosis
|
J:7245
|
Npc1tm1.1Apl/Npc1tm1.2Apl Tg(Pcp2-cre)2Mpin/0
(B6.Cg-Npc1tm1.1Apl/Npc1tm1.2Apl Tg(Pcp2-cre)2Mpin)
|
increased cholesterol level
|
J:157113
|
Npc1tm1.1Dso/Npc1+
(B6.129-Npc1tm1.1Dso)
|
increased brain cholesterol level
|
J:221855
|
Npc1tm1.1Dso/Npc1tm1.1Dso
(B6.129-Npc1tm1.1Dso)
|
abnormal sphingolipid level
|
J:221855
|
increased brain cholesterol level
|
J:221855
|
increased ceramide level
|
J:221855
|
increased ganglioside level
|
J:221855
|
increased lipid level
|
J:221855
|
increased liver cholesterol level
|
J:221855
|
sphingomyelinosis
|
J:221855
|
Npc1tm1Mbjg/Npc1tm1Mbjg
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal lipid level
|
J:176587
|
increased cholesterol level
|
J:176587
|
increased liver cholesterol level
|
J:176587
|
Npc1tm1Tacf/Npc1tm1Tacf
(B6(Cg)-Npc1tm1Tacf)
|
increased ceramide level
|
J:266795
|
increased liver cholesterol level
|
J:266795
|
Npc1tm1Tacf/Npc1tm2Tacf
(B6(Cg)-Npc1tm1Tacf Npc1tm2Tacf)
|
increased ceramide level
|
J:266795
|
increased liver cholesterol level
|
J:266795
|
Npc1l1tm1a(EUCOMM)Hmgu/Npc1l1tm1a(EUCOMM)Hmgu
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating cholesterol level
|
J:226578
|
Npc1l1tm1Swa/Npc1l1tm1Swa
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased liver cholesterol level
|
J:89712
|
Npc1l1tm1Yaio/Npc1l1tm1Yaio
(C57BL/6-Npc1l1tm1Yaio)
|
abnormal circulating LDL cholesterol level
|
J:98568
|
abnormal triglyceride level
|
J:98568
|
decreased circulating cholesterol level
|
J:98568
|
decreased circulating HDL cholesterol level
|
J:98568
|
Npc2tm1Plob/Npc2tm1Plob
(involves: 129S1/Sv * BALB/c * C57BL/6)
|
increased liver cholesterol level
|
J:89617
|
Npc2tm1Plob/Npc2tm1Plob
(involves: 129S1/Sv * BALB/c)
|
abnormal lipid level
|
J:204311
|
abnormal phospholipid level
|
J:204311
|
increased lung cholesterol level
|
J:204311
|
lipidosis
|
J:204311
|
Npcdem1(IMPC)J/Npcdem1(IMPC)J
(C57BL/6NJ-Npcdem1(IMPC)J/Mmjax)
|
decreased circulating triglyceride level
|
J:211773
|
Nphp3pcy/Nphp3pcy
(involves: DBA/2Fg * KK)
|
abnormal circulating phospholipid level
|
J:2203
|
abnormal phospholipid level
|
J:2203
|
increased circulating cholesterol level
|
J:2203
|
Nphs2tm1Antc/Nphs2tm3.1Antc Tg(CAG-cre/Esr1*)86Lbgn/0
(involves: 129 * C57BL/6 * DBA)
|
increased circulating cholesterol level
|
J:166320
|
Nphs2tm2.1Antc/Nphs2tm3.1Antc Tg(CAG-cre/Esr1*)86Lbgn/0
(involves: 129S2/SvPas * C57BL/6 * DBA)
|
increased circulating cholesterol level
|
J:245693
|
NplGt(OST15553)Lex/NplGt(OST15553)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:103485
|
Npr1tm1.1Rsha/Npr1+
(involves: C57BL/6)
|
increased circulating aldosterone level
|
J:201932
|
Npr1tm1.1Rsha/Npr1tm1.1Rsha
(involves: C57BL/6)
|
increased circulating aldosterone level
|
J:201932
|
Nptntm1b(EUCOMM)Hmgu/Nptntm1b(EUCOMM)Hmgu
(C57BL/6N-Nptntm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
Npy1rtm1.1Ceva/Npy1rtm1.1Ceva Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * SJL)
|
increased circulating corticosterone level
|
J:180396
|
Npy1rtm1Tped/Npy1rtm1Tped
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating free fatty acids level
|
J:47972
|
Npy1rtm1Tped/Npy1rtm1Tped
(B6.129P2-Npy1rtm1Tped)
|
increased circulating corticosterone level
|
J:87424
|
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
decreased circulating corticosterone level
|
J:107169
|
Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating corticosterone level
|
J:77345,
J:97455
|
Npy5rem1(IMPC)H/Npy5rem1(IMPC)H
(C57BL/6NTac-Npy5rem1(IMPC)H/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Npy5rtm1Rpa/Npy5rtm1Rpa
(involves: 129S7/SvEvBrd)
|
increased circulating corticosterone level
|
J:87424
|
Npy6rtm1Hhzg/Npy6rtm1Hhzg
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal circulating corticosterone level
|
J:210546
|
Npytm1(rtTA,tetO-cre/EGFP)Snby/Npy+ Npy2rtm1Hhz/Npy2rtm1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
increased liver triglyceride level
|
J:162000
|
Nqo1tm1Akj/Nqo1tm1Akj
(involves: C57BL/6)
|
increased circulating triglyceride level
|
J:120478
|
increased triglyceride level
|
J:120478
|
Nr0b1em2(IMPC)Wtsi/Y
(C57BL/6N-Nr0b1em2(IMPC)Wtsi/Wtsi)
|
increased circulating LDL cholesterol level
|
J:211773
|
Nr0b2tm1.1Mjev/Nr0b2tm1.1Mjev
(involves: 129S/SvEvBrd * 129S4/SvJae)
|
decreased circulating cholesterol level
|
J:149005
|
decreased circulating HDL cholesterol level
|
J:149005
|
decreased circulating LDL cholesterol level
|
J:149005
|
decreased circulating VLDL cholesterol level
|
J:149005
|
Nr0b2tm1Ddm/Nr0b2tm1Ddm
(involves: 129 * C57BL/6)
|
abnormal bile salt level
|
J:77065
|
decreased circulating cholesterol level
|
J:77065
|
increased bile salt level
|
J:77065
|
increased liver triglyceride level
|
J:77065
|
Nr0b2tm1Mjev/Nr0b2tm1Mjev Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEvBrd * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:149005
|
decreased circulating LDL cholesterol level
|
J:149005
|
Nr0b2tm1Rus/Nr0b2tm1Rus
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal bile salt level
|
J:102129
|
Nr1d1tm1.1Rev/Nr1d1tm1.1Rev Nr1d2tm1.1Rev/Nr1d2tm1.1Rev Tg(CAG-cre/Esr1*)5Amc/0
(involves: BALB/cJ * C57BL/6 * C57BL/6J * CBA)
|
decreased circulating triglyceride level
|
J:183855
|
increased circulating free fatty acids level
|
J:183855
|
Nr1d1tm1Schb/Nr1d1tm1Schb
(involves: 129S2/SvPas)
|
decreased liver cholesterol level
|
J:153064
|
decreased liver triglyceride level
|
J:153064
|
increased circulating HDL cholesterol level
|
J:153064
|
increased circulating LDL cholesterol level
|
J:153064
|
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lipid level
|
J:234268
|
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lipid level
|
J:234268
|
Nr1h2tm1Djm/Nr1h2tm1Djm Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac)
|
increased liver cholesterol level
|
J:64343
|
Nr1h3tm1.1Djm/Nr1h3tm1.1Djm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA)
|
increased liver cholesterol level
|
J:184536
|
Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating LDL cholesterol level
|
J:82096
|
increased liver cholesterol level
|
J:82096
|
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating cholesterol level
|
J:47971
|
increased circulating LDL cholesterol level
|
J:47971
|
increased liver cholesterol level
|
J:243753,
J:47971
|
Nr1h3tm1Djm/Nr1h3tm1Djm Nus1tm1.1Qrm/Nus1tm1.1Qrm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL)
|
increased liver cholesterol level
|
J:243753
|
Nr1h4tm1.1Gonz/Nr1h4tm1.1Gonz Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6)
|
increased bile salt level
|
J:129978
|
increased circulating cholesterol level
|
J:129978
|
increased circulating triglyceride level
|
J:129978
|
Nr1h4tm1.1Gonz/Nr1h4tm1.1Gonz Tg(Vil1-cre)997Gum/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
increased bile salt level
|
J:129978
|
Nr1h4tm1.1Mbj/Nr1h4tm1.1Mbj
(B6N.B6-Nr1h4tm1.1Mbj)
|
decreased circulating free fatty acids level
|
J:200842
|
increased bile salt level
|
J:200842
|
increased circulating cholesterol level
|
J:200842
|
increased liver triglyceride level
|
J:200842
|
Nr1h4tm1.2Auw/Nr1h4tm1.2Auw
(involves: 129 * C57BL/6J)
|
increased bile salt level
|
J:157882
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6N)
|
abnormal bile salt level
|
J:64792
|
increased bile salt level
|
J:121075
|
increased circulating cholesterol level
|
J:64792
|
increased circulating phospholipid level
|
J:64792
|
increased circulating triglyceride level
|
J:64792
|
increased liver cholesterol level
|
J:64792
|
increased liver triglyceride level
|
J:64792
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ)
|
increased bile salt level
|
J:129978
|
increased circulating cholesterol level
|
J:129978
|
increased circulating triglyceride level
|
J:129978
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(STOCK Nr1h4tm1Gonz/J)
|
increased circulating cholesterol level
|
J:149005
|
increased circulating triglyceride level
|
J:149005
|
Nr1h4tm1Gonz/Nr1h4tm1Gonz
(involves: 129X1/SvJ * C57BL/6)
|
increased bile salt level
|
J:118204
|
Nr1h4tm1Kok/Nr1h4tm1Kok
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased bile salt level
|
J:86154
|
Nr2c2tm1Amj/Nr2c2tm1Amj
(B6.129-Nr2c2tm1Amj)
|
decreased circulating cholesterol level
|
J:169333
|
decreased circulating LDL cholesterol level
|
J:169333
|
decreased circulating triglyceride level
|
J:169333
|
decreased liver triglyceride level
|
J:169333
|
Nr2f2tm1Vco/Nr2f2+ Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal lipid level
|
J:98195
|
decreased fatty acids level
|
J:98195
|
increased circulating triglyceride level
|
J:98195
|
Nr3c1Gt(ESKN92)Hgs/Nr3c1+
(B6.Cg-Nr3c1Gt(ESKN92)Hgs)
|
abnormal circulating corticosterone level
|
J:141205
|
increased circulating aldosterone level
|
J:141205
|
increased circulating corticosterone level
|
J:141205
|
increased liver triglyceride level
|
J:141205
|
Nr3c1tm1.1Mvc/Nr3c1+ Tg(Sim1-cre)1Lowl/0
(involves: 129 * C57BL/6 * FVB)
|
increased circulating corticosterone level
|
J:179918
|
Nr3c1tm1Dage/Nr3c1+
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating corticosterone level
|
J:147914
|
Nr3c1tm1Dage/Nr3c1tm1Dage
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating corticosterone level
|
J:147914
|
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating corticosterone level
|
J:27441
|
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd * 129/Sv)
|
increased circulating corticosterone level
|
J:98065
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc Tg(Camk2a-cre/ERT2)2Gsc/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased circulating corticosterone level
|
J:125230
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL)
|
increased circulating glucocorticoid level
|
J:57315
|
Nr3c1tm2Ljm/Nr3c1tm2Ljm Tg(Camk2a-cre)T50Stl/?
(involves: 129 * BALB/c * C57BL/6 * CBA)
|
increased circulating corticosterone level
|
J:96260
|
Nr3c1tm3Gsc/Nr3c1tm3Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating corticosterone level
|
J:67720
|
Nr3c2tm1Gsc/Nr3c2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating aldosterone level
|
J:77285
|
Nr3c2tm1Gsc/Nr3c2tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating aldosterone level
|
J:77285
|
Nr3c2tm2Gsc/Nr3c2tm2Gsc Tg(Aqp2-cre/ERT2)4Gsc/0
(involves: C57BL/6 * FVB/N)
|
increased circulating aldosterone level
|
J:169670
|
Nr5a1tm1.1Hain/Nr5a1tm1.1Hain
(Not Specified)
|
abnormal corticosterone level
|
J:175843
|
Nr5a2tm1Bel/Nr5a2+
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal bile salt level
|
J:89523
|
decreased circulating cholesterol level
|
J:91695
|
Nr5a2tm1Sakl/Nr5a2tm1Sakl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:135822
|
Nr5a2tm1Sakl/Nr5a2tm1Sakl Tg(Vil1-cre)997Gum/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:135822
|
Nrastm1b(EUCOMM)Hmgu/Nras+
(C57BL/6N-Nrastm1b(EUCOMM)Hmgu/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Nrxn1tm1b(KOMP)Wtsi/Nrxn1tm1b(KOMP)Wtsi
(C57BL/6N-Nrxn1tm1b(KOMP)Wtsi/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Nrxn2em1(IMPC)H/Nrxn2em1(IMPC)H
(C57BL/6NTac-Nrxn2em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Nsftm1b(KOMP)Mbp/Nsf+
(C57BL/6N-Nsftm1b(KOMP)Mbp/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Nsmce1em1(IMPC)Wtsi/Nsmce1+
(C57BL/6N-Nsmce1em1(IMPC)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating cholesterol level
|
J:213427
|
decreased circulating free fatty acids level
|
J:213427
|
decreased circulating glycerol level
|
J:213427
|
decreased circulating HDL cholesterol level
|
J:213427
|
decreased circulating LDL cholesterol level
|
J:213427
|
Ntf5tm1b(EUCOMM)Hmgu/Ntf5tm1b(EUCOMM)Hmgu
(C57BL/6N-Ntf5tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ntrk2tm1b(EUCOMM)Wtsi/Ntrk2+
(C57BL/6N-Ntrk2tm1b(EUCOMM)Wtsi/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Ntrk2tm1Rohr/Ntrk2+
(Not Specified)
|
abnormal circulating corticosterone level
|
J:179918
|
decreased circulating corticosterone level
|
J:179918
|
Ntrk2tm2Kln/Ntrk2tm2Kln Tg(Cck-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
abnormal circulating corticosterone level
|
J:210229
|
abnormal lipid level
|
J:210229
|
Nuak2tm1Esu/Nuak2+
(B6.129S4-Nuak2tm1Esu)
|
decreased circulating free fatty acids level
|
J:139603
|
increased circulating triglyceride level
|
J:139603
|
Nucb2tm1.2Vdix/Nucb2tm1.2Vdix
(involves: C57BL/6)
|
increased circulating free fatty acids level
|
J:270674
|
Nucks1tm1b(EUCOMM)Hmgu/Nucks1tm1b(EUCOMM)Hmgu
(C57BL/6N-Nucks1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
Numbtm1Zili/Numbtm1Zili Tg(Vil1-cre/ERT2)23Syr/?
(involves: 129/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:226578
|
Nup205em1(IMPC)J/Nup205+
(C57BL/6NJ-Nup205em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Nus1tm1.1Qrm/Nus1tm1.1Qrm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL)
|
abnormal circulating cholesterol level
|
J:243753
|
decreased liver cholesterol level
|
J:243753
|
increased circulating free fatty acids level
|
J:243753
|
increased circulating triglyceride level
|
J:243753
|
increased liver free fatty acids level
|
J:243753
|
increased liver triglyceride level
|
J:243753
|
Nxntm1b(EUCOMM)Wtsi/Nxn+
(C57BL/6N-Nxntm1b(EUCOMM)Wtsi/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Nxph4tm1Lex/Nxph4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased circulating triglyceride level
|
J:171883
|
Obp2atm1b(EUCOMM)Wtsi/Obp2atm1b(EUCOMM)Wtsi
(C57BL/6N-Obp2atm1b(EUCOMM)Wtsi/Ics)
|
increased circulating cholesterol level
|
J:211773
|
Obrq13A/J/Obrq13A/J
(C57BL/6J-Chr 17A/J/NaJ)
|
decreased circulating cholesterol level
|
J:145148
|
decreased circulating triglyceride level
|
J:145148
|
Obrq14A/J/Obrq14A/J
(C57BL/6J-Chr 17A/J/NaJ)
|
increased circulating cholesterol level
|
J:145148
|
Obrq15A/J/Obrq15A/J
(C57BL/6J-Chr 17A/J/NaJ)
|
increased circulating free fatty acids level
|
J:145148
|
Obrq16A/J/Obrq16A/J
(C57BL/6J-Chr 17A/J/NaJ)
|
decreased liver triglyceride level
|
J:145148
|
Obrq17A/J/Obrq17A/J
(C57BL/6J-Chr 17A/J/NaJ)
|
decreased circulating triglyceride level
|
J:145148
|
Obsty5SM/J/?
(involves: LG/J * SM/J)
|
increased circulating cholesterol level
|
J:94605
|
Oca2p-30PUb/Oca2p-x
(Not Specified)
|
abnormal circulating cholesterol level
|
J:89922
|
abnormal circulating HDL cholesterol level
|
J:89922
|
increased circulating cholesterol level
|
J:89922
|
increased circulating triglyceride level
|
J:89922
|
oed/oed
(STOCK pc-oed)
|
abnormal circulating cholesterol level
|
J:5609
|
abnormal circulating HDL cholesterol level
|
J:5609
|
decreased circulating cholesterol level
|
J:5609
|
decreased circulating LDL cholesterol level
|
J:5609
|
decreased fatty acids level
|
J:5609
|
decreased triglyceride level
|
J:5609
|
Olahem1Kedk/Olahem1Kedk
(involves: C57BL/6)
|
abnormal lipid level
|
J:353571
|
decreased fatty acids level
|
J:353571
|
Oma1tm1Otin/Oma1tm1Otin
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr)
|
increased circulating triglyceride level
|
J:184716
|
Opa3m1Votr/Opa3m1Votr
(involves: C3H * C57BL/6JCrl)
|
abnormal phospholipid level
|
J:188346
|
increased liver triglyceride level
|
J:188346
|
Opn3tm2c(EUCOMM)Wtsi/Opn3tm2c(EUCOMM)Wtsi Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6N * FVB/NJ)
|
abnormal circulating glycerol level
|
J:287419
|
Optntm1a(EUCOMM)Wtsi/Optntm1a(EUCOMM)Wtsi
(C57BL/6N-Optntm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Or4m1em1Tshu/Or4m1em1Tshu
(involves: C57BL/6J)
|
decreased circulating cholesterol level
|
J:279017
|
decreased circulating free fatty acids level
|
J:279017
|
decreased circulating triglyceride level
|
J:279017
|
decreased liver cholesterol level
|
J:279017
|
decreased liver triglyceride level
|
J:279017
|
Or9g4em1(IMPC)Mbp/Or9g4em1(IMPC)Mbp
(C57BL/6N-Or9g4em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Orai1Gt(XL922)Byg/Orai1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased leukotriene level
|
J:130479
|
Orai1Gt(XL922)Byg/Orai1Gt(XL922)Byg
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased leukotriene level
|
J:130479
|
Orm2em1Bcgen/Orm2+
(involves: C57BL/6J)
|
increased circulating triglyceride level
|
J:333118
|
increased liver triglyceride level
|
J:333118
|
Orm2em1Bcgen/Orm2em1Bcgen
(involves: C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:333118
|
increased circulating triglyceride level
|
J:333118
|
increased liver triglyceride level
|
J:333118
|
Ormdl1em1Pdra/Ormdl1em1Pdra Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl1em1Pdra Ormdl3em1Pdra)
|
increased ceramide level
|
J:349248
|
increased sphingosine level
|
J:349248
|
Ormdl2em1Pdra/Ormdl2em1Pdra Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl2em1Pdra Ormdl3em1Pdra)
|
increased ceramide level
|
J:328837
|
increased sphingosine level
|
J:328837
|
Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl3em1Pdra)
|
increased ceramide level
|
J:349248,
J:328837
|
increased sphingosine level
|
J:349248,
J:328837
|
Osbpl8Gt(DD0748)Wtsi/Osbpl8Gt(DD0748)Wtsi
(B6.129P2-Osbpl8Gt(DD0748)Wtsi)
|
increased circulating cholesterol level
|
J:199891
|
increased circulating phospholipid level
|
J:199891
|
increased circulating triglyceride level
|
J:199891
|
Osbpl11tm1b(EUCOMM)Hmgu/Osbpl11+
(C57BL/6N-Osbpl11tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Osmtm1b(KOMP)Wtsi/Osmtm1b(KOMP)Wtsi
(C57BL/6N-Osmtm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan)
|
increased circulating cholesterol level
|
J:214124
|
increased circulating free fatty acids level
|
J:214124
|
increased circulating triglyceride level
|
J:214124
|
increased liver cholesterol level
|
J:214124
|
increased liver triglyceride level
|
J:214124
|
Ostm1om/Ostm1om
(C3HeB/FeJ-Ostm1om)
|
decreased circulating LDL cholesterol level
|
J:195249
|
decreased circulating triglyceride level
|
J:195249
|
Otcem1(IMPC)Tcp/Otc+
(C57BL/6NCrl-Otcem1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Otud6atm1(KOMP)Vlcg/Otud6atm1(KOMP)Vlcg
(C57BL/6N-Otud6atm1(KOMP)Vlcg/Nju)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Otud7btm1(NCOM)Cmhd/Otud7btm1(NCOM)Cmhd
(C57BL/6N-Otud7btm1(NCOM)Cmhd/Tcp)
|
decreased circulating cholesterol level
|
J:165965
|
Oxtrtm1.1(KOMP)Vlcg/Oxtrtm1.1(KOMP)Vlcg
(C57BL/6N-Oxtrtm1.1(KOMP)Vlcg/Rbrc)
|
increased circulating LDL cholesterol level
|
J:211773
|
P2rx7tm1a(EUCOMM)Wtsi/P2rx7tm1a(EUCOMM)Wtsi
(C57BL/6N-P2rx7tm1a(EUCOMM)Wtsi/Ieg)
|
decreased circulating glycerol level
|
J:165965
|
P2ry13tm1Dgen/P2ry13tm1Dgen
(B6N.Cg-P2ry13tm1Dgen)
|
decreased circulating cholesterol level
|
J:170217
|
decreased circulating glycerol level
|
J:170217
|
decreased circulating HDL cholesterol level
|
J:170217
|
decreased circulating LDL cholesterol level
|
J:170217
|
decreased fatty acids level
|
J:170217
|
increased feces cholesterol level
|
J:170217
|
P2ry13tm1Loma/P2ry13tm1Loma
(B6.129-P2ry13tm1Loma)
|
decreased liver cholesterol level
|
J:166205
|
Pabpc4tm1a(KOMP)Wtsi/Pabpc4tm1a(KOMP)Wtsi
(C57BL/6N-Pabpc4tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Pacrgem1(IMPC)J/Pacrgem1(IMPC)J
(C57BL/6NJ-Pacrgem1(IMPC)J/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Padi3tm1b(KOMP)Wtsi/Padi3tm1b(KOMP)Wtsi
(C57BL/6N-Padi3tm1b(KOMP)Wtsi/Orl)
|
increased circulating HDL cholesterol level
|
J:211773
|
Padi4em1(IMPC)Mbp/Padi4em1(IMPC)Mbp
(C57BL/6N-Padi4em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Pahem1Skym/Pahem1Skym
(C57BL/6J-Pahem1Skym)
|
decreased circulating cholesterol level
|
J:305392
|
decreased circulating HDL cholesterol level
|
J:305392
|
decreased circulating LDL cholesterol level
|
J:305392
|
Pak1tm1b(EUCOMM)Hmgu/Pak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Pak1tm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Palb2tm1.1(KOMP)Vlcg/Palb2+
(C57BL/6N-Palb2tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Palmem1(IMPC)Wtsi/Palmem1(IMPC)Wtsi
(C57BL/6N-Palmem1(IMPC)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pank1tm1.1Suja/Pank1tm1.1Suja
(involves: 129S/SvEv * C57BL/6J)
|
abnormal triglyceride level
|
J:161798
|
decreased circulating triglyceride level
|
J:161798
|
decreased liver triglyceride level
|
J:161798
|
increased liver triglyceride level
|
J:161798
|
Pank1tm1.1Suja/Pank1tm1.1Suja Pank2tm1.1Suja/Pank2tm1.1Suja
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
abnormal fatty acids level
|
J:189609
|
increased liver triglyceride level
|
J:189609
|
Park7em1(IMPC)H/Park7em1(IMPC)H
(C57BL/6NTac-Park7em1(IMPC)H/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Parp4em1(IMPC)Mbp/Parp4em1(IMPC)Mbp
(C57BL/6N-Parp4em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
Parvbtm1a(EUCOMM)Wtsi/Parvbtm1a(EUCOMM)Wtsi
(C57BL/6N-Parvbtm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating cholesterol level
|
J:165965
|
Pax5tm1b(EUCOMM)Wtsi/Pax5+
(C57BL/6N-Pax5tm1b(EUCOMM)Wtsi/Ieg)
|
increased circulating triglyceride level
|
J:211773
|
Pax7tm1.1(KOMP)Vlcg/Pax7+
(C57BL/6N-Pax7tm1.1(KOMP)Vlcg/J)
|
decreased circulating triglyceride level
|
J:211773
|
Pbx3tm1a(EUCOMM)Wtsi/Pbx3tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating cholesterol level
|
J:165965
|
increased circulating cholesterol level
|
J:165965
|
Pcdh15av-3J/Pcdh15av-3J
(C57BL/6J-Pcdh15av-3J/J)
|
abnormal circulating lipid level
|
J:320724
|
decreased circulating cholesterol level
|
J:320724
|
decreased circulating triglyceride level
|
J:320724
|
Pcdhb13em1(IMPC)Tcp/Pcdhb13em1(IMPC)Tcp
(C57BL/6N-Pcdhb13em1(IMPC)Tcp/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pck1tm1.1Lre/Pck1tm1.1Lre
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased circulating triglyceride level
|
J:73977
|
decreased liver triglyceride level
|
J:73977
|
Pck1tm1.1Mgn/Pck1tm1.1Mgn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac)
|
increased circulating free fatty acids level
|
J:63929
|
increased circulating triglyceride level
|
J:63929
|
increased liver triglyceride level
|
J:63929
|
Pck1tm1Rwh/Pck1tm1Rwh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating lipid level
|
J:145210
|
increased circulating triglyceride level
|
J:145210
|
Pck2em1(IMPC)Tcp/Pck2em1(IMPC)Tcp
(C57BL/6N-Pck2em1(IMPC)Tcp/Tcp)
|
decreased circulating triglyceride level
|
J:211773
|
Pcmt1tm1Shs/Pcmt1tm1Shs
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating cholesterol level
|
J:46228
|
increased circulating aldosterone level
|
J:46228
|
increased circulating corticosterone level
|
J:46228
|
increased circulating triglyceride level
|
J:46228
|
Pcsk2em1(IMPC)H/Pcsk2em1(IMPC)H
(C57BL/6NTac-Pcsk2em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Pcsk5tm1b(KOMP)Mbp/Pcsk5+
(C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pcsk9m1Bms/Pcsk9+
(B6.Cg-Pcsk9m1Bms)
|
decreased circulating LDL cholesterol level
|
J:200728
|
Pcsk9m1Bms/Pcsk9m1Bms
(B6.Cg-Pcsk9m1Bms)
|
decreased circulating LDL cholesterol level
|
J:200728
|
increased bile salt level
|
J:200728
|
Pcsk9tm1.1Prat/Pcsk9tm1.1Prat Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:169834
|
decreased circulating HDL cholesterol level
|
J:169834
|
decreased circulating LDL cholesterol level
|
J:169834
|
Pcsk9tm1.2Prat/Pcsk9tm1.2Prat
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating cholesterol level
|
J:169834
|
decreased circulating HDL cholesterol level
|
J:169834
|
decreased circulating LDL cholesterol level
|
J:169834
|
Pcsk9tm1Jdh/Pcsk9tm1Jdh
(involves: 129S6/SvEvTac)
|
decreased circulating cholesterol level
|
J:97836
|
decreased circulating HDL cholesterol level
|
J:97836
|
decreased circulating LDL cholesterol level
|
J:97836
|
Pcsk9tm2b(EUCOMM)Hmgu/Pcsk9tm2b(EUCOMM)Hmgu
(C57BL/6N-Pcsk9tm2b(EUCOMM)Hmgu/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pctptm1Bor/Pctptm1Bor
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal bile salt level
|
J:115285
|
abnormal phospholipid level
|
J:115285
|
Pctptm1Bor/Pctptm1Bor
(involves: 129P2/OlaHsd * FVB/NJ)
|
abnormal bile salt level
|
J:115285
|
decreased cholesterol level
|
J:115285
|
increased cholesterol level
|
J:115285
|
Pcxtm1c(EUCOMM)Wtsi/Pcxtm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA * SJL)
|
increased circulating free fatty acids level
|
J:332296
|
increased circulating triglyceride level
|
J:332296
|
increased liver triglyceride level
|
J:332296
|
Pcyt1atm1Irt/Pcyt1atm1Irt Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/Tg(tetO-cre)1Jaw
(involves: C57BL/6J * FVB/N)
|
increased triglyceride level
|
J:118292
|
Pcyt2tm1.1Suja/Pcyt2tm1.1Suja Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
decreased circulating triglyceride level
|
J:155630
|
increased liver cholesterol level
|
J:155630
|
increased liver triglyceride level
|
J:155630
|
Pdcd6ipem1(IMPC)Mbp/Pdcd6ipem1(IMPC)Mbp
(C57BL/6NCrl-Pdcd6ipem1(IMPC)Mbp/Mmucd)
|
increased circulating HDL cholesterol level
|
J:211773
|
Pde1aem1(IMPC)H/Pde1aem1(IMPC)H
(C57BL/6N-Pde1aem1(IMPC)H/H)
|
decreased circulating triglyceride level
|
J:211773
|
Pde3btm1Yhc/Pde3btm1Yhc
(129X1/SvJ-Pde3btm1Yhc)
|
increased circulating free fatty acids level
|
J:117353
|
increased circulating glycerol level
|
J:117353
|
increased fatty acids level
|
J:117353
|
increased glycerol level
|
J:117353
|
increased triglyceride level
|
J:117353
|
Pde8btm1Dgen/Pde8btm1Dgen
(B6.129P2-Pde8btm1Dgen)
|
increased urine corticosterone level
|
J:203335
|
Pde10atm1Smsh/Pde10atm1Smsh
(B6NTac.Cg-Pde10atm1Smsh)
|
decreased circulating cholesterol level
|
J:209032
|
Pdgfrbtm1b(EUCOMM)Hmgu/Pdgfrb+
(C57BL/6N-Pdgfrbtm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Pdia6em1Btlr/Pdia6m1Btlr
(involves: C57BL/6J)
|
decreased circulating triglyceride level
|
J:288824
|
Pdk4tm1Rhar/Pdk4tm1Rhar
(B6.129-Pdk4tm1Rhar)
|
abnormal glycerol level
|
J:115895
|
increased circulating free fatty acids level
|
J:115895
|
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating corticosterone level
|
J:134336
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(CAG-cat,-lacZ)11Miya/0 Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)
|
decreased circulating corticosterone level
|
J:162892
|
Pdpntm1b(EUCOMM)Wtsi/Pdpn+
(C57BL/6N-Pdpntm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
Pdss2tm1Dalg/Pdss2tm1Dalg Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating cholesterol level
|
J:136670
|
Pdss2tm1Dalg/Pdss2tm1Dalg Tg(NPHS2-cre)295Lbh/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating cholesterol level
|
J:136670
|
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(involves: 129X1/SvJ * C57BL/6)
|
increased circulating corticosterone level
|
J:122399
|
Pdzd8tm1b(EUCOMM)Wtsi/Pdzd8tm1b(EUCOMM)Wtsi
(C57BL/6N-Pdzd8tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Pdzk1tm1Oko/Pdzk1tm1Oko
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
increased circulating cholesterol level
|
J:81814
|
Pdzk1tm2b(EUCOMM)Wtsi/Pdzk1+
(C57BL/6N-Pdzk1tm2b(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Peak1em1(IMPC)J/Peak1em1(IMPC)J
(C57BL/6NJ-Peak1em1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Peds1tm1a(KOMP)Wtsi/Peds1tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased brain plasmalogen level
|
J:287476
|
decreased plasmalogen level
|
J:287476
|
Peds1tm1a(KOMP)Wtsi/Peds1tm1a(KOMP)Wtsi
(B6Dnk;B6Brd;B6N-Tyrc-Brd Peds1tm1a(KOMP)Wtsi/Wtsi)
|
abnormal ether lipid level
|
J:333103
|
decreased brain plasmalogen level
|
J:333103
|
decreased plasmalogen level
|
J:333103
|
Pemttm1J/Pemttm1J
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal circulating cholesterol level
|
J:83870
|
abnormal lipid level
|
J:83870
|
decreased circulating cholesterol level
|
J:83870
|
decreased circulating HDL cholesterol level
|
J:83870
|
Pepdtm1b(KOMP)Wtsi/Pepdtm1b(KOMP)Wtsi
(C57BL/6N-Pepdtm1b(KOMP)Wtsi/Ieg)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac)
|
abnormal fatty acids level
|
J:278655
|
abnormal phospholipid level
|
J:278655
|
increased liver cholesterol level
|
J:278655
|
increased liver triglyceride level
|
J:278655
|
Pex1tm1.1Sjms/Pex1tm1.1Sjms
(involves: 129 * C57BL/6N)
|
abnormal circulating phospholipid level
|
J:210296
|
decreased fatty acids level
|
J:210296
|
increased fatty acids level
|
J:210296
|
increased saturated fatty acids level
|
J:210296
|
Pex2tm1Plf/Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster)
|
decreased cholesterol level
|
J:87591
|
decreased circulating cholesterol level
|
J:87591
|
decreased circulating HDL cholesterol level
|
J:87591
|
decreased liver cholesterol level
|
J:87591
|
Pex2tm1Plf/Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating free fatty acids level
|
J:44975
|
decreased circulating cholesterol level
|
J:87591
|
Pex3tm1a(EUCOMM)Wtsi/Pex3tm1a(EUCOMM)Wtsi
(C57BL/6N-Pex3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Pex7tm1Nbra/Pex7tm1Nbra
(involves: 129S/SvEv * C57BL/6)
|
decreased fatty acids level
|
J:158845
|
decreased saturated fatty acids level
|
J:158845
|
increased fatty acids level
|
J:158845
|
lipidosis
|
J:158845
|
Pex7tm1Rjaw/Pex7tm1Rjaw
(Swiss)
|
abnormal lipid level
|
J:92346
|
increased fatty acids level
|
J:92346
|
Pex10m1Nisw/Pex10+
(129S1.B6-Pex10m1Nisw)
|
decreased plasmalogen level
|
J:216140
|
Pex10m1Nisw/Pex10m1Nisw
(129S1.B6-Pex10m1Nisw)
|
decreased plasmalogen level
|
J:216140
|
increased fatty acids level
|
J:216140
|
Pex11atm1Itl/Pex11atm1Itl
(C57BL/6-Pex11atm1Itl)
|
abnormal circulating triglyceride level
|
J:195940
|
increased circulating free fatty acids level
|
J:195940
|
increased liver triglyceride level
|
J:195940
|
Pex13tm1Crne/Pex13tm1.1Crne Tg(Nes-cre)1Kln/0
(involves: 129T2/SvEms * C57BL/6 * C57BL/6J * SJL)
|
abnormal fatty acids level
|
J:167578
|
decreased brain plasmalogen level
|
J:167578
|
increased plasmalogen level
|
J:167578
|
Pfasem1(IMPC)J/Pfas+
(C57BL/6NJ-Pfasem1(IMPC)J/Mmjax)
|
decreased circulating triglyceride level
|
J:211773
|
Pgam5tm1b(EUCOMM)Wtsi/Pgam5tm1b(EUCOMM)Wtsi
(C57BL/6N-Pgam5tm1b(EUCOMM)Wtsi/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pgrmc1em1Ejho/Pgrmc1em1Ejho
(involves: C57BL/6N)
|
decreased circulating triglyceride level
|
J:268130
|
increased circulating free fatty acids level
|
J:268130
|
increased liver triglyceride level
|
J:268130
|
Phb1em1(IMPC)H/Phb1+
(C57BL/6NTac-Phb1em1(IMPC)H/H)
|
increased circulating triglyceride level
|
J:211773
|
Phdlc1C57BL/6J/Phdlc1CASA/RkJ
(involves: C57BL/6J * CASA/RkJ)
|
increased circulating HDL cholesterol level
|
J:94547
|
Phdlc1CASA/RkJ/Phdlc1CASA/RkJ
(involves: C57BL/6J * CASA/RkJ)
|
increased circulating HDL cholesterol level
|
J:94547
|
Phdlc2C57BL/6J/Phdlc2C57BL/6J
(involves: C57BL/6J * CASA/RkJ)
|
increased circulating HDL cholesterol level
|
J:94547
|
PhexHyp/Y
(Not Specified)
|
abnormal vitamin D level
|
J:110579
|
PhexMhdabap024/Y
(C3HeB/FeJ-PhexMhdabap024)
|
decreased vitamin D level
|
J:264682
|
Phf8em2(IMPC)Wtsi/Phf8em2(IMPC)Wtsi
(C57BL/6N-Phf8em2(IMPC)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Phf8tm1dIcs/Y
(C57BL/6N-Phf8tm1dIcs/Ics)
|
increased circulating HDL cholesterol level
|
J:211773
|
Phf8tm1dIcs/Phf8tm1dIcs
(C57BL/6N-Phf8tm1dIcs/Ics)
|
increased circulating HDL cholesterol level
|
J:211773
|
Phkbem1(IMPC)J/Phkb+
(C57BL/6NJ-Phkbem1(IMPC)J/Mmjax)
|
decreased liver triglyceride level
|
J:330539
|
increased circulating triglyceride level
|
J:330539
|
Phospq1SM/J/?
(involves: A/J * SM/J)
|
abnormal lipid level
|
J:64138
|
Phrf1em1(IMPC)Tcp/Phrf1em1(IMPC)Tcp
(C57BL/6N-Phrf1em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Phyhtm1Safe/Phyhtm1Safe
(involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N)
|
abnormal circulating lipid level
|
J:142512
|
decreased circulating cholesterol level
|
J:142512
|
decreased circulating free fatty acids level
|
J:142512
|
decreased circulating triglyceride level
|
J:142512
|
lipidosis
|
J:142512
|
Piezo2em2(IMPC)J/Piezo2+
(C57BL/6NJ-Piezo2em2(IMPC)J/Mmjax)
|
increased circulating triglyceride level
|
J:211773
|
Pightm1.1(KOMP)Vlcg/Pigh+
(C57BL/6N-Pightm1.1(KOMP)Vlcg/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased circulating cholesterol level
|
J:169710
|
Pik3c2gtm1Ehi/Pik3c2gtm1Ehi
(involves: 129 * C57BL/6)
|
increased circulating cholesterol level
|
J:223018
|
increased circulating triglyceride level
|
J:223018
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J)
|
decreased circulating cholesterol level
|
J:152332
|
decreased circulating triglyceride level
|
J:152332
|
Pik3r1tm1Khn/Pik3r1tm1Khn
(involves: 129S4/SvJae * C57BL/6J)
|
decreased triglyceride level
|
J:87598
|
PikfyveGt(AT0926)Wtsi/PikfyveGt(AT0926)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lipid level
|
J:190368
|
Pikfyvetm1.1Ashi/Pikfyvetm1.1Ashi Tg(Ckm-cre)28Arte/0
(involves: C57BL/6)
|
increased circulating triglyceride level
|
J:199213
|
Pikfyvetm2.1Tssk/Pikfyvetm2.1Tssk Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased circulating free fatty acids level
|
J:193689
|
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd)
|
decreased circulating triglyceride level
|
J:85204
|
increased circulating corticosterone level
|
J:85204
|
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd)
|
decreased circulating triglyceride level
|
J:85204
|
increased circulating corticosterone level
|
J:85204
|
Pitpnc1em1(IMPC)Kmpc/Pitpnc1em1(IMPC)Kmpc
(C57BL/6NTac-Pitpnc1em1(IMPC)Kmpc/Kmpc)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Pitpnm1tm1a(EUCOMM)Wtsi/Pitpnm1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased circulating cholesterol level
|
J:207051
|
Pitx3eyl/Pitx3eyl
(involves: C3H/He * C57BL/6)
|
decreased circulating cholesterol level
|
J:156878
|
decreased circulating triglyceride level
|
J:156878
|
Pitx3tm1.1(KOMP)Vlcg/Pitx3tm1.1(KOMP)Vlcg
(C57BL/6N-Pitx3tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Pkd1tm2Som/Pkd1tm2.1Som Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * ICR * SJL)
|
increased circulating cholesterol level
|
J:135301
|
Pkd1tm2Som/Pkd1tm2Som Tg(Cdh16-cre)91Igr/0
(involves: C57BL/6 * ICR * SJL)
|
increased circulating cholesterol level
|
J:135301
|
Pklrem1Appsc/Pklrem1Appsc
(involves: C57BL/6J)
|
abnormal sphingomyelin level
|
J:342736
|
decreased ceramide level
|
J:342736
|
decreased saturated fatty acids level
|
J:342736
|
Pkn2tm1b(KOMP)Wtsi/Pkn2+
(C57BL/6N-Pkn2tm1b(KOMP)Wtsi/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Pla2g2dtm1.1Mhg/Pla2g2dtm1.1Mhg
(B6NCrSlc.Cg-Pla2g2dtm1.1Mhg)
|
decreased unsaturated fatty acids level
|
J:229035
|
Pla2g3tm1Murm/Pla2g3tm1Murm
(involves: 129S/SvEv * C57BL/6J)
|
abnormal phospholipid level
|
J:161462
|
Pla2g4eem1Murm/Pla2g4eem1Murm
(C57BL/6NSlc-Pla2g4eem1Murm)
|
abnormal lipid level
|
J:333700
|
Pla2g6tm1Zyao/Pla2g6tm1Zyao
(involves: 129S6/SvEvTac * C57BL/6)
|
increased cholesterol level
|
J:203038
|
Pla2g10Gt712Lex/Pla2g10Gt712Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal prostaglandin level
|
J:125607
|
Pla2g10tm1Itl/Pla2g10tm1Itl
(involves: C57BL/6NTac)
|
increased circulating corticosterone level
|
J:164545
|
Pla2g12bhlb218/Pla2g12bhlb218
(C57BL/6J-Pla2g12bhlb218/J)
|
decreased circulating cholesterol level
|
J:187708,
J:82961
|
decreased circulating HDL cholesterol level
|
J:187708,
J:82961
|
decreased circulating triglyceride level
|
J:187708
|
Pla2g12bmpc96H/Pla2g12bmpc96H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:234901
|
decreased circulating LDL cholesterol level
|
J:234901
|
Pla2g15tm1Ytan/Pla2g15tm1Ytan
(involves: 129S/SvEv)
|
abnormal circulating cholesterol level
|
J:97471
|
Plaat3tm1.1Hsul/Plaat3tm1.1Hsul
(B6.129P2-Pla2g16tm1.1Hsul)
|
decreased circulating free fatty acids level
|
J:239202
|
decreased circulating triglyceride level
|
J:239202
|
decreased liver triglyceride level
|
J:239202
|
decreased triglyceride level
|
J:239202
|
Plagl2tm1Wjmv/Plagl2tm1Wjmv
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
increased circulating cholesterol level
|
J:130260
|
increased circulating triglyceride level
|
J:130260
|
Plast1C57BL/6J/Plast1C57BL/6J
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast1C57BL/6J/Plast1C57BL/6J Plast2bCASA/Rk/Plast2bCASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast1C57BL/6J/Plast1CASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast1C57BL/6J/Plast1CASA/Rk Plast2bCASA/Rk/Plast2bCASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast1aCASA/Rk/Plast1aCASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:116492
|
Plast1bCASA/Rk/Plast1bCASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:116492
|
Plast2aC57BL/6J/Plast2aC57BL/6J
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast2aC57BL/6J/Plast2aCASA/Rk
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plast2bC57BL/6J/Plast2bC57BL/6J
(involves: C57BL/6J * CASA/Rk)
|
abnormal circulating cholesterol level
|
J:119976
|
Plattm1Mlg/Plattm1Mlg
(B6.Cg-Plattm1Mlg)
|
increased circulating corticosterone level
|
J:81694,
J:94733
|
Pld2tm1.1Gdp/Pld2tm1.1Gdp
(involves: 129X1/SvJ * C57BL/6)
|
abnormal lipid level
|
J:166741
|
Pld2tm1.1Gdp/Pld2tm1.1Gdp Tg(APPSWE)2576Kha/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
abnormal lipid level
|
J:166741
|
Pld5tm1b(KOMP)Wtsi/Pld5tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Pld5tm1b(KOMP)Wtsi Tyrc-Brd/Wtsi)
|
increased circulating HDL cholesterol level
|
J:211773
|
Plekhf2em1(IMPC)Wtsi/Plekhf2em1(IMPC)Wtsi
(C57BL/6NCrl-Plekhf2em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Plin1tm1Asg/Plin1tm1Asg
(B6.129S6-Plin1tm1Asg)
|
abnormal circulating free fatty acids level
|
J:113735
|
Plin1tm1Chan/Plin1tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal circulating free fatty acids level
|
J:66267
|
abnormal glycerol level
|
J:66267
|
Plin2tm1.1Asg/Plin2tm1.1Asg
(B6.129S2(Cg)-Plin2tm1.1Asg)
|
decreased circulating free fatty acids level
|
J:196302
|
decreased circulating triglyceride level
|
J:196302
|
decreased liver triglyceride level
|
J:196302
|
Plin2tm1Chan/Plin2tm1Chan
(B6.129-Plin2tm1Chan)
|
decreased liver triglyceride level
|
J:105572
|
Plin4tm1Vlcg/Plin4tm1Vlcg
(B6.Cg-Plin4tm1Vlcg)
|
decreased cardiac muscle triglyceride level
|
J:195987
|
Plin5tm1e(KOMP)Wtsi/Plin5tm1e(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal ceramide level
|
J:221539
|
abnormal sphingomyelin level
|
J:221539
|
decreased cardiac muscle triglyceride level
|
J:221539
|
decreased skeletal muscle triglyceride level
|
J:221539
|
Plin5tm1Macl/Plin5tm1Macl
(involves: 129S6/SvEvTac * C57BL/6JBomTac)
|
decreased cardiac muscle triglyceride level
|
J:286482
|
Plin5tm1Tosu/Plin5tm1Tosu
(involves: C57BL/6JJcl)
|
abnormal lipid level
|
J:188390
|
decreased cardiac muscle triglyceride level
|
J:188390
|
decreased fatty acids level
|
J:188390
|
decreased liver free fatty acids level
|
J:188390
|
decreased liver triglyceride level
|
J:188390
|
decreased triglyceride level
|
J:188390
|
increased circulating free fatty acids level
|
J:188390
|
increased liver free fatty acids level
|
J:188390
|
increased liver triglyceride level
|
J:188390
|
Pllptm1(KOMP)Vlcg/Pllptm1(KOMP)Vlcg
(C57BL/6NCrl-Pllptm1(KOMP)Vlcg/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
Plp1jp-rsh/Plp1jp-rsh
(C3H * C57BL/6 * STOCK Rb(1.3)1Bnr)
|
abnormal phospholipid level
|
J:31089
|
Plp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cholesterol level
|
J:193310
|
Plpp3tm1Stw/Plpp3tm1Stw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
abnormal phospholipid level
|
J:84753
|
Pls3tm1a(EUCOMM)Wtsi/Y
(C57BL/6N-Pls3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Plscr3tm1Sims/Plscr3tm1Sims
(involves: 129S/SvEvBrd * C57BL/6J)
|
abnormal circulating cholesterol level
|
J:92404
|
increased circulating free fatty acids level
|
J:92404
|
increased circulating triglyceride level
|
J:92404
|
Pltptm1Jia/Pltptm1Jia
(involves: C57BL/6)
|
abnormal circulating cholesterol level
|
J:53521
|
abnormal phospholipid level
|
J:53521
|
decreased circulating HDL cholesterol level
|
J:53521
|
increased circulating LDL cholesterol level
|
J:53521
|
increased circulating VLDL cholesterol level
|
J:53521
|
Pltptm2.1Jia/Pltptm2.1Jia
(involves: C57BL/6J)
|
abnormal circulating non-HDL cholesterol level
|
J:239143
|
decreased circulating cholesterol level
|
J:239143
|
decreased circulating HDL cholesterol level
|
J:239143
|
decreased circulating HDL phospholipid level
|
J:239143
|
decreased circulating non-HDL phospholipid level
|
J:239143
|
decreased circulating phospholipid level
|
J:239143
|
decreased circulating triglyceride level
|
J:239143
|
Plvaptm1.1Rvst/Plvaptm1.1Rvst Tg(Cdh5-cre)1Spe/0
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6 * C57BL/6J)
|
abnormal circulating lipid level
|
J:191046
|
decreased circulating HDL cholesterol level
|
J:191046
|
increased circulating cholesterol level
|
J:191046
|
increased circulating triglyceride level
|
J:191046
|
Plvaptm1.1Rvst/Plvaptm1.1Rvst Tg(Tek-cre)12Flv/0
(involves: 129S4/SvJae * C3H * C57BL/6)
|
abnormal circulating lipid level
|
J:191046
|
decreased circulating HDL cholesterol level
|
J:191046
|
increased circulating cholesterol level
|
J:191046
|
increased circulating triglyceride level
|
J:191046
|
Plvaptm1.2Rvst/Plvaptm1.2Rvst
(involves: 129S4/SvJae * BALB/c * C57BL/6 * SJL)
|
abnormal lipid level
|
J:191046
|
decreased circulating HDL cholesterol level
|
J:191046
|
increased circulating cholesterol level
|
J:191046
|
increased circulating triglyceride level
|
J:191046
|
Plxnc1em1(IMPC)Mbp/Plxnc1em1(IMPC)Mbp
(C57BL/6N-Plxnc1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Pm20d1em1(IMPC)H/Pm20d1em1(IMPC)H
(C57BL/6NTac-Pm20d1em1(IMPC)H/H)
|
increased circulating triglyceride level
|
J:211773
|
Pmchtm1Emf/Pmchtm1Emf
(involves: 129S4/SvJae * C57BL/6)
|
decreased triglyceride level
|
J:51659
|
Pnhdlc1C57BL/6J/Pnhdlc1C57BL/6J
(involves: C57BL/6J * CASA/RkJ)
|
abnormal circulating cholesterol level
|
J:94547
|
Pnhdlc2C57BL/6J/Pnhdlc2C57BL/6J
(involves: C57BL/6J * CASA/RkJ)
|
abnormal circulating cholesterol level
|
J:94547
|
Pnhdlc3C57BL/6J/Pnhdlc3CASA/RkJ
(involves: C57BL/6J * CASA/RkJ)
|
abnormal circulating cholesterol level
|
J:94547
|
Pnhdlc3CASA/RkJ/Pnhdlc3CASA/RkJ
(involves: C57BL/6J * CASA/RkJ)
|
abnormal circulating cholesterol level
|
J:94547
|
Pnliptm1Dyh/Pnliptm1Dyh
(B6.129-Pnliptm1Dyh)
|
increased feces cholesterol level
|
J:86414
|
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:124658
|
Pnpla1tm1.1Fpwr/Pnpla1tm1.1Fpwr
(B6.129P2(Cg)-Pnpla1tm1.1Fpwr)
|
abnormal ceramide level
|
J:240053
|
Pnpla1tm1.1Murm/Pnpla1tm1.1Murm Tg(KRT14-cre/ERT2)1Ipc/0
(involves: C57BL/6N)
|
abnormal ceramide level
|
J:240682
|
Pnpla1tm1a(KOMP)Wtsi/Pnpla1tm1a(KOMP)Wtsi
(B6NTac;B6N-Atm1Brd Pnpla1tm1a(KOMP)Wtsi/Ics)
|
abnormal ceramide level
|
J:242353
|
abnormal free fatty acids level
|
J:242353
|
abnormal sphingomyelin level
|
J:242353
|
decreased fatty acids level
|
J:242353
|
Pnpla1tm1Murm/Pnpla1tm1Murm
(involves: C57BL/6N)
|
abnormal ceramide level
|
J:240682
|
abnormal free fatty acids level
|
J:240682
|
increased cholesterol level
|
J:240682
|
increased triglyceride level
|
J:240682
|
Pnpla2tm1Eek/Pnpla2tm1Eek Tg(Ckmm-cre)5Khn/0
(involves: 129S * FVB/N)
|
increased cardiac muscle triglyceride level
|
J:176252
|
Pnpla2tm1Eek/Pnpla2tm1Eek Tg(Myog-cre)1Eno/0
(involves: 129S * C57BL/6)
|
abnormal lipid level
|
J:207007
|
increased fatty acids level
|
J:207007
|
increased skeletal muscle triglyceride level
|
J:207007
|
Pnpla2tm1Gam/Pnpla2tm1Gam Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA)
|
increased circulating free fatty acids level
|
J:185116
|
increased liver triglyceride level
|
J:185116
|
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased circulating free fatty acids level
|
J:108546
|
decreased circulating HDL cholesterol level
|
J:108546
|
decreased circulating triglyceride level
|
J:108546
|
decreased circulating VLDL triglyceride level
|
J:108546
|
increased cardiac muscle triglyceride level
|
J:108546
|
increased liver triglyceride level
|
J:108546
|
increased triglyceride level
|
J:108546
|
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd)
|
decreased circulating free fatty acids level
|
J:176252
|
decreased circulating triglyceride level
|
J:176252
|
increased fatty acids level
|
J:176252
|
increased liver triglyceride level
|
J:176252,
J:160725
|
increased triglyceride level
|
J:176252,
J:160725
|
Pnpla2tm1Rze/Pnpla2tm1Rze Tg(Myh6-Pnpla2)94Biat/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased circulating free fatty acids level
|
J:176252
|
decreased circulating triglyceride level
|
J:176252
|
Pnpla3tm1.1Hobb/Pnpla3tm1.1Hobb
(involves: 129 * C57BL/6J)
|
increased fatty acids level
|
J:264475
|
increased liver triglyceride level
|
J:264475
|
Pnpla3tm2.1Hobb/Pnpla3+
(involves: 129 * C57BL/6J)
|
increased liver triglyceride level
|
J:264475
|
Pnpla3tm2.1Hobb/Pnpla3tm2.1Hobb
(involves: 129 * C57BL/6J)
|
increased liver triglyceride level
|
J:264475
|
Pnpla6tm1Mvc/Pnpla6tm1Mvc Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal phospholipid level
|
J:152759
|
Pnpla7tm1.2Murm/Pnpla7tm1.2Murm
(B6.Cg-Pnpla7tm1.2Murm)
|
abnormal circulating triglyceride level
|
J:333442
|
decreased liver triglyceride level
|
J:333442
|
Pnpla8tm1Rigr/Pnpla8tm1Rigr
(involves: 129X1/SvJ)
|
decreased circulating triglyceride level
|
J:333442
|
decreased liver triglyceride level
|
J:333442
|
Polr2htm1.1(KOMP)Wtsi/Polr2h+
(B6N(Cg)-Polr2htm1.1(KOMP)Wtsi/J)
|
increased circulating free fatty acids level
|
J:211773
|
Polr2mtm1.1Rgr/Polr2mtm1.1Rgr Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
decreased circulating triglyceride level
|
J:291184
|
Pom121l2em1(IMPC)J/Pom121l2em1(IMPC)J
(C57BL/6NJ-Pom121l2em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * C57BL/6)
|
decreased circulating corticosterone level
|
J:102955
|
Pomctm1Low/Pomctm1Low
(B6.129S2-Pomctm1Low/J)
|
increased circulating corticosterone level
|
J:84463
|
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased circulating corticosterone level
|
J:119240
|
Pomctm1Low/Pomctm1Low Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster)
|
abnormal corticosterone level
|
J:119240
|
increased circulating corticosterone level
|
J:119240
|
Pomctm1Low/Pomctm1Low Tg(Pomc)#Low/Tg(Pomc)#Low
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster)
|
increased circulating corticosterone level
|
J:119240
|
Pomctm1Sora/Pomc+
(involves: 129S2/SvHsd * 129S6/SvEvTac)
|
decreased circulating corticosterone level
|
J:89244
|
Pomctm1Sora/Pomctm1Sora
(involves: 129S2/SvHsd * 129S6/SvEvTac)
|
decreased circulating corticosterone level
|
J:89244
|
Pomctm2Ute/Pomctm2Ute
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased circulating aldosterone level
|
J:57503
|
decreased circulating corticosterone level
|
J:57503
|
Pon1tm1Lus/Pon1tm1Lus
(involves: 129X1/SvJ * C57BL/6J)
|
increased circulating LDL cholesterol level
|
J:63392
|
increased circulating VLDL cholesterol level
|
J:63392
|
Pon2Gt(XE661)Byg/Pon2Gt(XE661)Byg
(B6.129P2-Pon2Gt(XE661)Byg)
|
decreased circulating cholesterol level
|
J:116935
|
decreased circulating LDL cholesterol level
|
J:116935
|
decreased circulating VLDL cholesterol level
|
J:116935
|
Pon2tm1b(EUCOMM)Hmgu/Pon2tm1b(EUCOMM)Hmgu
(C57BL/6N-Pon2tm1b(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:211773
|
Pon3tm1b(KOMP)Wtsi/Pon3tm1b(KOMP)Wtsi
(C57BL/6N-Pon3tm1b(KOMP)Wtsi/Kmpc)
|
increased circulating triglyceride level
|
J:211773
|
Pon3tm1Dmsh/Pon3tm1Dmsh
(B6J.129X1-Pon3tm1Dmsh)
|
abnormal lipid level
|
J:234615
|
decreased bile salt level
|
J:234615
|
decreased circulating free fatty acids level
|
J:234615
|
decreased circulating HDL cholesterol level
|
J:234615
|
decreased circulating triglyceride level
|
J:234615
|
decreased liver triglyceride level
|
J:234615
|
increased bile salt level
|
J:234615
|
increased circulating cholesterol level
|
J:234615
|
increased circulating LDL cholesterol level
|
J:234615
|
increased circulating triglyceride level
|
J:234615
|
increased liver cholesterol level
|
J:234615
|
Portm1Ding/Portm1Ding Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:84422
|
Portm1Wolf/Portm1Wolf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal bile salt level
|
J:82951
|
decreased circulating cholesterol level
|
J:82951
|
decreased circulating triglyceride level
|
J:82951
|
Portm2Ding/Portm2Ding
(involves: 129S1/Sv * C57BL/6)
|
decreased circulating cholesterol level
|
J:119630
|
Portm2Wolf/Portm1Wolf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal bile salt level
|
J:82951
|
decreased circulating cholesterol level
|
J:82951
|
decreased circulating triglyceride level
|
J:82951
|
Portm3Ding/Portm3Ding
(C57BL/6-Portm3Ding)
|
decreased circulating cholesterol level
|
J:159168
|
Pparatm1Gonz/Pparatm1Gonz
(129S4/SvJae-Pparatm1Gonz)
|
abnormal circulating HDL cholesterol level
|
J:72185
|
increased circulating cholesterol level
|
J:72185
|
increased circulating free fatty acids level
|
J:56056
|
Pparatm1Gonz/Pparatm1Gonz
(B6.129S4-Pparatm1Gonz)
|
increased circulating triglyceride level
|
J:72185
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae)
|
increased circulating cholesterol level
|
J:127793
|
increased circulating free fatty acids level
|
J:127793
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6J)
|
increased skeletal muscle triglyceride level
|
J:129848
|
Ppardtm1(PPARD)Bsls/Ppardtm1(PPARD)Bsls
(B6.Cg-Ppardtm1(PPARD)Bsls)
|
decreased circulating cholesterol level
|
J:211453
|
decreased circulating HDL cholesterol level
|
J:211453
|
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N)
|
abnormal lipid level
|
J:76564
|
decreased liver cholesterol level
|
J:89827
|
decreased liver triglyceride level
|
J:89827
|
increased circulating triglyceride level
|
J:89827
|
increased circulating VLDL cholesterol level
|
J:89827
|
increased fatty acids level
|
J:89827
|
Ppardtm1Mtz/Ppardtm1Mtz Tg(KRT14-cre)1Ipc/0
(involves: C57BL/6 * SJL)
|
decreased cholesterol level
|
J:109090
|
Ppargtm1.1Auw/Ppargtm1.1Auw
(B6.Cg-Ppargtm1.1Auw)
|
decreased circulating cholesterol level
|
J:144344
|
decreased circulating triglyceride level
|
J:144344
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz Tg(Aqp2-cre)1Dek/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
abnormal circulating aldosterone level
|
J:99873
|
Ppargtm1Auw/Ppargtm1Auw
(either: 129 or C57BL/6J or (involves: 129 * C57BL/6J))
|
hyperlipidemia
|
J:86705
|
increased circulating free fatty acids level
|
J:86705
|
increased circulating triglyceride level
|
J:86705
|
increased liver triglyceride level
|
J:86705
|
Ppargtm1Avp/Pparg+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal triglyceride level
|
J:116568
|
increased circulating triglyceride level
|
J:116568
|
Ppargtm1Laz/Ppargtm1Laz
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased circulating free fatty acids level
|
J:135904
|
decreased circulating triglyceride level
|
J:135904
|
Ppargtm1Lja/Pparg+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased circulating free fatty acids level
|
J:98786
|
increased liver triglyceride level
|
J:98786
|
Ppargtm2(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6)
|
increased circulating cholesterol level
|
J:125992
|
increased circulating free fatty acids level
|
J:125992
|
increased circulating triglyceride level
|
J:125992
|
Ppargtm2Rev/Ppargtm2Rev Tg(Tek-cre)1Ywa/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased triglyceride level
|
J:155909
|
Ppargtm3(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6)
|
increased circulating triglyceride level
|
J:125992
|
Ppargc1atm1Aztc/Ppargc1a+
(C57BL/6-Ppargc1atm1Aztc)
|
decreased circulating cholesterol level
|
J:82809
|
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N)
|
decreased liver triglyceride level
|
J:93896
|
Ppargc1atm1Dpk/Ppargc1atm1Dpk
(involves: 129X1/SvJ)
|
decreased triglyceride level
|
J:137598
|
Ppargc1atm1Dpk/Ppargc1atm1Dpk Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N)
|
decreased triglyceride level
|
J:137598
|
Ppargc1btm1.1Avp/Ppargc1btm1.1Avp
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
decreased circulating cholesterol level
|
J:116167
|
decreased circulating triglyceride level
|
J:116167
|
Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N)
|
decreased triglyceride level
|
J:137598
|
Ppargc1btm1.1Rev/Ppargc1btm1.1Rev
(involves: 129 * C57BL/6J)
|
decreased circulating free fatty acids level
|
J:120079
|
decreased circulating triglyceride level
|
J:120079
|
increased circulating free fatty acids level
|
J:120079
|
increased circulating triglyceride level
|
J:120079
|
increased liver triglyceride level
|
J:120079
|
Ppargc1btm1Lowl/Ppargc1btm1Lowl
(involves: C57BL/6)
|
increased liver triglyceride level
|
J:129775
|
Ppdpftm1Nju/Ppdpftm1Nju Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
increased circulating free fatty acids level
|
J:307283
|
increased circulating triglyceride level
|
J:307283
|
increased liver triglyceride level
|
J:307283
|
Ppil3tm1b(EUCOMM)Wtsi/Ppil3tm1b(EUCOMM)Wtsi
(C57BL/6N-Ppil3tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ppm1ltm1Dgen/Ppm1ltm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating free fatty acids level
|
J:134171
|
Ppme1em1(IMPC)Rbrc/Ppme1+
(C57BL/6NJcl-Ppme1em1(IMPC)Rbrc/Rbrc)
|
increased circulating triglyceride level
|
J:211773
|
Ppp1r3btm1.1Arte/Ppp1r3b+
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating triglyceride level
|
J:157291
|
Ppp1r3ctm1Ars/Ppp1r3c+
(B6.129-Ppp1r3ctm1Ars)
|
increased circulating triglyceride level
|
J:83297
|
increased skeletal muscle triglyceride level
|
J:83297
|
Ppp2r5cem1(IMPC)Mbp/Ppp2r5cem1(IMPC)Mbp
(C57BL/6N-Ppp2r5cem1(IMPC)Mbp/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
Ppp5ctm1a(EUCOMM)Wtsi/Ppp5ctm1a(EUCOMM)Wtsi
(B6Dnk;B6Brd;B6N-Ppp5ctm1a(EUCOMM)Wtsi Tyrc-Brd/WtsiH)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating triglyceride level
|
J:175295
|
Prdm12tm2b(EUCOMM)Hmgu/Prdm12+
(C57BL/6N-Prdm12tm2b(EUCOMM)Hmgu/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp Tg(Adipoq-cre)1Evdr/0
(involves: 129/Sv * C57BL/6 * FVB/N)
|
increased liver triglyceride level
|
J:208683
|
Prdx3tm1Hjha/Prdx3tm1Hjha
(involves: 129S4/SvJae * C57BL/6)
|
decreased circulating triglyceride level
|
J:228860
|
increased circulating cholesterol level
|
J:228860
|
Prdx5tm1Dsle/Prdx5tm1Dsle
(involves: C57BL/6)
|
increased liver triglyceride level
|
J:294801
|
Prdx6tm2Abf/Prdx6tm2Abf
(involves: C57BL/6J)
|
abnormal phospholipid level
|
J:237406
|
Preptm1b(KOMP)Wtsi/Prep+
(C57BL/6N-Preptm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz/J)
|
increased circulating triglyceride level
|
J:92260
|
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating free fatty acids level
|
J:81120
|
Prkaa2tm1Vio/Prkaa2tm1Vio Tg(Alb1-cre)7Gsc/0
(involves: 129S2/SvPas * FVB/N)
|
increased fatty acids level
|
J:108399
|
increased triglyceride level
|
J:108399
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(B6N(Cg)-Prkab1tm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Prkab1tm1Eihl/Prkab1tm1Eihl
(involves: C57BL/6)
|
abnormal lipid level
|
J:158295
|
decreased liver triglyceride level
|
J:158295
|
Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi
(B6.129P2-Prkab2Gt(AL0483)Wtsi)
|
increased circulating triglyceride level
|
J:186658
|
Prkacatm3Gsm/Prkacatm3Gsm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J)
|
increased circulating triglyceride level
|
J:103418
|
Prkar1atm1Lsk/Prkar1atm1Lsk Tg(Akr1b7-cre)1Anm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased circulating corticosterone level
|
J:161521
|
Prkar2btm1Gsm/Prkar2btm1Gsm
(Not Specified)
|
decreased triglyceride level
|
J:34751
|
Prkar2btm1Gsm/Prkar2btm1Gsm
(B6.129-Prkar2btm1Gsm)
|
decreased circulating cholesterol level
|
J:72414
|
decreased circulating LDL cholesterol level
|
J:72414
|
decreased circulating VLDL cholesterol level
|
J:72414
|
decreased liver triglyceride level
|
J:72414
|
Prkar2btm3Gsm/Prkar2btm3Gsm
(B6.Cg-Prkar2btm3Gsm)
|
decreased circulating cholesterol level
|
J:196157
|
decreased circulating LDL cholesterol level
|
J:196157
|
decreased circulating VLDL cholesterol level
|
J:196157
|
decreased liver triglyceride level
|
J:196157
|
decreased triglyceride level
|
J:196157
|
Prkcdtm1Qxu/Prkcdtm1Qxu
(B6.129P2-Prkcdtm1Qxu)
|
decreased liver triglyceride level
|
J:173902
|
Prkcitm1Rfar/Prkci+ Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal circulating lipid level
|
J:123964
|
decreased circulating HDL cholesterol level
|
J:123964
|
increased circulating cholesterol level
|
J:123964
|
increased circulating free fatty acids level
|
J:123964
|
increased circulating LDL cholesterol level
|
J:123964
|
increased circulating triglyceride level
|
J:123964
|
Prkcitm1Rfar/Prkcitm1Rfar Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal circulating lipid level
|
J:123964
|
decreased circulating HDL cholesterol level
|
J:123964
|
increased circulating cholesterol level
|
J:123964
|
increased circulating free fatty acids level
|
J:123964
|
increased circulating LDL cholesterol level
|
J:123964
|
increased circulating triglyceride level
|
J:123964
|
Prkd3tm1b(EUCOMM)Wtsi/Prkd3+
(C57BL/6N-Prkd3tm1b(EUCOMM)Wtsi/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Prkg1tm1Hfm/Prkg1tm1Hfm
(involves: C57BL/6N)
|
decreased triglyceride level
|
J:199222
|
Prkraem1(IMPC)H/Prkraem1(IMPC)H
(C57BL/6N-Prkraem1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
Prlhtm1Taon/Prlhtm1Taon
(B6N.129X1-Prlhtm1Taon)
|
increased circulating triglyceride level
|
J:144729
|
increased liver triglyceride level
|
J:144729
|
Prlhrtm1Dgen/Prlhrtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cholesterol level
|
J:127335
|
increased circulating corticosterone level
|
J:127335
|
increased circulating HDL cholesterol level
|
J:127335
|
increased circulating LDL cholesterol level
|
J:127335
|
Prlhrtm1Map/Prlhrtm1Map
(involves: 129S6/SvEvTac * CD-1)
|
decreased circulating corticosterone level
|
J:103932
|
Prop1tm1Sac/Prop1tm1Sac
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J)
|
increased circulating corticosterone level
|
J:94409
|
Prox1tm1Gco/Prox1+
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
increased liver triglyceride level
|
J:102652
|
Prr5em1(IMPC)J/Prr5em1(IMPC)J
(C57BL/6NJ-Prr5em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Prss8tm1.1Hum/Prss8tm1.2Hum Tg(KRT14-cre)1Ipc/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal lipid level
|
J:100139
|
Prxl2btm1.2Ksak/Prxl2btm1.2Ksak
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal lipid level
|
J:307536
|
Psaptm1Ggb/Psaptm1Ggb
(involves: 129S/SvEv * C57BL/6J)
|
abnormal lipid level
|
J:121761
|
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd)
|
abnormal lipid level
|
J:78223
|
Psaptm1Suz/Psaptm1Suz
(B6.129P2-Psaptm1Suz)
|
abnormal lipid level
|
J:120657
|
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J)
|
abnormal lipid level
|
J:73188,
J:78223,
J:120657
|
Psen1tm1Lpr/Psen1tm1Lpr
(involves: 129 * C57BL/6 * CBA)
|
increased circulating cholesterol level
|
J:128243
|
Psen1tm1Lpr/Psen1tm1Lpr Tg(Thy1-APPSL)28Lpr/0
(involves: 129 * C57BL/6 * CBA)
|
decreased circulating cholesterol level
|
J:128243
|
increased circulating cholesterol level
|
J:128243
|
Psg20em1(IMPC)Wtsi/Psg20em1(IMPC)Wtsi
(C57BL/6N-Psg20em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Psphtm1.1(KOMP)Vlcg/Psph+
(C57BL/6N-Psphtm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating triglyceride level
|
J:211773
|
Ptcd1tm1(KOMP)Vlcg/Ptcd1+
(C57BL/6N-Ptcd1tm1(KOMP)Vlcg)
|
increased circulating triglyceride level
|
J:256004
|
Ptcd3tm1.1(KOMP)Vlcg/Ptcd3+
(C57BL/6N-Ptcd3tm1.1(KOMP)Vlcg/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ptdss1tm1Jev/Ptdss1+ Ptdss2Gt(KST314)Byg/Ptdss2Gt(KST314)Byg
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
abnormal phospholipid level
|
J:137106
|
Ptdss1tm1Jev/Ptdss1tm1Jev
(involves: 129S/SvEv * C57BL/6)
|
abnormal phospholipid level
|
J:137106
|
Ptdss1tm1Jev/Ptdss1tm1Jev Ptdss2Gt(KST314)Byg/Ptdss2+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
abnormal phospholipid level
|
J:137106
|
Ptentm1Hwu/Ptentm1Hwu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
abnormal fatty acids level
|
J:88441
|
decreased circulating free fatty acids level
|
J:88441
|
increased liver triglyceride level
|
J:88441,
J:160759
|
Ptentm2Mak/Ptentm2Mak Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased liver cholesterol level
|
J:138099
|
increased liver triglyceride level
|
J:138099
|
Ptentm2Mak/Ptentm2Mak Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA)
|
increased liver triglyceride level
|
J:90905
|
increased saturated fatty acids level
|
J:90905
|
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(C.129-Ptgdr2tm1Tasa)
|
decreased prostaglandin level
|
J:131146
|
Ptger4tm1Bhk/Ptger4tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal prostaglandin level
|
J:78964
|
Ptges3tm1Nkt/Ptges3tm1Nkt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prostaglandin level
|
J:125188
|
Ptgestm1.1Gaf/Ptgestm1.1Gaf Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6)
|
decreased prostaglandin level
|
J:210141
|
increased prostaglandin level
|
J:210141
|
Ptgestm1.1Gaf/Ptgestm1.1Gaf Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased prostaglandin level
|
J:210141
|
increased prostaglandin level
|
J:210141
|
Ptgestm1.1Gaf/Ptgestm1.1Gaf Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased prostaglandin level
|
J:210141
|
increased prostaglandin level
|
J:210141
|
Ptgestm1Aki/Ptgestm1Aki
(involves: 129P2/OlaHsd)
|
decreased leukotriene level
|
J:92047
|
Ptgestm1Aki/Ptgestm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
abnormal prostaglandin level
|
J:91821
|
Ptgestm1Lpa/Ptgestm1Lpa
(DBA/1LacJ-Ptgestm1Lpa)
|
decreased prostaglandin level
|
J:106147
|
Ptgirtm1Sna/Ptgirtm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thromboxane level
|
J:79049
|
decreased prostaglandin level
|
J:42275
|
Ptgistm1Tada/Ptgistm1Tada
(B6.129-Ptgistm1Tada)
|
abnormal thromboxane level
|
J:103380
|
decreased prostaglandin level
|
J:103380
|
increased prostaglandin level
|
J:103380
|
Ptgs1tm1Fun/Ptgs1tm1Fun
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal thromboxane level
|
J:108957
|
Ptgs1tm1Unc/Ptgs1+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prostaglandin level
|
J:29511
|
Ptgs1tm1Unc/Ptgs1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased prostaglandin level
|
J:106147
|
Ptgs1tm1Unc/Ptgs1+
(D1.129P2-Ptgs1tm1Unc)
|
increased prostaglandin level
|
J:102779
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prostaglandin level
|
J:103388,
J:117986,
J:60668,
J:50148,
J:29511
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased prostaglandin level
|
J:106147
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd)
|
decreased prostaglandin level
|
J:108679
|
Ptgs1tm1Unc/Ptgs1tm1Unc Oxttm1Ljm/Oxttm1Ljm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prostaglandin level
|
J:50148
|
Ptgs2tm1.1Fun/Ptgs2tm1.1Fun
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased prostaglandin level
|
J:109548
|
Ptgs2tm1Fun/Ptgs2tm1Fun
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased prostaglandin level
|
J:109548
|
Ptgs2tm1Jed/Ptgs2tm1Jed
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased prostaglandin level
|
J:109548
|
Ptgs2tm1Unc/Ptgs2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased prostaglandin level
|
J:124756
|
Ptgs2tm1Unc/Ptgs2+
(D1.129P2-Ptgs2tm1Unc)
|
increased prostaglandin level
|
J:102779
|
Ptgs2tm1Unc/Ptgs2+
(B6.129P2-Ptgs2tm1Unc)
|
decreased prostaglandin level
|
J:67211
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased prostaglandin level
|
J:109021,
J:55145
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased prostaglandin level
|
J:124756
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prostaglandin level
|
J:117986,
J:60668
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(D1.129P2-Ptgs2tm1Unc)
|
decreased prostaglandin level
|
J:102779
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
|
decreased prostaglandin level
|
J:67211
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac)
|
decreased prostaglandin level
|
J:141610
|
Pthlhtm1Ack/Pthlhtm1Hmk Tg(LGB-cre)74Acl/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal vitamin D level
|
J:86536
|
Ptpn1tm1Bpk/Ptpn1tm1Bpk
(involves: 129S4/SvJae * BALB/c)
|
decreased triglyceride level
|
J:53437
|
Ptpn1tm2Bbk/Ptpn1tm2Bbk Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased triglyceride level
|
J:111969
|
Ptpn11tm1.1Ics/Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
abnormal lipid level
|
J:216593
|
decreased liver triglyceride level
|
J:216593
|
decreased skeletal muscle triglyceride level
|
J:216593
|
increased glycerol level
|
J:216593
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Tg(Camk2a-cre)2Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased circulating corticosterone level
|
J:94738
|
increased circulating triglyceride level
|
J:94738
|
increased liver triglyceride level
|
J:94738
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
increased cardiac muscle triglyceride level
|
J:144767
|
increased circulating triglyceride level
|
J:144767
|
increased skeletal muscle triglyceride level
|
J:144767
|
Ptpn11tm3Bgn/Ptpn11tm3Bgn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA)
|
decreased circulating triglyceride level
|
J:167406
|
Ptpn23tm1b(EUCOMM)Hmgu/Ptpn23+
(C57BL/6N-Ptpn23tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ptprvtm1Kry/Ptprvtm1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
decreased circulating free fatty acids level
|
J:126780
|
decreased circulating triglyceride level
|
J:126780
|
Pttg1tm1b(EUCOMM)Wtsi/Pttg1tm1b(EUCOMM)Wtsi
(C57BL/6N-Pttg1tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Pycr1tm1(KOMP)Vlcg/Pycr1tm1(KOMP)Vlcg
(C57BL/6NTac-Pycr1tm1(KOMP)Vlcg)
|
decreased circulating triglyceride level
|
J:308336
|
Pycr1tm1.1(KOMP)Vlcg/Pycr1tm1.1(KOMP)Vlcg
(B6N(Cg)-Pycr1tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Pycr2m1J/Pycr2m1J
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:308336
|
decreased circulating HDL cholesterol level
|
J:308336
|
decreased circulating triglyceride level
|
J:308336
|
Pygltm1a(KOMP)Wtsi/Pygltm1a(KOMP)Wtsi
(C57BL/6N-Pygltm1a(KOMP)Wtsi)
|
decreased circulating cholesterol level
|
J:284765
|
decreased circulating triglyceride level
|
J:284765
|
Rab3gap2tm1b(KOMP)Wtsi/Rab3gap2tm1b(KOMP)Wtsi
(C57BL/6N-Rab3gap2tm1b(KOMP)Wtsi/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Rab5atm1b(KOMP)Wtsi/Rab5atm1b(KOMP)Wtsi
(C57BL/6N-Rab5atm1b(KOMP)Wtsi/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Rab5ctm1a(EUCOMM)Wtsi/Rab5c+
(C57BL/6N-Rab5ctm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Rab28em1(IMPC)J/Rab28em1(IMPC)J
(C57BL/6NJ-Rab28em1(IMPC)J/Mmjax)
|
increased circulating triglyceride level
|
J:211773
|
Rab33bem1(IMPC)J/Rab33bem1(IMPC)J
(C57BL/6NJ-Rab33bem1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
Rab36tm1b(KOMP)Wtsi/Rab36tm1b(KOMP)Wtsi
(C57BL/6N-Rab36tm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Rab43tm1.1(KOMP)Vlcg/Rab43tm1.1(KOMP)Vlcg
(C57BL/6N-Rab43tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rad1tm1b(KOMP)Wtsi/Rad1+
(C57BL/6N-Rad1tm1b(KOMP)Wtsi/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Rai1tm1Jrl/Rai1+
(B6.129S7-Rai1tm1Jrl/J)
|
increased circulating corticosterone level
|
J:164451
|
Rai1tm2.1Luo/Rai1tm2.1Luo Tg(Sim1-cre)1Lowl/?
(either: (involves: 129S1/Sv * C57BL/6 * FVB) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB))
|
increased cholesterol level
|
J:237687
|
increased circulating HDL cholesterol level
|
J:237687
|
increased circulating LDL cholesterol level
|
J:237687
|
increased circulating VLDL cholesterol level
|
J:237687
|
increased triglyceride level
|
J:237687
|
Ralgapa1tm1.1Schen/Ralgapa1tm1.1Schen
(involves: C57BL/6J)
|
increased circulating cholesterol level
|
J:287672
|
increased circulating free fatty acids level
|
J:287672
|
increased circulating triglyceride level
|
J:287672
|
increased liver cholesterol level
|
J:287672
|
increased liver triglyceride level
|
J:287672
|
Ralgapa1tm2c(KOMP)Wtsi/Ralgapa1tm2c(KOMP)Wtsi Myl1tm1(cre)Sjb/Myl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N)
|
increased circulating cholesterol level
|
J:287672
|
increased circulating free fatty acids level
|
J:287672
|
increased circulating triglyceride level
|
J:287672
|
Ralyem2(IMPC)Tcp/Ralyem2(IMPC)Tcp
(C57BL/6NCrl-Ralyem2(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Rapgef3tm1Skc/Rapgef3tm1Skc
(Not Specified)
|
decreased circulating cholesterol level
|
J:201171
|
decreased circulating HDL cholesterol level
|
J:201171
|
increased circulating triglyceride level
|
J:201171
|
Rapsntm1b(EUCOMM)Wtsi/Rapsn+
(C57BL/6N-Rapsntm1b(EUCOMM)Wtsi/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Rarres2tm1Yktk/Rarres2tm1Yktk
(B6.Cg-Rarres2tm1Yktk)
|
decreased circulating free fatty acids level
|
J:206120
|
Rars2tm1a(EUCOMM)Wtsi/Rars2+
(B6JTyr;B6N-Rars2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:175295
|
Rasa3scat/Rasa3scat
(involves: BALB/cBy)
|
hyperlipidemia
|
J:186485
|
Rasal3tm1b(EUCOMM)Hmgu/Rasal3tm1b(EUCOMM)Hmgu
(C57BL/6N-Rasal3tm1b(EUCOMM)Hmgu/Orl)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating triglyceride level
|
J:211773
|
Rbl2tm1b(EUCOMM)Hmgu/Rbl2+
(C57BL/6N-Rbl2tm1b(EUCOMM)Hmgu/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rbm14tm1a(KOMP)Wtsi/Rbm14tm1a(KOMP)Wtsi
(C57BL/6N-Rbm14tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rbm20em1(IMPC)Mbp/Rbm20em1(IMPC)Mbp
(C57BL/6N-Rbm20em1(IMPC)Mbp/MbpMmucd)
|
increased circulating triglyceride level
|
J:211773
|
Rbpjtm1b(EUCOMM)Hmgu/Rbpj+
(C57BL/6N-Rbpjtm1b(EUCOMM)Hmgu/J)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Rcn3tm1Rzm/Rcn3tm1Rzm
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal phospholipid level
|
J:265611
|
Rec8tm1b(KOMP)Wtsi/Rec8tm1b(KOMP)Wtsi
(C57BL/6N-Rec8tm1b(KOMP)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Reep1Gt(OST398247)Tigm/Reep1Gt(OST398247)Tigm
(B6J.Cg-Reep1Gt(OST398247)Tigm)
|
decreased circulating cholesterol level
|
J:239250
|
decreased circulating triglyceride level
|
J:239250
|
Reg3gtm1a(KOMP)Wtsi/Reg3gtm1a(KOMP)Wtsi
(C57BL/6N-Reg3gtm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Ren1tm1.2Sig/Ren1tm1.2Sig
(involves: C57BL/6J)
|
increased circulating aldosterone level
|
J:169129
|
Resp18tm1.1(KOMP)Vlcg/Resp18+
(C57BL/6N-Resp18tm1.1(KOMP)Vlcg/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Resp18tm1.1(KOMP)Vlcg/Resp18tm1.1(KOMP)Vlcg
(C57BL/6N-Resp18tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Retntm1Laz/Retntm1Laz
(involves: 129S/SvEv * C57BL/6)
|
decreased liver triglyceride level
|
J:90033
|
Retntm1Laz/Retntm1Laz Tg(CD68-RETN)#Laz/?
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating free fatty acids level
|
J:171262
|
increased circulating glycerol level
|
J:171262
|
increased skeletal muscle triglyceride level
|
J:171262
|
Retreg3tm2b(EUCOMM)Wtsi/Retreg3tm2b(EUCOMM)Wtsi
(C57BL/6N-Fam134ctm2b(EUCOMM)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Rexo2tm1b(EUCOMM)Wtsi/Rexo2+
(C57BL/6N-Rexo2tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rfc1tm1b(KOMP)Mbp/Rfc1+
(B6N(Cg)-Rfc1tm1b(KOMP)Mbp/J)
|
decreased circulating free fatty acids level
|
J:211773
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rgntm1Aish/Y
(involves: 129P2/OlaHsd)
|
abnormal phospholipid level
|
J:88791
|
increased liver cholesterol level
|
J:88791
|
increased liver triglyceride level
|
J:88791
|
Rgp1tm1.1(KOMP)Vlcg/Rgp1+
(C57BL/6N-Rgp1tm1.1(KOMP)Vlcg/J)
|
decreased circulating cholesterol level
|
J:211773
|
Rgs4tm1Dgen/Rgs4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:101679
|
increased circulating HDL cholesterol level
|
J:101679
|
Rgsc197/Rgsc197+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc273/Rgsc273+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc333/Rgsc333+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc391/Rgsc391+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc453/Rgsc453+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc528/Rgsc528+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc545/Rgsc545+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc663/Rgsc663+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc668/Rgsc668+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc679/Rgsc679+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased circulating cholesterol level
|
J:133634
|
increased circulating HDL cholesterol level
|
J:133634
|
Rgsc733/Rgsc733+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc855/Rgsc855+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased circulating cholesterol level
|
J:133634
|
decreased circulating HDL cholesterol level
|
J:133634
|
Rgsc1851/Rgsc1851
(C57BL/6JJcl-Rgsc1851)
|
increased circulating triglyceride level
|
J:133634
|
Rhagem1(IMPC)Ccpcz/Rhagem1(IMPC)Ccpcz
(C57BL/6NCrl-Rhagem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rhpn1tm1b(KOMP)Wtsi/Rhpn1tm1b(KOMP)Wtsi
(C57BL/6N-Rhpn1tm1b(KOMP)Wtsi/Ucd)
|
increased circulating HDL cholesterol level
|
J:211773
|
Rictortm1.1Mnh/Rictortm1.1Mnh Tg(Fabp4-cre)1Rev/0
(B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev)
|
increased circulating cholesterol level
|
J:150064
|
Rilpl2tm1b(KOMP)Wtsi/Rilpl2tm1b(KOMP)Wtsi
(C57BL/6N-Rilpl2tm1b(KOMP)Wtsi/J)
|
decreased circulating cholesterol level
|
J:211773
|
Rint1tm1b(KOMP)Wtsi/Rint1+
(C57BL/6N-Rint1tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Rmrpem1(IMPC)Ccpcz/Rmrp+
(C57BL/6NCrl-Rmrpem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rnf4em1(IMPC)Ccpcz/Rnf4+
(C57BL/6N-Rnf4em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating triglyceride level
|
J:211773
|
Rnf7tm1a(EUCOMM)Wtsi/Rnf7+
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Rnf10tm1a(KOMP)Wtsi/Rnf10tm1a(KOMP)Wtsi
(C57BL/6N-Rnf10tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
increased circulating cholesterol level
|
J:175295
|
increased circulating HDL cholesterol level
|
J:175295
|
increased circulating triglyceride level
|
J:175295
|
Rnf10tm1b(KOMP)Wtsi/Rnf10+
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ucd)
|
decreased circulating triglyceride level
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10+
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/MbpMmucd)
|
increased circulating HDL cholesterol level
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ieg)
|
increased circulating triglyceride level
|
J:211773
|
Rnf14em1(IMPC)Ccpcz/Rnf14em1(IMPC)Ccpcz
(C57BL/6N-Rnf14em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
Rnf25tm1.1(KOMP)Vlcg/Rnf25tm1.1(KOMP)Vlcg
(C57BL/6N-Rnf25tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Rnf130tm1a(EUCOMM)Wtsi/Rnf130tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased circulating cholesterol level
|
J:338210
|
decreased circulating LDL cholesterol level
|
J:338210
|
Rnf144btm1b(EUCOMM)Hmgu/Rnf144btm1b(EUCOMM)Hmgu
(C57BL/6N-Rnf144btm1b(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:211773
|
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1)
|
increased circulating triglyceride level
|
J:244583
|
Rnf169tm1a(EUCOMM)Hmgu/Rnf169tm1a(EUCOMM)Hmgu
(B6NTac;B6N-Rnf169tm1a(EUCOMM)Hmgu/H)
|
decreased circulating free fatty acids level
|
J:165965
|
Rnf180em1(IMPC)J/Rnf180em1(IMPC)J
(C57BL/6NJ-Rnf180em1(IMPC)J/Mmjax)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Rock2tm1Zpj/Rock2+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal circulating cholesterol level
|
J:224630
|
decreased circulating free fatty acids level
|
J:224630
|
Rorasg/Rorasg
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:52105
|
decreased circulating HDL cholesterol level
|
J:52105
|
Rpa1tm1b(KOMP)Wtsi/Rpa1+
(C57BL/6N-Rpa1tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Rpiatm1a(KOMP)Wtsi/Rpia+
(C57BL/6N-Rpiatm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Rpn2tm1a(EUCOMM)Wtsi/Rpn2+
(B6JTyr;B6N-Rpn2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:175295
|
increased circulating free fatty acids level
|
J:175295
|
increased circulating glycerol level
|
J:175295
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho Rps6kb2tm1Gtho/Rps6kb2tm1Gtho
(involves: 129P2/OlaHsd)
|
abnormal lipid level
|
J:129852
|
Rptortm1Rueg/Rptortm1Rueg Tg(Fabp4-cre)1Rev/0
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:143749
|
decreased liver triglyceride level
|
J:143749
|
Rr401em1Yushi/Rr401em1Yushi
(Not Specified)
|
decreased sterol level
|
J:334319
|
Rrasem1(IMPC)H/Rrasem1(IMPC)H
(C57BL/6N-Rrasem1(IMPC)H/H)
|
increased circulating triglyceride level
|
J:211773
|
Rrm2bGt(OST85254)Lex/Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
hyperlipidemia
|
J:186071
|
increased circulating cholesterol level
|
J:186071
|
increased circulating triglyceride level
|
J:186071
|
Rsbn1tm1b(EUCOMM)Wtsi/Rsbn1+
(C57BL/6N-Rsbn1tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
Rsc1a1tm1Koep/Rsc1a1tm1Koep
(B6.129-Rsc1a1tm1Koep)
|
increased circulating cholesterol level
|
J:95148
|
Rubcnlem1Qsun/Rubcnlem1Qsun Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Rubcnlem1Qsun)
|
increased liver triglyceride level
|
J:272052
|
Rundc1tm1a(EUCOMM)Wtsi/Rundc1+
(C57BL/6N-Rundc1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Runx1t1tm1b(EUCOMM)Hmgu/Runx1t1+
(C57BL/6N-Runx1t1tm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Rwdd1tm1b(KOMP)Wtsi/Rwdd1tm1b(KOMP)Wtsi
(C57BL/6N-Rwdd1tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Rxratm4Ipc/Rxratm4Ipc Rxrbtm1Pcn/Rxrbtm1Pcn Tg(KRT14-cre)1Ipc/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
decreased cholesterol level
|
J:109090
|
S2bpcox16em1(IMPC)J/S2bpcox16em1(IMPC)J
(C57BL/6NJ-S2bpcox16em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Saa3tm1(KOMP)Vlcg/Saa3+
(involves: C57BL/6NTac)
|
decreased circulating LDL cholesterol level
|
J:220630
|
Saa3tm1(KOMP)Vlcg/Saa3tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased circulating cholesterol level
|
J:220630
|
decreased circulating LDL cholesterol level
|
J:220630
|
decreased circulating triglyceride level
|
J:220630
|
Sagtm1a(EUCOMM)Wtsi/Sagtm1a(EUCOMM)Wtsi
(C57BL/6N-Sagtm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Samd1tm1Pfi/Samd1+
(involves: C57BL/6J * C57BL/6N)
|
decreased circulating HDL cholesterol level
|
J:333561
|
decreased circulating VLDL cholesterol level
|
J:333561
|
increased circulating aldosterone level
|
J:333561
|
increased circulating corticosterone level
|
J:333561
|
Samd4m1Btlr/Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr)
|
decreased circulating cholesterol level
|
J:208616
|
decreased circulating HDL cholesterol level
|
J:208616
|
increased circulating LDL cholesterol level
|
J:208616
|
Samd8tm1.1Kwi/Samd8tm1.1Kwi
(involves: 129P2/OlaHsd)
|
abnormal ceramide level
|
J:228568
|
Samd8tm1.1Kwi/Samd8tm1.1Kwi Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129P2/OlaHsd)
|
abnormal ceramide level
|
J:228568
|
abnormal sphingomyelin level
|
J:228568
|
Samd8tm1Jia/Samd8tm1Jia Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal ceramide level
|
J:220024
|
abnormal sphingomyelin level
|
J:220024
|
Samd8tm2.2Kwi/Samd8tm2.2Kwi
(involves: 129P2/OlaHsd)
|
abnormal ceramide level
|
J:228568
|
Samd8tm2.2Kwi/Samd8tm2.2Kwi Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129P2/OlaHsd)
|
abnormal ceramide level
|
J:228568
|
Sar1bem1Emle/Sar1b+
(C57BL/6N-Sar1bem1Emle)
|
abnormal circulating non-HDL cholesterol level
|
J:319817
|
decreased circulating cholesterol level
|
J:319817
|
decreased circulating HDL cholesterol level
|
J:319817
|
decreased circulating triglyceride level
|
J:319817
|
Sar1bem2Emle/Sar1b+
(C57BL/6N-Sar1bem2Emle)
|
abnormal circulating non-HDL cholesterol level
|
J:319817
|
decreased circulating cholesterol level
|
J:319817
|
decreased circulating HDL cholesterol level
|
J:319817
|
decreased circulating triglyceride level
|
J:319817
|
increased liver cholesterol level
|
J:319817
|
steatorrhea
|
J:319817
|
Sar1btm1a(EUCOMM)Wtsi/Sar1b+
(C57BL/6N-Sar1btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating free fatty acids level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased circulating free fatty acids level
|
J:175295
|
Saraftm1c(KOMP)Wtsi/Saraftm1c(KOMP)Wtsi Tg(Pgk1-cre)1Lni/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N)
|
increased circulating corticosterone level
|
J:337869
|
Sc5dtm1Fdp/Sc5dtm1Fdp
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased brain cholesterol level
|
J:84450
|
decreased cholesterol level
|
J:84450
|
Scaptm1Mbjg/Scaptm1Mbjg Tg(Mx1-cre)29-4Her/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL)
|
decreased circulating free fatty acids level
|
J:69592
|
decreased liver cholesterol level
|
J:69592
|
decreased liver triglyceride level
|
J:69592
|
Scarb1Chohd1/Scarb1+
(C3HeB/FeJ-Scarb1Chohd1/Ieg)
|
increased circulating cholesterol level
|
J:94145
|
increased circulating HDL cholesterol level
|
J:94145
|
increased circulating LDL cholesterol level
|
J:94145
|
Scarb1Hdlq1-129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:144089
|
Scarb1Hdlq1-129S1/SvImJ/Scarb1Hdlq1-129S1/SvImJ Hdlq16129S1/SvImJ/Hdlq16129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:144089
|
Scarb1Hdlq1-NZB/BlNJ/Scarb1Hdlq1-NZB/BlNJ
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707,
J:89309
|
Scarb1Hdlq1-NZB/BlNJ/Scarb1Hdlq1-SM/J
(involves: NZB/BlNJ * SM/J)
|
increased circulating HDL cholesterol level
|
J:76707,
J:89309
|
Scarb1Hlb398/?
(C57BL/6J-Scarb1Hlb398)
|
increased circulating cholesterol level
|
J:82961
|
increased circulating HDL cholesterol level
|
J:82961
|
Scarb1Hlb398/Scarb1+
(C57BL/6J-Scarb1Hlb398)
|
increased circulating HDL cholesterol level
|
J:152482
|
Scarb1Hlb398/Scarb1Hlb398
(C57BL/6J-Scarb1Hlb398)
|
abnormal lipid level
|
J:152482
|
increased circulating cholesterol level
|
J:152482
|
increased circulating HDL cholesterol level
|
J:152482
|
increased circulating phospholipid level
|
J:152482
|
increased circulating triglyceride level
|
J:152482
|
Scarb1tm1.1Thh/Scarb1tm1.1Thh
(B6.129X1-Scarb1tm1.1Thh)
|
increased circulating cholesterol level
|
J:114663
|
increased circulating HDL cholesterol level
|
J:114663
|
Scarb1tm1b(EUCOMM)Wtsi/Scarb1tm1b(EUCOMM)Wtsi
(C57BL/6N-Scarb1tm1b(EUCOMM)Wtsi/Bay)
|
increased circulating cholesterol level
|
J:211773
|
Scarb1tm1Dhu/Scarb1tm1Dhu
(involves: 129S4/SvJae * BALB/cByJ)
|
abnormal circulating HDL cholesterol level
|
J:47439
|
increased circulating cholesterol level
|
J:47439
|
increased circulating HDL cholesterol level
|
J:47439
|
Scarb1tm1Kri/Scarb1+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cholesterol level
|
J:44187
|
increased circulating cholesterol level
|
J:44187
|
Scarb1tm1Kri/Scarb1tm1Kri
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cholesterol level
|
J:44187
|
abnormal circulating cholesterol level
|
J:73138
|
increased cholesterol level
|
J:216748
|
increased circulating cholesterol level
|
J:44187
|
Scarb1tm1Thh/Scarb1tm1Thh
(B6.129X1-Scarb1tm1Thh)
|
increased circulating cholesterol level
|
J:114663
|
increased circulating HDL cholesterol level
|
J:114663
|
Scarb1tm1Thh/Scarb1tm1Thh Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Scarb1tm1Thh Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased circulating cholesterol level
|
J:114663
|
increased circulating HDL cholesterol level
|
J:114663
|
Scd1ab-2J/Scd1ab-2J
(DBA/1LacJ-Scd1ab-2J/J)
|
abnormal lipid level
|
J:62699
|
Scd1tm1Ntam/Scd1tm1Ntam
(involves: 129S6/SvEvTac)
|
decreased unsaturated fatty acids level
|
J:71350
|
increased saturated fatty acids level
|
J:71350
|
Scd1tm1Ntam/Scd1tm1Ntam
(involves: C57BL/6)
|
decreased circulating triglyceride level
|
J:130441
|
decreased liver triglyceride level
|
J:130441
|
Scd1tm1Ntam/Scd1tm1Ntam Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased liver triglyceride level
|
J:178653
|
Scd1tm2Ntam/Scd1tm2Ntam Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Scd1tm2Ntam)
|
decreased circulating triglyceride level
|
J:130441
|
decreased circulating VLDL triglyceride level
|
J:130441
|
decreased liver triglyceride level
|
J:130441
|
increased circulating cholesterol level
|
J:130441
|
Scd2tm1Myz/Scd2tm1Myz
(129S6.129-Scd2tm1Myz)
|
decreased circulating triglyceride level
|
J:101158
|
decreased fatty acids level
|
J:101158
|
decreased liver triglyceride level
|
J:101158
|
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6))
|
increased circulating corticosterone level
|
J:53349
|
Scimptm1Lex/Scimptm1Lex
(B6;129S5-Scimptm1Lex/Mmucd)
|
increased circulating cholesterol level
|
J:171883
|
Sclt1em1(IMPC)Tcp/Sclt1+
(C57BL/6NCrl-Sclt1em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Scnn1atm1Rss/Scnn1atm1Rss Tg(CMV-Scnn1a)1352Rss/0
(involves: 129P2/OlaHsd * NMRI)
|
increased circulating aldosterone level
|
J:43583
|
Scnn1btm1.1Ipt/Scnn1b+
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
decreased circulating aldosterone level
|
J:59840
|
Scnn1btm1.1Ipt/Scnn1btm1.1Ipt
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
decreased circulating aldosterone level
|
J:59840
|
Scnn1btm1Wsh/Scnn1btm1Wsh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased circulating aldosterone level
|
J:53058
|
Sco1tm1c(KOMP)Wtsi/Sco1tm1c(KOMP)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA)
|
increased liver cholesterol level
|
J:222036
|
increased liver triglyceride level
|
J:222036
|
Scp2tm1Kier/Scp2tm1Kier
(involves: 129P2/OlaHsd * C57BL/6NCr)
|
abnormal lipid level
|
J:124895
|
decreased circulating triglyceride level
|
J:124895
|
decreased liver triglyceride level
|
J:124895
|
increased circulating cholesterol level
|
J:124895
|
increased fatty acids level
|
J:124895
|
Scp2tm1Usee/Scp2tm1Usee
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal bile salt level
|
J:73460
|
abnormal circulating cholesterol level
|
J:73460
|
abnormal lipid level
|
J:47280
|
decreased circulating free fatty acids level
|
J:47280
|
decreased liver cholesterol level
|
J:73460,
J:47280
|
decreased liver triglyceride level
|
J:47280
|
increased circulating HDL cholesterol level
|
J:73460
|
increased circulating LDL cholesterol level
|
J:73460
|
increased circulating triglyceride level
|
J:47280
|
increased circulating VLDL cholesterol level
|
J:73460
|
increased fatty acids level
|
J:47280
|
Scribtm1b(NCOM)Mfgc/Scrib+
(C57BL/6N-Scribtm1a(NCOM)Mfgc/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Scube3m1Mhda/Scube3m1Mhda
(C3HeB/FeJ-Scube3m1Mhda)
|
decreased circulating cholesterol level
|
J:237904
|
decreased circulating free fatty acids level
|
J:237904
|
decreased circulating glycerol level
|
J:237904
|
decreased circulating triglyceride level
|
J:237904
|
Sdc1em1(IMPC)H/Sdc1em1(IMPC)H
(C57BL/6NTac-Sdc1em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Sdc2tm1b(KOMP)Wtsi/Sdc2tm1b(KOMP)Wtsi
(C57BL/6N-Sdc2tm1b(KOMP)Wtsi/Ieg)
|
increased circulating triglyceride level
|
J:211773
|
Sdhatm2b(KOMP)Wtsi/Sdha+
(C57BL/6N-Sdhatm2b(KOMP)Wtsi/J)
|
increased circulating free fatty acids level
|
J:211773
|
Sec14l2tm1Arai/Sec14l2tm1Arai
(involves: 129S7/SvEvBrd)
|
decreased circulating cholesterol level
|
J:129749
|
decreased circulating VLDL cholesterol level
|
J:129749
|
Sec16btm1a(KOMP)Wtsi/Sec16btm1a(KOMP)Wtsi
(C57BL/6N-Sec16btm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Sec24atm1a(KOMP)Wtsi/Sec24atm1a(KOMP)Wtsi
(B6JTyr;B6N-Sec24atm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating free fatty acids level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Sec24atm1a(KOMP)Wtsi/Sec24atm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating cholesterol level
|
J:213427
|
decreased circulating LDL cholesterol level
|
J:213427
|
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek)
|
increased circulating cholesterol level
|
J:164159
|
increased circulating triglyceride level
|
J:164159
|
Secisbp2lem1(IMPC)J/Secisbp2lem1(IMPC)J
(C57BL/6NJ-Secisbp2lem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Sel1ltm1c(KOMP)Wtsi/Sel1ltm1c(KOMP)Wtsi Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * C57BL/6N * CBA * SJL)
|
steatorrhea
|
J:206568
|
Selenomtm1(KOMP)Vlcg/Selenomtm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
decreased circulating corticosterone level
|
J:203545
|
Senp1tm1Wami/Senp1tm1Wami Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel)
|
decreased circulating cholesterol level
|
J:228009
|
decreased circulating triglyceride level
|
J:228009
|
Serac1em1Bcgen/Serac1em1Bcgen
(C57BL/6N-Serac1em1Bcgen)
|
decreased circulating cholesterol level
|
J:326672
|
increased liver cholesterol level
|
J:326672
|
increased liver triglyceride level
|
J:326672
|
Serf1tm1a(EUCOMM)Hmgu/Serf1tm1a(EUCOMM)Hmgu
(C57BL/6N-Serf1tm1a(EUCOMM)Hmgu/H)
|
increased circulating cholesterol level
|
J:165965
|
increased circulating HDL cholesterol level
|
J:165965
|
Serpina3cem1Smoc/Serpina3cem1Smoc
(C57BL/6-Serpina3cem1Smoc)
|
increased circulating triglyceride level
|
J:343846
|
Serpina6tm1.1Mmp/Serpina6+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
abnormal circulating corticosterone level
|
J:164345
|
Serpina6tm1.1Mmp/Serpina6tm1.1Mmp
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
abnormal circulating corticosterone level
|
J:164345
|
Serpina6tm1Tew/Serpina6tm1Tew
(involves: 129/SvEmcTer * C57BL/6N)
|
abnormal circulating corticosterone level
|
J:112974
|
Serpina12tm1Jwada/Serpina12+
(B6JJcl.129P2-Serpina12tm1Jwada)
|
increased liver triglyceride level
|
J:208508
|
Serpina12tm1Jwada/Serpina12tm1Jwada
(B6JJcl.129P2-Serpina12tm1Jwada)
|
increased circulating cholesterol level
|
J:208508
|
increased circulating LDL cholesterol level
|
J:208508
|
increased liver triglyceride level
|
J:208508
|
Serpinb2tm1b(EUCOMM)Wtsi/Serpinb2tm1b(EUCOMM)Wtsi
(C57BL/6N-Serpinb2tm1b(EUCOMM)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Serpinb5tm1b(KOMP)Wtsi/Serpinb5tm1b(KOMP)Wtsi
(C57BL/6N-Serpinb5tm1b(KOMP)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
Serpinb10em1(IMPC)Mbp/Serpinb10em1(IMPC)Mbp
(C57BL/6NCrl-Serpinb10em1(IMPC)Mbp/Mmucd)
|
decreased circulating triglyceride level
|
J:211773
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
decreased liver triglyceride level
|
J:87982
|
decreased skeletal muscle triglyceride level
|
J:87982
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6 * C57BLKS/J)
|
decreased circulating cholesterol level
|
J:127478
|
Sertad2Gt(OST98734)Lex/Sertad2+
(B6.129S5-Sertad2Gt(OST98734)Lex)
|
decreased circulating cholesterol level
|
J:194928
|
Sertad2Gt(OST98734)Lex/Sertad2Gt(OST98734)Lex
(B6.129S5-Sertad2Gt(OST98734)Lex)
|
decreased circulating cholesterol level
|
J:194928
|
decreased liver triglyceride level
|
J:194928
|
Sesn2Gt(RRJ141)Byg/Sesn2Gt(RRJ141)Byg
(involves: 129P2/OlaHsd)
|
increased liver triglyceride level
|
J:189021
|
Setbp1tm1b(EUCOMM)Wtsi/Setbp1+
(C57BL/6N-Setbp1tm1b(EUCOMM)Wtsi/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
Setd1atm1a(EUCOMM)Wtsi/Setd1a+
(C57BL/6N-Setd1atm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Setmartm1a(EUCOMM)Wtsi/Setmartm1a(EUCOMM)Wtsi
(C57BL/6N-Setmartm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating glycerol level
|
J:165965
|
Sftpa1tm1Kor/Sftpa1tm1Kor
(involves: 129P2/OlaHsd)
|
abnormal phospholipid level
|
J:107841
|
Sftpa1tm1Kor/Sftpa1tm1Kor
(B6.129P2-Sftpa1tm1Kor)
|
abnormal phospholipid level
|
J:130520
|
Sftpa1tm2Haw/Sftpa1tm2Haw Sftpdtm2Haw/Sftpdtm2Haw
(involves: C57BL/6J * CD-1)
|
abnormal phospholipid level
|
J:86022
|
Sgk1tm1.2Palm/Sgk1tm1.2Palm
(129/Sv-Sgk1tm1.2Palm)
|
increased circulating aldosterone level
|
J:148648
|
Sgk1tm1Kuhl/Sgk1tm1Kuhl
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * 129X1/SvJ))
|
increased circulating aldosterone level
|
J:80115
|
Sgms1Gt(E201D11)Wrst/Sgms1Gt(E201D11)Wrst
(B6.129P2-Sgms1Gt(E201D11)Wrst)
|
abnormal ceramide level
|
J:249941
|
abnormal lipid level
|
J:249941
|
abnormal sphingolipid level
|
J:249941
|
abnormal sphingomyelin level
|
J:249941
|
decreased plasmalogen level
|
J:249941
|
decreased unsaturated fatty acids level
|
J:249941
|
Sgms1tm1Jia/Sgms1tm1Jia
(involves: C57BL/6)
|
abnormal ceramide level
|
J:201497
|
abnormal sphingomyelin level
|
J:201497
|
Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129 * C57BL/6)
|
abnormal lipid level
|
J:162192,
J:162226
|
abnormal sphingomyelin level
|
J:162192
|
Sgms2tm1Jia/Sgms2tm1Jia
(Not Specified)
|
abnormal ceramide level
|
J:228568,
J:220024
|
abnormal sphingomyelin level
|
J:228568
|
Sgms2tm1Kenw/Sgms2tm1Kenw
(B6.129S2-Sgms2tm1Kenw)
|
decreased circulating triglyceride level
|
J:175924
|
increased circulating free fatty acids level
|
J:175924
|
Sgo1tm1a(EUCOMM)Wtsi/Sgo1+
(B6JTyr;B6N-Sgo1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
Sgpp1tm1(KOMP)Vlcg/Sgpp1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal ceramide level
|
J:199597
|
Sgpp2tm1Rlp/Sgpp2tm1Rlp
(B6.129S6-Sgpp2tm1Rlp)
|
abnormal ceramide level
|
J:235035
|
Sh3tc1tm1b(EUCOMM)Hmgu/Sh3tc1tm1b(EUCOMM)Hmgu
(C57BL/6N-Sh3tc1tm1b(EUCOMM)Hmgu/Orl)
|
decreased circulating triglyceride level
|
J:211773
|
Shhtm1b(EUCOMM)Wtsi/Shh+
(C57BL/6N-Shhtm1b(EUCOMM)Wtsi/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Shhtm2Amc/Shhtm2.1Amc Tg(Nr5a1-cre)2Klp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased circulating corticosterone level
|
J:168522
|
Shkbp1em1(IMPC)J/Shkbp1em1(IMPC)J
(C57BL/6NJ-Shkbp1em1(IMPC)J/Mmjax)
|
increased circulating HDL cholesterol level
|
J:211773
|
Shld1em1(IMPC)Wtsi/Shld1em1(IMPC)Wtsi
(C57BL/6N-Shld1em1(IMPC)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Sidt2em1(IMPC)Wtsi/Sidt2em1(IMPC)Wtsi
(C57BL/6N-Sidt2em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating glycerol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
Sidt2tm1.1Hzha/Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased circulating triglyceride level
|
J:236042
|
increased liver free fatty acids level
|
J:236042
|
increased liver triglyceride level
|
J:236042
|
Sik1tm1.1(KOMP)Vlcg/Sik1tm1.1(KOMP)Vlcg
(C57BL/6N-Sik1tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
Sik2tm1Lex/Sik2tm1Lex
(involves: 129S/SvEvBrd)
|
increased circulating triglyceride level
|
J:229999
|
Sik3tm1a(EUCOMM)Hmgu/Sik3tm1a(EUCOMM)Hmgu
(C57BL/6N-Sik3tm1a(EUCOMM)Hmgu/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Sik3tm1Htake/Sik3tm1Htake
(involves: C57BL/6JJcl * C57BL/6N)
|
abnormal cholesterol level
|
J:183827
|
decreased circulating cholesterol level
|
J:183827
|
decreased circulating HDL cholesterol level
|
J:183827
|
decreased circulating triglyceride level
|
J:183827
|
decreased circulating VLDL triglyceride level
|
J:183827
|
decreased liver cholesterol level
|
J:183827
|
decreased liver triglyceride level
|
J:183827
|
increased bile salt level
|
J:183827
|
increased circulating triglyceride level
|
J:183827
|
increased liver cholesterol level
|
J:183827
|
Sirt1tm1.2Cxd/Sirt1tm1.2Cxd Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * FVB/N)
|
increased circulating free fatty acids level
|
J:179193
|
increased circulating triglyceride level
|
J:179193
|
increased liver triglyceride level
|
J:179193
|
Sirt2tm1a(EUCOMM)Wtsi/Sirt2tm1a(EUCOMM)Wtsi
(C57BL/6N-Sirt2tm1a(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:165965
|
Sirt3tm1.1Fwa/Sirt3tm1.1Fwa
(involves: 129S6/SvEvTac)
|
increased circulating cholesterol level
|
J:178653
|
increased circulating LDL cholesterol level
|
J:178653
|
increased circulating triglyceride level
|
J:178653
|
increased circulating VLDL cholesterol level
|
J:178653
|
increased liver cholesterol level
|
J:178653
|
increased liver triglyceride level
|
J:178653
|
Sirt6tm1a(EUCOMM)Wtsi/Sirt6+
(C57BL/6N-Sirt6tm1a(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:165965
|
Sirt7tm1Fwa/Sirt7tm1Fwa
(involves: 129S1/Sv)
|
decreased circulating triglyceride level
|
J:205529
|
decreased circulating VLDL triglyceride level
|
J:205529
|
increased liver triglyceride level
|
J:205529
|
Sisem1(IMPC)J/Sisem1(IMPC)J
(C57BL/6NJ-Sisem1(IMPC)J)
|
decreased liver triglyceride level
|
J:344683
|
increased fatty acids level
|
J:344683
|
Ska2tm1b(KOMP)Wtsi/Ska2+
(B6N(Cg)-Ska2tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Sla2em1(IMPC)Ccpcz/Sla2em1(IMPC)Ccpcz
(C57BL/6N-Sla2em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slain2em1(IMPC)J/Slain2+
(C57BL/6NJ-Slain2em1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Slc2a2tm1Thor/Slc2a2tm1Thor
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased fatty acids level
|
J:43839
|
Slc2a4tm1Abel/Slc2a4tm1Abel Tg(Ckmm-cre)5Khn/?
(involves: 129/Sv * C57BL/6)
|
abnormal lipid level
|
J:75418
|
decreased fatty acids level
|
J:75418
|
decreased triglyceride level
|
J:75418
|
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1 * SJL)
|
decreased circulating free fatty acids level
|
J:49328
|
Slc2a8tm1Khm/Slc2a8tm1Khm
(involves: 129X1/SvJ)
|
increased circulating cholesterol level
|
J:189148
|
increased circulating LDL cholesterol level
|
J:189148
|
Slc2a9tm1Khm/Slc2a9tm1Khm Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
abnormal circulating lipid level
|
J:221544
|
increased circulating cholesterol level
|
J:221544
|
increased circulating free fatty acids level
|
J:221544
|
increased circulating triglyceride level
|
J:221544
|
increased liver free fatty acids level
|
J:221544
|
increased liver triglyceride level
|
J:221544
|
Slc3a1pbl/Slc3a1pbl
(C3HeB/FeJ-Slc3a1pbl)
|
increased circulating cholesterol level
|
J:85461
|
increased circulating LDL cholesterol level
|
J:85461
|
Slc3a1pbl/Slc3a1pbl
(involves: C3HeB/FeJ * MRL/MpJ)
|
increased circulating cholesterol level
|
J:85461
|
increased circulating LDL cholesterol level
|
J:85461
|
Slc3a1tm1.1(KOMP)Vlcg/Slc3a1tm1.1(KOMP)Vlcg
(C57BL/6N-Slc3a1tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc4a4tm1.1Slin/Slc4a4tm1.1Slin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating aldosterone level
|
J:186877
|
Slc4a4tm1Ges/Slc4a4tm1Ges
(involves: 129S6/SvEvTac * Black Swiss)
|
increased circulating aldosterone level
|
J:120867
|
Slc4a5tm1.1Boet/Slc4a5tm1.1Boet
(involves: 129 * C57BL/6)
|
decreased circulating aldosterone level
|
J:180608
|
Slc5a2tm1Lex/Slc5a2tm1Lex
(B6.129S5-Slc5a2tm1Lex)
|
decreased circulating aldosterone level
|
J:169917
|
Slc5a5tm1b(KOMP)Wtsi/Slc5a5tm1b(KOMP)Wtsi
(C57BL/6N-Slc5a5tm1b(KOMP)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc5a10tm1Csk/Slc5a10tm1Csk
(C57BL/6-Slc5a10tm1Csk)
|
decreased circulating triglyceride level
|
J:199406
|
increased liver triglyceride level
|
J:199406
|
Slc6a3tm1b(KOMP)Wtsi/Slc6a3+
(C57BL/6N-Slc6a3tm1b(KOMP)Wtsi/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Slc7a2tm1b(EUCOMM)Hmgu/Slc7a2tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc7a2tm1b(EUCOMM)Hmgu/BayMmucd)
|
increased circulating cholesterol level
|
J:211773
|
Slc9a3tm1Ges/Slc9a3tm1Ges
(Not Specified)
|
increased circulating aldosterone level
|
J:70885
|
Slc9a4tm1b(EUCOMM)Wtsi/Slc9a4tm1b(EUCOMM)Wtsi
(C57BL/6N-Slc9a4tm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
Slc9a6tm1Dgen/Y
(B6.129P2-Slc9a6tm1Dgen/J)
|
increased ganglioside level
|
J:241124,
J:229166
|
Slc9a6tm1Dgen/Slc9a6+
(B6.129P2-Slc9a6tm1Dgen/J)
|
increased ganglioside level
|
J:229166
|
Slc9a6tm1Dgen/Slc9a6tm1Dgen
(B6.129P2-Slc9a6tm1Dgen/J)
|
abnormal brain cholesterol level
|
J:241124
|
increased ganglioside level
|
J:241124
|
Slc9a9em1(IMPC)J/Slc9a9em1(IMPC)J
(C57BL/6NJ-Slc9a9em1(IMPC)J/Mmjax)
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc10a1tm1Tac/Slc10a1tm1Tac
(either: B6.Cg-Slc10a1tm1Tac or (involves: 129S/SvEv * C57BL/6J))
|
increased bile salt level
|
J:274149
|
Slc10a2tm1Pda/Slc10a2tm1Pda
(either: (involves: 129P2/OlaHsd * 129S6/SvEv) or (involves: 129P2/OlaHsd * C57BL/6J))
|
abnormal bile salt level
|
J:85312
|
increased circulating cholesterol level
|
J:85312
|
increased feces bile salt level
|
J:85312
|
steatorrhea
|
J:85312
|
Slc10a3em1(IMPC)J/Y
(C57BL/6NJ-Slc10a3em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc10a3em1(IMPC)J/Slc10a3em1(IMPC)J
(C57BL/6NJ-Slc10a3em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Slc10a6tm1Jmge/Slc10a6tm1Jmge
(B6N.129S5-Slc10a6tm1Jmge)
|
increased circulating cholesterol level
|
J:301761
|
Slc13a1tm1Mark/Slc13a1+
(involves: 129T2/SvEms * C57BL/6J)
|
increased bile salt level
|
J:86561
|
Slc13a1tm1Mark/Slc13a1tm1Mark
(involves: 129T2/SvEms * C57BL/6J)
|
increased bile salt level
|
J:86561
|
Slc13a5tm1.2Helf/Slc13a5tm1.2Helf
(B6.Cg-Slc13a5tm1.2Helf)
|
abnormal glycerol level
|
J:176732
|
decreased liver triglyceride level
|
J:176732
|
Slc16a1tm2.1Lupel/Slc16a1+
(B6.129P2-Slc16a1tm2.1Lupel)
|
decreased circulating triglyceride level
|
J:205481
|
Slc16a2tm1.1Sref/Y
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased circulating cholesterol level
|
J:113732
|
Slc16a2tm1a(KOMP)Wtsi/Y
(B6JTyr;B6N-Slc16a2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Slc16a2tm1a(KOMP)Wtsi/Slc16a2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Slc16a2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Slc18a2tm1Mca/Slc18a2+
(B6.129X1-Slc18a2tm1Mca)
|
abnormal corticosterone level
|
J:125273
|
Slc20a1tm1Lbek/Slc20a1tm1Lbek
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal fatty acids level
|
J:157997
|
Slc22a18tm1Tgot/Slc22a18tm1Tgot
(B6.Cg-Slc22a18tm1Tgot)
|
decreased liver triglyceride level
|
J:349247
|
Slc23a2tm1Nbm/Slc23a2tm1Nbm
(129S6/SvEvTac-Slc23a2tm1Nbm)
|
decreased circulating corticosterone level
|
J:85988
|
Slc24a4tm1b(KOMP)Wtsi/Slc24a4+
(C57BL/6N-Slc24a4tm1b(KOMP)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc25a13tm1Lct/Slc25a13tm1Lct
(B6.129-Slc25a13tm1Lct)
|
increased liver triglyceride level
|
J:124766
|
Slc25a21tm1a(KOMP)Wtsi/Slc25a21tm1a(KOMP)Wtsi
(B6JTyr;B6N-Slc25a21tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
Slc25a24tm1Sinos/Slc25a24tm1Sinos
(B6(Cg)-Slc25a24tm1Sinos)
|
decreased liver triglyceride level
|
J:312208
|
Slc25a34em1Duna/Slc25a34em1Duna
(C57BL/6J-Slc25a34em1Duna)
|
decreased cholesterol level
|
J:344152
|
decreased triglyceride level
|
J:344152
|
Slc25a48em1(IMPC)J/Slc25a48em1(IMPC)J
(involves: C57BL/6J * C57BL/6NJ)
|
abnormal glycerophosphocholine level
|
J:353858
|
abnormal phospholipid level
|
J:353858
|
increased ceramide level
|
J:353858
|
Slc26a3tm1Sole/Slc26a3tm1Sole
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating aldosterone level
|
J:117587
|
Slc27a1tm1Jkk/Slc27a1tm1Jkk
(involves: 129S/SvEv * C57BL/6J)
|
abnormal fatty acids level
|
J:88657
|
abnormal lipid level
|
J:88657
|
abnormal skeletal muscle triglyceride level
|
J:88657
|
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129/Sv * C57BL/6)
|
abnormal lipid level
|
J:124917
|
decreased circulating cholesterol level
|
J:124917
|
decreased circulating free fatty acids level
|
J:124917
|
decreased circulating triglyceride level
|
J:124917
|
decreased fatty acids level
|
J:124917
|
decreased liver cholesterol level
|
J:124917
|
decreased liver triglyceride level
|
J:124917
|
decreased saturated fatty acids level
|
J:124917
|
decreased unsaturated fatty acids level
|
J:124917
|
Slc27a5tm1Asta/Slc27a5tm1Asta
(involves: 129)
|
abnormal lipid level
|
J:124916
|
Slc28a1em1Govr/Slc28a1em1Govr
(C57BL/6NTac-Slc28a1em1Govr)
|
increased circulating cholesterol level
|
J:336148
|
Slc29a3em1(IMPC)Wtsi/Slc29a3em1(IMPC)Wtsi
(C57BL/6N-Slc29a3em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Slc34a1tm1Hten/Slc34a1tm1Hten
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal vitamin D level
|
J:47637
|
Slc34a1tm1Hten/Slc34a1tm1Hten
(B6.129S2-Slc34a1tm1Hten/J)
|
abnormal vitamin D level
|
J:152195
|
Slc34a1tm1Hten/Slc34a1tm1Hten Slc34a3tm1Kimi/Slc34a3tm1Kimi
(B6.129-Slc34a3tm1Kimi Slc34a1tm1Hten)
|
abnormal vitamin D level
|
J:152195
|
Slc34a2tm1Sega/Slc34a2+
(involves: 129S6/SvEvTac * C57BL/6JJcl)
|
abnormal vitamin D level
|
J:179947
|
Slc34a3tm1Kimi/Slc34a3tm1Kimi
(B6.129-Slc34a3tm1Kimi)
|
abnormal vitamin D level
|
J:152521
|
Slc35f6tm1a(EUCOMM)Wtsi/Slc35f6tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
hyperlipidemia
|
J:86005
|
increased circulating cholesterol level
|
J:86005
|
increased circulating triglyceride level
|
J:86005
|
Slc38a2tm1a(KOMP)Wtsi/Slc38a2+
(C57BL/6N-Slc38a2tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Slc38a10tm2a(EUCOMM)Wtsi/Slc38a10tm2a(EUCOMM)Wtsi
(C57BL/6N-Slc38a10tm2a(EUCOMM)Wtsi/H)
|
increased circulating triglyceride level
|
J:165965
|
Slc39a8tm1b(EUCOMM)Wtsi/Slc39a8+
(C57BL/6N-Slc39a8tm1b(EUCOMM)Wtsi/Cnrm)
|
increased circulating triglyceride level
|
J:211773
|
Slc40a1tm1b(EUCOMM)Hmgu/Slc40a1+
(C57BL/6N-Slc40a1tm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Slc43a2Gt(258C1)Cmhd/Slc43a2Gt(258C1)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased fatty acids level
|
J:237439
|
Slc46a3tm1.1(KOMP)Vlcg/Slc46a3tm1.1(KOMP)Vlcg
(C57BL/6N-Slc46a3tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Slc51atm1Pda/Slc51atm1Pda
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal bile salt level
|
J:132778
|
abnormal cholesterol level
|
J:132778
|
decreased circulating cholesterol level
|
J:132778
|
decreased circulating triglyceride level
|
J:132778
|
increased feces cholesterol level
|
J:132778
|
Slc52a3tm2a(KOMP)Wtsi/Slc52a3tm2a(KOMP)Wtsi
(involves: C57BL/6N)
|
hyperlipidemia
|
J:236029
|
Slco1b2tm1Cdk/Slco1b2tm1Cdk
(B6.129S1-Slco1b2tm1Cdk)
|
increased circulating cholesterol level
|
J:133919
|
Slco2a1tm1.2Vsch/Slco2a1tm1.2Vsch
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal prostaglandin level
|
J:168442
|
Slco3a1em1Smoc/Slco3a1em1Smoc
(C57BL/6JSmoc-Slco3a1em1Smoc/Smoc)
|
increased bile salt level
|
J:279167
|
Slntm1Peri/Slntm1Peri
(involves: C57BL/6J)
|
increased circulating cholesterol level
|
J:193427
|
increased circulating triglyceride level
|
J:193427
|
Slurp1tm1Lex/Slurp1tm1Lex
(Not Specified)
|
decreased circulating cholesterol level
|
J:210836
|
decreased circulating triglyceride level
|
J:210836
|
Slurp2tm1Lex/Slurp2tm1Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:231067
|
Smarcd1tm1.1Jddl/Smarcd1tm1.1Jddl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
decreased bile salt level
|
J:228944
|
decreased circulating cholesterol level
|
J:228944
|
decreased circulating HDL cholesterol level
|
J:228944
|
decreased circulating LDL cholesterol level
|
J:228944
|
decreased circulating VLDL cholesterol level
|
J:228944
|
increased cholesterol level
|
J:228944
|
increased feces cholesterol level
|
J:228944
|
increased liver cholesterol level
|
J:228944
|
Smc5tm1b(KOMP)Wtsi/Smc5+
(C57BL/6N-Smc5tm1b(KOMP)Wtsi/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Smc6tm1.1Arln/Smc6tm1.1Arln
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased circulating HDL cholesterol level
|
J:220422
|
Smpd1tm1Esc/Smpd1tm1Esc
(involves: 129S1/Sv * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:26732
|
Smpd1tm1Esc/Smpd1tm1Esc
(involves: 129S1/Sv)
|
abnormal ceramide level
|
J:199833
|
Smpd3fro/Smpd3fro
(involves: C3H/HeN * C57BL/6N)
|
abnormal lipid level
|
J:193949
|
Smpd3tm1Wst/Smpd3tm1Wst
(involves: 129S1/Sv)
|
decreased circulating cortisol level
|
J:97284
|
Smyd2tm1a(KOMP)Wtsi/Smyd2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Smyd2tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:175295
|
increased circulating LDL cholesterol level
|
J:175295
|
Snap25tm1.1Bark/Snap25tm1.1Bark
(Not Specified)
|
increased circulating cholesterol level
|
J:226064
|
increased circulating triglyceride level
|
J:226064
|
Snf8tm1a(EUCOMM)Wtsi/Snf8+
(C57BL/6N-Snf8tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating free fatty acids level
|
J:165965
|
Snorctm1Lex/Snorctm1Lex
(B6;129S5-Snorctm1Lex/Mmucd)
|
decreased circulating triglyceride level
|
J:171883
|
Snrktm1.1Hxu/Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Snrktm1.1Hxu Tg(Adipoq-cre)1Evdr)
|
increased circulating free fatty acids level
|
J:257980
|
increased circulating triglyceride level
|
J:257980
|
Snrktm1Hxu/Snrk+
(C57BL/6-Snrktm1Hxu)
|
decreased triglyceride level
|
J:257980
|
Snrktm1Rra/Snrktm1Rra
(involves: C57BL/6J)
|
abnormal lipid level
|
J:218247
|
decreased circulating free fatty acids level
|
J:218247
|
decreased circulating triglyceride level
|
J:218247
|
increased circulating cholesterol level
|
J:218247
|
Snrktm2Rra/Snrktm2Rra Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * FVB/N)
|
abnormal lipid level
|
J:218247
|
Snx5tm1a(KOMP)Wtsi/Snx5tm1a(KOMP)Wtsi
(B6JTyr;B6N-Snx5tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Snx6em1(IMPC)J/Snx6em1(IMPC)J
(C57BL/6NJ-Snx6em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Snx8tm2a(EUCOMM)Hmgu/Snx8tm2a(EUCOMM)Hmgu
(C57BL/6N-Snx8tm2a(EUCOMM)Hmgu/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Snx10em1Ael/Snx10em1Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd)
|
decreased vitamin D level
|
J:289051
|
Snx10em2Ael/Snx10em2Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd)
|
decreased vitamin D level
|
J:289051
|
Snx10tm1a(EUCOMM)Raba/Snx10tm1a(EUCOMM)Raba
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
decreased vitamin D level
|
J:224711
|
Snx12em1(IMPC)J/Y
(C57BL/6NJ-Snx12em1(IMPC)J/Mmjax)
|
decreased circulating triglyceride level
|
J:211773
|
Snx13tm1b(EUCOMM)Hmgu/Snx13+
(C57BL/6N-Snx13tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating triglyceride level
|
J:211773
|
Snx15tm1.1(KOMP)Vlcg/Snx15tm1.1(KOMP)Vlcg
(C57BL/6N-Snx15tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * C57BL/6)
|
abnormal lipid level
|
J:37049
|
increased circulating cholesterol level
|
J:37049
|
increased circulating HDL cholesterol level
|
J:37049
|
Soat1tm1Ishi/Soat1tm1Ishi Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:63468
|
Soat1tm1Ishi/Soat1tm1Ishi Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:63468
|
Soat2tm1.1Llr/Soat2tm1.1Llr Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:184908
|
decreased circulating LDL cholesterol level
|
J:184908
|
decreased circulating VLDL cholesterol level
|
J:184908
|
decreased liver cholesterol level
|
J:184908
|
decreased liver triglyceride level
|
J:184908
|
increased circulating triglyceride level
|
J:184908
|
Soat2tm1.1Llr/Soat2tm1.1Llr Tg(Vil1-cre)997Gum/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * SJL)
|
decreased cholesterol level
|
J:184908
|
decreased circulating cholesterol level
|
J:184908
|
decreased circulating VLDL cholesterol level
|
J:184908
|
decreased liver cholesterol level
|
J:184908
|
decreased liver triglyceride level
|
J:184908
|
increased cholesterol level
|
J:184908
|
increased circulating triglyceride level
|
J:184908
|
Soat2tm1Far/Soat2tm1Far
(involves: 129S4/SvJae * C57BL/6J)
|
decreased circulating cholesterol level
|
J:82032
|
decreased circulating LDL cholesterol level
|
J:82032
|
decreased circulating VLDL cholesterol level
|
J:82032
|
increased circulating HDL cholesterol level
|
J:82032
|
increased circulating triglyceride level
|
J:82032
|
Socs2tm1Wehi/Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J)
|
decreased liver triglyceride level
|
J:186227
|
increased skeletal muscle triglyceride level
|
J:186227
|
Socs3tm1Ayos/Socs3tm1Ayos Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6)
|
decreased circulating free fatty acids level
|
J:91796
|
decreased circulating triglyceride level
|
J:91796
|
Socs3tm1Ayos/Socs3tm1Ayos Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6)
|
decreased circulating free fatty acids level
|
J:91796
|
decreased circulating triglyceride level
|
J:91796
|
Sorbs1tm1Krc/Sorbs1tm1Krc
(B6.129-Sorbs1tm1Krc)
|
decreased triglyceride level
|
J:121762
|
Sorbs2tm1.1(KOMP)Mbp/Sorbs2tm1.1(KOMP)Mbp
(C57BL/6N-Sorbs2tm1.1(KOMP)Mbp/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating free fatty acids level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Sox17SHIVA/Sox17+
(either: C57BL/6-Sox17SHIVA or (involves: C57BL/6 * C3H/HeN))
|
decreased circulating HDL cholesterol level
|
J:219119
|
decreased liver triglyceride level
|
J:219119
|
Sox17tm1Ysk/Sox17+
(B6.129S1-Sox17tm1Ysk)
|
increased bile salt level
|
J:194071
|
Sox21em1(IMPC)Mbp/Sox21em1(IMPC)Mbp
(C57BL/6NCrl-Sox21em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Sparttm1.1Xen/Sparttm1.1Xen
(involves: C57BL/6J)
|
decreased circulating triglyceride level
|
J:185987
|
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(CAG-cat,-Creg1)#Yal/0
(involves: C57BL/6J * DBA)
|
decreased liver cholesterol level
|
J:263073
|
decreased liver free fatty acids level
|
J:263073
|
decreased liver triglyceride level
|
J:263073
|
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(CAG-Dusp26)#Jhxia/0
(involves: C57BL/6 * DBA)
|
decreased liver cholesterol level
|
J:279111
|
decreased liver free fatty acids level
|
J:279111
|
decreased liver triglyceride level
|
J:279111
|
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Trmutm1Tomik/Trmutm1Tomik
(involves: C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:235644
|
decreased circulating HDL cholesterol level
|
J:235644
|
Spns2tm1Tni/Spns2tm1Tni
(B6.Cg-Spns2tm1Tni)
|
decreased sphingosine level
|
J:225108
|
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating triglyceride level
|
J:127389
|
Spryd3tm1b(EUCOMM)Hmgu/Spryd3tm1b(EUCOMM)Hmgu
(C57BL/6N-Spryd3tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Sptbn1tm1a(EUCOMM)Wtsi/Sptbn1+
(B6JTyr;B6N-Sptbn1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
Sptlc1tm1Jia/Sptlc1+
(B6.Cg-Sptlc1tm1Jia)
|
abnormal circulating lipid level
|
J:140627
|
abnormal lipid level
|
J:140627
|
Sptlc2tm1Jia/Sptlc2+
(B6.Cg-Sptlc2tm1Jia)
|
abnormal circulating lipid level
|
J:140627
|
abnormal lipid level
|
J:140627
|
Sptlc2tm1Yhir/Sptlc2tm1Yhir Tg(KRT5-cre)1Tak/0
(involves: C3H * C57BL/6)
|
abnormal ceramide level
|
J:202388
|
Sptlc2tm2.1Jia/Sptlc2tm2.1Jia
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal sphingomyelin level
|
J:155507
|
increased circulating cholesterol level
|
J:155507
|
increased circulating HDL cholesterol level
|
J:155507
|
increased circulating phospholipid level
|
J:155507
|
Sqstm1em1Kmts/Sqstm1+
(involves: C57BL/6N)
|
increased circulating cholesterol level
|
J:342766
|
Sra1tm1a(EUCOMM)Hmgu/Sra1tm1a(EUCOMM)Hmgu
(involves: C57BL/6J * C57BL/6N)
|
decreased liver free fatty acids level
|
J:214131
|
decreased liver triglyceride level
|
J:214131
|
Srebf1Gt(XC354)Byg/Srebf1Gt(XC354)Byg
(either: B6.129P2-Srebf1Gt(XC354)Byg or (involves: 129P2/OlaHsd * C57BL/6))
|
decreased liver triglyceride level
|
J:152612
|
Srebf1tm1Jdh/Srebf1tm1Jdh
(involves: 129S/SvEvBrd * C57BL/6)
|
increased liver cholesterol level
|
J:43570
|
Srebf1tm1Mbr/Srebf1tm1Mbr
(involves: 129S6/SvEvTac)
|
decreased circulating cholesterol level
|
J:75320
|
decreased circulating triglyceride level
|
J:75320
|
increased liver cholesterol level
|
J:75320
|
Srebf1tm1Mbr/Srebf1tm1Mbr
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal triglyceride level
|
J:101307
|
decreased circulating cholesterol level
|
J:101307
|
decreased circulating triglyceride level
|
J:101307
|
Srebf1tm2Jdh/Srebf1tm2Jdh
(involves: 129S/SvEvBrd * C57BL/6)
|
decreased circulating cholesterol level
|
J:43570
|
decreased circulating triglyceride level
|
J:43570
|
increased liver cholesterol level
|
J:43570
|
Srebf2lop13/Srebf2lop13
(STOCK Srebf2lop13/J)
|
decreased brain cholesterol level
|
J:176249
|
decreased cholesterol level
|
J:176249
|
decreased liver cholesterol level
|
J:176249
|
Srebf2tm1Jdh/Srebf2tm1Jdh Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:241873
|
decreased circulating triglyceride level
|
J:241873
|
decreased liver cholesterol level
|
J:241873
|
decreased liver triglyceride level
|
J:241873
|
Srsf3tm1Pjln/Srsf3tm1Pjln Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/c * C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:205756
|
decreased circulating HDL cholesterol level
|
J:205756
|
decreased circulating triglyceride level
|
J:205756
|
decreased liver cholesterol level
|
J:205756
|
decreased liver triglyceride level
|
J:205756
|
Srxn1tm1Sgrh/Srxn1tm1Sgrh Tg(Cyp11a1-cre)16Mchu/?
(involves: C57BL/6J)
|
abnormal circulating corticosterone level
|
J:222986
|
Ssttm1Ute/Ssttm1Ute
(129-Ssttm1Ute/J)
|
increased circulating corticosterone level
|
J:70426
|
Sstr1tm1Dgen/Sstr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:101679
|
increased circulating HDL cholesterol level
|
J:101679
|
St3gal5tm1Skoz/St3gal5tm1Skoz
(Not Specified)
|
abnormal glycosphingolipid level
|
J:229230
|
St18tm1a(KOMP)Wtsi/St18tm1a(KOMP)Wtsi
(C57BL/6N-St18tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
Stag1em1(IMPC)Mbp/Stag1+
(C57BL/6N-Stag1em1(IMPC)Mbp/MbpMmucd)
|
increased circulating triglyceride level
|
J:211773
|
Startm1Klp/Startm1Klp
(involves: 129P2/OlaHsd)
|
decreased circulating aldosterone level
|
J:43589
|
decreased circulating corticosterone level
|
J:43589
|
Stard3tm1Jfs/Stard3tm1Jfs
(involves: 129X1/SvJ * C57BL/6J)
|
increased liver cholesterol level
|
J:89362
|
Stard4tm1.2Bres/Stard4tm1.2Bres
(involves: BALB/cJ * C57BL/6 * C57BL/6J * SJL)
|
decreased circulating cholesterol level
|
J:160807
|
decreased circulating LDL cholesterol level
|
J:160807
|
Stard10tm1Saaa/Stard10tm1Saaa
(B6.Cg-Stard10tm1Saaa)
|
abnormal phospholipid level
|
J:198860
|
decreased circulating cholesterol level
|
J:198860
|
decreased circulating free fatty acids level
|
J:198860
|
decreased circulating triglyceride level
|
J:198860
|
decreased liver cholesterol level
|
J:198860
|
decreased liver triglyceride level
|
J:198860
|
increased bile salt level
|
J:198860
|
Stat3tm1Flv/Stat3tm1Flv Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
increased circulating corticosterone level
|
J:89242
|
increased circulating triglyceride level
|
J:89242
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
|
increased circulating triglyceride level
|
J:119237
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased circulating free fatty acids level
|
J:127051
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Nes-cre)1Kln/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL)
|
increased circulating free fatty acids level
|
J:132806
|
increased circulating triglyceride level
|
J:132806
|
Stat5btm1Mam/Stat5btm1Mam Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
increased circulating free fatty acids level
|
J:127051
|
Stat5btm1Mam/Stat5btm1Mam Tg(Nes-cre)1Kln/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL)
|
increased circulating free fatty acids level
|
J:132806
|
increased circulating triglyceride level
|
J:132806
|
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru)
|
decreased fatty acids level
|
J:178294
|
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd)
|
abnormal circulating cholesterol level
|
J:187736
|
increased circulating triglyceride level
|
J:187736
|
increased liver triglyceride level
|
J:187736
|
Stk39tm1.2Slin/Stk39tm1.2Slin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating aldosterone level
|
J:165706
|
Strntm1a(KOMP)Wtsi/Strn+
(C57BL/6N-Strntm1a(KOMP)Wtsi)
|
increased circulating aldosterone level
|
J:232621
|
Stt3bem1(IMPC)J/Stt3b+
(C57BL/6NJ-Stt3bem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Stx2tm1b(EUCOMM)Wtsi/Stx2tm1b(EUCOMM)Wtsi
(C57BL/6N-Stx2tm1b(EUCOMM)Wtsi/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Stx6em1(IMPC)H/Stx6em1(IMPC)H
(C57BL/6NTac-Stx6em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
Sult2b1tm1Rus/Sult2b1tm1Rus
(B6;129-Sult2b1tm1Rus/J)
|
abnormal cholesterol level
|
J:186536
|
Surf4em1Bcgen/Surf4+
(C57BL/6J-Surf4em1Bcgen)
|
decreased circulating cholesterol level
|
J:302969
|
decreased circulating triglyceride level
|
J:302969
|
Surf4em1Bcgen/Surf4em1Bcgen
(C57BL/6J-Surf4em1Bcgen)
|
decreased circulating cholesterol level
|
J:302969
|
decreased circulating triglyceride level
|
J:302969
|
increased liver cholesterol level
|
J:302969
|
Susd6tm1b(KOMP)Wtsi/Susd6tm1b(KOMP)Wtsi
(C57BL/6N-Susd6tm1b(KOMP)Wtsi/Bay)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Syce1ltm1.1(KOMP)Vlcg/Syce1ltm1.1(KOMP)Vlcg
(C57BL/6N-Syce1ltm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Syne3tm1b(KOMP)Wtsi/Syne3tm1b(KOMP)Wtsi
(C57BL/6N-Syne3tm1b(KOMP)Wtsi/Ucd)
|
increased circulating triglyceride level
|
J:211773
|
Taco1em1(IMPC)J/Taco1em1(IMPC)J
(C57BL/6NJ-Taco1em1(IMPC)J/Mmjax)
|
decreased circulating triglyceride level
|
J:211773
|
Tacr1tm1Rhn/Tacr1tm1Rhn
(129S/SvEv-Tacr1tm1Rhn)
|
decreased circulating corticosterone level
|
J:77640
|
Taf2tm1b(EUCOMM)Hmgu/Taf2+
(C57BL/6N-Taf2tm1b(EUCOMM)Hmgu/Ics)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Tafazzinem1Xfa/Y Tg(myl7.L-cre)1118Tmhn/0
(involves: C57BL/6NCrl * MF1)
|
abnormal phospholipid level
|
J:339058
|
Tagap1em1(IMPC)Tcp/Tagap1em1(IMPC)Tcp
(C57BL/6N-Tagap1em1(IMPC)Tcp/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Tars3em1(IMPC)J/Tars3em1(IMPC)J
(C57BL/6NJ-Tars3em1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
Tars3em1Smoc/Tars3em1Smoc
(C57BL/6-Tars3em1Smoc)
|
decreased circulating cholesterol level
|
J:341137
|
decreased circulating HDL cholesterol level
|
J:341137
|
decreased circulating LDL cholesterol level
|
J:341137
|
decreased circulating triglyceride level
|
J:341137
|
Tbc1d4tm1.2Arte/Tbc1d4tm1.2Arte
(involves: C57BL/6 * CBA)
|
increased circulating free fatty acids level
|
J:194026
|
Tbc1d5em1(IMPC)J/Tbc1d5em1(IMPC)J
(C57BL/6NJ-Tbc1d5em1(IMPC)J/J)
|
increased circulating cholesterol level
|
J:211773
|
Tbc1d9bem1(IMPC)J/Tbc1d9bem1(IMPC)J
(C57BL/6NJ-Tbc1d9bem1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Tbc1d10atm2a(EUCOMM)Wtsi/Tbc1d10atm2a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased circulating LDL cholesterol level
|
J:213427
|
Tbc1d22atm1b(KOMP)Wtsi/Tbc1d22atm1b(KOMP)Wtsi
(C57BL/6N-Tbc1d22atm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating triglyceride level
|
J:211773
|
increased circulating free fatty acids level
|
J:211773
|
Tbl1xr1tm1.1Arte/Tbl1xr1tm1.1Arte Tg(Fabp4-cre)1Rev/0
(involves: C57BL/6)
|
increased liver triglyceride level
|
J:198124
|
increased skeletal muscle triglyceride level
|
J:198124
|
Tbl1xr1tm1b(EUCOMM)Hmgu/Tbl1xr1+
(C57BL/6N-Tbl1xr1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Tbx19tm1Jdr/Tbx19tm1Jdr
(either: (involves: 129/Sv) or (involves: BALB/c))
|
decreased circulating corticosterone level
|
J:82562
|
Tbx22tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Tbx22tm1.1(KOMP)Vlcg/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Tbxa2rtm1Cof/Tbxa2rtm1Cof
(C.129P2(B6)-Tbxa2rtm1Cof)
|
abnormal thromboxane level
|
J:79049
|
Tcaimtm1b(EUCOMM)Wtsi/Tcaimtm1b(EUCOMM)Wtsi
(C57BL/6N-Tcaimtm1b(EUCOMM)Wtsi/H)
|
increased circulating cholesterol level
|
J:211773
|
Tchol1BALB/c/Tchol1KK/Ta
(involves: BALB/c * KK/Ta)
|
increased circulating cholesterol level
|
J:88209
|
Tchol1KK/Ta/Tchol1KK/Ta
(involves: BALB/c * KK/Ta)
|
increased circulating cholesterol level
|
J:88209
|
Tchptm1a(EUCOMM)Wtsi/Tchptm1a(EUCOMM)Wtsi
(C57BL/6N-Tchptm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Tchptm1Inag/Tchptm1Inag
(B6.129P2-Tchptm1Inag)
|
decreased circulating cholesterol level
|
J:304307
|
decreased circulating triglyceride level
|
J:304307
|
Tcirg1tm1Ypl/Tcirg1tm1Ypl
(involves: 129S4/SvJae * C57BL/6J)
|
decreased vitamin D level
|
J:224711
|
Tcq1CAST/EiJ/Tcq1CAST/EiJ
(involves: C57BL/6J * CAST/EiJ)
|
decreased circulating cholesterol level
|
J:117545
|
Tcq2CAST/EiJ/Tcq2CAST/EiJ
(involves: C57BL/6J * CAST/EiJ)
|
decreased circulating cholesterol level
|
J:117545
|
Tecrem1(IMPC)Rbrc/Tecr+
(C57BL/6NJcl-Tecrem1(IMPC)Rbrc/Rbrc)
|
increased circulating LDL cholesterol level
|
J:211773
|
Terf2iptm1.2Tdl/Terf2iptm1.2Tdl
(involves: C57BL/6J * FVB/N)
|
increased cholesterol level
|
J:199372
|
Tex261tm1b(EUCOMM)Wtsi/Tex261tm1b(EUCOMM)Wtsi
(C57BL/6N-Tex261tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
Tfectm1b(KOMP)Wtsi/Tfectm1b(KOMP)Wtsi
(C57BL/6N-Tfectm1b(KOMP)Wtsi/Ucd)
|
increased circulating cholesterol level
|
J:211773
|
Tg(Abcg1)80-90Ssf/?
(C57BL/6-Tg(Abcg1)80-90Ssf)
|
abnormal phospholipid level
|
J:94077
|
increased liver cholesterol level
|
J:94077
|
Tg(Abcg1)123Ssf/?
(C57BL/6-Tg(Abcg1)123Ssf)
|
abnormal phospholipid level
|
J:94077
|
increased liver cholesterol level
|
J:94077
|
Tg(ABCG5/ABCG8)14-2Hobb/0
(involves: C57BL/6J * SJL)
|
abnormal feces lipid level
|
J:78963,
J:100491
|
decreased circulating cholesterol level
|
J:78963
|
decreased circulating HDL cholesterol level
|
J:78963
|
decreased circulating phytosterol level
|
J:78963,
J:100491
|
increased cholesterol level
|
J:78963
|
steatorrhea
|
J:78963
|
Tg(Adipoq-LPL)1Fnln/?
(B6.Cg-Tg(Adipoq-LPL)1Fnln)
|
decreased circulating cholesterol level
|
J:226970
|
decreased circulating HDL cholesterol level
|
J:226970
|
decreased circulating LDL cholesterol level
|
J:226970
|
decreased liver triglyceride level
|
J:226970
|
increased liver triglyceride level
|
J:226970
|
Tg(ALB-cre,CMV-rtTA)#Wcyy/0 Tg(CMV-EGFP,Rnu6-siAbca1)#Wcyy/0
(involves: ICR)
|
decreased circulating cholesterol level
|
J:93624
|
Tg(Alb-MYLIP*)1Pton/?
(involves: C57BL/6J)
|
decreased circulating triglyceride level
|
J:228420
|
increased circulating cholesterol level
|
J:228420
|
increased circulating LDL cholesterol level
|
J:228420
|
increased circulating triglyceride level
|
J:228420
|
Tg(Alb-Nos2)1Mkan/?
(FVB-Tg(Alb-Nos2)1Mkan)
|
increased circulating triglyceride level
|
J:177591
|
increased circulating VLDL triglyceride level
|
J:177591
|
increased liver triglyceride level
|
J:177591
|
increased triglyceride level
|
J:177591
|
Tg(Alb-SREBF1_ic)#Jkot/0
(involves: C57BL/6)
|
abnormal ceramide level
|
J:249664
|
decreased saturated fatty acids level
|
J:185313
|
decreased unsaturated fatty acids level
|
J:185313
|
increased circulating free fatty acids level
|
J:185313
|
increased fatty acids level
|
J:185313
|
increased triglyceride level
|
J:185313
|
increased unsaturated fatty acids level
|
J:185313
|
Tg(AlbLCAT)1Jdm/0
(involves: FVB/N)
|
decreased circulating triglyceride level
|
J:121992
|
increased circulating cholesterol level
|
J:121992
|
increased circulating HDL cholesterol level
|
J:121992
|
Tg(AlbLCAT)1Jdm/0 Tg(APOA1)1Rub/0
(involves: C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:121992
|
increased circulating HDL cholesterol level
|
J:121992
|
increased circulating LDL cholesterol level
|
J:121992
|
increased circulating VLDL cholesterol level
|
J:121992
|
Tg(AlbLCAT)1Jdm/0 Tg(APOA1)1Rub/0 Tg(APOA2)3Rub/0
(involves: C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:121992
|
increased circulating HDL cholesterol level
|
J:121992
|
Tg(AlbLCAT)1Jdm/0 Tg(APOA2)3Rub/0
(involves: C57BL/6 * FVB/N)
|
decreased circulating cholesterol level
|
J:121992
|
decreased circulating HDL cholesterol level
|
J:121992
|
Tg(aP2-SREBF1c)9884Reh/0
(involves: C57BL/6J * SJL)
|
abnormal lipid level
|
J:249664
|
decreased ceramide level
|
J:249664
|
increased ceramide level
|
J:249664
|
increased circulating cholesterol level
|
J:50770
|
increased circulating triglyceride level
|
J:50770
|
increased liver triglyceride level
|
J:50770
|
increased unsaturated fatty acids level
|
J:249664
|
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6 * DBA/2)
|
abnormal lipid level
|
J:57075
|
decreased circulating triglyceride level
|
J:57075
|
decreased liver triglyceride level
|
J:57075
|
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6J * FVB/N)
|
abnormal lipid level
|
J:69591
|
decreased circulating free fatty acids level
|
J:69591
|
decreased circulating triglyceride level
|
J:69591
|
Tg(APOA1)1Rub/0
(involves: C57BL/6)
|
decreased circulating triglyceride level
|
J:121992
|
Tg(APOA1)1Rub/0 Tg(APOA2)3Rub/0
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:121992
|
decreased circulating HDL cholesterol level
|
J:121992
|
increased circulating cholesterol level
|
J:129136
|
increased circulating HDL cholesterol level
|
J:129136
|
increased circulating triglyceride level
|
J:129136
|
Tg(APOA1)1Rub/Tg(APOA1)1Rub
(C57BL/6-Tg(APOA1)1Rub/J)
|
abnormal circulating HDL cholesterol level
|
J:190966
|
abnormal lipid level
|
J:42425
|
increased circulating cholesterol level
|
J:42425
|
increased circulating HDL cholesterol level
|
J:42425
|
Tg(Apoa2)1Lus/?
(involves: C57BL/6J * DBA/2)
|
increased circulating cholesterol level
|
J:92454,
J:127063
|
increased circulating HDL cholesterol level
|
J:92454,
J:127063
|
increased circulating LDL cholesterol level
|
J:92454
|
increased circulating triglyceride level
|
J:92454
|
increased circulating VLDL cholesterol level
|
J:92454
|
Tg(APOA2)3Rub/0
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:121992
|
decreased circulating HDL cholesterol level
|
J:121992
|
decreased circulating triglyceride level
|
J:121992
|
Tg(APOA5)1Hgc/0
(FVB/N-Tg(APOA5)1Hgc)
|
decreased circulating triglyceride level
|
J:72092
|
decreased circulating VLDL cholesterol level
|
J:72092
|
Tg(APOB)11Rub/?
(involves: FVB)
|
increased circulating cholesterol level
|
J:78212
|
increased circulating LDL cholesterol level
|
J:78212
|
Tg(APOB)11Rub/0 Tg(UcpDta)1Kz/0
(involves: C57BL/6J * FVB/N)
|
decreased circulating HDL cholesterol level
|
J:73122
|
increased circulating cholesterol level
|
J:73122
|
increased circulating LDL cholesterol level
|
J:73122
|
increased circulating triglyceride level
|
J:73122
|
Tg(APOC1)1Bres/Tg(APOC1)1Bres
(involves: C57BL/6J * CBA/J)
|
hyperlipidemia
|
J:80950
|
increased circulating cholesterol level
|
J:80950
|
increased circulating LDL cholesterol level
|
J:80950
|
increased circulating triglyceride level
|
J:80950
|
increased circulating VLDL cholesterol level
|
J:80950
|
increased circulating VLDL triglyceride level
|
J:80950
|
Tg(APOC1)1Lmh/0
(C57BL/6-Tg(APOC1)1Lmh)
|
increased circulating cholesterol level
|
J:65036
|
increased circulating free fatty acids level
|
J:65036
|
increased circulating triglyceride level
|
J:65036
|
increased circulating VLDL cholesterol level
|
J:65036
|
increased circulating VLDL triglyceride level
|
J:65036
|
Tg(APOC1)1Lmh/?
(C57BL/6-Tg(APOC1)1Lmh)
|
increased circulating cholesterol level
|
J:65146
|
increased circulating triglyceride level
|
J:65146
|
increased circulating VLDL cholesterol level
|
J:65146
|
increased circulating VLDL triglyceride level
|
J:65146
|
Tg(APOC1)1Lmh/0 Tg(APOC1)3Lmh/0
(C57BL/6-Tg(APOC1)1Lmh Tg(APOC1)3Lmh)
|
increased circulating cholesterol level
|
J:65036
|
increased circulating free fatty acids level
|
J:65036
|
increased circulating triglyceride level
|
J:65036
|
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(C57BL/6-Tg(APOC1)1Lmh)
|
increased circulating cholesterol level
|
J:65036
|
increased circulating free fatty acids level
|
J:65036
|
increased circulating triglyceride level
|
J:65036
|
increased circulating VLDL cholesterol level
|
J:65036
|
increased circulating VLDL triglyceride level
|
J:65036
|
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(involves: C57BL/6J)
|
increased circulating cholesterol level
|
J:117317
|
increased circulating triglyceride level
|
J:117317
|
Tg(APOC1)3Lmh/Y
(C57BL/6-Tg(APOC1)3Lmh)
|
increased circulating cholesterol level
|
J:65036
|
increased circulating free fatty acids level
|
J:65036
|
increased circulating triglyceride level
|
J:65036
|
increased circulating VLDL cholesterol level
|
J:65036
|
increased circulating VLDL triglyceride level
|
J:65036
|
Tg(APOC1)3Lmh/0
(C57BL/6-Tg(APOC1)3Lmh)
|
increased circulating cholesterol level
|
J:65036
|
increased circulating free fatty acids level
|
J:65036
|
increased circulating triglyceride level
|
J:65036
|
Tg(APOC1)3Lmh/?
(C57BL/6-Tg(APOC1)3Lmh)
|
increased circulating cholesterol level
|
J:65146
|
Tg(APOC2)2Bres/0
(involves: C57BL/6J * CBA/J)
|
increased cholesterol level
|
J:81186
|
increased circulating triglyceride level
|
J:81186
|
increased circulating VLDL triglyceride level
|
J:81186
|
Tg(APOC3)2674Bres/0
(involves: C57BL/6J * CBA/J)
|
increased circulating triglyceride level
|
J:81184
|
increased circulating VLDL triglyceride level
|
J:81184
|
Tg(APOC3)2674Bres/Tg(APOC3)2674Bres
(involves: C57BL/6J * CBA/J)
|
increased circulating triglyceride level
|
J:81184
|
Tg(APOC3)2721Bres/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating HDL cholesterol level
|
J:81184
|
increased circulating triglyceride level
|
J:81184
|
increased circulating VLDL triglyceride level
|
J:81184
|
Tg(APOC3)3707Bres/0
(involves: C57BL/6J * CBA/J)
|
increased circulating cholesterol level
|
J:119638
|
increased circulating triglyceride level
|
J:119638
|
Tg(APOE-ABCA1)30Ssf/?
(C57BL/6N-Tg(APOE-ABCA1)30Ssf)
|
increased circulating cholesterol level
|
J:70494
|
increased circulating HDL cholesterol level
|
J:70494
|
increased circulating phospholipid level
|
J:70494
|
increased liver cholesterol level
|
J:70494
|
increased triglyceride level
|
J:70494
|
Tg(APOE-ABCG1)1Ssf/?
(C57BL/6-Tg(APOE-ABCG1)1Ssf)
|
abnormal phospholipid level
|
J:94077
|
decreased circulating HDL cholesterol level
|
J:94077
|
increased liver cholesterol level
|
J:94077
|
Tg(APOE-ANGPTL4)1Akos/0
(involves: C57BL/6 * SJL)
|
increased circulating cholesterol level
|
J:103363
|
increased circulating triglyceride level
|
J:103363
|
increased circulating VLDL cholesterol level
|
J:103363
|
Tg(APOE-Cyp7a1)1Road/?
(B6.Cg-Tg(APOE-Cyp7a1)1Road)
|
decreased circulating HDL cholesterol level
|
J:70134
|
decreased circulating LDL cholesterol level
|
J:70134
|
decreased circulating VLDL cholesterol level
|
J:70134
|
increased bile salt level
|
J:70134
|
increased triglyceride level
|
J:70134
|
Tg(APOE-DGAT1)1Far/0
(involves: C57BL/6NHsd)
|
abnormal fatty acids level
|
J:124005
|
abnormal lipid level
|
J:124005
|
increased liver triglyceride level
|
J:124005
|
Tg(APOE-DGAT2)1Far/0
(involves: C57BL/6NHsd)
|
abnormal fatty acids level
|
J:124005
|
abnormal lipid level
|
J:124005
|
decreased circulating free fatty acids level
|
J:124005
|
decreased circulating triglyceride level
|
J:124005
|
increased triglyceride level
|
J:124005
|
Tg(APOE-DGAT2)24Far/0
(involves: C57BL/6NHsd)
|
abnormal fatty acids level
|
J:124005
|
abnormal lipid level
|
J:124005
|
decreased circulating free fatty acids level
|
J:124005
|
decreased circulating triglyceride level
|
J:124005
|
increased triglyceride level
|
J:124005
|
Tg(APOE-FGF23*R176Q)#Ack/0
(involves: C57BL/6J * CBA)
|
abnormal vitamin D level
|
J:93981
|
Tg(APOE-NPC1L1)20Lqyu/0
(involves: C57BL/6 * DBA/2)
|
increased cholesterol level
|
J:124193
|
increased circulating cholesterol level
|
J:124193
|
Tg(APOE-PCSK9)1Jdh/0
(Not Specified)
|
increased circulating LDL cholesterol level
|
J:114949
|
Tg(Apoe-Pcsk9)#Prat/?
(involves: C3H * C57BL/6)
|
increased circulating cholesterol level
|
J:169834
|
increased circulating HDL cholesterol level
|
J:169834
|
increased circulating LDL cholesterol level
|
J:169834
|
Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw/0
(involves: C57BL/6 * DBA)
|
decreased circulating cholesterol level
|
J:172091
|
increased circulating triglyceride level
|
J:172091
|
increased liver triglyceride level
|
J:172091
|
Tg(APOE-SGMS2)#Jia/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
abnormal sphingomyelin level
|
J:162192
|
Tg(APOE_i3*,APOC1)2Lmh/?
(involves: C57BL/6J * CBA)
|
increased circulating cholesterol level
|
J:228420
|
increased circulating LDL cholesterol level
|
J:228420
|
increased circulating triglyceride level
|
J:228420
|
increased circulating VLDL cholesterol level
|
J:228420
|
Tg(APOM)HCchr/0
(B6.Cg-Tg(APOM)HCchr)
|
increased circulating cholesterol level
|
J:130647
|
increased circulating phospholipid level
|
J:130647
|
increased circulating triglyceride level
|
J:130647
|
Tg(APPswe,PSEN1dE9)85Dbo/0
(B6;C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax)
|
increased circulating cholesterol level
|
J:129021
|
increased circulating triglyceride level
|
J:113199
|
Tg(AZIP/F)1Vsn/0
(involves: FVB/N)
|
increased circulating free fatty acids level
|
J:50807
|
increased circulating triglyceride level
|
J:50807
|
increased liver triglyceride level
|
J:50807
|
Tg(CAG-CYP27A1)23Etl/0
(involves: C57BL/6JOlaHsd * CBA)
|
abnormal bile salt level
|
J:78951
|
abnormal cholesterol level
|
J:78951
|
abnormal feces lipid level
|
J:78951
|
Tg(Cdh16-Wnk1*)#Cihu/0
(involves: C57BL/6)
|
increased circulating aldosterone level
|
J:168700
|
Tg(CETP)5203Tall/0
(involves: C57BL/6 * CBA/J)
|
abnormal lipid level
|
J:117482
|
abnormal phospholipid level
|
J:117482
|
decreased cholesterol level
|
J:117482
|
decreased liver triglyceride level
|
J:117482
|
Tg(CETP)5203Tall/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating HDL cholesterol level
|
J:48202
|
Tg(CETP)UCTP20Pnu/0
(C57BL/6-Tg(CETP)UCTP20Pnu)
|
abnormal circulating cholesterol level
|
J:118358,
J:92448
|
decreased circulating HDL cholesterol level
|
J:118358
|
increased circulating LDL cholesterol level
|
J:118358
|
increased circulating VLDL cholesterol level
|
J:118358
|
Tg(Ckm-Cd36)1Naa/0
(involves: FVB)
|
decreased circulating cholesterol level
|
J:57650
|
decreased circulating free fatty acids level
|
J:57650
|
decreased circulating triglyceride level
|
J:57650
|
decreased circulating VLDL triglyceride level
|
J:57650
|
Tg(Ckm-DGAT2)10Far/0
(involves: C57BL/6NHsd)
|
abnormal lipid level
|
J:129495
|
increased skeletal muscle triglyceride level
|
J:129495
|
Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr)
|
increased circulating cholesterol level
|
J:210518
|
increased circulating free fatty acids level
|
J:71205
|
increased circulating triglyceride level
|
J:71205
|
increased liver triglyceride level
|
J:71205
|
Tg(Ckm-LPL)HRze/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating triglyceride level
|
J:101818
|
decreased circulating VLDL triglyceride level
|
J:101818
|
increased muscle free fatty acids level
|
J:101818
|
Tg(Ckm-LPL)LRze/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating triglyceride level
|
J:101818
|
decreased circulating VLDL triglyceride level
|
J:101818
|
Tg(Ckm-LPL)MRze/0
(involves: C57BL/6J * CBA/J)
|
decreased circulating triglyceride level
|
J:101818
|
decreased circulating VLDL triglyceride level
|
J:101818
|
increased muscle free fatty acids level
|
J:101818
|
Tg(Ckm-Pnpla2)164Eek/0
(involves: FVB/N)
|
decreased skeletal muscle triglyceride level
|
J:207007
|
Tg(Ckm-Ppara)HEDpk/0
(involves: C57BL/6 * CBA)
|
increased skeletal muscle triglyceride level
|
J:129848
|
Tg(CMV-tTA)3Bjd/0 Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL)
|
increased circulating corticosterone level
|
J:95465
|
Tg(Crh)227.1Pbl/0
(involves: C57BL/6 * SJL)
|
increased circulating corticosterone level
|
J:92996
|
Tg(CSN2-fat-1)1Vane/0
(involves: C57BL/6 * DBA)
|
decreased unsaturated fatty acids level
|
J:168456
|
increased unsaturated fatty acids level
|
J:168456
|
Tg(Cyp21a1-Apoe)614Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:130658
|
Tg(Cyp21a1-Apoe)619Fet/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased circulating cholesterol level
|
J:130658
|
Tg(Fabp1-Nr1h3)#Wexi/?
(involves: 129X1/SvJ * C57BL/6)
|
increased liver triglyceride level
|
J:135594
|
Tg(Fabp1-Nr1h3)#Wexi/? Tg(Fabp1-NR1I2)#Wexi/?
(involves: 129X1/SvJ * C57BL/6)
|
increased liver triglyceride level
|
J:135594
|
Tg(Fabp1-NR1I2)#Wexi/?
(involves: 129X1/SvJ * C57BL/6)
|
increased liver triglyceride level
|
J:135594
|
Tg(Fabp4-Apol6)#Hsul/0
(C57BL/6J-Tg(Fabp4-Apol6)#Hsul)
|
abnormal circulating glycerol level
|
J:344362
|
decreased circulating free fatty acids level
|
J:344362
|
increased circulating cholesterol level
|
J:344362
|
increased circulating HDL cholesterol level
|
J:344362
|
increased circulating LDL cholesterol level
|
J:344362
|
increased circulating triglyceride level
|
J:344362
|
increased liver triglyceride level
|
J:344362
|
Tg(Fabp4-Ccl2)BYt/0
(involves: C57BL/6N)
|
increased circulating free fatty acids level
|
J:110277
|
increased liver triglyceride level
|
J:110277
|
Tg(Fabp4-ENPP1)#Naba/0
(involves: C57BL/6J)
|
increased circulating free fatty acids level
|
J:182179
|
increased circulating triglyceride level
|
J:182179
|
increased liver triglyceride level
|
J:182179
|
Tg(Fabp4-Fam13a)1Iked/0
(C57BL/6J-Tg(Fabp4-Fam13a)1Iked)
|
decreased circulating free fatty acids level
|
J:258290
|
Tg(Fabp4-FOXC2)ASven/0
(involves: C57BL/6J * CBA)
|
decreased circulating free fatty acids level
|
J:94144
|
decreased circulating triglyceride level
|
J:94144
|
Tg(Fabp4-Hsd11b1)7Jesf/0
(FVB-Tg(Fabp4-Hsd11b1)7Jesf)
|
abnormal corticosterone level
|
J:107046
|
increased circulating free fatty acids level
|
J:107046
|
increased circulating triglyceride level
|
J:107046
|
increased fatty acids level
|
J:107046
|
Tg(Fabp4-LEP)F8Ffc/0
(involves: C57BL/6J * DBA/2J)
|
decreased circulating cholesterol level
|
J:67311
|
decreased circulating triglyceride level
|
J:67311
|
Tg(Fabp4-LEP)F8Ffc/?
(B6.Cg-Tg(Fabp4-LEP)F8Ffc)
|
decreased circulating triglyceride level
|
J:84349
|
Tg(Fabp4-Phb)#Smis/0
(involves: CD-1)
|
decreased circulating cholesterol level
|
J:230172
|
decreased circulating glycerol level
|
J:230172
|
decreased circulating triglyceride level
|
J:230172
|
increased circulating free fatty acids level
|
J:230172
|
Tg(Fabp4-Serpina12)1Jwada/0
(involves: C57BL/6JJcl)
|
decreased circulating LDL cholesterol level
|
J:208508
|
decreased liver triglyceride level
|
J:208508
|
Tg(Fabp4-SREBF1)#Dajl/0
(involves: FVB)
|
decreased triglyceride level
|
J:189510
|
Tg(GAS7)63.2Lus/0
(involves: FVB/N)
|
abnormal cholesterol level
|
J:148831
|
decreased triglyceride level
|
J:148831
|
increased cholesterol level
|
J:148831
|
Tg(Gh-Gal)4599Vron/Tg(Gh-Gal)4599Vron
(B6.Cg-Tg(Gh-Gal)4599Vron)
|
increased cholesterol level
|
J:210298
|
increased triglyceride level
|
J:210298
|
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish)
|
decreased circulating triglyceride level
|
J:128016
|
Tg(Hmgcr-PSEN1*M146L)#Lpr/0 Tg(Thy1-APPSL)28Lpr/0
(involves: C57BL/6 * CBA)
|
decreased circulating cholesterol level
|
J:128243
|
Tg(IGFBP2)1Miel/0
(FVB/N-Tg(IGFBP2)1Miel)
|
decreased circulating triglyceride level
|
J:121961
|
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * SJL)
|
increased circulating triglyceride level
|
J:127706
|
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * SJL)
|
increased circulating free fatty acids level
|
J:141527
|
increased circulating triglyceride level
|
J:141527
|
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * C57BLKs/J * SJL)
|
increased circulating free fatty acids level
|
J:141527
|
increased circulating triglyceride level
|
J:141527
|
Tg(K5-Ptgs2)19Kmd/0
(involves: NMRI)
|
increased prostaglandin level
|
J:70039
|
Tg(K5-Ptgs2)667Kmd/0
(involves: NMRI)
|
increased prostaglandin level
|
J:70039
|
Tg(K5-Ptgs2)675Kmd/0
(involves: NMRI)
|
increased prostaglandin level
|
J:70039
|
Tg(KB1430A10)1Ped/0
(involves: BALB/cJ * C57BL/6)
|
abnormal phospholipid level
|
J:117028
|
decreased cholesterol level
|
J:117028
|
decreased liver triglyceride level
|
J:117028
|
decreased triglyceride level
|
J:117028
|
Tg(Lcat)1Ssf/Tg(Lcat)1Ssf
(C57BL/6-Tg(Lcat)1Ssf)
|
increased circulating cholesterol level
|
J:94077
|
increased circulating HDL cholesterol level
|
J:94077
|
increased circulating phospholipid level
|
J:94077
|
Tg(LCAT)A31Ssf/0
(C57BL/6N-Tg(LCAT)A31Ssf)
|
increased circulating cholesterol level
|
J:118356
|
increased circulating HDL cholesterol level
|
J:118356
|
increased circulating phospholipid level
|
J:118356
|
Tg(LCAT)A31Ssf/Tg(LCAT)A31Ssf
(C57BL/6N-Tg(LCAT)A31Ssf)
|
increased circulating cholesterol level
|
J:118356
|
increased circulating HDL cholesterol level
|
J:118356
|
increased circulating phospholipid level
|
J:118356
|
Tg(LCAT)T59Ssf/0
(C57BL/6N-Tg(LCAT)T59Ssf)
|
increased circulating cholesterol level
|
J:118356
|
increased circulating HDL cholesterol level
|
J:118356
|
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf)
|
increased circulating cholesterol level
|
J:120962
|
increased circulating triglyceride level
|
J:120962
|
Tg(Lck-Tnfsf14)24Yxf/? Tnfrsf14tm1Kpf/Tnfrsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6)
|
increased circulating cholesterol level
|
J:120962
|
Tg(LIPC)6784His/0
(C57BL/6-Tg(LIPC)6784His)
|
decreased circulating HDL cholesterol level
|
J:48486
|
decreased circulating phospholipid level
|
J:48486
|
decreased circulating triglyceride level
|
J:48486
|
Tg(LIPG)1Tq/0
(involves: C57BL/6)
|
abnormal circulating phospholipid level
|
J:81821
|
decreased circulating cholesterol level
|
J:81821
|
decreased circulating HDL cholesterol level
|
J:81821
|
decreased triglyceride level
|
J:81821
|
Tg(Mc2r-Arntl)1Kyki/0
(C57BL/6J-Tg(Mc2r-Arntl)1Kyki)
|
abnormal circulating corticosterone level
|
J:146305
|
abnormal corticosterone level
|
J:146305
|
Tg(MECP2)1Hzo/0
(either: (FVB/N x 129S6/SvEvTac)F1 or (FVB/N x C57BL/6J)F1)
|
abnormal corticosterone level
|
J:181213
|
Tg(Mt1-LDLR)93-4Reh/0
(involves: C57BL/6 * SJL)
|
decreased circulating cholesterol level
|
J:127519
|
decreased circulating LDL cholesterol level
|
J:127519
|
Tg(Mup3-Plau)350-2Eps/?
(C57BL/6-Tg(Mup3-Plau)350-2Eps)
|
increased liver cholesterol level
|
J:233146
|
increased liver free fatty acids level
|
J:233146
|
increased liver triglyceride level
|
J:233146
|
Tg(Myh6-Acsl1)O7Jesc/0
(FVB/N-Tg(Myh6-Acsl1)O7Jesc)
|
abnormal lipid level
|
J:68639
|
abnormal phospholipid level
|
J:68639
|
increased cardiac muscle triglyceride level
|
J:68639
|
Tg(Myh6-Med13)1Eno/0
(B6.Cg-Tg(Myh6-Med13)1Eno)
|
abnormal circulating cholesterol level
|
J:186193
|
abnormal liver triglyceride level
|
J:186193
|
Tg(Myh6-Ppara)402-2Dpk/0
(involves: C57BL/6 * CBA/J)
|
abnormal lipid level
|
J:110580
|
increased fatty acids level
|
J:110580
|
Tg(Myh6-Ppara)404-3Dpk/0
(involves: C57BL/6 * CBA/J)
|
abnormal lipid level
|
J:110580
|
increased fatty acids level
|
J:110580
|
Tg(Myh6-Ppara)404-4Dpk/0
(involves: C57BL/6 * CBA/J)
|
abnormal lipid level
|
J:110580
|
increased fatty acids level
|
J:110580
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-HDAC5*)1Eno/0
(involves: C3H * C57BL/6 * CBA)
|
abnormal lipid level
|
J:81967
|
Tg(Myl1-Prkag3*R225Q)1Sson/0
(involves: C57BL/6J * CBA)
|
abnormal triglyceride level
|
J:92821
|
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB)
|
decreased liver triglyceride level
|
J:76323
|
decreased skeletal muscle triglyceride level
|
J:76323
|
Tg(Nphs1-ACE2)#Kdbu/0
(FVB//N-Tg(Nphs1-ACE2)#Kdbu)
|
decreased circulating triglyceride level
|
J:198181
|
Tg(Plp1-LMNB1)1108Qsp/0
(involves: FVB/N)
|
abnormal lipid level
|
J:226169
|
abnormal phospholipid level
|
J:226169
|
abnormal sphingomyelin level
|
J:226169
|
decreased cholesterol level
|
J:226169
|
Tg(PLTP)1Pgn/0
(C57BL/6J-Tg(PLTP)1Pgn/J)
|
abnormal circulating cholesterol level
|
J:92804
|
decreased circulating cholesterol level
|
J:92804
|
decreased circulating LDL phospholipid level
|
J:92804
|
decreased circulating VLDL phospholipid level
|
J:92804
|
increased circulating HDL phospholipid level
|
J:92804
|
Tg(PRNP-APPSweInd)8Dwst/?
(involves: 129S6/SvEvTac)
|
increased circulating triglyceride level
|
J:113199
|
increased circulating VLDL triglyceride level
|
J:113199
|
Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA)
|
decreased circulating cholesterol level
|
J:182671
|
Tg(RNU6-RNAi:Cldn16)551Dago/0
(involves: C57BL/6 * DBA/2)
|
increased circulating aldosterone level
|
J:122766
|
Tg(RP11-578M14)5Mkru/0
(involves: FVB/N)
|
decreased circulating free fatty acids level
|
J:256501
|
increased cholesterol level
|
J:256501
|
increased circulating phospholipid level
|
J:256501
|
increased triglyceride level
|
J:256501
|
Tg(rPEPCKSREBF2)788Reh/0
(Not Specified)
|
abnormal lipid level
|
J:86518
|
increased circulating cholesterol level
|
J:86518
|
increased fatty acids level
|
J:86518
|
increased liver cholesterol level
|
J:86518
|
increased liver triglyceride level
|
J:86518
|
Tg(Sod1*G86R)M1Jwg/0
(involves: FVB/N)
|
abnormal glycerol level
|
J:91800
|
increased circulating corticosterone level
|
J:91800
|
Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * SJL)
|
increased circulating corticosterone level
|
J:91800
|
Tg(SREBP1a)7343Reh/0
(involves: C57BL/6J * SJL/J)
|
decreased circulating triglyceride level
|
J:35770
|
increased liver cholesterol level
|
J:35770
|
increased liver triglyceride level
|
J:35770
|
Tg(SREBP1a)7343Reh/?
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
decreased cholesterol level
|
J:93775
|
decreased circulating cholesterol level
|
J:93775
|
decreased circulating HDL cholesterol level
|
J:93775
|
Tg(Ttr-Foxo1)307Dac/0
(involves: C57BL/6J)
|
increased circulating cholesterol level
|
J:94423
|
increased circulating HDL cholesterol level
|
J:94423
|
increased circulating triglyceride level
|
J:94423
|
Tg(UcpDta)1Kz/?
(involves: FVB/N)
|
hyperlipidemia
|
J:78211
|
increased circulating cholesterol level
|
J:78211
|
increased circulating triglyceride level
|
J:147417,
J:78211
|
Tg(Vil1-cre)20Syr/0 Vmp1tm1.1Arte/Vmp1tm1.1Arte
(involves: C57BL/6 * DBA/2)
|
abnormal lipid level
|
J:280741
|
Tg(Vil1-cre)997Gum/? Tlr5tm1.1Gewr/Tlr5tm1.1Gewr
(involves: C57BL/6J * C57BL/6NTac * SJL/J)
|
increased circulating cholesterol level
|
J:229155
|
increased circulating triglyceride level
|
J:229155
|
Tgfb1tm1.1Mki/Tgfb1tm1.1Mki
(C57BL/6-Tgfb1tm1.1Mki)
|
decreased circulating aldosterone level
|
J:194237
|
Tgfb1tm1Mki/Tgfb1tm1Mki
(C57BL/6-Tgfb1tm1Mki)
|
increased circulating aldosterone level
|
J:194237
|
increased circulating corticosterone level
|
J:194237
|
Tgfb1i1tm1b(KOMP)Wtsi/Tgfb1i1tm1b(KOMP)Wtsi
(C57BL/6N-Tgfb1i1tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
Tgfbr2tm1Dgen/Tgfbr2+
(involves: 129P2/OlaHsd)
|
increased fatty acids level
|
J:148831
|
Tgl1KK/Ta/Tgl1KK/Ta
(involves: BALB/c * KK/Ta)
|
increased triglyceride level
|
J:88209
|
Tglq1MRL/MpJ/Tglq1MRL/MpJ
(involves: MRL/MpJ * SJL/J)
|
increased circulating triglyceride level
|
J:106033
|
Tglq1MRL/MpJ/Tglq1SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating triglyceride level
|
J:106033
|
Tglq2MRL/MpJ/Tglq2SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating triglyceride level
|
J:106033,
J:123776
|
Tglq2SJL/J/Tglq2SJL/J
(involves: MRL/MpJ * SJL/J)
|
increased circulating triglyceride level
|
J:106033,
J:123776
|
Tglq3RF/J/Tglq3RF/J
(involves: NZB/BlNJ * RF/J)
|
decreased circulating triglyceride level
|
J:123776
|
Tglq4NZB/BlNJ/Tglq4NZB/BlNJ
(involves: NZB/BlNJ * RF/J)
|
increased circulating triglyceride level
|
J:123776
|
Tglq4NZB/BlNJ/Tglq4RF/J
(involves: NZB/BlNJ * RF/J)
|
increased circulating triglyceride level
|
J:123776
|
Tgls1KK/Ta/Tgls1KK/Ta
(involves: BALB/c * KK/Ta)
|
decreased circulating triglyceride level
|
J:88209
|
Tgq1129S1/SvImJ/Tgq1C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J)
|
increased triglyceride level
|
J:93243
|
Tgq2C57BL/6J/Tgq2C57BL/6J Tgq3129S1/SvImJ/Tgq3129S1/SvImJ
(involves: 129S1/SvImJ * C57BL/6J)
|
increased triglyceride level
|
J:93243
|
Tgq4NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased triglyceride level
|
J:138463
|
Tgq5NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased triglyceride level
|
J:138463
|
Tgq6NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ)
|
increased triglyceride level
|
J:138463
|
Tgq7NZB/BlNJ/Tgq7NZB/BlNJ Tgq8NZW/LacJ/Tgq8NZW/LacJ
(involves: NZB/BlNJ * NZW/LacJ)
|
increased triglyceride level
|
J:138463
|
Tgq9DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq10DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq11DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq13DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq14DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq15DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq17DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq18DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq19DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq20DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq21DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq22DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq23DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq24DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq25DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq26DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq27DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq28DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgq29DBA/2J/?
(involves: DBA/1J * DBA/2J)
|
increased circulating triglyceride level
|
J:142770
|
Tgyl1SM/J/?
(involves: LG/J * SM/J)
|
increased triglyceride level
|
J:94605
|
Them5tm1Hem/Them5tm1Hem
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fatty acids level
|
J:186657
|
increased circulating free fatty acids level
|
J:186657
|
Thrap3tm1c(KOMP)Wtsi/Thrap3tm1c(KOMP)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA)
|
decreased circulating cholesterol level
|
J:339439
|
decreased circulating free fatty acids level
|
J:339439
|
decreased circulating triglyceride level
|
J:339439
|
decreased liver cholesterol level
|
J:339439
|
decreased liver triglyceride level
|
J:339439
|
Thrbtm2a(EUCOMM)Wtsi/Thrbtm2a(EUCOMM)Wtsi
(C57BL/6N-Thrbtm2a(EUCOMM)Wtsi/H)
|
decreased circulating glycerol level
|
J:165965
|
Thrsptm1Cnm/Thrsptm1Cnm
(B6.129-Thrsptm1Cnm)
|
decreased triglyceride level
|
J:129452
|
Tial1tm1b(EUCOMM)Wtsi/Tial1+
(C57BL/6N-Tial1tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Tigittm1.1(IMPC)Wtsi/Tigittm1.1(IMPC)Wtsi
(C57BL/6N-Tigittm1.1(IMPC)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Timo/Timo
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ))
|
increased circulating cholesterol level
|
J:127183
|
increased circulating LDL cholesterol level
|
J:127183
|
Timo/Timo+
(either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ))
|
increased circulating LDL cholesterol level
|
J:127183
|
Tjp1tm1.1Whun/Tjp1tm1.1Whun Tjp2tm2Whun/Tjp2tm2Whun Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * C57BL/6NTac * DBA/2)
|
increased bile salt level
|
J:306936
|
increased circulating LDL cholesterol level
|
J:306936
|
Tjp2tm2Whun/Tjp2tm2Whun Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * DBA/2)
|
increased circulating LDL cholesterol level
|
J:306936
|
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki)
|
abnormal circulating cholesterol level
|
J:158035
|
abnormal circulating LDL cholesterol level
|
J:158035
|
abnormal circulating lipid level
|
J:158035
|
decreased circulating VLDL cholesterol level
|
J:158035
|
increased circulating free fatty acids level
|
J:158035
|
Tlr2tm1Kir/Tlr2tm1Kir
(involves: 129)
|
abnormal circulating corticosterone level
|
J:94463
|
decreased circulating corticosterone level
|
J:94463
|
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d)
|
abnormal fatty acids level
|
J:126488
|
abnormal lipid level
|
J:126488
|
decreased liver triglyceride level
|
J:126488
|
Tlr4tm1.1Djh/Tlr4tm1.1Djh
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal bile salt level
|
J:193668
|
Tlr4tm1Djh/Tlr4tm1Djh Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL)
|
abnormal bile salt level
|
J:193668
|
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
increased circulating cholesterol level
|
J:158055
|
increased circulating triglyceride level
|
J:158055
|
Tm6sf2em1Yech/Tm6sf2em1Yech
(C57BL/6-Tm6sf2em1Yech)
|
decreased circulating cholesterol level
|
J:235704
|
decreased circulating HDL cholesterol level
|
J:235704
|
decreased circulating LDL cholesterol level
|
J:235704
|
increased circulating triglyceride level
|
J:235704
|
Tm6sf2tm1a(KOMP)Wtsi/Tm6sf2+
(C57BL/6N-Tm6sf2tm1a(KOMP)Wtsi)
|
increased liver triglyceride level
|
J:234195
|
Tm6sf2tm1a(KOMP)Wtsi/Tm6sf2tm1a(KOMP)Wtsi
(C57BL/6N-Tm6sf2tm1a(KOMP)Wtsi)
|
decreased circulating cholesterol level
|
J:234195
|
decreased circulating HDL cholesterol level
|
J:234195
|
decreased circulating LDL cholesterol level
|
J:234195
|
decreased circulating VLDL triglyceride level
|
J:234195
|
increased circulating triglyceride level
|
J:234195
|
increased liver triglyceride level
|
J:234195
|
increased triglyceride level
|
J:234195
|
Tm6sf2tm1b(KOMP)Wtsi/Tm6sf2tm1b(KOMP)Wtsi
(C57BL/6N-Tm6sf2tm1b(KOMP)Wtsi/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Tm9sf3em1(IMPC)Mbp/Tm9sf3+
(C57BL/6NCrl-Tm9sf3em1(IMPC)Mbp/Mmucd)
|
increased circulating triglyceride level
|
J:211773
|
Tm9sf4tm1a(KOMP)Wtsi/Tm9sf4tm1a(KOMP)Wtsi
(C57BL/6N-Tm9sf4tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Tmc7em1(IMPC)Mbp/Tmc7em1(IMPC)Mbp
(C57BL/6NCrl-Tmc7em1(IMPC)Mbp/Mmucd)
|
increased circulating cholesterol level
|
J:211773
|
Tmem9bem1(IMPC)J/Tmem9bem1(IMPC)J
(C57BL/6NJ-Tmem9bem1(IMPC)J/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Tmem30atm1.1Xjz/Tmem30atm1.1Xjz Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * DBA)
|
increased bile salt level
|
J:249038
|
Tmem35atm1.1(KOMP)Vlcg/Y
(B6(FVB)-Tmem35atm1.1(KOMP)Vlcg)
|
increased circulating corticosterone level
|
J:244268
|
Tmem41bem1Cya/Tmem41b+
(involves: C57BL/6)
|
decreased circulating cholesterol level
|
J:316472
|
decreased circulating LDL cholesterol level
|
J:316472
|
decreased circulating triglyceride level
|
J:316472
|
Tmem42tm1b(KOMP)Wtsi/Tmem42tm1b(KOMP)Wtsi
(C57BL/6N-Tmem42tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Tmem51tm1b(EUCOMM)Hmgu/Tmem51tm1b(EUCOMM)Hmgu
(C57BL/6N-Tmem51tm1b(EUCOMM)Hmgu/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Tmem68tm1a(EUCOMM)Wtsi/Tmem68tm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem68tm1a(EUCOMM)Wtsi)
|
decreased circulating triglyceride level
|
J:339870
|
decreased liver triglyceride level
|
J:339870
|
decreased triglyceride level
|
J:339870
|
Tmem87bem1(IMPC)J/Tmem87bem1(IMPC)J
(C57BL/6NJ-Tmem87bem1(IMPC)J/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Tmem129tm1.1(KOMP)Vlcg/Tmem129tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem129tm1.1(KOMP)Vlcg/J)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Tmem167tm1a(EUCOMM)Hmgu/Tmem167+
(C57BL/6N-Tmem167tm1a(EUCOMM)Hmgu/H)
|
decreased circulating triglyceride level
|
J:165965
|
Tmem203em1(IMPC)H/Tmem203em1(IMPC)H
(C57BL/6N-Tmem203em1(IMPC)H/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Tmem237tm1b(EUCOMM)Hmgu/Tmem237+
(C57BL/6N-Tmem237tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased circulating triglyceride level
|
J:211773
|
Tmem241em1Blsg/Tmem241em1Blsg
(involves: C57BL/6J)
|
increased lung cholesterol level
|
J:344360
|
Tmem248tm1.1(KOMP)Vlcg/Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
Tmlheem1Plaa/Tmlheem1Plaa
(C57BL/6N-Tmlheem1Plaa)
|
abnormal fatty acids level
|
J:341247
|
increased fatty acids level
|
J:341247
|
increased unsaturated fatty acids level
|
J:341247
|
Tmprss15tm1a(KOMP)Wtsi/Tmprss15tm1a(KOMP)Wtsi
(C57BL/6N-Tmprss15tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6)
|
decreased circulating triglyceride level
|
J:42579
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6)
|
steatorrhea
|
J:204922
|
Tnftm2Jods/Tnftm2Jods
(involves: C57BL/6 * C57BL/6J)
|
decreased liver free fatty acids level
|
J:112797
|
Tnfaip1tm1a(EUCOMM)Wtsi/Tnfaip1tm1a(EUCOMM)Wtsi
(C57BL/6N-Tnfaip1tm1a(EUCOMM)Wtsi/H)
|
increased circulating triglyceride level
|
J:165965
|
Tnfrsf11atm1.1Pngr/Tnfrsf11atm1.2Pngr Tg(Gfap-cre)2Brn/0
(involves: 129 * C57BL/6 * C57BL/6NTac * FVB/N)
|
decreased prostaglandin level
|
J:155398
|
Tnfrsf11atm1.1Pngr/Tnfrsf11atm1.2Pngr Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6NTac * SJL)
|
decreased prostaglandin level
|
J:155398
|
Tnfsf4Ath1-A/J/Tnfsf4Ath1-A/J Ath2A/J/Ath2A/J
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:9832
|
Tnfsf4Ath1-BALB/cJ/?
(involves: BALB/cJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:8735
|
Tnfsf4Ath1-C3H/HeJ/?
(involves: C3H/HeJ * C57BL/6J)
|
increased circulating HDL cholesterol level
|
J:9135
|
Tnfsf4Ath1-C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:8735,
J:9135
|
Tnfsf4Ath1-C57BL/6J/Tnfsf4Ath1-C57BL/6J Ath2C57BL/6J/Ath2C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased circulating HDL cholesterol level
|
J:9832
|
Tnfsf4Ath1-PERA/EiJ/Tnfsf4Ath1-C57BL/6J
(B6.PERA-Tnfsf4Ath1-PERA/EiJ/Pgn)
|
increased circulating HDL cholesterol level
|
J:79722
|
Tnfsf4Ath1-PERA/EiJ/Tnfsf4Ath1-PERA/EiJ
(B6.PERA-Tnfsf4Ath1-PERA/EiJ/Pgn)
|
increased circulating HDL cholesterol level
|
J:79722
|
Tniktm1Teya/Tniktm1Teya
(involves: C57BL/6J)
|
decreased circulating cholesterol level
|
J:241611
|
decreased circulating HDL cholesterol level
|
J:241611
|
Tnip1tm1b(EUCOMM)Hmgu/Tnip1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tnip1tm1b(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Tnksem1(IMPC)Hmgu/Tnksem1(IMPC)Hmgu
(C57BL/6N-Tnksem1(IMPC)Hmgu/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Tns2nph/Tns2nph
(involves: ICR)
|
increased circulating cholesterol level
|
J:24698
|
Toxtm1b(KOMP)Wtsi/Toxtm1b(KOMP)Wtsi
(C57BL/6N-Toxtm1b(KOMP)Wtsi/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
Tpcn2tm1b(EUCOMM)Hmgu/Tpcn2tm1b(EUCOMM)Hmgu
(C57BL/6N-Tpcn2tm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Tpgs2tm1.1(KOMP)Vlcg/Tpgs2tm1.1(KOMP)Vlcg
(C57BL/6N-Tpgs2tm1.1(KOMP)Vlcg/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Tpoem1(IMPC)H/Tpoem1(IMPC)H
(C57BL/6NTac-Tpoem1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
Tra2bGt(P142D08)Wrst/Tra2b+
(involves: 129S2/SvPas * C57BL/6J)
|
increased circulating triglyceride level
|
J:176730
|
increased circulating VLDL triglyceride level
|
J:176730
|
Traf3tm1Bal/Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
increased circulating corticosterone level
|
J:37065
|
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased circulating cholesterol level
|
J:294716
|
increased circulating glycerol level
|
J:294716
|
increased circulating HDL cholesterol level
|
J:294716
|
increased circulating LDL cholesterol level
|
J:294716
|
increased circulating triglyceride level
|
J:294716
|
Trappc10tm1b(KOMP)Wtsi/Trappc10tm1b(KOMP)Wtsi
(C57BL/6N-Trappc10tm1b(KOMP)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
TrglydRR/?
(involves: C57BL/6J * RR)
|
increased triglyceride level
|
J:94251
|
Trhem1(IMPC)Tcp/Trhem1(IMPC)Tcp
(C57BL/6NCrl-Trhem1(IMPC)Tcp/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Triglq1SM/J/?
(involves: A/J * SM/J)
|
increased circulating triglyceride level
|
J:64138
|
Triglq2SM/J/?
(involves: A/J * SM/J)
|
increased circulating triglyceride level
|
J:64138
|
Trigq2KK/Trigq2KK
(involves: KK-Ay * RR)
|
increased triglyceride level
|
J:87328
|
Trim8em1(IMPC)Wtsi/Trim8em1(IMPC)Wtsi
(C57BL/6N-Trim8em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Trim13em1(IMPC)Tcp/Trim13em1(IMPC)Tcp
(C57BL/6N-Trim13em1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg)
|
increased liver triglyceride level
|
J:232482
|
Trim56tm1a(EUCOMM)Wtsi/Trim56tm1a(EUCOMM)Wtsi
(C57BL/6N-Trim56tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Trip13tm1.1(KOMP)Vlcg/Trip13tm1.1(KOMP)Vlcg
(C57BL/6N-Trip13tm1.1(KOMP)Vlcg/Ucd)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Trmt1tm1b(EUCOMM)Hmgu/Trmt1+
(C57BL/6N-Trmt1tm1b(EUCOMM)Hmgu/Ics)
|
decreased circulating cholesterol level
|
J:211773
|
Trmt10atm1a(EUCOMM)Wtsi/Trmt10atm1a(EUCOMM)Wtsi
(C57BL/6N-Trmt10atm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:175295
|
decreased circulating HDL cholesterol level
|
J:175295
|
decreased circulating LDL cholesterol level
|
J:175295
|
increased circulating free fatty acids level
|
J:175295
|
increased circulating glycerol level
|
J:175295
|
Trpc2Gt(OST448844)Lex/Trpc2Gt(OST448844)Lex
(involves: 129S5/SvEvBrd)
|
increased circulating cholesterol level
|
J:103485
|
increased circulating triglyceride level
|
J:103485
|
Trpm1tm1b(KOMP)Wtsi/Trpm1tm1b(KOMP)Wtsi
(C57BL/6N-Trpm1tm1b(KOMP)Wtsi/H)
|
increased circulating HDL cholesterol level
|
J:211773
|
Trpv5Hcalc1/Trpv5Hcalc1
(involves: C3H/HeH * C57BL/6J)
|
abnormal vitamin D level
|
J:196612
|
Trpv5tm1Bind/Trpv5tm1Bind
(involves: 129 * C57BL/6)
|
abnormal vitamin D level
|
J:86949
|
Trub2tm2a(EUCOMM)Wtsi/Trub2+
(C57BL/6N-Trub2tm2a(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
Tsc1tm1Djk/Tsc1tm1Djk Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
decreased circulating triglyceride level
|
J:171445
|
Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ)
|
decreased circulating corticosterone level
|
J:223992
|
Tsga13em1(IMPC)J/Tsga13em1(IMPC)J
(C57BL/6NJ-Tsga13em1(IMPC)J/Mmjax)
|
increased circulating triglyceride level
|
J:211773
|
Tshrhyt/Tshrhyt
(involves: BALB/cByJ * RF/J)
|
increased circulating cholesterol level
|
J:6479
|
Tspan17em1(IMPC)H/Tspan17em1(IMPC)H
(C57BL/6N-Tspan17em1(IMPC)H/H)
|
increased circulating cholesterol level
|
J:211773
|
Ttbk1em1(IMPC)J/Ttbk1em1(IMPC)J
(C57BL/6NJ-Ttbk1em1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
Ttc17em1(IMPC)J/Ttc17em1(IMPC)J
(C57BL/6NJ-Ttc17em1(IMPC)J/J)
|
increased circulating cholesterol level
|
J:211773
|
Ttc28tm1b(EUCOMM)Hmgu/Ttc28tm1b(EUCOMM)Hmgu
(C57BL/6N-Ttc28tm1b(EUCOMM)Hmgu/Tcp)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Ttc39btm1e(EUCOMM)Wtsi/Ttc39b+
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Tti1em1(IMPC)J/Tti1+
(C57BL/6NJ-Tti1em1(IMPC)J/Mmjax)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Tubtub/Tubtub
(B6(AU)-Tubtub/J)
|
increased circulating cholesterol level
|
J:18161
|
increased circulating triglyceride level
|
J:18161
|
Tuft1tm1a(KOMP)Wtsi/Tuft1tm1a(KOMP)Wtsi
(C57BL/6N-Tuft1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Txndc5tm1.1(KOMP)Vlcg/Txndc5+
(C57BL/6N-Txndc5tm1.1(KOMP)Vlcg/Ucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Txndc11em1(IMPC)J/Txndc11em1(IMPC)J
(C57BL/6NJ-Txndc11em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
TxnipHyplip1/TxnipHyplip1
(HcB19/Dem-TxnipHyplip1)
|
increased circulating cholesterol level
|
J:47109
|
increased circulating triglyceride level
|
J:47109
|
increased circulating VLDL cholesterol level
|
J:47109
|
TxnipHyplip1/TxnipHyplip1
(B6.HcB19-TxnipHyplip1)
|
increased fatty acids level
|
J:102224
|
Txniptm1.1Road/Txniptm1.1Road
(B6.Cg-Txniptm1.1Road)
|
increased circulating triglyceride level
|
J:132756
|
Txniptm1b(EUCOMM)Hmgu/Txniptm1b(EUCOMM)Hmgu
(C57BL/6N-Txniptm1b(EUCOMM)Hmgu/H)
|
increased circulating triglyceride level
|
J:211773
|
Txniptm1Jjy/Txniptm1Jjy
(involves: C57BL/6 * CBA)
|
abnormal circulating phospholipid level
|
J:104563
|
increased circulating cholesterol level
|
J:104563
|
increased circulating free fatty acids level
|
J:104563
|
increased circulating triglyceride level
|
J:104563
|
Txniptm1Road/Txniptm1Road Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
increased circulating triglyceride level
|
J:132756
|
Tyk2tm1Shmd/Tyk2tm1Shmd
(either: (involves: 129 * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
increased cholesterol level
|
J:195099
|
increased circulating free fatty acids level
|
J:195099
|
Tyk2tm2b(EUCOMM)Hmgu/Tyk2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tyk2tm2b(EUCOMM)Hmgu/Ieg)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Tysnd1tm1.1Arte/Tysnd1tm1.1Arte
(involves: C57BL/6J * C57BL/6N)
|
decreased plasmalogen level
|
J:223054
|
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy)
|
increased circulating cholesterol level
|
J:157049
|
Ubash3atm1b(KOMP)Wtsi/Ubash3atm1b(KOMP)Wtsi
(C57BL/6N-Ubash3atm1b(KOMP)Wtsi/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Ube2btm1a(EUCOMM)Wtsi/Ube2b+
(C57BL/6N-Ube2btm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating triglyceride level
|
J:165965
|
increased circulating triglyceride level
|
J:165965
|
Ube2d1tm3e(EUCOMM)Wtsi/Ube2d1tm3e(EUCOMM)Wtsi
(C57BL/6N-Ube2d1tm3e(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
Ube2j1tm1.1(NCOM)Mfgc/Ube2j1tm1.1(NCOM)Mfgc
(C57BL/6N-Ube2j1tm1.1(NCOM)Mfgc/Rbrc)
|
increased circulating cholesterol level
|
J:211773
|
Ube2otm1.1(KOMP)Mbp/Ube2o+
(B6N(Cg)-Ube2otm1.1(KOMP)Mbp/J)
|
increased circulating cholesterol level
|
J:211773
|
Ube3bGt(RRJ142)Byg/Ube3bGt(RRJ142)Byg
(involves: 129P2/OlaHsd * CBA/Ca)
|
decreased circulating cholesterol level
|
J:203652
|
decreased circulating LDL cholesterol level
|
J:203652
|
Ube3ctm1b(EUCOMM)Hmgu/Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6NCrl-Ube3ctm1b(EUCOMM)Hmgu/Rbrc)
|
increased circulating cholesterol level
|
J:211773
|
Ubiad1em1Wwk/Ubiad1em1Wwk
(C57BL/6N-Ubiad1em1Wwk)
|
abnormal phospholipid level
|
J:268574
|
Ubiad1tm1.1Thka/Ubiad1+
(C57BL/6-Ubiad1tm1.1Thka)
|
increased circulating cholesterol level
|
J:221005
|
increased circulating HDL cholesterol level
|
J:221005
|
Ubr1tm1Avar/Ubr1tm1Avar
(either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))
|
decreased circulating triglyceride level
|
J:72859
|
Ucn2tm1Pbl/Ucn2tm1Pbl
(involves: 129 * C57BL/6)
|
increased circulating corticosterone level
|
J:108744
|
Ucntm1Abas/Ucntm1Abas
(B6.129S4-Ucntm1Abas)
|
abnormal circulating corticosterone level
|
J:122730
|
increased circulating corticosterone level
|
J:122730
|
Ucp1tm1b(EUCOMM)Hmgu/Ucp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ucp1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating triglyceride level
|
J:211773
|
Ucp1tm1Kz/Ucp1tm1Kz
(B6.Cg-Ucptm1Kz)
|
decreased circulating free fatty acids level
|
J:81820
|
decreased circulating triglyceride level
|
J:81820
|
Ucp3tm1Brnd/Ucp3tm1Brnd
(Not Specified)
|
decreased skeletal muscle triglyceride level
|
J:106901
|
Ucp3tm1Lowl/Ucp3tm1Lowl
(involves: 129S4/SvJae * C57BL/6)
|
increased fatty acids level
|
J:62313
|
Ucp3tm1Rei/Ucp3tm1Rei
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased circulating free fatty acids level
|
J:62312
|
Ugt8atm1Pop/Ugt8a+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lipid level
|
J:77226
|
Ugt8atm1Pop/Ugt8atm1Pop
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lipid level
|
J:77226
|
Ugt8atm1Wst/Ugt8atm1Wst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lipid level
|
J:36558
|
Uhmk1tm1Enbl/Uhmk1tm1Enbl
(involves: 129/Sv * C57BL/6)
|
increased circulating cholesterol level
|
J:144737
|
UmodUrehd1/Umod+
(involves: C3HeB/FeJ)
|
decreased circulating cholesterol level
|
J:201084
|
decreased circulating triglyceride level
|
J:201084
|
Umodurehr4/Umod+
(C3HeB/FeJ-Umodurehr4)
|
abnormal circulating lipid level
|
J:153895
|
decreased circulating cholesterol level
|
J:153895
|
decreased circulating triglyceride level
|
J:153895
|
Umodurehr4/Umodurehr4
(C3HeB/FeJ-Umodurehr4)
|
abnormal circulating lipid level
|
J:153895
|
decreased circulating cholesterol level
|
J:153895
|
decreased circulating triglyceride level
|
J:153895
|
Unc5clem1(IMPC)Mbp/Unc5clem1(IMPC)Mbp
(C57BL/6NCrl-Unc5clem1(IMPC)Mbp/Mmucd)
|
increased circulating cholesterol level
|
J:211773
|
Uoxem1Cli/Uoxem1Cli
(C57BL/6J-Uoxem1Cli)
|
decreased circulating triglyceride level
|
J:271949
|
increased circulating cholesterol level
|
J:271949
|
increased circulating LDL cholesterol level
|
J:271949
|
increased circulating triglyceride level
|
J:271949
|
urehr1/urehr1
(C3HeB/FeJ-urehr1)
|
increased circulating cholesterol level
|
J:121470
|
Usp11tm1(KOMP)Wtsi/Y
(C57BL/6N-Usp11tm1(KOMP)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:211773
|
increased circulating LDL cholesterol level
|
J:211773
|
Usp12tm1b(EUCOMM)Hmgu/Usp12tm1b(EUCOMM)Hmgu
(C57BL/6N-Usp12tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
Usp20em1Cya/Usp20em1Cya
(Not Specified)
|
decreased circulating cholesterol level
|
J:299971
|
decreased circulating triglyceride level
|
J:299971
|
Usp20em1Gpt/Usp20em1Gpt Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6JGpt * DBA)
|
decreased circulating cholesterol level
|
J:299971
|
decreased circulating free fatty acids level
|
J:299971
|
decreased circulating HDL cholesterol level
|
J:299971
|
decreased circulating LDL cholesterol level
|
J:299971
|
decreased circulating triglyceride level
|
J:299971
|
decreased circulating VLDL triglyceride level
|
J:299971
|
decreased liver cholesterol level
|
J:299971
|
decreased liver triglyceride level
|
J:299971
|
Usp24tm1a(KOMP)Wtsi/Usp24tm1a(KOMP)Wtsi
(C57BL/6N-Usp24tm1a(KOMP)Wtsi/Wtsi)
|
increased circulating triglyceride level
|
J:211773
|
Usp47tm1b(EUCOMM)Wtsi/Usp47tm1b(EUCOMM)Wtsi
(C57BL/6N-Usp47tm1b(EUCOMM)Wtsi/Nju)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Usp53em1(IMPC)Tcp/Usp53em1(IMPC)Tcp
(C57BL/6N-Usp53em1(IMPC)Tcp/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
Uts2tm1Ags/Uts2tm1Ags
(B6.129P2-Uts2tm1Ags)
|
decreased circulating LDL cholesterol level
|
J:214289
|
increased circulating HDL cholesterol level
|
J:214289
|
Vamp7tm1.1Ics/Y
(involves: 129S2/SvPas * C57BL/6)
|
increased circulating glycerol level
|
J:181320
|
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
increased circulating aldosterone level
|
J:124056
|
Vav3tm1Xrb/Vav3tm1Xrb
(Not Specified)
|
increased circulating aldosterone level
|
J:111973
|
Vcpem1Kene/Vcp+
(C57BL/6J-Vcpem1Kene)
|
increased circulating triglyceride level
|
J:325062
|
Vdrtm1.1Gcm/Vdrtm1.1Gcm
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vitamin D level
|
J:111515
|
Vdrtm1.1Gcm/Vdrtm1.1Gcm
(involves: 129 * BALB/c * C57BL/6 * Swiss)
|
abnormal vitamin D level
|
J:72578
|
Vdrtm1Gcm/Vdrtm1Gcm Tg(Col2a1-cre)1Bhr/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal vitamin D level
|
J:117377
|
Vdrtm1Rge/Vdrtm1Rge
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vitamin D level
|
J:77748
|
Vdrtm1Ska/Vdrtm1Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal vitamin D level
|
J:42054
|
Vdrtm1Tyam/Vdrtm1Tyam
(involves: C57BL/6 * CBA)
|
abnormal vitamin D level
|
J:101456
|
Vdrtm2.1Ska/Vdrtm2.1Ska
(involves: C57BL/6 * CBA/JNCrlj * SJL)
|
abnormal vitamin D level
|
J:196471
|
Vgftm1Srjs/Vgftm1Srjs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased circulating corticosterone level
|
J:56499
|
Vil1em1(IMPC)Wtsi/Vil1em1(IMPC)Wtsi
(C57BL/6N-Vil1em1(IMPC)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Vkorc1l1em1(IMPC)J/Vkorc1l1em1(IMPC)J
(C57BL/6NJ-Vkorc1l1em1(IMPC)J/Mmjax)
|
decreased circulating cholesterol level
|
J:211773
|
Vldlrtm1Her/Vldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased circulating cholesterol level
|
J:117317
|
increased circulating triglyceride level
|
J:117317
|
Vmp1tm1a(KOMP)Wtsi/Vmp1tm1a(KOMP)Wtsi
(C57BL/6-Vmp1tm1a(KOMP)Wtsi)
|
abnormal lipid level
|
J:280741
|
Vps33btm1a(EUCOMM)Wtsi/Vps33b+
(C57BL/6N-Vps33btm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating HDL cholesterol level
|
J:211773
|
Wactm2b(EUCOMM)Wtsi/Wac+
(C57BL/6N-Wactm2b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating triglyceride level
|
J:211773
|
Wdfy2tm1.1Wgz/Wdfy2tm1.1Wgz
(involves: C57BL/6J)
|
increased circulating cholesterol level
|
J:296933
|
increased circulating triglyceride level
|
J:296933
|
increased liver cholesterol level
|
J:296933
|
increased liver triglyceride level
|
J:296933
|
Wdr27em1(IMPC)Ccpcz/Wdr27em1(IMPC)Ccpcz
(C57BL/6NCrl-Wdr27em1(IMPC)Ccpcz/Ccpcz)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Wdr41em1(IMPC)J/Wdr41em1(IMPC)J
(C57BL/6NJ-Wdr41em1(IMPC)J/Mmjax)
|
increased circulating HDL cholesterol level
|
J:211773
|
Wdr45em1(IMPC)J/Y
(C57BL/6NJ-Wdr45em1(IMPC)J/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Wdr45em1Wrst/Y
(involves: C57BL/6N * FVB)
|
decreased circulating triglyceride level
|
J:307284
|
Wdr47tm1a(EUCOMM)Wtsi/Wdr47tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Wdr47tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased circulating LDL cholesterol level
|
J:175295
|
Wdr53em1(IMPC)J/Wdr53em1(IMPC)J
(C57BL/6NJ-Wdr53em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Wdtc1tm1a(KOMP)Wtsi/Wdtc1tm1a(KOMP)Wtsi
(C57BL/6N-Wdtc1tm1a(KOMP)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
Wfdc2tm1.1Ohbo/Wfdc2tm1.1Ohbo
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal phospholipid level
|
J:282576
|
Wfs1tm1Koks/Wfs1tm1Koks
(involves: 129S6/SvEvTac * C57BL/6)
|
increased circulating corticosterone level
|
J:145548
|
Whrnwi/Whrnwi
(involves: C57BL/6J * STOCK a Tyrp1b Myo5ad Oca2p Ednrbs)
|
increased circulating corticosterone level
|
J:5538
|
Wnk4tm1Pfi/Wnk4tm1Pfi
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased circulating aldosterone level
|
J:184790
|
Wnt1tm1b(EUCOMM)Wtsi/Wnt1+
(C57BL/6N-Wnt1tm1b(EUCOMM)Wtsi/Tcp)
|
increased circulating cholesterol level
|
J:211773
|
Wnt3aem1(IMPC)Ccpcz/Wnt3a+
(C57BL/6NCrl-Wnt3aem1(IMPC)Ccpcz/Ccpcz)
|
increased circulating triglyceride level
|
J:211773
|
Wrap53tm1b(EUCOMM)Wtsi/Wrap53+
(C57BL/6N-Wrap53tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating LDL cholesterol level
|
J:211773
|
Wrntm1Led/Wrntm1Led
(B6.129S6(BKSW)-Wrntm1Led)
|
hyperlipidemia
|
J:106446
|
increased circulating cholesterol level
|
J:106446
|
increased circulating triglyceride level
|
J:106446
|
Wrnip1tm1a(EUCOMM)Wtsi/Wrnip1tm1a(EUCOMM)Wtsi
(C57BL/6N-Wrnip1tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased circulating triglyceride level
|
J:165965
|
Wwoxtm1Ria/Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6J)
|
decreased circulating cholesterol level
|
J:138140
|
decreased circulating triglyceride level
|
J:138140
|
Xbp1tm1a(EUCOMM)Wtsi/Xbp1+
(C57BL/6N-Xbp1tm1a(EUCOMM)Wtsi/Ics)
|
decreased circulating cholesterol level
|
J:165965
|
decreased circulating triglyceride level
|
J:165965
|
Xbp1tm2Glm/Xbp1tm2Glm Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased cholesterol level
|
J:137188
|
decreased circulating triglyceride level
|
J:137188
|
decreased fatty acids level
|
J:137188
|
Xdhtm1Fink/Xdhtm1Fink
(involves: 129X1/SvJ * C57BL/6J)
|
increased triglyceride level
|
J:166326
|
Xpatm1Tnka/Xpatm1Tnka
(involves: C57BL/6 * CBA)
|
increased prostaglandin level
|
J:60201
|
Xrcc5em1(IMPC)Ccpcz/Xrcc5em1(IMPC)Ccpcz
(C57BL/6NCrl-Xrcc5em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating triglyceride level
|
J:211773
|
Yae1d1tm1b(EUCOMM)Hmgu/Yae1d1+
(C57BL/6N-Yae1d1tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Ydjctm1.1(KOMP)Vlcg/Ydjctm1.1(KOMP)Vlcg
(C57BL/6N-Ydjctm1.1(KOMP)Vlcg/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Ypel4tm1a(EUCOMM)Wtsi/Ypel4tm1a(EUCOMM)Wtsi
(C57BL/6N-Ypel4tm1a(EUCOMM)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Ywhabtm1b(EUCOMM)Hmgu/Ywhabtm1b(EUCOMM)Hmgu
(C57BL/6N-Ywhabtm1b(EUCOMM)Hmgu/Ieg)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
decreased circulating triglyceride level
|
J:211773
|
Zbtb22em1Yga/Zbtb22em1Yga
(Not Specified)
|
decreased circulating triglyceride level
|
J:344976
|
decreased liver triglyceride level
|
J:344976
|
Zbtb24tm1b(EUCOMM)Hmgu/Zbtb24+
(C57BL/6N-Zbtb24tm1b(EUCOMM)Hmgu/Ieg)
|
increased circulating HDL cholesterol level
|
J:211773
|
Zbtb32tm1b(KOMP)Mbp/Zbtb32tm1b(KOMP)Mbp
(C57BL/6N-Zbtb32tm1b(KOMP)Mbp/J)
|
decreased circulating free fatty acids level
|
J:211773
|
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA)
|
increased bile salt level
|
J:304105
|
Zc3h12cem1(IMPC)Tcp/Zc3h12cem1(IMPC)Tcp
(C57BL/6NCrl-Zc3h12cem1(IMPC)Tcp/Tcp)
|
increased circulating triglyceride level
|
J:211773
|
Zc3h13em1(IMPC)J/Zc3h13+
(C57BL/6NJ-Zc3h13em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Zdhhc4em1Smoc/Zdhhc4em1Smoc
(C57BL/6JSmoc-Zdhhc4em1Smoc)
|
increased circulating free fatty acids level
|
J:270120
|
increased circulating triglyceride level
|
J:270120
|
Zdhhc5tm1.1Smoc/Zdhhc5tm1.1Smoc Tg(Adipoq-cre)1Evdr/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/NJ)
|
increased circulating free fatty acids level
|
J:270120
|
increased circulating triglyceride level
|
J:270120
|
Zeb1tm1.1Ajg/Zeb1tm2.1Ajg
(C57BL/6-Zeb1tm1.1Ajg/Zeb1tm2.1Ajg)
|
abnormal circulating lipid level
|
J:177274
|
increased circulating corticosterone level
|
J:177274
|
increased circulating free fatty acids level
|
J:177274
|
increased circulating triglyceride level
|
J:177274
|
Zeb1Tw/Zeb1+
(B6.Cg-Zeb1Tw)
|
abnormal circulating lipid level
|
J:177274
|
increased circulating corticosterone level
|
J:177274
|
increased circulating free fatty acids level
|
J:177274
|
increased circulating triglyceride level
|
J:177274
|
Zfand6em1(IMPC)Mbp/Zfand6em1(IMPC)Mbp
(C57BL/6N-Zfand6em1(IMPC)Mbp/MbpMmucd)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Zfp84tm1b(KOMP)Wtsi/Zfp84tm1b(KOMP)Wtsi
(C57BL/6N-Zfp84tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|
Zfp175tm1b(EUCOMM)Wtsi/Zfp175tm1b(EUCOMM)Wtsi
(C57BL/6N-Zfp175tm1b(EUCOMM)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Zfp182tm1b(KOMP)Wtsi/Zfp182tm1b(KOMP)Wtsi
(C57BL/6N-Zfp182tm1b(KOMP)Wtsi/Wtsi)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Zfp202em1(IMPC)J/Zfp202em1(IMPC)J
(C57BL/6NJ-Zfp202em1(IMPC)J/Mmjax)
|
increased circulating cholesterol level
|
J:211773
|
Zfp346tm1.1(KOMP)Vlcg/Zfp346+
(C57BL/6N-Zfp346tm1.1(KOMP)Vlcg/J)
|
increased circulating free fatty acids level
|
J:211773
|
Zfp532em1(IMPC)J/Zfp532+
(C57BL/6NJ-Zfp532em1(IMPC)J/J)
|
increased circulating HDL cholesterol level
|
J:211773
|
Zfp605em1(IMPC)J/Zfp605em1(IMPC)J
(C57BL/6NJ-Zfp605em1(IMPC)J/Mmjax)
|
increased circulating HDL cholesterol level
|
J:211773
|
Zfp637em1(IMPC)Wtsi/Zfp637em1(IMPC)Wtsi
(C57BL/6N-Zfp637em1(IMPC)Wtsi/Wtsi)
|
increased circulating free fatty acids level
|
J:211773
|
Zfp644em1(IMPC)Ccpcz/Zfp644em1(IMPC)Ccpcz
(C57BL/6N-Zfp644em1(IMPC)Ccpcz/Ccpcz)
|
increased circulating HDL cholesterol level
|
J:211773
|
Zfp697em1(IMPC)J/Zfp697em1(IMPC)J
(C57BL/6NJ-Zfp697em1(IMPC)J/Mmjax)
|
decreased circulating triglyceride level
|
J:211773
|
Zfp704tm1a(EUCOMM)Wtsi/Zfp704tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased circulating triglyceride level
|
J:165965
|
Zfp715tm1a(EUCOMM)Hmgu/Zfp715tm1a(EUCOMM)Hmgu
(C57BL/6N-Zfp715tm1a(EUCOMM)Hmgu/H)
|
decreased circulating cholesterol level
|
J:165965
|
increased circulating cholesterol level
|
J:165965
|
Zfp750tm1b(EUCOMM)Wtsi/Zfp750tm1b(EUCOMM)Wtsi
(B6(Cg)-Zfp750tm1b(EUCOMM)Wtsi)
|
abnormal ceramide level
|
J:335426
|
abnormal phospholipid level
|
J:335426
|
abnormal sphingomyelin level
|
J:335426
|
decreased triglyceride level
|
J:335426
|
Zfp763em1(IMPC)Wtsi/Zfp763em1(IMPC)Wtsi
(C57BL/6N-Zfp763em1(IMPC)Wtsi/Wtsi)
|
increased circulating glycerol level
|
J:211773
|
Zfp787em1(IMPC)J/Zfp787em1(IMPC)J
(C57BL/6NJ-Zfp787em1(IMPC)J/Mmjax)
|
decreased circulating HDL cholesterol level
|
J:211773
|
Zmym4em1(IMPC)Wtsi/Zmym4+
(C57BL/6N-Zmym4em1(IMPC)Wtsi/Wtsi)
|
increased circulating cholesterol level
|
J:211773
|
increased circulating glycerol level
|
J:211773
|
increased circulating HDL cholesterol level
|
J:211773
|
Zranb3em1(IMPC)Mbp/Zranb3em1(IMPC)Mbp
(C57BL/6N-Zranb3em1(IMPC)Mbp/MbpMmucd)
|
increased circulating triglyceride level
|
J:211773
|
Zscan10Gt(285B6)1.1Cmhd/Zscan10Gt(285B6)1.1Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased circulating corticosterone level
|
J:221010
|
Zzef1tm2.1(KOMP)Vlcg/Zzef1tm2.1(KOMP)Vlcg
(B6N(Cg)-Zzef1tm2.1(KOMP)Vlcg/J)
|
decreased circulating cholesterol level
|
J:211773
|
decreased circulating HDL cholesterol level
|
J:211773
|